COMMUNITY HEALTH SYSTEMS, INC. - FORM 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of report (Date of earliest event reported): September 24, 2007
COMMUNITY HEALTH SYSTEMS, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
|
|
|
|
|
Delaware
|
|
001-15925
|
|
13-3893191 |
(State or other jurisdiction of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.) |
4000 Meridian Boulevard
Franklin, Tennessee 37067
(Address of Principal Executive Offices, including Zip Code)
(615) 465-7000
(Registrants Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
As previously announced, on July 25, 2007, in connection with the Companys acquisition of
Triad Hospitals, Inc. (now Triad Healthcare Corporation) (Triad), CHS/Community Health Systems,
Inc. (CHS/CHS), the Companys wholly-owned subsidiary, issued $3,021,331,000 aggregate principal
amount of its 8.875% senior notes due 2015 (the Notes) pursuant to an indenture (the Indenture)
dated as of July 25, 2007 by and among CHS/CHS, the Company, the guarantors party thereto, and U.S.
Bank National Association, as trustee. The Notes are senior obligations of CHS/CHS and are
guaranteed on a senior basis by the Company and by certain of the Companys subsidiaries.
Also in connection with the acquisition of Triad, the Company entered into a credit agreement
(the New Credit Agreement) with a syndicate of financial institutions with Credit Suisse, as
administrative agent and collateral agent, which provides for a new credit facility consisting of a
$6,065 million term loan facility with a maturity of seven years, a $400 million delayed draw term
loan with a maturity of seven years and a $750 million revolving credit facility with a maturity of
six years. Certain of the Companys domestic subsidiaries and, to the extent no adverse tax
consequences to the Company would result therefrom, foreign subsidiaries, are guarantors of the New
Credit Agreement.
The
Company is filing this Current Report on Form 8-K to file the
unaudited financial statements of Triad for the three and six months
ended June 30, 2007 and to add a footnote to (i) its audited
financial statements for the fiscal year ended December 31, 2006, (ii) its unaudited financial
statements for the three and six months ended June 30, 2007, and (iii) the audited financial statements
of Triad for the fiscal year ended December 31, 2006, as required by Rule 3-10 of Regulation
S-X Financial Statements of Guarantors and Affiliates whose
Securities Collateralize an Issue Registered or Being Registered.
Item 9.01. Financial Statements and Exhibits.
The following items are included as Exhibits to this report and incorporated herein by
reference:
|
|
|
|
|
Exhibit No. |
|
Description |
|
23.1 |
|
|
Consent
of Deloitte & Touche LLP. |
|
|
|
|
|
|
23.2 |
|
|
Consent
of Ernst & Young LLP. |
|
|
|
|
|
|
99.1 |
|
|
Consolidated Financial Statements of Community Health Systems, Inc. for the fiscal
year ended
December 31, 2006, as supplemented on September 24, 2007 by the
updating of Note 13, Subsequent Events, and the addition of Note 15,
Acquisition of Triad, Related Financing and Supplemental Condensed Consolidating Financial Information. |
|
|
|
|
|
|
99.2 |
|
|
Consolidated Financial Statements of Community Health Systems, Inc. for the three
and six months ended June 30, 2006, as supplemented on September
24, 2007 by the
addition of Note 15, Supplemental Condensed Consolidating Financial Information. |
|
|
|
|
|
|
99.3 |
|
|
Consolidated Financial Statements of Triad Hospitals, Inc. (now Triad Healthcare
Corporation) for the fiscal year ended December 31, 2006, as supplemented on
September 24, 2007 by the addition of Note 22, Supplemental Condensed Financial
Information. |
|
|
|
|
|
|
99.4 |
|
|
Consolidated Financial Statements of Triad Hospitals, Inc. (now Triad Healthcare Corporation) for
the three and six months ended June 30, 2006, as supplemented on
September 24, 2007 by the addition
of Note 14, Supplemental Condensed Financial Information. |
2
SIGNATURES
According to the requirements of the Securities Exchange Act of 1934, the Company has duly
caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date:
September 24, 2007
|
|
|
|
|
|
COMMUNITY HEALTH SYSTEMS, INC.
|
|
|
By: |
/s/ Wayne T. Smith |
|
|
|
Name: |
Wayne T. Smith |
|
|
|
Title: |
Chairman, President and Chief
Executive Officer |
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ W. Larry Cash |
|
|
|
Name: |
W. Larry Cash |
|
|
|
Title: |
Executive Vice President and
Chief Financial Officer |
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ T. Mark Buford |
|
|
|
Name: |
T. Mark Buford |
|
|
|
Title: |
Vice President and
Corporate Controller |
|
|
3
Ex-23.1 Consent of Deloitte & Touche LLP
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-100349, 333-61614,
333-44870, 333-107810, 333-121282, 333-121283, and 333-144525 on Form S-8 of our report dated
February 20, 2007 (September 20, 2007 as to Notes 13 and 15) relating to the consolidated financial
statements of Community Health Systems, Inc. (which report expresses an unqualified opinion and
includes an explanatory paragraph referring to the Company adopting the fair value recognition
provisions of Statement of Financial Standards No. 123 (Revised 2004), Share Based Payment
effective January 1, 2006,) appearing in this current report on
Form 8-K dated September 24, 2007
of Community Health Systems, Inc.
/s/ Deloitte & Touche LLP
Nashville, Tennessee
September 20, 2007
Ex-23.2 Consent of Ernst & Young, LLP
Exhibit 23.2
Consent
of Independent Registered Public Accounting Firm
We consent to the use of our report dated February 27, 2007 (except for Note 22, as to which
the date is September 21, 2007), with respect to the consolidated financial statements of
Triad Hospitals, Inc., for the year ended December 31, 2006, included in the Community
Health Systems, Inc. Current Report on Form 8-K dated September 24, 2007.
/s/ ERNST & YOUNG, LLP
Dallas, Texas
September 21, 2007
EX-99.1 CONSOLIDATED FINANCIAL STATEMENTS
Exhibit 99.1
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of
Community Health Systems, Inc.
Franklin, Tennessee
We have audited the accompanying consolidated balance sheets of
Community Health Systems, Inc. and subsidiaries (the
Company) as of December 31, 2006 and 2005, and
the related consolidated statements of income,
stockholders equity, and cash flows for each of the three
years in the period ended December 31, 2006. These
consolidated financial statements are the responsibility of the
Companys management. Our responsibility is to express an
opinion on these consolidated financial statements based on our
audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, such consolidated financial statements present
fairly, in all material respects, the financial position of
Community Health Systems, Inc. and subsidiaries as of
December 31, 2006 and 2005, and the results of their
operations and their cash flows for each of the three years in
the period ended December 31, 2006, in conformity with
accounting principles generally accepted in the United States of
America.
As discussed in Note 2 to the consolidated financial
statements, the Company adopted the fair value recognition
provisions of Statement of Financial Accounting Standards
No. 123 (Revised 2004), Share-Based Payment
effective January 1, 2006, which resulted in the
Company changing the method in which it accounts for share-based
compensation.
/s/ Deloitte &
Touche LLP
Nashville, Tennessee
February 20, 2007
(September 20, 2007 as to Notes 13 and 15)
1
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
(In thousands, except share and per share data)
|
|
|
Net operating revenues
|
|
$
|
4,365,576
|
|
|
$
|
3,738,320
|
|
|
$
|
3,203,507
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits
|
|
|
1,741,223
|
|
|
|
1,486,407
|
|
|
|
1,279,136
|
|
Provision for bad debts
|
|
|
547,781
|
|
|
|
377,596
|
|
|
|
324,643
|
|
Supplies
|
|
|
510,351
|
|
|
|
448,210
|
|
|
|
389,584
|
|
Rent
|
|
|
97,104
|
|
|
|
87,210
|
|
|
|
76,986
|
|
Other operating expenses
|
|
|
897,091
|
|
|
|
765,697
|
|
|
|
639,037
|
|
Minority interest in earnings
|
|
|
2,795
|
|
|
|
3,104
|
|
|
|
2,494
|
|
Depreciation and amortization
|
|
|
188,771
|
|
|
|
164,563
|
|
|
|
149,155
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating costs and expenses
|
|
|
3,985,116
|
|
|
|
3,332,787
|
|
|
|
2,861,035
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
380,460
|
|
|
|
405,533
|
|
|
|
342,472
|
|
Interest expense, net of interest
income of $1,779, $5,742 and $526 in 2006, 2005 and 2004,
respectively
|
|
|
102,299
|
|
|
|
94,613
|
|
|
|
75,256
|
|
Loss from early extinguishment of
debt
|
|
|
|
|
|
|
|
|
|
|
788
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes
|
|
|
278,161
|
|
|
|
310,920
|
|
|
|
266,428
|
|
Provision for income taxes
|
|
|
106,682
|
|
|
|
120,782
|
|
|
|
104,071
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
171,479
|
|
|
|
190,138
|
|
|
|
162,357
|
|
Discontinued operations, net of
taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations of hospitals
sold or held for sale
|
|
|
(657
|
)
|
|
|
(10,505
|
)
|
|
|
(7,279
|
)
|
Net loss on sale of hospitals
|
|
|
(2,559
|
)
|
|
|
(7,618
|
)
|
|
|
(2,020
|
)
|
Impairment of long-lived assets of
hospital held for sale
|
|
|
|
|
|
|
(4,471
|
)
|
|
|
(1,625
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on discontinued operations
|
|
|
(3,216
|
)
|
|
|
(22,594
|
)
|
|
|
(10,924
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
168,263
|
|
|
$
|
167,544
|
|
|
$
|
151,433
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common
sharebasic:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1.81
|
|
|
$
|
2.15
|
|
|
$
|
1.70
|
|
Loss on discontinued operations
|
|
$
|
(0.04
|
)
|
|
$
|
(0.26
|
)
|
|
$
|
(0.12
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1.77
|
|
|
$
|
1.89
|
|
|
$
|
1.58
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common
sharediluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1.78
|
|
|
$
|
2.02
|
|
|
$
|
1.62
|
|
Loss on discontinued operations
|
|
$
|
(0.03
|
)
|
|
$
|
(0.23
|
)
|
|
$
|
(0.11
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1.75
|
|
|
$
|
1.79
|
|
|
$
|
1.51
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares
outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
94,983,646
|
|
|
|
88,601,168
|
|
|
|
95,643,733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
|
96,232,910
|
|
|
|
98,579,977
|
|
|
|
105,863,790
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See notes to consolidated financial statements.
2
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
CONSOLIDATED
BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands, except share data)
|
|
|
ASSETS
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
40,566
|
|
|
$
|
104,108
|
|
Patient accounts receivable, net of
allowance for doubtful accounts of $478,565 and $346,024 in 2006
and 2005, respectively
|
|
|
773,984
|
|
|
|
656,029
|
|
Supplies
|
|
|
113,320
|
|
|
|
95,200
|
|
Deferred income taxes
|
|
|
13,249
|
|
|
|
4,128
|
|
Prepaid expenses and taxes
|
|
|
32,385
|
|
|
|
33,377
|
|
Other current assets
|
|
|
47,880
|
|
|
|
21,367
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
1,021,384
|
|
|
|
914,209
|
|
|
|
|
|
|
|
|
|
|
Property and equipment:
|
|
|
|
|
|
|
|
|
Land and improvements
|
|
|
163,988
|
|
|
|
121,637
|
|
Buildings and improvements
|
|
|
1,634,893
|
|
|
|
1,307,978
|
|
Equipment and fixtures
|
|
|
831,485
|
|
|
|
699,024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,630,366
|
|
|
|
2,128,639
|
|
Less accumulated depreciation and
amortization
|
|
|
(643,789
|
)
|
|
|
(517,648
|
)
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
|
1,986,577
|
|
|
|
1,610,991
|
|
|
|
|
|
|
|
|
|
|
Goodwill
|
|
|
1,336,525
|
|
|
|
1,259,816
|
|
|
|
|
|
|
|
|
|
|
Other assets, net of accumulated
amortization of $92,921 and $78,599 in 2006 and 2005,
respectively
|
|
|
162,093
|
|
|
|
149,202
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
4,506,579
|
|
|
$
|
3,934,218
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
STOCKHOLDERS EQUITY
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Current maturities of long-term debt
|
|
$
|
35,396
|
|
|
$
|
19,124
|
|
Accounts payable
|
|
|
247,747
|
|
|
|
189,940
|
|
Current income taxes payable
|
|
|
7,626
|
|
|
|
19,811
|
|
Accrued liabilities:
|
|
|
|
|
|
|
|
|
Employee compensation
|
|
|
162,188
|
|
|
|
121,775
|
|
Interest
|
|
|
7,122
|
|
|
|
8,591
|
|
Other
|
|
|
115,204
|
|
|
|
78,162
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
575,283
|
|
|
|
437,403
|
|
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
|
1,905,781
|
|
|
|
1,648,500
|
|
|
|
|
|
|
|
|
|
|
Deferred income taxes
|
|
|
141,472
|
|
|
|
157,579
|
|
|
|
|
|
|
|
|
|
|
Other long-term liabilities
|
|
|
160,370
|
|
|
|
126,159
|
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
Preferred stock, $.01 par
value per share, 100,000,000 shares authorized; none issued
|
|
|
|
|
|
|
|
|
Common stock, $.01 par value
per share, 300,000,000 shares authorized;
95,026,494 shares issued and 94,050,945 shares
outstanding at December 31, 2006 and 94,539,837 shares
issued and 93,564,288 shares outstanding at
December 31, 2005
|
|
|
950
|
|
|
|
945
|
|
Additional paid-in capital
|
|
|
1,195,947
|
|
|
|
1,208,930
|
|
Treasury stock, at cost,
975,549 shares at December 31, 2006 and 2005
|
|
|
(6,678
|
)
|
|
|
(6,678
|
)
|
Unearned stock compensation
|
|
|
|
|
|
|
(13,204
|
)
|
Accumulated other comprehensive
income
|
|
|
5,798
|
|
|
|
15,191
|
|
Retained earnings
|
|
|
527,656
|
|
|
|
359,393
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
1,723,673
|
|
|
|
1,564,577
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
stockholders equity
|
|
$
|
4,506,579
|
|
|
$
|
3,934,218
|
|
|
|
|
|
|
|
|
|
|
See notes to consolidated financial statements.
3
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF STOCKHOLDERS EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
Retained
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
|
|
|
Unearned
|
|
|
Other
|
|
|
Earnings
|
|
|
|
|
|
|
Common Stock
|
|
|
Paid-in
|
|
|
Treasury Stock
|
|
|
Stock
|
|
|
Comprehensive
|
|
|
(Accumulated
|
|
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Shares
|
|
|
Amount
|
|
|
Compensation
|
|
|
Income (Loss)
|
|
|
Deficit)
|
|
|
Total
|
|
|
|
(In thousands, except share data)
|
|
|
BALANCE, December 31, 2003
|
|
|
99,657,532
|
|
|
$
|
997
|
|
|
$
|
1,315,959
|
|
|
$
|
(975,549
|
)
|
|
$
|
(6,678
|
)
|
|
$
|
(2
|
)
|
|
$
|
(103
|
)
|
|
$
|
40,416
|
|
|
$
|
1,350,589
|
|
Comprehensive Income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
151,433
|
|
|
|
151,433
|
|
Net change in fair value of
interest rate swaps, net of tax expense of $3,459
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,149
|
|
|
|
|
|
|
|
6,149
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,149
|
|
|
|
151,433
|
|
|
|
157,582
|
|
Repurchase of common stock
|
|
|
(12,000,000
|
)
|
|
|
(120
|
)
|
|
|
(290,400
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(290,520
|
)
|
Issuance of common stock in
connection with the exercise of options
|
|
|
701,641
|
|
|
|
7
|
|
|
|
9,893
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,900
|
|
Issuance of common stock to
employee benefit plan
|
|
|
232,560
|
|
|
|
2
|
|
|
|
6,151
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,153
|
|
Tax benefit from exercise of
options and offering costs
|
|
|
|
|
|
|
|
|
|
|
6,285
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,285
|
|
Earned stock compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE, December 31, 2004
|
|
|
88,591,733
|
|
|
$
|
886
|
|
|
$
|
1,047,888
|
|
|
|
(975,549
|
)
|
|
$
|
(6,678
|
)
|
|
$
|
|
|
|
$
|
6,046
|
|
|
$
|
191,849
|
|
|
$
|
1,239,991
|
|
Comprehensive Income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
167,544
|
|
|
|
167,544
|
|
Net change in fair value of
interest rate swaps, net of tax expense of $5,019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,923
|
|
|
|
|
|
|
|
8,923
|
|
Net change in fair value of
available for sale securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
222
|
|
|
|
|
|
|
|
222
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,145
|
|
|
|
167,544
|
|
|
|
176,689
|
|
Repurchases of common stock
|
|
|
(2,239,700
|
)
|
|
|
(22
|
)
|
|
|
(79,830
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(79,852
|
)
|
Issuance of common stock in
connection with the exercise of options
|
|
|
3,134,721
|
|
|
|
31
|
|
|
|
49,543
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
49,574
|
|
Issuance of common stock in
connection with the conversion of convertible debt
|
|
|
4,495,083
|
|
|
|
44
|
|
|
|
148,576
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
148,620
|
|
Restricted stock grant
|
|
|
558,000
|
|
|
|
6
|
|
|
|
18,160
|
|
|
|
|
|
|
|
|
|
|
|
(18,160
|
)
|
|
|
|
|
|
|
|
|
|
|
6
|
|
Tax benefit from exercise of options
|
|
|
|
|
|
|
|
|
|
|
24,453
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,453
|
|
Earned stock compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,956
|
|
|
|
|
|
|
|
|
|
|
|
4,956
|
|
Miscellaneous
|
|
|
|
|
|
|
|
|
|
|
140
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
140
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE, December 31, 2005
|
|
|
94,539,837
|
|
|
$
|
945
|
|
|
$
|
1,208,930
|
|
|
|
(975,549
|
)
|
|
$
|
(6,678
|
)
|
|
$
|
(13,204
|
)
|
|
$
|
15,191
|
|
|
$
|
359,393
|
|
|
$
|
1,564,577
|
|
Comprehensive Income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
168,263
|
|
|
|
168,263
|
|
Net change in fair value of
interest rate swaps, net of tax benefit of $931
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,654
|
)
|
|
|
|
|
|
|
(1,654
|
)
|
Net change in fair value of
available for sale securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
562
|
|
|
|
|
|
|
|
562
|
|
Adjustment to adopt FASB statement
No. 158, net of tax benefit of $5,465
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8,301
|
)
|
|
|
|
|
|
|
(8,301
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(9,393
|
)
|
|
|
168,263
|
|
|
|
158,870
|
|
Repurchases of common stock
|
|
|
(5,000,000
|
)
|
|
|
(50
|
)
|
|
|
(176,265
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(176,315
|
)
|
Issuance of common stock in
connection with the exercise of options
|
|
|
867,833
|
|
|
|
9
|
|
|
|
14,564
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,573
|
|
Issuance of common stock in
connection with the conversion of convertible debt
|
|
|
4,074,510
|
|
|
|
41
|
|
|
|
137,157
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
137,198
|
|
Restricted stock grant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax benefit from exercise of options
|
|
|
|
|
|
|
|
|
|
|
4,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,750
|
|
Earned stock compensation
|
|
|
544,314
|
|
|
|
5
|
|
|
|
20,068
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,073
|
|
Reclassification of unearned stock
compensation
|
|
|
|
|
|
|
|
|
|
|
(13,257
|
)
|
|
|
|
|
|
|
|
|
|
|
13,204
|
|
|
|
|
|
|
|
|
|
|
|
(53
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE, December 31, 2006
|
|
|
95,026,494
|
|
|
$
|
950
|
|
|
$
|
1,195,947
|
|
|
|
(975,549
|
)
|
|
$
|
(6,678
|
)
|
|
$
|
|
|
|
$
|
5,798
|
|
|
$
|
527,656
|
|
|
$
|
1,723,673
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See notes to consolidated financial statements.
4
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
(In thousands)
|
|
|
Cash flows from operating
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
168,263
|
|
|
$
|
167,544
|
|
|
$
|
151,433
|
|
Adjustments to reconcile net
income to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
188,771
|
|
|
|
166,162
|
|
|
|
158,380
|
|
Deferred income taxes
|
|
|
(25,228
|
)
|
|
|
9,889
|
|
|
|
41,902
|
|
Stock compensation expense
|
|
|
20,073
|
|
|
|
4,957
|
|
|
|
2
|
|
Excess tax benefits relating to
stock-based compensation
|
|
|
(6,819
|
)
|
|
|
|
|
|
|
|
|
Loss on early extinguishment of
debt
|
|
|
|
|
|
|
|
|
|
|
788
|
|
Minority interest in earnings
|
|
|
2,795
|
|
|
|
3,104
|
|
|
|
1,578
|
|
Impairment on hospital held for
sale
|
|
|
|
|
|
|
6,718
|
|
|
|
2,539
|
|
Loss on sale of hospitals
|
|
|
3,937
|
|
|
|
6,295
|
|
|
|
2,186
|
|
Other non-cash expenses, net
|
|
|
500
|
|
|
|
740
|
|
|
|
669
|
|
Changes in operating assets and
liabilities, net of effects of acquisitions and divestitures:
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient accounts receivable
|
|
|
(71,141
|
)
|
|
|
(47,455
|
)
|
|
|
(31,814
|
)
|
Supplies, prepaid expenses and
other current assets
|
|
|
(4,544
|
)
|
|
|
(16,838
|
)
|
|
|
(13,549
|
)
|
Accounts payable, accrued
liabilities and income taxes
|
|
|
52,151
|
|
|
|
84,956
|
|
|
|
(24,371
|
)
|
Other
|
|
|
21,497
|
|
|
|
24,977
|
|
|
|
36,007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating
activities
|
|
|
350,255
|
|
|
|
411,049
|
|
|
|
325,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisitions of facilities and
other related equipment
|
|
|
(384,618
|
)
|
|
|
(158,379
|
)
|
|
|
(133,033
|
)
|
Purchases of property and equipment
|
|
|
(224,519
|
)
|
|
|
(188,365
|
)
|
|
|
(164,286
|
)
|
Disposition of hospitals
|
|
|
750
|
|
|
|
51,998
|
|
|
|
7,850
|
|
Proceeds from sale of equipment
|
|
|
4,480
|
|
|
|
2,325
|
|
|
|
790
|
|
Increase in other assets
|
|
|
(36,350
|
)
|
|
|
(34,851
|
)
|
|
|
(29,800
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing
activities
|
|
|
(640,257
|
)
|
|
|
(327,272
|
)
|
|
|
(318,479
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of stock
options
|
|
|
14,573
|
|
|
|
49,580
|
|
|
|
9,900
|
|
Proceeds from issuance of senior
subordinated notes
|
|
|
|
|
|
|
|
|
|
|
300,000
|
|
Stock buy-back
|
|
|
(176,316
|
)
|
|
|
(79,853
|
)
|
|
|
(290,520
|
)
|
Deferred financing costs
|
|
|
(2,153
|
)
|
|
|
(1,259
|
)
|
|
|
(12,783
|
)
|
Excess tax benefits relating to
stock-based compensation
|
|
|
6,819
|
|
|
|
|
|
|
|
|
|
Redemption of convertible notes
|
|
|
(128
|
)
|
|
|
(298
|
)
|
|
|
|
|
Proceeds from minority investors
in joint ventures
|
|
|
6,890
|
|
|
|
1,383
|
|
|
|
|
|
Redemption of minority investments
in joint ventures
|
|
|
(915
|
)
|
|
|
(3,242
|
)
|
|
|
(3,522
|
)
|
Distribution to minority investors
in joint ventures
|
|
|
(3,220
|
)
|
|
|
(1,939
|
)
|
|
|
(1,238
|
)
|
Borrowings under Credit Agreement
|
|
|
1,031,000
|
|
|
|
|
|
|
|
1,725,768
|
|
Repayments of long-term
indebtedness
|
|
|
(650,090
|
)
|
|
|
(26,539
|
)
|
|
|
(1,668,709
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by
financing activities
|
|
|
226,460
|
|
|
|
(62,167
|
)
|
|
|
58,896
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash
equivalents
|
|
|
(63,542
|
)
|
|
|
21,610
|
|
|
|
66,167
|
|
Cash and cash equivalents at
beginning of period
|
|
|
104,108
|
|
|
|
82,498
|
|
|
|
16,331
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end
of period
|
|
$
|
40,566
|
|
|
$
|
104,108
|
|
|
$
|
82,498
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See notes to consolidated financial statements.
5
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
1.
|
Business
and Summary of Significant Accounting Policies
|
Business. Community Health Systems, Inc.,
through its subsidiaries (collectively the Company),
owns, leases and operates acute care hospitals that are the
principal providers of primary healthcare services in non-urban
communities. As of December 31, 2006, the Company owned,
leased or operated 77 hospitals, licensed for 9,117 beds in
22 states. Pennsylvania represents the only area of
geographic concentration; net operating revenues generated by
the Companys hospitals in that state, as a percentage of
consolidated net operating revenues, were 21.0% in 2006, 22.1%
in 2005 and 19.0% in 2004.
Use of Estimates. The preparation of financial
statements in conformity with accounting principles generally
accepted in the United States of America requires management to
make estimates and assumptions that affect the reported amounts
of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the consolidated financial
statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from
those estimates under different assumptions or conditions.
Principles of Consolidation. The consolidated
financial statements include the accounts of the Company and its
subsidiaries, all of which are controlled by the Company through
majority voting control. All significant intercompany accounts
and transactions have been eliminated. Certain of the
subsidiaries have minority stockholders. The amount of minority
interest in equity is not material and is included in other
long-term liabilities on the consolidated balance sheets and
minority interest in income or loss is disclosed separately on
the consolidated statements of income.
Cost of Revenue. The majority of the
Companys operating expenses are cost of
revenue items. Operating costs that could be classified as
general and administrative by the Company would include the
Companys corporate office costs, which were
$88.9 million, $67.5 million and $47.9 million
for the years ended December 31, 2006, 2005 and 2004,
respectively.
Cash Equivalents. The Company considers highly
liquid investments with original maturities of three months or
less to be cash equivalents.
Supplies. Supplies, principally medical
supplies, are stated at the lower of cost
(first-in,
first-out basis) or market.
Marketable Securities. The Company accounts
for marketable securities in accordance with the provisions of
Statement of Financial Accounting Standards No. 115,
Accounting for Certain Investments in Debt and Equity
Securities (SFAS 115). Currently, all of
the Companys marketable securities are classified as
available-for-sale. Available-for-sale securities are carried at
fair value as determined by quoted market prices, with
unrealized gains and losses reported as a separate component of
stockholders equity. Interest and dividends on securities
classified as available-for-sale are included in net revenue.
Accumulated other comprehensive income included an unrealized
gain of $0.6 million and $0.2 million at
December 31, 2006 and December 31, 2005, respectively,
related to these available-for-sale securities. The gross
realized gains and losses from the sale of available-for-sale
securities were not material in all periods presented.
Property and Equipment. Property and equipment
are recorded at cost. Depreciation is recognized using the
straight-line method over the estimated useful lives of the land
and improvements (2 to 15 years; weighted-average useful
life is 14 years), buildings and improvements (5 to
40 years; weighted-average useful life is 24 years)
and equipment and fixtures (4 to 18 years; weighted-average
useful life is 8 years). Costs capitalized as construction
in progress were $61.2 million and $54 million at
December 31, 2006 and 2005, respectively. Expenditures for
renovations and other significant improvements are capitalized;
however, maintenance and repairs which do not improve or extend
the useful lives of the respective assets are charged to
operations as incurred. Interest capitalized in accordance with
Statement of Financial Accounting Standards (SFAS)
No. 34, Capitalization of Interest Cost, was
$3.0 million for the year ended December 31, 2006, and
$2.1 million for each of the years ended December 31,
2005 and 2004.
6
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The Company also leases certain facilities and equipment under
capital leases (see Notes 3 and 8). Such assets are
amortized on a straight-line basis over the lesser of the term
of the lease or the remaining useful lives of the applicable
assets.
Goodwill. Goodwill represents the excess cost
over the fair value of net assets acquired. Goodwill arising
from business combinations is accounted for under the provisions
of SFAS No. 141, Business Combinations,
and SFAS No. 142, Goodwill and Other Intangible
Assets, and is not amortized. SFAS No. 142
requires goodwill to be evaluated for impairment at the same
time every year and when an event occurs or circumstances change
such that it is reasonably possible that an impairment may
exist. The Company selected September 30th as its
annual testing date.
Other Assets. Other assets consist of costs
associated with the issuance of debt, which are included in
interest expense over the life of the related debt using the
effective interest method, and costs to recruit physicians to
the Companys markets, which are deferred and amortized in
amortization expense over the term of the respective physician
recruitment contract, which is generally three years.
Third-Party Reimbursement. Net operating
revenues include amounts estimated by management to be
reimbursable by Medicare and Medicaid under prospective payment
systems, provisions of cost-reimbursement and other payment
methods. Approximately 42% of net operating revenues for the
year ended December 31, 2006, 43% of net operating revenues
for the year ended December 31, 2005 and 42% of net
operating revenues for the year ended December 31, 2004,
are related to services rendered to patients covered by the
Medicare and Medicaid programs. Included in the amounts received
from Medicare are approximately 0.44% of net operating revenues
for 2006, 0.47% for 2005 and 0.45% for 2004 related to Medicare
outlier payments. In addition, the Company is reimbursed by
non-governmental payors using a variety of payment
methodologies. Amounts received by the Company for treatment of
patients covered by such programs are generally less than the
standard billing rates. The differences between the estimated
program reimbursement rates and the standard billing rates are
accounted for as contractual adjustments, which are deducted
from gross revenues to arrive at net operating revenues. Final
settlements under certain of these programs are subject to
adjustment based on administrative review and audit by third
parties. Adjustments to the estimated billings are recorded in
the periods that such adjustments become known. Adjustments to
previous program reimbursement estimates are accounted for as
contractual allowance adjustments and reported in the periods in
which final settlements are determined. Adjustments related to
final settlements or appeals increased revenue by an
insignificant amount in each of the years ended
December 31, 2006, 2005 and 2004. Amounts due to
third-party payors were $55 million as of December 31,
2006 and $43 million as of December 31, 2005 and are
included in accrued liabilitiesother in the accompanying
consolidated balance sheets. Substantially all Medicare and
Medicaid cost reports are final settled through 2004.
Allowance for Doubtful Accounts. Accounts
receivable are reduced by an allowance for amounts that could
become uncollectible in the future. Substantially all of the
Companys receivables are related to providing healthcare
services to its hospitals patients.
The Company experienced a significant increase in self-pay
volume and related revenue, combined with lower cash collections
during the quarter ended September 30, 2006. The Company
believes this trend reflects an increased collection risk from
self-pay accounts, and as a result the Company performed a
review and an alternative analysis of the adequacy of its
allowance for doubtful accounts. Based on this review, the
Company recorded a $65 million increase to its allowance
for doubtful accounts to maintain an adequate allowance for
doubtful accounts as of September 30, 2006. The Company
believes that the increase in self-pay accounts is a result of
current economic trends, including an increase in the number of
uninsured patients, reduced enrollment under Medicaid programs
such as Tenncare, and higher deductibles and co-payments for
patients with insurance.
7
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
In conjunction with recording a $65 million increase to the
allowance for doubtful accounts, the Company changed its
methodology for estimating its allowance for doubtful accounts
effective September 30, 2006, as follows: The Company will
reserve a percentage of all self-pay accounts receivable without
regard to aging category, based on collection history adjusted
for expected recoveries and, if present, other changes in
trends. For all other payor categories the Company will reserve
100% of all accounts aging over 365 days from the date of
discharge. Previously, the Company estimated its allowance for
doubtful accounts by reserving all accounts aging over
150 days from the date of discharge without regard to payor
class. The Company believes its revised methodology provides a
better approach to reflect changes in payor mix and historical
collection patterns and to respond to changes in trends. The
revised accounting methodology and the adequacy of resulting
estimates will continue to be reviewed by monitoring historical
cash collections as a percentage of trailing net revenues less
provision for bad debts, as well as analyzing current period net
revenue and admissions by payor classification, aged accounts
receivable by payor, days revenue outstanding, and the impact of
recent acquisitions and dispositions.
The effect of this change in estimate was to increase the
allowance for doubtful accounts by $65 million which
resulted in an after tax decrease of income from continuing
operations of $40 million, or $0.42 per share (diluted) for
the year ended December 31, 2006.
Concentrations of Credit Risk. The Company
grants unsecured credit to its patients, most of whom reside in
the service area of the Companys facilities and are
insured under third-party payor agreements. Because of the
economic diversity of the Companys facilities and
non-governmental third-party payors, Medicare represents the
only significant concentration of credit risk from payors. The
following table presents accounts receivable, net of the related
contractual allowance (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
|
|
|
Medicaid,
|
|
|
|
|
|
Medicaid,
|
|
|
|
|
|
|
Managed Care,
|
|
|
|
|
|
Managed Care,
|
|
|
|
|
|
|
Self-pay and
|
|
|
|
|
|
Self-pay and
|
|
|
|
Medicare
|
|
|
Other
|
|
|
Medicare
|
|
|
Other
|
|
|
Gross accounts receivable
|
|
$
|
499,419
|
|
|
$
|
1,773,775
|
|
|
$
|
433,369
|
|
|
$
|
1,455,716
|
|
Contractual allowance
|
|
|
(382,614
|
)
|
|
|
(638,031
|
)
|
|
|
(349,807
|
)
|
|
|
(537,225
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable, net of
contractual allowance
|
|
$
|
116,805
|
|
|
$
|
1,135,744
|
|
|
$
|
83,562
|
|
|
$
|
918,491
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Operating Revenues. Net operating revenues
are recorded net of provisions for contractual allowance of
approximately $10,569 million, $8,893 million and
$7,214 million in 2006, 2005 and 2004, respectively. Net
operating revenues are recognized when services are provided. In
the ordinary course of business the Company renders services to
patients who are financially unable to pay for hospital care.
Included in the provision for contractual allowance shown above,
is the value (at the Companys standard charges) of these
services to patients who are unable to pay that is eliminated
from net operating revenues when it is determined they qualify
under the Companys charity care policy. The value of these
services was $222.9 million, $182.3 million and
$133.4 million for the years ended December 31, 2006,
2005 and 2004, respectively. Also included in the provision for
contractual allowance shown above is the value of administrative
discounts provided to self-pay patients eliminated from net
operating revenues which was $107.7 million,
$82.5 million and $59.7 million for the years ended
December 31, 2006, 2005 and 2004, respectively.
Professional Liability Insurance Claims. The
Company accrues for estimated losses resulting from professional
liability. The accrual, which includes an estimate for incurred
but not reported claims, is based on historical loss patterns
and actuarially determined projections and is discounted to its
net present value. To the extent that subsequent claims
information varies from managements estimates, the
liability is adjusted currently.
8
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Accounting for the Impairment or Disposal of Long-Lived
Assets. In accordance with
SFAS No. 144, Accounting for the Impairment or
Disposal of Long-Lived Assets, whenever events or changes
in circumstances indicate that the carrying values of certain
long-lived assets may be impaired, the Company projects the
undiscounted cash flows expected to be generated by these
assets. If the projections indicate that the reported amounts
are not expected to be recovered, such amounts are reduced to
their estimated fair value based on a quoted market price, if
available, or an estimate based on valuation techniques
available in the circumstances.
Income Taxes. The Company accounts for income
taxes under the asset and liability method, in which deferred
income tax assets and liabilities are recognized for the tax
consequences of temporary differences by applying
enacted statutory tax rates applicable to future years to
differences between the financial statement carrying amounts and
the tax bases of existing assets and liabilities. The effect on
deferred taxes of a change in tax rates is recognized in the
consolidated statement of income during the period in which the
tax rate change becomes law.
Comprehensive Income. Comprehensive income is
the change in equity of a business enterprise during a period
from transactions and other events and circumstances from
non-owner sources.
Accumulated Other Comprehensive Income consists of the following
(in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
Change in Fair
|
|
|
Change in Fair
|
|
|
Adjustment
|
|
|
Other
|
|
|
|
Value of Interest
|
|
|
Value of Available
|
|
|
to Pension
|
|
|
Comprehensive
|
|
|
|
Rate Swaps
|
|
|
for Sale Securities
|
|
|
Liability
|
|
|
Income
|
|
|
Balance as of December 31,
2004
|
|
$
|
6,046
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
6,046
|
|
2005 Activity, net of tax
|
|
|
8,923
|
|
|
|
222
|
|
|
|
|
|
|
|
9,145
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31,
2005
|
|
|
14,969
|
|
|
|
222
|
|
|
|
|
|
|
|
15,191
|
|
2006 Activity, net of tax
|
|
|
(1,654
|
)
|
|
|
562
|
|
|
|
(8,301
|
)
|
|
|
(9,393
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31,
2006
|
|
$
|
13,315
|
|
|
$
|
784
|
|
|
$
|
(8,301
|
)
|
|
$
|
5,798
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Reporting. SFAS No. 131,
Disclosures about Segments of an Enterprise and Related
Information, requires that a public company report annual
and interim financial and descriptive information about its
reportable operating segments. Operating segments, as defined,
are components of an enterprise about which separate financial
information is available that is evaluated regularly by the
chief operating decision maker in deciding how to allocate
resources and in assessing performance. SFAS No. 131
allows aggregation of similar operating segments into a single
operating segment if the businesses have similar economic
characteristics and are considered similar under the criteria
established by SFAS No. 131. The Companys
operating segments have similar services, have similar types of
patients, operate in a consistent manner and have similar
economic and regulatory characteristics. Therefore, the Company
has aggregated its operating segments into one reportable
segment.
Derivative Instruments and Hedging
Activities. In accordance with
SFAS No. 133, Accounting for Derivative
Instruments and Hedging Activities, as amended, the
Company records derivative instruments (including certain
derivative instruments embedded in other contracts) on the
consolidated balance sheet as either an asset or liability
measured at its fair value. Changes in a derivatives fair
value are recorded each period in earnings or other
comprehensive income, or OCI, depending on whether the
derivative is designated and is effective as a hedged
transaction, and on the type of hedge transaction. Changes in
the fair value of derivative instruments recorded to OCI are
reclassified to earnings in the period affected by the
underlying hedged item. Any portion of the fair value of a
derivative instrument determined to be ineffective under the
standard is recognized in current earnings.
9
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The Company has entered into several interest rate swap
agreements subject to the scope of this pronouncement. See
Note 6 for further discussion about the swap transactions.
New Accounting Pronouncements. In June 2006,
the Financial Accounting Standards Board issued FASB
Interpretation No. 48, Accounting for Uncertainty in
Income Taxesan interpretation of FASB Statement
No. 109 (FIN 48), which prescribes a recognition
threshold and measurement attribute for the financial statement
recognition and measurement of a tax position taken or expected
to be taken in a tax return. FIN 48 also provides guidance
on de-recognition, classification, interest and penalties,
accounting in interim periods, disclosure and transition.
FIN 48 is effective for fiscal years beginning after
December 15, 2006. The Company adopted FIN 48 as of
January 1, 2007. The adoption of this interpretation will
not have a material effect on the Companys consolidated
results of operations or consolidated financial position.
Reclassifications. Certain prior year amounts
have been reclassified to conform to current year presentation.
The Company disposed of four hospitals in March 2005, one lease
expired pursuant to its terms during the quarter ended
March 31, 2005, designated one hospital as being held for
sale in the second quarter of 2005 which was sold during the
first quarter 2006 and disposed of two hospitals in August 2004.
The operating results of those hospitals have been classified as
discontinued operations on the consolidated statements of income
for all periods presented. There is no effect on net income for
all periods presented related to the reclassifications made for
the discontinued operations.
|
|
2.
|
Accounting
for Stock-Based Compensation
|
The Company adopted the provisions of SFAS No. 123(R),
Share-Based Payment,
(SFAS No. 123(R)) on January 1, 2006,
electing to use the modified prospective method for transition
purposes. The modified prospective method requires that
compensation expense be recorded for all unvested stock options
and share awards that subsequently vest or are modified, without
restatement of prior periods. Prior to January 1, 2006, the
Company accounted for stock-based compensation using the
recognition and measurement principles of APB Opinion
No. 25 and provided the pro forma disclosure requirements
of SFAS No. 123 Accounting for Stock-Based
Compensation, and SFAS No. 148, Accounting
for Stock-Based Compensation Transition and Disclosuresan
Amendment of FASB Statement No. 123. Under APB
Opinion No. 25, when the exercise price of the
Companys stock was equal to the market price of the
underlying stock on the date of grant, no compensation expense
was recognized.
10
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The pro forma table below reflects net income and earnings per
share had the Company applied the fair value recognition
provisions of SFAS No. 123, for each of the two years
ended prior to the adoption of SFAS No. 123(R) (in
thousands, except per share data):
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
2005
|
|
|
2004
|
|
|
Net Income:
|
|
$
|
167,544
|
|
|
$
|
151,433
|
|
Add: Stock-Based compensation
expense recognized under APB 25, net of tax
|
|
|
3,493
|
|
|
|
|
|
Deduct: Total stock-based
compensation under fair value based method for all awards, net
of tax
|
|
$
|
14,232
|
|
|
$
|
6,601
|
|
|
|
|
|
|
|
|
|
|
Pro-forma net income
|
|
$
|
156,805
|
|
|
$
|
144,832
|
|
|
|
|
|
|
|
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
Basic as reported
|
|
$
|
1.89
|
|
|
$
|
1.58
|
|
|
|
|
|
|
|
|
|
|
Basic pro forma
|
|
$
|
1.77
|
|
|
$
|
1.51
|
|
|
|
|
|
|
|
|
|
|
Diluted as reported
|
|
$
|
1.79
|
|
|
$
|
1.51
|
|
|
|
|
|
|
|
|
|
|
Diluted pro forma
|
|
$
|
1.68
|
|
|
$
|
1.45
|
|
|
|
|
|
|
|
|
|
|
For purposes of the above table the fair value of each option
grant was estimated on the date of grant using the Black-Scholes
option pricing model with the following weighted-average
assumptions used for grants during each of the years ended
December 31:
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
2005
|
|
|
2004
|
|
|
Expected volatility
|
|
|
36
|
%
|
|
|
33
|
%
|
Expected dividends
|
|
|
0
|
|
|
|
0
|
|
Expected term
|
|
|
4 years
|
|
|
|
4 years
|
|
Risk-free interest rate
|
|
|
3.88
|
%
|
|
|
3.16
|
%
|
On September 22, 2005 the Compensation Committee of the
Board of Directors of Community Health Systems, Inc. approved an
immediate acceleration of the vesting of unvested stock options
awarded to employees and officers, including executive officers,
on each of three grant dates, December 10, 2002,
February 25, 2003, and May 22, 2003. Each of the
grants accelerated had a three-year vesting period and would
have otherwise become fully vested on their respective
anniversary dates no later than May 22, 2006. All other
terms and conditions applicable to the outstanding stock option
grants remain in effect. A total of 1,235,885 stock options,
with a weighted exercise price of $20.26 per share, were
accelerated.
The accelerated options were issued under the Community Health
Systems, Inc. Amended and Restated 2000 Stock Option and Award
Plan (the Plan). No performance shares or units or
incentive stock options have been granted under the Plan.
Options granted to non-employee directors of the Company and
restricted shares were not affected by this action. The
Compensation Committees decision to accelerate the vesting
of the affected options was based primarily on the relatively
short period of time until such stock options otherwise become
fully vested making them no longer a significant motivator for
retention and the fact the Company anticipated that up to
approximately $3.8 million of compensation expense
($2.3 million, net of tax) associated with certain of these
stock options would have otherwise been recognized in the first
two quarters of 2006 pursuant to Statement of Financial
Accounting Standards (SFAS) No. 123 (revised
2004), Share-Based Payment, would be avoided.
11
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Since the Company accounted for its stock options prior to
January 1, 2006 using the intrinsic value method of
accounting prescribed in APB No. 25, the accelerated
vesting did not result in the recognition of compensation
expense in net income for the year ended December 31, 2005.
However, in accordance with the disclosure requirements of
SFAS No. 148, Accounting for Stock-Based
CompensationTransition and Disclosure an
Amendment of FASB Statement No. 123, the pro forma
results presented in the table above include approximately
$5.9 million ($3.6 million, net of tax) of
compensation expense for the year ended December 31, 2005,
resulting from the vesting acceleration.
Stock-based compensation awards are granted under the Community
Health Systems, Inc. Amended and Restated 2000 Stock Option and
Award Plan (the 2000 Plan). The 2000 Plan allows for
the grant of incentive stock options intended to qualify under
Section 422 of the Internal Revenue Code as well as stock
options which do not so qualify, stock appreciation rights,
restricted stock, performance units and performance shares,
phantom stock awards and share awards. Persons eligible to
receive grants under the 2000 Plan include the Companys
directors, officers, employees and consultants. To date, the
options granted under the 2000 Plan are nonqualified
stock options for tax purposes. Vesting of these granted options
occurs in one third increments on each of the first three
anniversaries of the award date. Options granted prior to 2005
have a
10-year contractual term and options granted in 2005 and 2006
have an 8 year contractual term. The exercise price of
options granted to employees under the 2000 Plan were equal to
the fair value of the Companys common stock on the option
grant date. As of December 31, 2006, 5,954,865 shares
of common stock remain reserved for future grants under the 2000
Plan. The Company also has options outstanding under its
Employee Stock Option Plan (the 1996 Plan). These
options are fully vested and exercisable and no additional
grants of options will be made under the 1996 Plan.
The following table reflects the impact of total compensation
expense related to stock-based equity plans under
SFAS No. 123(R) for periods beginning January 1,
2006 and under APB 25 for periods prior to January 1, 2006,
on the reported operating results for the respective periods (in
thousands, except per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Effect on income from continuing
operations before income taxes
|
|
$
|
(19,851
|
)
|
|
$
|
(4,960
|
)
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect on net income
|
|
$
|
(12,549
|
)
|
|
$
|
(3,493
|
)
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect on net income per
share-diluted
|
|
$
|
(0.13
|
)
|
|
$
|
(0.04
|
)
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SFAS No. 123(R) also requires the benefits of tax
deductions in excess of the recognized tax benefit on
compensation expense to be reported as a financing cash flow,
rather than as an operating cash flow as required under APB 25
and related interpretations. This requirement reduced the
Companys net operating cash flows and increased the
Companys financing cash flows by $6.8 million for the
year ended December 31, 2006. In addition, the
Companys deferred compensation cost at December 31,
2005, of $13.2 million, arising from the issuance of
restricted stock in 2005 and recorded as a component of
stockholders equity as required under APB 25, was
reclassified into additional paid-in capital upon the adoption
of SFAS No. 123(R).
At December 31, 2006, $36.8 million of unrecognized
stock-based compensation expense from all outstanding unvested
stock options and restricted stock is expected to be recognized
over a weighted-average period of 20 months. There were no
modifications to awards during 2006.
12
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The fair value of stock options was estimated using the
Black-Scholes option pricing model with the assumptions and
weighted-average fair values during the year ended
December 31, 2006, as follows:
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
Expected volatility
|
|
|
24.2
|
%
|
Expected dividends
|
|
|
0
|
|
Expected term
|
|
|
4 years
|
|
Risk-free interest rate
|
|
|
4.67
|
%
|
As part of adopting SFAS No. 123(R), the Company
examined concentrations of holdings, its historical patterns of
option exercises and forfeitures, as well as forward-looking
factors, in an effort to determine if there were any discernable
employee populations. From this analysis, the Company identified
two employee populations, one consisting primarily of certain
senior executives and the other consisting of all other
recipients.
The expected volatility rate was estimated based on historical
volatility. As part of adopting SFAS No. 123(R), the
Company also reviewed the market based implied volatility of
actively traded options of its common stock and determined that
historical volatility did not differ significantly from the
implied volatility.
The expected life computation is based on historical exercise
and cancellation patterns and forward-looking factors, where
present, for each population identified. The risk-free interest
rate is based on the U.S. Treasury yield curve in effect at
the time of the grant. The pre-vesting forfeiture rate is based
on historical rates and forward looking factors for each
population identified. As required under
SFAS No. 123(R), the Company will adjust the estimated
forfeiture rate to its actual experience.
13
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Options outstanding and exercisable under the 1996 Plan and 2000
Plan as of December 31, 2006, and changes during each of
the three years then ended were as follows (in thousands, except
share and per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-
|
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
|
|
|
|
|
|
|
Weighted-
|
|
|
Remaining
|
|
|
Aggregate
|
|
|
|
|
|
|
Average
|
|
|
Contractual
|
|
|
Intrinsic
|
|
|
|
|
|
|
Exercise
|
|
|
Term
|
|
|
Value as of
|
|
|
|
Shares
|
|
|
Price
|
|
|
(In Years)
|
|
|
December 31, 2006
|
|
|
Outstanding at December 31,
2003
|
|
|
8,029,370
|
|
|
$
|
17.59
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
387,000
|
|
|
|
26.41
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(614,444
|
)
|
|
|
15.19
|
|
|
|
|
|
|
|
|
|
Forfeited and canceled
|
|
|
(345,647
|
)
|
|
|
22.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31,
2004
|
|
|
7,456,279
|
|
|
|
18.03
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
1,325,700
|
|
|
|
33.02
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(3,134,721
|
)
|
|
|
15.81
|
|
|
|
|
|
|
|
|
|
Forfeited and canceled
|
|
|
(276,984
|
)
|
|
|
26.02
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31,
2005
|
|
|
5,370,274
|
|
|
|
22.63
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
1,151,000
|
|
|
|
38.07
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(865,833
|
)
|
|
|
16.47
|
|
|
|
|
|
|
$
|
18,200
|
|
Forfeited and canceled
|
|
|
(172,913
|
)
|
|
|
34.02
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31,
2006
|
|
|
5,482,528
|
|
|
$
|
26.48
|
|
|
|
6.8 years
|
|
|
$
|
56,941
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at December 31,
2006
|
|
|
3,562,002
|
|
|
$
|
21.55
|
|
|
|
6.3 years
|
|
|
$
|
53,391
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The weighted-average grant date fair value of stock options
granted during the year ended December 31, 2006, was
$10.38. The aggregate intrinsic value (the number of
in-the-money stock options multiplied by the difference between
the Companys closing stock price on the last trading day
of the reporting period and the exercise price of the respective
stock options) in the table above represents the amount that
would have been received by the option holders had all option
holders exercised their options on December 31, 2006. This
amount changes based on the market value of the Companys
common stock.
The Company has also awarded restricted stock under the 2000
Plan to various employees and its directors. The restrictions on
these shares generally lapse in one-third increments on each of
the first three anniversaries of the award date. Certain of the
restricted stock awards granted to the Companys senior
executives also contain a performance objective that must be met
in addition to the vesting requirements. If the performance
objective is not attained the awards will be forfeited in their
entirety. Once the performance objective has been attained,
restrictions will lapse in one-third increments on each of the
first three anniversaries of the award date. Notwithstanding the
above-mentioned performance objectives and vesting requirements,
the restrictions will lapse earlier in the event of death,
disability, termination of employment by employer for reason
other than for cause of the holder of the restricted stock or in
the event of change in control of the Company. Restricted stock
awards subject to performance standards are not considered
outstanding for purposes of determining earnings per share until
the performance objectives have been satisfied.
14
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Restricted stock outstanding under the 2000 Plan as of
December 31, 2006, and changes during each of the two years
then ended are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Average
|
|
|
|
|
|
|
Fair
|
|
|
|
Shares
|
|
|
Value
|
|
|
Unvested at December 31, 2004
|
|
|
|
|
|
$
|
|
|
Granted
|
|
|
563,000
|
|
|
|
32.37
|
|
Vested
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
(5,000
|
)
|
|
|
32.37
|
|
|
|
|
|
|
|
|
|
|
Unvested at December 31, 2005
|
|
|
558,000
|
|
|
$
|
32.37
|
|
Granted
|
|
|
606,000
|
|
|
|
38.26
|
|
Vested
|
|
|
(185,975
|
)
|
|
|
32.43
|
|
Forfeited
|
|
|
(8,334
|
)
|
|
|
35.93
|
|
|
|
|
|
|
|
|
|
|
Unvested at December 31, 2006
|
|
|
969,691
|
|
|
$
|
36.05
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2006, there was $23.4 million of
unrecognized stock-based compensation expense related to
unvested restricted stock expected to be recognized over a
weighted-average period of 21 months.
Under the Directors Fee Deferral Plan, the Companys
outside directors may elect to receive share equivalent units in
lieu of cash for their directors fee. These units are held
in the plan until the director electing to receive the share
equivalent units retires or otherwise terminates
his/her
directorship with the Company. Share equivalent units are
converted to shares of common stock of the Company at the time
of distribution. The following table represents the amount of
directors fees which were deferred and the equivalent
units into which they converted for each of the respective
periods:
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
Directors fees earned and
deferred into plan
|
|
$
|
177,500
|
|
|
$
|
184,500
|
|
|
|
|
|
|
|
|
|
|
Equivalent units
|
|
|
4,843.449
|
|
|
|
4,942.552
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2006, there are a total of
9,786.001 units deferred in the plan with an aggregate fair
value of $357,385, based on the closing market price of the
Companys common stock at December 31, 2006 of $36.52.
|
|
3.
|
Long-Term
Leases, Acquisitions and Divestitures of Hospitals
|
During 2006, the Company acquired through 7 separate purchase
transactions and three capital lease transactions, substantially
all of the assets and working capital of eight hospitals and
three home health agencies. On March 1, 2006, the Company
acquired, through a combination of purchasing certain assets and
entering into a capital lease for other related assets, Forrest
City Hospital, a 118-bed hospital located in Forrest City,
Arkansas. On April 1, 2006, the Company completed the
acquisition of two hospitals from Baptist Health System,
Birmingham, Alabama: Baptist Medical Center DeKalb
(134 beds) and Baptist Medical Center Cherokee (60
beds). On May 1, 2006, the Company acquired Via Christi
Oklahoma Regional Medical Center, a 140-bed hospital located in
Ponca City, Oklahoma. On June 1, 2006, the Company acquired
Mineral Area Regional Medical Center, a 135-bed hospital located
in Farmington, Missouri. On June 30, 2006 the Company
acquired Cottage Home Options, a home health agency and related
business, located in Galesburg, Illinois. On July 1, 2006,
the Company acquired the healthcare assets of Vista Health,
which included Victory Memorial Hospital (336 beds) and St.
Therese Medical
15
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Center (71 non-acute care beds), both located in Waukegan,
Illinois. On September 1, 2006, the Company acquired Humble
Texas Home Care, a home health agency located in Humble, Texas.
On October 1, 2006, the Company acquired Helpsource Home
Health, a home health agency located in Wichita Falls, Texas. On
November 1, 2006 the Company acquired through two separate
capital lease transactions, Campbell Memorial Hospital, a 99-bed
hospital located in Weatherford, Texas and Union County
Hospital, a 25-bed hospital located in Anna, Illinois. The
aggregate consideration for these eight hospitals and three home
health agencies totaled approximately $385.7 million, of
which $353.8 million was paid in cash and
$31.9 million was assumed in liabilities. Goodwill
recognized in these transactions totaled $65.6 million,
which is expected to be fully deductible for tax purposes.
Effective March 18, 2006, the Company sold Highland Medical
Center, a 123-bed facility located in Lubbock, Texas, to Shiloh
Health Services, Inc. of Louisville, Kentucky. The proceeds from
this sale were $0.5 million. This hospital had previously
been classified as held for sale.
Effective January 31, 2005, the Companys lease of
Scott County Hospital, a 99-bed facility located in Oneida,
Tennessee, expired pursuant to its terms.
Effective March 31, 2005, the Company sold The Kings
Daughters Hospital, a 137-bed facility located in Greenville,
Mississippi, to Delta Regional Medical Center, also located in
Greenville, Mississippi. In a separate transaction, also
effective March 31, 2005, the Company sold Troy Regional
Medical Center, a
97-bed
facility located in Troy, Alabama, Lakeview Community Hospital,
a 74-bed facility located in Eufaula, Alabama and Northeast
Medical Center, a 75-bed facility located in Bonham, Texas to
Attentus Healthcare Company of Brentwood, Tennessee. The
aggregate sales price for these four hospitals was approximately
$52 million and was received in cash.
During 2005, the Company acquired through four separate purchase
transactions and one capital lease transaction, substantially
all of the assets and working capital of five hospitals. On
March 1, 2005, the Company acquired an 85% controlling
interest in Chestnut Hill Hospital, a 222-bed hospital located
in Philadelphia, Pennsylvania. On June 30, 2005, the
Company acquired, through a capital lease, Bedford County
Medical Center, a 104-bed hospital located in Shelbyville,
Tennessee. On September 30, 2005, the Company acquired the
assets of Newport Hospital and Clinic located in Newport,
Arkansas. This facility, which was previously operated as an
83-bed acute care general hospital, was closed by its former
owner simultaneous with this transaction. The operations of this
hospital were consolidated with Harris Hospital, also located in
Newport, which is owned and operated by a wholly owned
subsidiary of the Company. On October 1, 2005, the Company
acquired Sunbury Community Hospital, a 123-bed hospital located
in Sunbury, Pennsylvania, and Bradley Memorial Hospital, a
251-bed hospital located in Cleveland, Tennessee. The aggregate
consideration for the five hospitals totaled approximately
$176 million, of which $138 million was paid in cash
and $38 million was assumed in liabilities. Goodwill
recognized in these transactions totaled approximately
$51 million, which is expected to be fully deductible for
tax purposes.
In connection with the above actions and in accordance with
SFAS No. 144, the Company has classified the results
of operations of Randolph County Medical Center, Sabine Medical
Center, Scott County Hospital, The Kings Daughters
Hospital, Troy Regional Medical Center, Lakeview Community
Hospital, Northeast Medical Center and Highland Medical Center
as discontinued operations in the accompanying consolidated
statements of income. The consolidated statements of income for
each period presented have been restated to reflect the
classification of these eight hospitals as discontinued
operations.
16
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Net operating revenues and loss reported for the eight hospitals
in discontinued operations are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
(In thousands)
|
|
|
Net operating revenues:
|
|
$
|
4,294
|
|
|
$
|
50,520
|
|
|
$
|
156,711
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations of hospitals
sold or held for sale before income taxes
|
|
|
(1,008
|
)
|
|
|
(16,141
|
)
|
|
|
(11,039
|
)
|
Loss on sale of hospitals
|
|
|
(3,938
|
)
|
|
|
(6,295
|
)
|
|
|
(2,186
|
)
|
Impairment of long-lived assets of
hospital held for sale
|
|
|
|
|
|
|
(6,718
|
)
|
|
|
(2,539
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations,
before taxes
|
|
|
(4,946
|
)
|
|
|
(29,154
|
)
|
|
|
(15,764
|
)
|
Income tax benefit
|
|
|
1,730
|
|
|
|
6,560
|
|
|
|
4,840
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations,
net of tax
|
|
$
|
(3,216
|
)
|
|
$
|
(22,594
|
)
|
|
$
|
(10,924
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The computation of loss from discontinued operations, before
taxes, for the year ended December 31, 2006, includes the
net write-off of $4.4 million of tangible assets at the one
hospital sold during the year ended December 31, 2006.
The computation of loss from discontinued operations, before
taxes, for the year ended December 31, 2005, includes the
net write-off of $51.5 million of tangible assets and
$17.1 million of goodwill of the four hospitals sold and
one hospital designated as held for sale in the second quarter
of 2005.
Included in the computation of the loss from discontinued
operations, before taxes for the year ended December 31,
2004, is a write-off of $7 million of tangible assets and
$2.7 million of goodwill at the two hospitals sold (see
Note 4 Goodwill and Other Intangible Assets) and a
write-down of $3 million of assets at the hospital held for
sale.
Assets and liabilities of the hospitals classified as
discontinued operations included in the accompanying
consolidated balance sheets are as follows. There are no
material assets or liabilities related to these hospitals
remaining at December 31, 2006.
|
|
|
|
|
|
|
December 31,
|
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Current assets
|
|
$
|
4,133
|
|
Property and equipment
|
|
|
|
|
Other assets
|
|
|
3,000
|
|
Current liabilities
|
|
|
(6,601
|
)
|
|
|
|
|
|
Net assets
|
|
$
|
532
|
|
|
|
|
|
|
During 2004, the Company acquired, through two separate purchase
transactions, most of the assets and working capital of two
hospitals. On July 1, 2004, the Company acquired Galesburg
Cottage Hospital, a
170-bed
facility located in Galesburg, Illinois. On August 1, 2004,
the Company acquired Phoenixville Hospital, a 143-bed facility
located in Phoenixville, Pennsylvania. This acquisition also
included a 95,000 square foot medical complex in nearby
Limerick, Pennsylvania which houses an ambulatory surgical
facility, an imaging center and medical office space. The
aggregate consideration for the two hospitals totaled
approximately $135 million, consisting of approximately
$123 million in cash and approximately $12 million in
assumed liabilities and acquisition costs. Goodwill recorded
during 2004 is expected to be fully deductible for tax purposes.
17
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Effective August 1, 2004, the Company sold Randolph County
Medical Center, a 50 bed facility located in Pocahontas,
Arkansas and Sabine Medical Center, a 48 bed facility located in
Many, Louisiana, two of the Companys underperforming
hospitals, to Associated Healthcare Systems in Brentwood,
Tennessee. The aggregate sales price for these two hospitals was
approximately $9.0 million of which $7.8 million was
received in cash and $1.2 million was received in the form
of a note, which was paid in full in 2005.
The aforementioned acquisitions were accounted for using the
purchase method of accounting. The allocation of the purchase
price has been determined by the Company based upon available
information and, for certain acquisition transactions closed in
2006, is subject to settling amounts related to purchased
working capital and in some instances final appraisals.
Independent asset valuations are generally completed within
120 days of the date of acquisition; working capital
settlements are generally made within 180 days of the date
of acquisition. Adjustments to the purchase price allocation are
not expected to be material.
The table below summarizes the allocations of the purchase price
(including assumed liabilities) for these acquisitions (in
thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Current assets
|
|
$
|
56,896
|
|
|
$
|
19,144
|
|
|
$
|
10,104
|
|
Property and equipment
|
|
|
262,335
|
|
|
|
110,854
|
|
|
|
76,917
|
|
Goodwill and other intangibles
|
|
|
66,490
|
|
|
|
43,619
|
|
|
|
49,048
|
|
The operating results of the foregoing hospitals have been
included in the consolidated statements of income from their
respective dates of acquisition. The following pro forma
combined summary of operations of the Company gives effect to
using historical information of the operations of the hospitals
purchased in 2006 and 2005 as if the acquisitions had occurred
as of January 1, 2005 (in thousands except per share data):
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
Pro forma net operating revenues
|
|
$
|
4,569,861
|
|
|
$
|
4,307,657
|
|
Pro forma net income
|
|
|
159,940
|
|
|
|
138,940
|
|
Pro forma net income per share:
|
|
|
|
|
|
|
|
|
Basic
|
|
|
1.68
|
|
|
|
1.57
|
|
Diluted
|
|
|
1.66
|
|
|
|
1.50
|
|
|
|
4.
|
Goodwill
and Other Intangible Assets
|
The changes in the carrying amount of goodwill are as follows
(in thousands):
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
Balance, beginning of year
|
|
$
|
1,259,816
|
|
|
$
|
1,213,783
|
|
Goodwill acquired as part of
acquisitions during the year
|
|
|
67,550
|
|
|
|
51,773
|
|
Consideration adjustments and
finalization of purchase price allocations for prior years
acquisitions
|
|
|
9,159
|
|
|
|
11,353
|
|
Goodwill written off as part of
disposals
|
|
|
|
|
|
|
(17,093
|
)
|
|
|
|
|
|
|
|
|
|
Balance, end of year
|
|
$
|
1,336,525
|
|
|
$
|
1,259,816
|
|
|
|
|
|
|
|
|
|
|
The Company performed its initial goodwill evaluation, as
required by SFAS No. 142, during the first quarter of
2002 and the annual evaluation as of each succeeding
September 30th. No impairment was indicated by these
evaluations.
18
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The gross carrying amount of the Companys other intangible
assets was $13.7 million as of December 31, 2006 and
$11.9 million as of December 31, 2005, and the net
carrying amount was $7.4 million and $7.6 million as
of December 31, 2006 and 2005, respectively. Other
intangible assets are included in other assets on the
Companys consolidated balance sheets.
The weighted average amortization period for the intangible
assets subject to amortization is approximately 5 years.
There are no expected residual values related to these
intangible assets. Amortization expense for these intangible
assets was $1.9 million, $1.3 million and
$1.1 million during the years ended December 31, 2006,
2005 and 2004, respectively. Amortization expense on intangible
assets is estimated to be $1.8 million in 2007,
$1.2 million in 2008, $0.9 million in 2009,
$0.8 million in 2010 and $0.5 million in 2011.
The provision for income taxes for income from continuing
operations consists of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Current
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
113,823
|
|
|
$
|
100,588
|
|
|
$
|
55,184
|
|
State
|
|
|
13,555
|
|
|
|
12,746
|
|
|
|
9,003
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
127,378
|
|
|
|
113,334
|
|
|
|
64,187
|
|
Deferred
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
(18,586
|
)
|
|
|
5,737
|
|
|
|
33,994
|
|
State
|
|
|
(2,110
|
)
|
|
|
1,711
|
|
|
|
5,890
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(20,696
|
)
|
|
|
7,448
|
|
|
|
39,884
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total provision for income taxes
for income from continuing operations
|
|
$
|
106,682
|
|
|
$
|
120,782
|
|
|
$
|
104,071
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table reconciles the differences between the
statutory federal income tax rate and the effective tax rate
(dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
Amount
|
|
|
%
|
|
|
Amount
|
|
|
%
|
|
|
Amount
|
|
|
%
|
|
|
Provision for income taxes at
statutory federal rate
|
|
$
|
97,356
|
|
|
|
35.0
|
%
|
|
$
|
108,822
|
|
|
|
35.0
|
%
|
|
$
|
93,250
|
|
|
|
35.0
|
%
|
State income taxes, net of federal
income tax benefit
|
|
|
7,439
|
|
|
|
2.7
|
|
|
|
9,570
|
|
|
|
3.0
|
|
|
|
9,608
|
|
|
|
3.6
|
|
Other
|
|
|
1,887
|
|
|
|
0.7
|
|
|
|
2,390
|
|
|
|
0.8
|
|
|
|
1,213
|
|
|
|
0.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes and
effective tax rate for income from continuing operations
|
|
$
|
106,682
|
|
|
|
38.4
|
%
|
|
$
|
120,782
|
|
|
|
38.8
|
%
|
|
$
|
104,071
|
|
|
|
39.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Deferred income taxes are based on the estimated future tax
effects of differences between the financial statement and tax
bases of assets and liabilities under the provisions of the
enacted tax laws. Deferred income taxes as of December 31,
consist of (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
|
Assets
|
|
|
Liabilities
|
|
|
Assets
|
|
|
Liabilities
|
|
|
Net operating loss and credit
carryforwards
|
|
$
|
26,709
|
|
|
$
|
|
|
|
$
|
27,798
|
|
|
$
|
|
|
Property and equipment
|
|
|
|
|
|
|
136,249
|
|
|
|
|
|
|
|
124,439
|
|
Self-insurance liabilities
|
|
|
35,607
|
|
|
|
|
|
|
|
28,639
|
|
|
|
|
|
Intangibles
|
|
|
|
|
|
|
101,569
|
|
|
|
|
|
|
|
85,745
|
|
Other liabilities
|
|
|
|
|
|
|
2,879
|
|
|
|
|
|
|
|
3,472
|
|
Long-term debt and interest
|
|
|
989
|
|
|
|
|
|
|
|
|
|
|
|
56
|
|
Accounts receivable
|
|
|
33,535
|
|
|
|
|
|
|
|
8,767
|
|
|
|
|
|
Accrued expenses
|
|
|
20,362
|
|
|
|
|
|
|
|
17,861
|
|
|
|
|
|
Other comprehensive income
|
|
|
|
|
|
|
1,952
|
|
|
|
|
|
|
|
8,391
|
|
Stock-Based compensation
|
|
|
6,353
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
12,078
|
|
|
|
|
|
|
|
6,733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
135,633
|
|
|
|
242,649
|
|
|
|
89,798
|
|
|
|
222,103
|
|
Valuation allowance
|
|
|
(21,207
|
)
|
|
|
|
|
|
|
(21,146
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total deferred income taxes
|
|
$
|
114,426
|
|
|
$
|
242,649
|
|
|
$
|
68,652
|
|
|
$
|
222,103
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Management believes that the net deferred tax assets will
ultimately be realized, except as noted below. Managements
conclusion is based on its estimate of future taxable income and
the expected timing of temporary difference reversals. The
Company has state net operating loss carry forwards of
approximately $458 million, which expire from 2007 to 2026.
With respect to the deferred tax liability pertaining to
intangibles, as included above, goodwill purchased in connection
with certain of the Companys business acquisitions is
amortizable for income tax reporting purposes. However, for
financial reporting purposes, there is no corresponding
amortization allowed with respect to such purchased goodwill.
The valuation allowance increased by $0.1 million and
$1.5 million during the years ended December 31, 2006
and 2005, respectively. In addition to amounts previously
discussed, the change in valuation allowance relates to a
redetermination of the amount of, and realizability of, net
operating losses in certain state income tax jurisdictions.
The Company paid income taxes, net of refunds received, of
$128.1 million, $68.1 million and $60.9 million
during 2006, 2005, and 2004, respectively.
Federal Income Tax Examination. The Company agreed to a
settlement at the Internal Revenue Service Appeals Office with
respect to the 2003 consolidated income tax return year. The
Company has since received closing letters with respect to the
examinations for the tax year 2003. This settlement was not
material to the Companys consolidated statement of income
or financial position.
20
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Long-term debt consists of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
Credit Facilities:
|
|
|
|
|
|
|
|
|
Revolving Credit Loans
|
|
$
|
|
|
|
$
|
|
|
Term Loans
|
|
|
1,572,000
|
|
|
|
1,185,000
|
|
Convertible Notes
|
|
|
|
|
|
|
136,624
|
|
Tax-exempt bonds
|
|
|
8,000
|
|
|
|
8,000
|
|
Senior Subordinated Notes
|
|
|
300,000
|
|
|
|
300,000
|
|
Capital lease obligations (see
Note 8)
|
|
|
44,670
|
|
|
|
21,792
|
|
Term loans from acquisitions
|
|
|
|
|
|
|
|
|
Other
|
|
|
16,507
|
|
|
|
16,208
|
|
|
|
|
|
|
|
|
|
|
Total debt
|
|
|
1,941,177
|
|
|
|
1,667,624
|
|
Less current maturities
|
|
|
(35,396
|
)
|
|
|
(19,124
|
)
|
|
|
|
|
|
|
|
|
|
Total long-term debt
|
|
$
|
1,905,781
|
|
|
$
|
1,648,500
|
|
|
|
|
|
|
|
|
|
|
Credit Facilities. On August 19, 2004,
the Company entered into a $1.625 billion senior secured
credit facility with a consortium of lenders which was
subsequently amended on December 16, 2004, July 8,
2005 and December 13, 2006. This facility replaced the
Companys previous credit facility and consists of a
$1.2 billion term loan that matures in 2011 and a
$425 million revolving credit facility that matures in
2009. The First Incremental Facility Amendment, dated as of
December 13, 2006, provides for an additional tranche of
term loans to the Credit Agreement in an aggregate principal
amount of $400 million (the Incremental Term Loan
Facility). The full amount of the Incremental Term Loan
Facility was funded on December 13, 2006, and the proceeds
were used to repay the full outstanding amount (approximately
$326 million) of the revolving credit facility under the
Credit Agreement and the balance is available to be used for
general corporate purposes. The Company may elect from time to
time an interest rate per annum for the borrowings under the
term loan, including the incremental term loan, and revolving
credit facility equal to (a) an alternate base rate, which
will be equal to the greatest of (i) the Prime Rate in
effect and (ii) the Federal Funds effective Rate, plus
50 basis points, plus (1) 75 basis points for the
term loan and (2) the Applicable Margin for revolving
credit loans or (b) the Eurodollar Rate plus
(1) 175 basis points for the term loan and
(2) the Applicable Margin for Eurodollar revolving credit
loans. The Company also pays a commitment fee for the daily
average unused commitments under the revolving credit facility.
The commitment fee is based on a pricing grid depending on the
Applicable Margin for Eurodollar revolving credit loans and
ranges from 0.250% to 0.500%. The commitment fee is payable
quarterly in arrears and on the revolving credit termination
date with respect to the available revolving credit commitments.
In addition, the Company will pay fees for each letter of credit
issued under the credit facility. The purpose of the facility
was to refinance the Companys previous credit agreement,
repay specified other indebtedness, and fund general corporate
purposes including amending the credit facility to permit
declaration and payment of cash dividends to repurchase shares
or make other distributions, subject to certain restrictions. In
connection with this refinancing, the Company recorded a pre-tax
write-off of approximately $0.8 million in deferred loan
costs relative to the early extinguishment of a portion of the
previous credit facility.
As of December 31, 2006, the Companys availability
for additional borrowings under its revolving tranche was
$425 million, of which $21 million was set aside for
outstanding letters of credit. The Company also has the ability
to add up to $200 million of borrowing capacity from
receivable transactions (including securitizations) under its
senior secured credit facility which has not yet been accessed.
The Company also has
21
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
the ability to amend the senior secured credit facility to
provide for one or more tranches of term loans in an aggregate
principal amount up to $400 million, which the Company has
not yet accessed. As of December 31, 2006, the
Companys weighted average interest rate under its credit
agreement was 7.3%.
The terms of the credit agreement include various restrictive
covenants. These covenants include restrictions on additional
indebtedness, liens, investments, asset sales, capital
expenditures, sale and leasebacks, contingent obligations,
transactions with affiliates, dividends and stock repurchases
and fundamental changes. The Company would be required to amend
the existing credit agreement in order to pay dividends in
excess of $300 million to the Companys shareholders.
The covenants also require maintenance of various ratios
regarding consolidated total indebtedness, consolidated
interest, and fixed charges.
The Term Loans are scheduled to be paid with principal payments
for future years as follows (in thousands):
|
|
|
|
|
|
|
Term Loans
|
|
|
2007
|
|
$
|
16,000
|
|
2008
|
|
|
16,000
|
|
2009
|
|
|
16,000
|
|
2010
|
|
|
295,000
|
|
2011
|
|
|
850,000
|
|
Thereafter
|
|
|
379,000
|
|
|
|
|
|
|
Total
|
|
$
|
1,572,000
|
|
|
|
|
|
|
As of December 31, 2006 and 2005, the Company had letters
of credit issued, primarily in support of potential insurance
related claims and certain bonds of approximately
$21 million and $23 million, respectively.
Convertible Notes. On October 15, 2001,
the Company sold $287.5 million aggregate principal amount
(including the underwriters over-allotment option) of
4.25% convertible notes for face value. The notes were scheduled
to mature on October 15, 2008 unless converted or redeemed
earlier. Interest on the notes was payable semi-annually on
April 15 and October 15 of each year. The interest payments
commenced April 15, 2002. The notes were convertible, at
the option of the holder, into shares of the Companys
common stock at any time before the maturity date, unless the
Company has previously redeemed or repurchased the notes, at a
conversion rate of 29.8507 shares of common stock per
$1,000 principal amount of notes representing a conversion price
of $33.50. The conversion rate was subject to anti-dilution
adjustment in some events.
On November 14, 2005 the Company elected to call for
redemption $150 million in principal amount of the
convertible notes. At the conclusion of the first call for
redemption, $0.3 million in principal amount of the
convertible notes were redeemed for cash, and
$149.7 million of the convertible notes called for
redemption, plus an additional $0.9 million of the
convertible notes, were converted by the holders into
4,495,083 shares of the Companys common stock,
$.01 par value per share. On December 16, 2005 the
Company elected to call for redemption the remaining convertible
notes. In January 2006, at the conclusion of this second call
for redemption $0.1 million in principal amount of the
convertible notes were redeemed for cash and the remaining
balance of $136.5 million were converted into
4,074,510 shares of the Companys common stock.
Tax-Exempt Bonds. Tax-Exempt Bonds bore
interest at floating rates, which averaged 3.51% and 2.51%
during 2006 and 2005, respectively.
Senior Subordinated Notes. On
December 16, 2004, the Company completed a private
placement offering of $300 million aggregate principal
amount of 6.5% senior subordinated notes due 2012. The
senior subordinated notes were sold in an offering pursuant to
Rule 144A and Regulation S under the Securities Act
22
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
of 1933. The senior subordinated notes have not been registered
under the Securities Act of 1933 or the securities laws of any
state and may not be offered or sold in the United States absent
registration or an applicable exemption from the registration
requirements under the Securities Act of 1933 and any applicable
state securities laws. On February 24, 2005, the Company
filed a registration statement to exchange these notes for
registered notes. This exchange was completed during the first
quarter of 2005.
Other Debt. As of December 31, 2006,
other debt consisted primarily of an industrial revenue bond and
other obligations maturing in various installments through 2014.
The Company is currently a party to twelve separate interest
swap agreements with an aggregate notional amount of
$1,250 million, to limit the effect of changes in interest
rates on a portion of the Companys long-term borrowings.
On each of these swaps, the Company receives a variable rate of
interest based on the three-month London Inter-Bank Offer Rate
(LIBOR) in exchange for the payment of a fixed rate
of interest. The Company currently pays, on a quarterly basis, a
margin above LIBOR of 175 basis points for revolver loans
and term loans under the senior secured credit facility. See
footnote 7 for additional information regarding these swaps.
As of December 31, 2006, the scheduled maturities of
long-term debt outstanding, including capital leases for each of
the next five years and thereafter are as follows (in thousands):
|
|
|
|
|
2007
|
|
$
|
35,396
|
|
2008
|
|
|
21,062
|
|
2009
|
|
|
18,523
|
|
2010
|
|
|
304,941
|
|
2011
|
|
|
851,714
|
|
Thereafter
|
|
|
709,541
|
|
|
|
|
|
|
|
|
$
|
1,941,177
|
|
|
|
|
|
|
The Company paid interest of $96 million, $90 million
and $74 million on borrowings during the years ended
December 31, 2006, 2005 and 2004, respectively.
|
|
7.
|
Fair
Values of Financial Instruments
|
The fair value of financial instruments has been estimated by
the Company using available market information as of
December 31, 2006 and 2005, and valuation methodologies
considered appropriate. The
23
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
estimates presented are not necessarily indicative of amounts
the Company could realize in a current market exchange (in
thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
|
Carrying
|
|
|
Estimated Fair
|
|
|
Carrying
|
|
|
Estimated Fair
|
|
|
|
Amount
|
|
|
Value
|
|
|
Amount
|
|
|
Value
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
40,566
|
|
|
$
|
40,566
|
|
|
$
|
104,108
|
|
|
$
|
104,108
|
|
Available-for-sale securities
|
|
|
25,334
|
|
|
|
25,334
|
|
|
|
19,778
|
|
|
|
19,778
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit facilities
|
|
|
1,572,000
|
|
|
|
1,573,540
|
|
|
|
1,185,000
|
|
|
|
1,199,072
|
|
Convertible Notes
|
|
|
|
|
|
|
|
|
|
|
136,624
|
|
|
|
156,434
|
|
Tax-exempt Bonds
|
|
|
8,000
|
|
|
|
8,000
|
|
|
|
8,000
|
|
|
|
8,000
|
|
Senior Subordinated Notes
|
|
|
300,000
|
|
|
|
295,500
|
|
|
|
300,000
|
|
|
|
294,750
|
|
Other debt
|
|
|
4,344
|
|
|
|
4,344
|
|
|
|
5,536
|
|
|
|
5,536
|
|
Cash and cash equivalents. The carrying amount
approximates fair value due to the short term maturity of these
instruments (less than three months).
Available-for-sale securities. Estimated fair
value is based on closing price as quoted in public markets.
Credit facilities, term loans from acquisitions and other
debt. Estimated fair value is based on
information from the Companys bankers regarding relevant
pricing for trading activity among the Companys lending
institutions.
Convertible Notes. Estimated fair value is
based on the average bid and ask price as quoted in public
markets for these instruments.
Tax Exempt Bonds. The carrying amount
approximates fair value as a result of the weekly interest rate
reset feature of these publicly traded instruments.
Senior Subordinated Notes. Estimated fair
value is based on the average bid and ask price as quoted by the
bank who served as underwriters in the sale of these notes.
Interest Rate Swaps. The fair value of
interest rate swap agreements is the amount at which they could
be settled, based on estimates obtained from the counterparty.
The Company has designated the interest rate swaps as cash flow
hedge instruments whose recorded value in the consolidated
balance sheet approximates fair market value.
The Company assesses the effectiveness of its hedge instruments
on a quarterly basis. For the years ended December 31, 2006
and 2005, the Company completed an assessment of the cash flow
hedge instruments and determined the hedges to be highly
effective. The Company has also determined that the ineffective
portion of the hedges do not have a material effect on the
Companys consolidated financial position, operations or
cash flows. The counterparty to the interest rate swap
agreements exposes the Company to credit risk in the event of
non-performance. However, the Company does not anticipate
non-performance by the counterparty. The
24
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Company does not hold or issue derivative financial instruments
for trading purposes. Interest rate swaps consisted of the
following at December 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional
|
|
|
Fixed
|
|
|
|
|
|
Fair
|
|
|
|
Amount
|
|
|
Interest
|
|
|
Termination
|
|
|
Value
|
|
Swap #
|
|
(In 000s)
|
|
|
Rate
|
|
|
Date
|
|
|
(000s)
|
|
|
1
|
|
|
100,000
|
|
|
|
2.04
|
%
|
|
|
June 13, 2007
|
|
|
$
|
1,466
|
|
2
|
|
|
150,000
|
|
|
|
3.30
|
%
|
|
|
November 4, 2007
|
|
|
|
2,451
|
|
3
|
|
|
100,000
|
|
|
|
2.40
|
%
|
|
|
June 13, 2008
|
|
|
|
3,848
|
|
4
|
|
|
100,000
|
|
|
|
3.586
|
%
|
|
|
August 29, 2008
|
|
|
|
2,429
|
|
5
|
|
|
100,000
|
|
|
|
4.06
|
%
|
|
|
May 30, 2008
|
|
|
|
1,486
|
|
6
|
|
|
100,000
|
|
|
|
3.9350
|
%
|
|
|
June 6, 2009
|
|
|
|
2,497
|
|
7
|
|
|
100,000
|
|
|
|
4.3375
|
%
|
|
|
November 30, 2009
|
|
|
|
1,810
|
|
8
|
|
|
100,000
|
|
|
|
4.9360
|
%
|
|
|
October 4, 2010
|
|
|
|
186
|
|
9
|
|
|
100,000
|
|
|
|
4.7090
|
%
|
|
|
January 24, 2011
|
|
|
|
1,043
|
|
10
|
|
|
100,000
|
|
|
|
4.7185
|
%
|
|
|
August 19, 2011
|
|
|
|
1,155
|
|
11
|
|
|
100,000
|
|
|
|
4.7040
|
%
|
|
|
August 19, 2011
|
|
|
|
1,249
|
|
12
|
|
|
100,000
|
|
|
|
4.6250
|
%
|
|
|
August 19, 2011
|
|
|
|
1,224
|
|
|
|
|
(1) |
|
This swap agreement becomes effective June 13, 2007,
concurrent with (1) the termination of agreement No. 1
listed above. |
Assuming no change in December 31, 2006 interest rates,
approximately $15.7 million will be recognized in earnings
through interest income during the year ending December 31,
2007 pursuant to the interest rate swap agreements. If interest
rate swaps do not remain highly effective as a cash flow hedge,
the derivatives gains or losses reported through other
comprehensive income will be reclassified into earnings.
The Company leases hospitals, medical office buildings, and
certain equipment under capital and operating lease agreements.
During 2006, the Company entered into $29.8 million of
capital leases. All lease agreements generally require the
Company to pay maintenance, repairs, property taxes and
insurance costs. Commitments relating to noncancellable
operating and capital leases for each of the next five years and
thereafter are as follows (in thousands):
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
Operating
|
|
|
Capital
|
|
|
2007
|
|
$
|
62,415
|
|
|
$
|
7,285
|
|
2008
|
|
|
47,087
|
|
|
|
6,734
|
|
2009
|
|
|
37,239
|
|
|
|
4,381
|
|
2010
|
|
|
28,553
|
|
|
|
3,694
|
|
2011
|
|
|
24,292
|
|
|
|
3,382
|
|
Thereafter
|
|
|
98,807
|
|
|
|
37,924
|
|
|
|
|
|
|
|
|
|
|
Total minimum future payments
|
|
$
|
298,393
|
|
|
$
|
63,400
|
|
|
|
|
|
|
|
|
|
|
Less imputed interest
|
|
|
|
|
|
|
(18,730
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
44,670
|
|
Less current portion
|
|
|
|
|
|
|
(5,182
|
)
|
|
|
|
|
|
|
|
|
|
Long-term capital lease obligations
|
|
|
|
|
|
$
|
39,488
|
|
|
|
|
|
|
|
|
|
|
25
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Assets capitalized under capital leases as reflected in the
accompanying consolidated balance sheets were $20.4 million
of land and improvements, $179.3 million of buildings and
improvements, and $49.5 million of equipment and fixtures
as of December 31, 2006 and $12.1 million of land and
improvements, $96.3 million of buildings and improvements
and $43.9 million of equipment and fixtures as of
December 31, 2005. The accumulated depreciation related to
assets under capital leases was $71.8 million and
$56.2 million as of December 31, 2006 and 2005,
respectively. Depreciation of assets under capital leases is
included in depreciation and amortization and amortization of
debt discounts on capital lease obligations is included in
interest expense in the consolidated statements of income.
|
|
9.
|
Employee
Benefit Plans
|
The Company maintains various benefit plans, including a defined
contribution plan, defined benefit plans, and deferred
compensation plans. The Companys defined contribution plan
is qualified under Section 401(k) of the Internal Revenue
Code, and covers substantially all employees at its hospitals,
clinics, and the corporate offices. Participants may contribute
a portion of their compensation not exceeding a limit set
annually by the Internal Revenue Service. This plan includes a
provision for the Company to match a portion of employee
contributions. Total expense under the 401(k) plan was
$10.7 million, $8.8 million and $8.3 million for
the years ended December 31, 2006, 2005 and 2004,
respectively. The Company has three defined benefit,
non-contributory pension plans (Pension plans) that covers
certain employees at three of its hospitals. One of the pension
plans was established in 2006. The Pension plans provide
benefits to covered individuals satisfying certain age and
service requirements. Employer contributions to the Pension
plans are in accordance with the minimum funding requirements of
the Employee Retirement Income Security Act of 1974, as amended.
The Company expects to contribute $0.2 million to the
Pension plans in fiscal 2007. The Company also provides an
unfunded supplemental executive retirement plan (SERP) for
certain members of its executive management. The Company uses a
December 31 measurement date for the benefit obligations and a
January 1 measurement date for its net periodic costs. Variances
from actuarially assumed rates will result in increases or
decreases in benefit obligations, net periodic cost and funding
requirements in future periods. The Companys deferred
compensation plans allow participants to defer receipt of a
portion of their compensation. The liability under the deferred
compensation plans was $17.7 million at December 31,
2006 and $13 million at December 31, 2005. The Company
has available-for-sale securities either restricted or generally
designated to pay benefits of the deferred compensation plans
and the SERP in the amounts of $25.3 million and
$19.8 million at December 31, 2006 and 2005,
respectively.
The Company adopted the provisions of SFAS No. 158,
Employers Accounting for Defined Benefit Pension and
Other Postretirement Plans, an amendment of
SFAS No. 87, 88, 106, and 132(R)
(SFAS No. 158), for the year ending
December 31, 2006. SFAS No. 158 requires an
employer to recognize the overfunded or underfunded status of
defined benefit pension and postretirement plans as an asset or
liability in its consolidated statement of financial position
and to recognize changes in that funded status in the year in
which the changes occur through comprehensive income. It also
requires disclosure in the notes to the consolidated financial
statements additional information about certain effects on net
periodic benefit cost for the next fiscal year that arise from
delayed recognition of the gains or losses, prior service costs
or credits, and transition assets or obligation. The adoption of
SFAS No. 158 resulted in an increase to the pension
liability of $13.8 million, deferred taxes of
$5.5 million, and an increase in the loss of accumulated
other comprehensive income of $8.3 million in the
consolidated balance sheet for the year ending December 31,
2006.
26
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
A summary of the benefit obligations and funded status for the
Companys pension and SERP plans follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Plans
|
|
|
SERP
|
|
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|
2005
|
|
|
Change in benefit obligation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit obligation, beginning of
year
|
|
$
|
27,467
|
|
|
$
|
22,747
|
|
|
$
|
22,280
|
|
|
$
|
14,722
|
|
Service cost
|
|
|
3,757
|
|
|
|
3,043
|
|
|
|
3,023
|
|
|
|
2,113
|
|
Interest cost
|
|
|
1,601
|
|
|
|
1,364
|
|
|
|
1,225
|
|
|
|
846
|
|
Plan amendment
|
|
|
(5,769
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Actuarial loss
|
|
|
(792
|
)
|
|
|
323
|
|
|
|
(3,235
|
)
|
|
|
4,599
|
|
Benefits paid
|
|
|
(44
|
)
|
|
|
(10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit obligation, end of year
|
|
|
26,220
|
|
|
|
27,467
|
|
|
|
23,293
|
|
|
|
22,280
|
|
Change in plan assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of assets, beginning of
year
|
|
|
12,452
|
|
|
|
5,336
|
|
|
|
|
|
|
|
|
|
Actual return on plan assets
|
|
|
1,262
|
|
|
|
507
|
|
|
|
|
|
|
|
|
|
Employer contributions
|
|
|
|
|
|
|
6,619
|
|
|
|
|
|
|
|
|
|
Benefits paid
|
|
|
(44
|
)
|
|
|
(10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of assets, end of year
|
|
|
13,670
|
|
|
|
12,452
|
|
|
|
|
|
|
|
|
|
Unfunded status
|
|
$
|
(12,550
|
)
|
|
$
|
(15,015
|
)
|
|
$
|
(23,293
|
)
|
|
$
|
(22,280
|
)
|
A summary of the amounts recognized in the accompanying
consolidated balance sheets follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Plans
|
|
|
SERP
|
|
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|
2005
|
|
|
Noncurrent Asset
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Current Liability
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Noncurrent Liability
|
|
|
(12,550
|
)
|
|
|
(3,186
|
)
|
|
|
(23,293
|
)
|
|
|
(7,290
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net amount recognized in the
consolidated balance sheets
|
|
$
|
(12,550
|
)
|
|
$
|
(3,186
|
)
|
|
$
|
(23,293
|
)
|
|
$
|
(7,290
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A summary of the plans benefit obligation in excess of the
fair value of plan assets as of the end of the year follows (in
thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Plans
|
|
|
SERP
|
|
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|
2005
|
|
|
Projected benefit obligation
|
|
$
|
26,220
|
|
|
$
|
27,467
|
|
|
$
|
23,293
|
|
|
$
|
22,280
|
|
Accumulated benefit obligation
|
|
|
17,127
|
|
|
|
12,113
|
|
|
|
18,214
|
|
|
|
8,231
|
|
Fair value of plan assets
|
|
|
13,670
|
|
|
|
12,452
|
|
|
|
|
|
|
|
|
|
As of December 31, 2005, the fair value of plan assets of
$9.8 million exceeds the accumulated benefit obligation of
$9.2 million by $0.6 million for one of the Pension
plans. The other Pension plans accumulated benefit
obligation of $2.9 million exceeds the fair value of its
plan assets of $2.6 million by $0.3 million.
27
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
A summary of the weighted-average assumptions used by the
Company to determine benefit obligations as of December 31
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Plans
|
|
|
SERP
|
|
|
|
2006
|
|
2005
|
|
|
2006
|
|
|
2005
|
|
|
Discount Rate
|
|
5.73% - 5.95%
|
|
|
5.80
|
%
|
|
|
5.75
|
%
|
|
|
5.25
|
%
|
Annual Salary Increases
|
|
4.00% - 5.00%
|
|
|
4.00
|
%
|
|
|
5.00
|
%
|
|
|
5.00
|
%
|
A summary of the amounts recognized in Accumulated Other
Comprehensive Income (AOCI) due to the adoption of
SFAS No. 158 as of the end of the year follows (in
thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Plans
|
|
|
SERP
|
|
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|
2005
|
|
|
Amount recognized in AOCI prior to
SFAS 158
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Amount recognized in AOCI due to
adoption of SFAS 158
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prior service cost (credit)
|
|
|
3,583
|
|
|
|
N/A
|
|
|
|
6,586
|
|
|
|
N/A
|
|
Net actuarial (gain) loss
|
|
|
141
|
|
|
|
N/A
|
|
|
|
2,937
|
|
|
|
N/A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amount recognized in AOCI
|
|
|
3,724
|
|
|
|
N/A
|
|
|
|
9,523
|
|
|
|
N/A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A summary of the expected amortization amounts to be included in
net periodic cost for 2007 are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Pension
|
|
|
|
|
|
|
Plans
|
|
|
SERP
|
|
|
Prior service cost
|
|
$
|
878
|
|
|
$
|
884
|
|
Actuarial (gain)/loss
|
|
|
(22
|
)
|
|
|
60
|
|
A summary of the weighted-average assumptions used by the
Company to determine net periodic cost follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Plans
|
|
|
SERP
|
|
|
|
2006
|
|
2005
|
|
|
2004
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Discount rate
|
|
5.40%-5.80%
|
|
|
6.00
|
%
|
|
|
6.50
|
%
|
|
|
5.50
|
%
|
|
|
5.75
|
%
|
|
|
6.00
|
%
|
Rate of compensation increase
|
|
4.00%-5.00%
|
|
|
4.00
|
%
|
|
|
4.00
|
%
|
|
|
5.00
|
%
|
|
|
5.00
|
%
|
|
|
5.00
|
%
|
Expected long term rate of return
on assets
|
|
8.50%
|
|
|
8.50
|
%
|
|
|
8.50
|
%
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
The Companys weighted-average asset allocations by asset
category for its pension plans as of the end of the year follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Plans
|
|
|
SERP
|
|
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|
2005
|
|
|
Equity securities
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
N/A
|
|
|
|
N/A
|
|
Debt securities
|
|
|
0
|
%
|
|
|
0
|
%
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
N/A
|
|
|
|
N/A
|
|
The Companys pension plan assets are invested in mutual
funds with an underlying investment allocation of 60% equity
securities and 40% debt securities. The expected long-term rate
of return for the Companys pension plan assets is based on
current expected long-term inflation and historical rates of
return on equities and fixed income securities, taking into
account the investment policy under the plan. The expected
long-term rate of return is weighted based on the target
allocation for each asset category. Equity securities are
expected to return between 8% and 12% and debt securities are
expected to return between 4% and 7%. The Company
28
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
expects its pension plan asset managers will provide a premium
of approximately 0.5% to 1.5% per annum to the respective market
benchmark indices.
The Companys investment policy related to its pension
plans is to provide for growth of capital with a moderate level
of volatility by investing in accordance with the target asset
allocations stated above. The Company reviews its investment
policy, including its target asset allocations, on a semi-annual
basis to determine whether any changes in market conditions or
amendments to its pension plans requires a revision to its
investment policy.
The estimated future benefit payments reflecting future service
as of the end of 2006 for the Companys pension and SERP
plans follows (in thousands):
|
|
|
|
|
|
|
|
|
Years Ending
|
|
Pension Plans
|
|
|
SERP
|
|
|
2007
|
|
|
182
|
|
|
|
|
|
2008
|
|
|
299
|
|
|
|
66
|
|
2009
|
|
|
468
|
|
|
|
66
|
|
2010
|
|
|
620
|
|
|
|
66
|
|
2011
|
|
|
717
|
|
|
|
1,486
|
|
2012 - 2016
|
|
|
8,499
|
|
|
|
12,062
|
|
On June 14, 2000, the Company closed its initial public
offering of 18,750,000 shares of common stock; and on
July 3, 2000, the underwriters exercised their
overallotment option and purchased 1,675,717 shares of
common stock. These shares were offered at $13.00 per share. On
November 3, 2000, the Company completed an offering of
18,000,000 shares of its common stock at an offering price
of $28.1875. Of these shares, 8,000,000 shares were sold by
affiliates of FL & Co. and other shareholders. On
October 15, 2001, the Company completed an offering of
12,000,000 shares of its common stock at an offering price
of $26.80 concurrent with its notes offering. The net proceeds
to the Company from the 2001 and the two 2000 common stock
offerings in the aggregate were $306.1 million and
$514.5 million, respectively, and were used to repay
long-term debt.
Authorized capital shares of the Company include
400,000,000 shares of capital stock consisting of
300,000,000 shares of common stock and
100,000,000 shares of Preferred Stock. Each of the
aforementioned classes of capital stock has a par value of $.01
per share. Shares of Preferred Stock, none of which are
outstanding as of December 31, 2006, may be issued in one
or more series having such rights, preferences and other
provisions as determined by the Board of Directors without
approval by the holders of common stock.
On January 14, 2006, the Company commenced an open market
repurchase program for up to 5,000,000 shares of the
Companys common stock, not to exceed $200 million in
repurchases. Under this program, the Company repurchased the
entire 5,000,000 shares at a weighted average price of
$35.23. This program concluded on November 8, 2006 when the
maximum number of shares had been repurchased. This repurchase
plan followed a prior repurchase plan for up to
5,000,000 shares which concluded on January 13, 2006.
The Company repurchased 3,029,700 shares at a weighted
average price of $31.20 per share under this program. On
December 13, 2006, the Company commenced another open
market repurchase program for up to 5,000,000 shares of the
Companys common stock not to exceed $200 million in
repurchases. This program will conclude at the earlier of three
years or when the maximum number of shares has been repurchased.
As of December 31, 2006, the Company has not repurchased
any shares under this program.
On September 21, 2004, the Company entered into an
underwriting agreement (the Underwriting Agreement)
among the Company, CHS/Community Health Systems, Inc., Citigroup
Global Markets Inc. (the Underwriter), Forstmann
Little & Co. Equity Partnership-V, L.P. and Forstmann
Little & Co. Subordinated
29
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Debt and Equity Management Buyout Partnership-VI, L.P.
(collectively, the Selling Stockholders). Pursuant
to the Underwriting Agreement, the Underwriters purchased
23,134,738 shares of common stock from the Selling
Stockholders for $24.21 per share. The Company did not receive
any proceeds from any sales of shares by the Selling
Stockholders. On September 27, 2004, the Company purchased
from the Underwriters 12,000,000 of these shares for $24.21 per
share. For corporate law purposes, the Company retired these
shares upon repurchase. Accordingly, these
12,000,000 shares are treated as authorized and unissued
shares.
The following table sets forth the components of the numerator
and denominator for the computation of basic and diluted income
from continuing operations per share (in thousands, except share
data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator for basic earnings per
share
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
available to common stockholders basic
|
|
$
|
171,479
|
|
|
$
|
190,138
|
|
|
$
|
162,357
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator for diluted earnings per
share
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
171,479
|
|
|
$
|
190,138
|
|
|
$
|
162,357
|
|
Interest, net of tax, on 4.25%
convertible notes
|
|
|
135
|
|
|
|
8,565
|
|
|
|
8,757
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
available to common stockholders diluted
|
|
$
|
171,614
|
|
|
$
|
198,703
|
|
|
$
|
171,114
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number of shares
outstanding basic
|
|
|
94,983,646
|
|
|
|
88,601,168
|
|
|
|
95,643,733
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-employee director options
|
|
|
11,825
|
|
|
|
11,715
|
|
|
|
32,336
|
|
Unvested common shares
|
|
|
|
|
|
|
|
|
|
|
23,499
|
|
Restricted Stock awards
|
|
|
140,959
|
|
|
|
115,411
|
|
|
|
|
|
Employee options
|
|
|
951,360
|
|
|
|
1,582,063
|
|
|
|
1,582,146
|
|
4.25% Convertible notes
|
|
|
145,120
|
|
|
|
8,385,031
|
|
|
|
8,582,076
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number of shares
outstanding diluted
|
|
|
96,232,910
|
|
|
|
98,695,388
|
|
|
|
105,863,790
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dilutive securities outstanding
not included in the computation of earnings per share because
their effect is antidilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee options
|
|
|
1,261,367
|
|
|
|
31,100
|
|
|
|
262,025
|
|
|
|
12.
|
Commitments
and Contingencies
|
Construction Commitments. The Company has
agreed, as part of the acquisition in 2003 of Southside Regional
Medical Center in Petersburg, Virginia, to build a replacement
facility with an aggregate estimated construction cost,
including equipment, of approximately $135 million. Of this
amount, approximately $18 million has been expended through
December 31, 2006. The Company expects to spend
$55 million in replacement hospital construction and
equipment costs related to this project in 2007. This project is
required to be completed in 2008. In addition, the Company has
agreed, as part of the acquisition in 2004 of
30
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Phoenixville Hospital in Phoenixville, Pennsylvania, to spend
$90 million in capital expenditures over eight years to
develop and improve the hospital; of this amount approximately
$19 million has been expended through December 2006. The
Company expects to spend $19 million of this commitment in
2007. The Company has agreed as part of the acquisition in 2005
of Chestnut Hill Hospital, in Philadelphia, Pennsylvania to
spend $41 million in capital expenditures over four years
to develop and improve the hospital; of this amount
approximately $7 million has been expended through December
2006. The Company expects to spend approximately $5 million
of this commitment in 2007. As part of the acquisition in 2005
of Bedford County Medical Center in Shelbyville, Tennessee, the
Company agreed to build a replacement facility with an aggregate
estimated construction cost of approximately $35 million.
Of this amount, approximately, $0.8 million has been
expended through December 31, 2006. The Company expects to
spend $12 million in replacement hospital construction
costs related to this project in 2007. The project is required
to be completed by June 30, 2009. Also as required by an
amendment to a lease agreement entered into in 2005, the Company
agreed to build a replacement facility at its Barstow,
California location. Construction costs for this replacement
facility are estimated to be approximately $60 million.
Also in 2005, the Company entered into an agreement with a
developer to build and lease to the Company new corporate
headquarters. The Company accounts for this project as if it
owns the assets. Construction of the new headquarters was
completed in December 2006. In January 2007, the Company
exercised a purchase option under that lease agreement and
acquired the new headquarters by purchasing the equity interests
of the previous owner for a purchase price of $34.9 million.
Physician Recruiting Commitments. As part of
its physician recruitment strategy, the Company provides income
guarantee agreements to certain physicians who agree to relocate
to its communities and commit to remain in practice there. Under
such agreements, the Company is required to make payments to the
physicians in excess of the amounts they earned in their
practice up to the amount of the income guarantee. These income
guarantee periods are typically for 12 months. Such
payments are recoverable by the Company from physicians who do
not fulfill their commitment period, which is typically three
years, to the respective community. At December 31, 2006,
the maximum potential amount of future payments under these
guarantees in excess of the liability recorded is
$20.8 million.
Other. Under specified acquisition agreements,
the Company has deposited funds into escrow accounts to be used
solely for the purpose of recruiting physicians to that
specified hospital. At December 31, 2006, the Company had
$4.4 million deposited in escrow accounts, which is
included in other long-term assets.
Professional Liability Risks. Substantially
all of the Companys professional and general liability
risks are subject to a per occurrence deductible. Prior to
June 1, 2002, substantially all of the Companys
professional and general liability risks were subject to a
$0.5 million per occurrence deductible, and for claims
reported from June 1, 2002 through June 1, 2003, these
deductibles were $2.0 million per occurrence. Additional
coverage above these deductibles was purchased through captive
insurance companies in which the Company had a 7.5% minority
ownership interest and to which the premiums paid by the Company
represented less than 8% of the total premium revenues of the
captive insurance companies. Concurrently, with the formation of
the Companys own wholly-owned captive insurance company in
June 2003, the Company terminated its minority interest
relationships in those entities. Substantially all claims
reported on or after June 1, 2003 and before June 1,
2005 are self-insured up to $4.0 million per claim.
Substantially all claims reported on or after June 1, 2005
are self insured up to $5 million per claim. Management on
occasion has changed the insured risk at certain hospitals based
upon insurance pricing and other factors and may continue that
practice in the future. Excess insurance for all hospitals is
purchased through commercial insurance companies and generally
after the self-insured amount covers up to $100 million per
occurrence for all claims reported on or after June 1,
2003. The Companys insurance is underwritten on a
claims-made basis. The Company accrues an estimated
liability for its uninsured exposure and self-insured retention
based on historical loss patterns and actuarial projections. The
Companys estimated liability for the self-insured portion
of professional and general liability claims was
$104.2 million and $88.4 million as of
December 31, 2006
31
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
and 2005, respectively. These estimated liabilities represent
the present value of estimated future professional liability
claims payments based on expected loss patterns using a
weighted-average discount rate of 4.6% and 4.1% in 2006 and
2005, respectively. The weighted-average discount rate is based
on an estimate of the risk- free interest rate for the duration
of the expected claim payments. The estimated undiscounted
claims liability was $119.8 million and $107.7 million
as of December 31, 2006 and 2005, respectively.
Legal Matters. The Company is a party to other
legal proceedings incidental to its business. In the opinion of
management, any ultimate liability with respect to these actions
will not have a material adverse effect on the Companys
consolidated financial position, cash flows or results of
operations.
On January 31, 2007, the Company exercised its purchase
option with the developer of its newly constructed corporate
headquarters and acquired the building by purchasing the equity
interests of the previous owner for a purchase price of
$34.9 million.
Effective April 1, 2007, the Company completed its acquisition
of Lincoln General Hospital (157 licensed beds), located in Ruston,
Louisiana. The total consideration for this hospital was
approximately $47.8 million, of which $43.6 million was paid in cash and
$4.2 million was assumed in liabilities. On May 1, 2007,
the Company completed its acquisition of Porter Health, a 301 bed
acute care hospital located in Valparaiso, Indiana, with a satellite
campus in Portage, Indiana, and outpatient medical campuses in
Chesterton, Demotte, and Hebron, Indiana. As part of this
acquisition, the Company has agreed to construct a 225-bed
replacement facility for the Valparaiso hospital no later than April
2011. The total consideration for Porter Health was approximately
$110.1 million, of which $83.2 million was paid in cash and
$26.9 million was assumed in liabilities. During the quarter
ended June 30, 2007, the Company made its initial purchase price
allocation relating to these acquisitions resulting in approximately
$6.6 million of goodwill being recorded. This allocation is
preliminary pending, among other things, finalization of the
determination of fair market value of tangible and intangible assets.
32
COMMUNITY
HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
14.
|
Quarterly
Financial Data (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter
|
|
|
|
|
|
|
1(st)
|
|
|
2(nd)
|
|
|
3(rd)
|
|
|
4(th)
|
|
|
Total
|
|
|
|
(In thousands, except share and per share data)
|
|
|
Year ended December 31,
2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net operating revenues
|
|
$
|
1,026,562
|
|
|
$
|
1,061,054
|
|
|
$
|
1,123,483
|
|
|
$
|
1,154,477
|
|
|
$
|
4,365,576
|
|
Income from continuing operations
before taxes
|
|
|
93,552
|
|
|
|
85,236
|
|
|
|
13,314
|
|
|
|
86,059
|
|
|
|
278,161
|
|
Income from continuing operations
|
|
|
57,254
|
|
|
|
52,369
|
|
|
|
8,241
|
|
|
|
53,615
|
|
|
|
171,479
|
|
Loss on discontinued operations
|
|
|
(3,216
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,216
|
)
|
Net income
|
|
|
54,038
|
|
|
|
52,369
|
|
|
|
8,241
|
|
|
|
53,615
|
|
|
|
168,263
|
|
Income from continuing operations
per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
0.59
|
|
|
|
0.55
|
|
|
|
0.09
|
|
|
|
0.57
|
|
|
|
1.80
|
|
Diluted
|
|
|
0.58
|
|
|
|
0.54
|
|
|
|
0.09
|
|
|
|
0.57
|
|
|
|
1.78
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
0.56
|
|
|
|
0.55
|
|
|
|
0.09
|
|
|
|
0.57
|
|
|
|
1.77
|
|
Diluted
|
|
|
0.55
|
|
|
|
0.54
|
|
|
|
0.09
|
|
|
|
0.57
|
|
|
|
1.75
|
|
Weighted-average number of shares:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
96,552,448
|
|
|
|
95,769,030
|
|
|
|
94,119,020
|
|
|
|
93,538,958
|
|
|
|
94,983,646
|
|
Diluted
|
|
|
98,209,271
|
|
|
|
96,870,315
|
|
|
|
95,258,771
|
|
|
|
94,644,589
|
|
|
|
96,232,910
|
|
Year ended December 31,
2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net operating revenues
|
|
$
|
908,263
|
|
|
$
|
918,718
|
|
|
$
|
929,269
|
|
|
$
|
982,070
|
|
|
$
|
3,738,320
|
|
Income from continuing operations
before taxes
|
|
|
80,317
|
|
|
|
75,540
|
|
|
|
72,122
|
|
|
|
82,941
|
|
|
|
310,920
|
|
Income from continuing operations
|
|
|
49,079
|
|
|
|
46,150
|
|
|
|
44,066
|
|
|
|
50,843
|
|
|
|
190,138
|
|
Loss on discontinued operations
|
|
|
(13,091
|
)
|
|
|
(5,622
|
)
|
|
|
(1,180
|
)
|
|
|
(2,701
|
)
|
|
|
(22,594
|
)
|
Net income
|
|
|
35,988
|
|
|
|
40,528
|
|
|
|
42,886
|
|
|
|
48,142
|
|
|
|
167,544
|
|
Income from continuing operations
per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
0.56
|
|
|
|
0.52
|
|
|
|
0.50
|
|
|
|
0.57
|
|
|
|
2.15
|
|
Diluted
|
|
|
0.52
|
|
|
|
0.49
|
|
|
|
0.47
|
|
|
|
0.54
|
|
|
|
2.02
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
0.41
|
|
|
|
0.45
|
|
|
|
0.49
|
|
|
|
0.54
|
|
|
|
1.89
|
|
Diluted
|
|
|
0.39
|
|
|
|
0.43
|
|
|
|
0.46
|
|
|
|
0.51
|
|
|
|
1.79
|
|
Weighted-average number of shares:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
87,926,338
|
|
|
|
89,149,815
|
|
|
|
88,325,411
|
|
|
|
89,011,180
|
|
|
|
88,601,168
|
|
Diluted
|
|
|
98,087,086
|
|
|
|
99,328,929
|
|
|
|
98,528,968
|
|
|
|
98,389,422
|
|
|
|
98,579,977
|
|
33
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
15.
Acquisition of Triad, Related Financing and Supplemental Condensed Consolidating Financial Information
On
July 25, 2007, the Company completed its acquisition of Triad
Hospitals, Inc. (Triad) pursuant to which the Company
acquired Triad for $54 per share in cash, or approximately
$6.968 billion in the aggregate, including the assumption of
approximately $1.702 billion of existing indebtedness of Triad.
In connection with the closing of the Triad acquisition, the Company
has assumed both recorded and unrecorded contingencies of Triad. The
merger was approved by Triads stockholders at a meeting held on
June 13, 2007. The combined company owns or operates
approximately 129 hospitals in 28 states, with a total bed count of
approximately 19,200.
In
connection with the consummation of the merger, the Company obtained
$7.215 billion of senior secured financing under a new credit
facility (the New Credit Facility) and its wholly-owned
subsidiary, CHS/Community Health Systems, Inc. (the
Issuer), issued $3.021 billion aggregate principal
amount ($3.000 billion, net of discount) of 8.875% senior notes
due 2015 (the Notes) at the closing of the merger. The
Notes are senior obligations of the Issuer and are guaranteed on a
senior basis by the Company and by certain of the Companys
domestic subsidiaries. The Company used the net proceeds from the
Notes offering and the net proceeds of the $6.065 billion of
term loans under the New Credit Facility to pay the consideration
under the merger agreement, to refinance certain of its indebtedness
and indebtedness of Triad, to complete certain related transactions,
to pay certain costs and expenses of the transactions and for general
corporate uses. A $750 million revolving credit facility and a
$400 million delayed draw term loan facility is available to the
Company for working capital and general corporate purposes under the
new credit facility. This revolving credit facility also will include
a sub facility for letters of credit and a swingline sub facility.
Also, in connection with the consummation of the merger, the Company
completed an early repayment of its outstanding $300 million
aggregate principal amount of 6-½% Senior Subordinated Notes due
2012 through a cash tender offer and consent solicitation.
The loans
under the New Credit Facility will bear interest on the outstanding
unpaid principal amount at a rate equal to an applicable percentage
plus, at the Companys option, either (a) an alternative
base rate determined by reference to the greater of (1) the
prime rate announced by Credit Suisse and (2) the federal funds
rate plus one-half of 1.0%, or (b) a reserve adjusted Eurodollar
rate. The applicable percentage for term loans is 1.25% for
alternative base rate loans and 2.25% for Eurodollar rate loans, and
the applicable percentage for revolving loans will be up to 1.25% for
alternative base rate revolving loans and up to 2.25% for Eurodollar
revolving loans, in each case based on the Companys leverage
ratio. Loans under the swingline sub facility bear interest at the
rate applicable to alternative base rate loans under the revolving
credit facility.
The Notes
issued in connection with the Triad acquisition were issued in the
principal amount of $3.021 billion. These Notes will mature on
July 15, 2015. Interest on the Notes will accrue at the rate of
8-7/8% per annum and will be payable
semiannually in arrears in January 15 and July 15,
commencing January 15, 2008. Interest on the Notes will accrue
from the date of original issuance. Interest will be completed on the
basis of 360-day year comprised of twelve 30-day month.
The Notes
are unsecured obligations of the Company. Secured debt and other
secured obligation of the Company (including obligations with
respect to the Credit Agreement) will be effectively senior to the
Notes to the extent of the value of the assets securing such debt or
other obligations. The Notes are fully and unconditionally guaranteed by the Company
and certain of its current and future, direct and indirect, 100% owned domestic subsidiaries.
Such guarantees are joint and several. The following condensed consolidating financial statements
present the parent guarantor, the issuer, the subsidiary guarantors, the subsidiary non-guarantors
and eliminations. This condensed consolidating financial information has been prepared and
presented in accordance with SEC Regulation S-X Rule 3-10 Financial Statements of Guarantors and
Affiliates whose Securities Collateralize an issue Registered or Being Registered.
34
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
15. Supplemental
Condensed Consolidating Financial Information (Continued)
CONSOLIDATED BALANCE SHEETS
(Amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
December 31, 2005: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
|
|
|
$ |
|
|
|
$ |
83,579 |
|
|
$ |
20,529 |
|
|
$ |
|
|
|
$ |
104,108 |
|
Patient accounts receivable,
net of allowance for doubtful accounts |
|
|
|
|
|
|
|
|
|
|
524,139 |
|
|
|
131,890 |
|
|
|
|
|
|
|
656,029 |
|
Supplies |
|
|
|
|
|
|
|
|
|
|
78,154 |
|
|
|
17,046 |
|
|
|
|
|
|
|
95,200 |
|
Deferred income taxes |
|
|
4,128 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,128 |
|
Prepaid expenses and taxes |
|
|
|
|
|
|
|
|
|
|
32,615 |
|
|
|
762 |
|
|
|
|
|
|
|
33,377 |
|
Other current assets |
|
|
|
|
|
|
|
|
|
|
19,306 |
|
|
|
2,061 |
|
|
|
|
|
|
|
21,367 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
4,128 |
|
|
|
|
|
|
|
737,793 |
|
|
|
172,288 |
|
|
|
|
|
|
|
914,209 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net |
|
|
|
|
|
|
|
|
|
|
1,310,004 |
|
|
|
300,987 |
|
|
|
|
|
|
|
1,610,991 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill |
|
|
|
|
|
|
|
|
|
|
1,120,660 |
|
|
|
139,156 |
|
|
|
|
|
|
|
1,259,816 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets, net of accumulated amortization |
|
|
|
|
|
|
23,390 |
|
|
|
106,772 |
|
|
|
19,040 |
|
|
|
|
|
|
|
149,202 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment in subsidiaries |
|
|
816,196 |
|
|
|
801,226 |
|
|
|
308,382 |
|
|
|
|
|
|
|
(1,925,804 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
820,324 |
|
|
$ |
824,616 |
|
|
$ |
3,583,611 |
|
|
$ |
631,471 |
|
|
$ |
(1,925,804 |
) |
|
$ |
3,934,218 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
STOCKHOLDERS EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current maturities of long-term debt |
|
$ |
126 |
|
|
$ |
12,000 |
|
|
$ |
5,933 |
|
|
$ |
1,065 |
|
|
$ |
|
|
|
$ |
19,124 |
|
Accounts payable |
|
|
|
|
|
|
|
|
|
|
134,147 |
|
|
|
55,793 |
|
|
|
|
|
|
|
189,940 |
|
Current income taxes payable |
|
|
|
|
|
|
|
|
|
|
19,811 |
|
|
|
|
|
|
|
|
|
|
|
19,811 |
|
Deferred income taxes-current |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment in subsidiary-liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee compensation |
|
|
|
|
|
|
|
|
|
|
97,174 |
|
|
|
24,601 |
|
|
|
|
|
|
|
121,775 |
|
Interest |
|
|
3,087 |
|
|
|
5,439 |
|
|
|
(21 |
) |
|
|
86 |
|
|
|
|
|
|
|
8,591 |
|
Other |
|
|
|
|
|
|
|
|
|
|
64,036 |
|
|
|
14,126 |
|
|
|
|
|
|
|
78,162 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
3,213 |
|
|
|
17,439 |
|
|
|
321,080 |
|
|
|
95,671 |
|
|
|
|
|
|
|
437,403 |
|
Long-term debt |
|
|
436,498 |
|
|
|
1,173,000 |
|
|
|
37,493 |
|
|
|
1,509 |
|
|
|
|
|
|
|
1,648,500 |
|
Deferred income taxes |
|
|
157,579 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
157,579 |
|
Other Long Term Liabilities |
|
|
|
|
|
|
|
|
|
|
96,993 |
|
|
|
29,166 |
|
|
|
|
|
|
|
126,159 |
|
Intercompany payable |
|
|
(1,341,543 |
) |
|
|
(1,182,015 |
) |
|
|
2,326,249 |
|
|
|
535,120 |
|
|
|
(337,811 |
) |
|
|
|
|
Stockholders equity: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock |
|
|
945 |
|
|
|
|
|
|
|
1 |
|
|
|
2 |
|
|
|
(3 |
) |
|
|
945 |
|
Additional paid-in Capital |
|
|
1,195,726 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,195,726 |
|
Treasury stock, at cost |
|
|
(6,678 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6,678 |
) |
Accumulated other comprehensive income |
|
|
15,191 |
|
|
|
15,191 |
|
|
|
222 |
|
|
|
|
|
|
|
(15,413 |
) |
|
|
15,191 |
|
Retained earnings |
|
|
359,393 |
|
|
|
801,001 |
|
|
|
801,573 |
|
|
|
(29,997 |
) |
|
|
(1,572,577 |
) |
|
|
359,393 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity |
|
|
1,564,577 |
|
|
|
816,192 |
|
|
|
801,796 |
|
|
|
(29,995 |
) |
|
|
(1,587,993 |
) |
|
|
1,564,577 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity |
|
$ |
820,324 |
|
|
$ |
824,616 |
|
|
$ |
3,583,611 |
|
|
$ |
631,471 |
|
|
$ |
(1,925,804 |
) |
|
$ |
3,934,218 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
15. Supplemental
Condensed Consolidating Financial Information (Continued)
CONSOLIDATED BALANCE SHEETS
(Amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
December 31, 2006: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
|
|
|
$ |
|
|
|
$ |
28,713 |
|
|
$ |
11,853 |
|
|
$ |
|
|
|
$ |
40,566 |
|
Patient accounts receivable,
net of allowance for doubtful accounts |
|
|
|
|
|
|
|
|
|
|
634,227 |
|
|
|
139,757 |
|
|
|
|
|
|
|
773,984 |
|
Supplies |
|
|
|
|
|
|
|
|
|
|
94,070 |
|
|
|
19,250 |
|
|
|
|
|
|
|
113,320 |
|
Deferred income taxes |
|
|
13,249 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,249 |
|
Prepaid expenses and taxes |
|
|
|
|
|
|
|
|
|
|
32,447 |
|
|
|
(62 |
) |
|
|
|
|
|
|
32,385 |
|
Other current assets |
|
|
|
|
|
|
|
|
|
|
27,727 |
|
|
|
20,153 |
|
|
|
|
|
|
|
47,880 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
13,249 |
|
|
|
|
|
|
|
817,184 |
|
|
|
190,951 |
|
|
|
|
|
|
|
1,021,384 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net |
|
|
|
|
|
|
|
|
|
|
1,657,517 |
|
|
|
329,060 |
|
|
|
|
|
|
|
1,986,577 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill |
|
|
|
|
|
|
|
|
|
|
1,178,014 |
|
|
|
158,511 |
|
|
|
|
|
|
|
1,336,525 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets, net of accumulated amortization |
|
|
|
|
|
|
20,804 |
|
|
|
127,367 |
|
|
|
13,922 |
|
|
|
|
|
|
|
162,093 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment in subsidiaries |
|
|
1,081,747 |
|
|
|
1,068,432 |
|
|
|
367,456 |
|
|
|
|
|
|
|
(2,517,635 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
1,094,996 |
|
|
$ |
1,089,236 |
|
|
$ |
4,147,538 |
|
|
$ |
692,444 |
|
|
$ |
(2,517,635 |
) |
|
$ |
4,506,579 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
STOCKHOLDERS EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current maturities of long-term debt |
|
$ |
|
|
|
$ |
16,000 |
|
|
$ |
20,375 |
|
|
$ |
(979 |
) |
|
$ |
|
|
|
$ |
35,396 |
|
Accounts payable |
|
|
|
|
|
|
|
|
|
|
209,354 |
|
|
|
38,393 |
|
|
|
|
|
|
|
247,747 |
|
Current income taxes payable |
|
|
|
|
|
|
|
|
|
|
7,626 |
|
|
|
|
|
|
|
|
|
|
|
7,626 |
|
Deferred income taxes current |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment in subsidiary liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee compensation |
|
|
|
|
|
|
|
|
|
|
132,883 |
|
|
|
29,305 |
|
|
|
|
|
|
|
162,188 |
|
Interest |
|
|
867 |
|
|
|
5,866 |
|
|
|
316 |
|
|
|
73 |
|
|
|
|
|
|
|
7,122 |
|
Other |
|
|
|
|
|
|
|
|
|
|
91,096 |
|
|
|
24,108 |
|
|
|
|
|
|
|
115,204 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
867 |
|
|
|
21,866 |
|
|
|
461,650 |
|
|
|
90,900 |
|
|
|
|
|
|
|
575,283 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
|
300,000 |
|
|
|
1,556,000 |
|
|
|
48,962 |
|
|
|
819 |
|
|
|
|
|
|
|
1,905,781 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred income taxes |
|
|
141,472 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
141,472 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other long-term liabilities |
|
|
|
|
|
|
|
|
|
|
125,427 |
|
|
|
34,943 |
|
|
|
|
|
|
|
160,370 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intercompany payable |
|
|
(1,071,016 |
) |
|
|
(1,570,373 |
) |
|
|
2,447,810 |
|
|
|
625,088 |
|
|
|
(431,509 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock |
|
|
950 |
|
|
|
|
|
|
|
1 |
|
|
|
2 |
|
|
|
(3 |
) |
|
|
950 |
|
Additional paid-in Capital |
|
|
1,195,947 |
|
|
|
|
|
|
|
|
|
|
|
(1 |
) |
|
|
1 |
|
|
|
1,195,947 |
|
Treasury stock, at cost |
|
|
(6,678 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6,678 |
) |
Accumulated other comprehensive income |
|
|
5,798 |
|
|
|
5,798 |
|
|
|
(7,516 |
) |
|
|
|
|
|
|
1,718 |
|
|
|
5,798 |
|
Retained earnings |
|
|
527,656 |
|
|
|
1,075,945 |
|
|
|
1,071,204 |
|
|
|
(59,307 |
) |
|
|
(2,087,842 |
) |
|
|
527,656 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity |
|
|
1,723,673 |
|
|
|
1,081,743 |
|
|
|
1,063,689 |
|
|
|
(59,306 |
) |
|
|
(2,086,126 |
) |
|
|
1,723,673 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity |
|
$ |
1,094,996 |
|
|
$ |
1,089,236 |
|
|
$ |
4,147,538 |
|
|
$ |
692,444 |
|
|
$ |
(2,517,635 |
) |
|
$ |
4,506,579 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
15. Supplemental
Condensed Consolidating Financial Information (Continued)
CONSOLIDATED
STATEMENTS OF INCOME
(Amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
Year
ended December 31, 2004: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net operating revenues |
|
$ |
|
|
|
|
|
|
|
|
2,632,377 |
|
|
|
571,130 |
|
|
|
|
|
|
|
3,203,507 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating costs and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits |
|
|
|
|
|
|
|
|
|
|
1,030,643 |
|
|
|
248,493 |
|
|
|
|
|
|
|
1,279,136 |
|
Provision for bad debts |
|
|
|
|
|
|
|
|
|
|
257,238 |
|
|
|
67,405 |
|
|
|
|
|
|
|
324,643 |
|
Supplies |
|
|
|
|
|
|
|
|
|
|
321,529 |
|
|
|
68,055 |
|
|
|
|
|
|
|
389,584 |
|
Rent |
|
|
|
|
|
|
|
|
|
|
58,486 |
|
|
|
18,500 |
|
|
|
|
|
|
|
76,986 |
|
Other operating expenses |
|
|
|
|
|
|
|
|
|
|
513,480 |
|
|
|
125,557 |
|
|
|
|
|
|
|
639,037 |
|
Minority interest in earnings |
|
|
|
|
|
|
|
|
|
|
130 |
|
|
|
2,364 |
|
|
|
|
|
|
|
2,494 |
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
129,225 |
|
|
|
19,930 |
|
|
|
|
|
|
|
149,155 |
|
Equity in earnings of subsidiaries |
|
|
(255,504 |
) |
|
|
(255,504 |
) |
|
|
10,844 |
|
|
|
|
|
|
|
500,164 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating costs and expenses |
|
|
(255,504 |
) |
|
|
(255,504 |
) |
|
|
2,321,575 |
|
|
|
550,304 |
|
|
|
500,164 |
|
|
|
2,861,035 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
255,504 |
|
|
|
255,504 |
|
|
|
310,802 |
|
|
|
20,826 |
|
|
|
(500,164 |
) |
|
|
342,472 |
|
Interest expense, net of interest income |
|
|
|
|
|
|
|
|
|
|
54,431 |
|
|
|
20,825 |
|
|
|
|
|
|
|
75,256 |
|
Loss from early extinguishment of debt |
|
|
|
|
|
|
|
|
|
|
788 |
|
|
|
|
|
|
|
|
|
|
|
788 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes |
|
|
255,504 |
|
|
|
255,504 |
|
|
|
255,583 |
|
|
|
1 |
|
|
|
(500,164 |
) |
|
|
266,428 |
|
Provision for income taxes |
|
|
104,071 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
104,071 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
151,433 |
|
|
|
255,504 |
|
|
|
255,583 |
|
|
|
1 |
|
|
|
(500,164 |
) |
|
|
162,357 |
|
Discontinued operations, net of taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations of hospitals sold or held for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(7,279 |
) |
|
|
|
|
|
|
(7,279 |
) |
Net loss on sale of hospitals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,020 |
) |
|
|
|
|
|
|
(2,020 |
) |
Impairment of long-lived assets of
hospital held for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,625 |
) |
|
|
|
|
|
|
(1,625 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(10,924 |
) |
|
|
|
|
|
|
(10,924 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
151,433 |
|
|
$ |
255,504 |
|
|
$ |
255,583 |
|
|
$ |
(10,923 |
) |
|
$ |
(500,164 |
) |
|
$ |
151,433 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
37
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
15. Supplemental
Condensed Consolidating Financial Information (Continued)
CONSOLIDATED
STATEMENTS OF INCOME
(Amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
Year
ended December 31, 2005: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net operating revenues |
|
$ |
|
|
|
$ |
|
|
|
$ |
2,987,635 |
|
|
$ |
750,685 |
|
|
$ |
|
|
|
$ |
3,738,320 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating costs and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits |
|
|
|
|
|
|
|
|
|
|
1,156,679 |
|
|
|
329,728 |
|
|
|
|
|
|
|
1,486,407 |
|
Provision for bad debts |
|
|
|
|
|
|
|
|
|
|
299,802 |
|
|
|
77,794 |
|
|
|
|
|
|
|
377,596 |
|
Supplies |
|
|
|
|
|
|
|
|
|
|
360,011 |
|
|
|
88,199 |
|
|
|
|
|
|
|
448,210 |
|
Rent |
|
|
|
|
|
|
|
|
|
|
63,629 |
|
|
|
23,581 |
|
|
|
|
|
|
|
87,210 |
|
Other operating expenses |
|
|
|
|
|
|
|
|
|
|
593,677 |
|
|
|
172,020 |
|
|
|
|
|
|
|
765,697 |
|
Minority interest in earnings |
|
|
|
|
|
|
|
|
|
|
129 |
|
|
|
2,975 |
|
|
|
|
|
|
|
3,104 |
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
135,306 |
|
|
|
29,257 |
|
|
|
|
|
|
|
164,563 |
|
Equity in earnings of subsidiaries |
|
|
(288,326 |
) |
|
|
(288,326 |
) |
|
|
12,021 |
|
|
|
|
|
|
|
564,631 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating costs and expenses |
|
|
(288,326 |
) |
|
|
(288,326 |
) |
|
|
2,621,253 |
|
|
|
723,555 |
|
|
|
564,631 |
|
|
|
3,332,787 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
288,326 |
|
|
|
288,326 |
|
|
|
366,382 |
|
|
|
27,130 |
|
|
|
(564,631 |
) |
|
|
405,533 |
|
Interest expense, net of interest income |
|
|
|
|
|
|
|
|
|
|
77,639 |
|
|
|
16,965 |
|
|
|
|
|
|
|
94,604 |
|
Loss from early extinguishment of debt |
|
|
|
|
|
|
|
|
|
|
9 |
|
|
|
|
|
|
|
|
|
|
|
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes |
|
|
288,326 |
|
|
|
288,326 |
|
|
|
288,734 |
|
|
|
10,165 |
|
|
|
(564,631 |
) |
|
|
310,920 |
|
Provision for income taxes |
|
|
120,782 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
120,782 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
167,544 |
|
|
|
288,326 |
|
|
|
288,734 |
|
|
|
10,165 |
|
|
|
(564,631 |
) |
|
|
190,138 |
|
Discontinued operations, net of taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations of hospitals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
sold or held for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(10,505 |
) |
|
|
|
|
|
|
(10,505 |
) |
Net loss on sale of hospitals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(7,618 |
) |
|
|
|
|
|
|
(7,618 |
) |
Impairment of long-lived assets of
hospital held for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,471 |
) |
|
|
|
|
|
|
(4,471 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(22,594 |
) |
|
|
|
|
|
|
(22,594 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
167,544 |
|
|
$ |
288,326 |
|
|
$ |
288,734 |
|
|
$ |
(12,429 |
) |
|
$ |
(564,631 |
) |
|
$ |
167,544 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
15. Supplemental
Condensed Consolidating Financial Information (Continued)
CONSOLIDATED
STATEMENTS OF INCOME
(Amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
Year
ended December 31, 2006: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net operating revenues |
|
$ |
|
|
|
$ |
|
|
|
$ |
3,519,487 |
|
|
$ |
846,089 |
|
|
$ |
|
|
|
$ |
4,365,576 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating costs and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits |
|
|
|
|
|
|
|
|
|
|
1,350,640 |
|
|
|
390,583 |
|
|
|
|
|
|
|
1,741,223 |
|
Provision for bad debts |
|
|
|
|
|
|
|
|
|
|
434,536 |
|
|
|
113,245 |
|
|
|
|
|
|
|
547,781 |
|
Supplies |
|
|
|
|
|
|
|
|
|
|
410,850 |
|
|
|
99,501 |
|
|
|
|
|
|
|
510,351 |
|
Other operating expenses |
|
|
|
|
|
|
|
|
|
|
707,585 |
|
|
|
189,506 |
|
|
|
|
|
|
|
897,091 |
|
Rent |
|
|
|
|
|
|
|
|
|
|
69,421 |
|
|
|
27,683 |
|
|
|
|
|
|
|
97,104 |
|
Minority interest in earnings |
|
|
|
|
|
|
|
|
|
|
59 |
|
|
|
2,736 |
|
|
|
|
|
|
|
2,795 |
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
157,307 |
|
|
|
31,464 |
|
|
|
|
|
|
|
188,771 |
|
Equity in earnings of subsidiaries |
|
|
(274,945 |
) |
|
|
(274,945 |
) |
|
|
34,624 |
|
|
|
|
|
|
|
515,266 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating costs and expenses |
|
|
(274,945 |
) |
|
|
(274,945 |
) |
|
|
3,165,022 |
|
|
|
854,718 |
|
|
|
515,266 |
|
|
|
3,985,116 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
274,945 |
|
|
|
274,945 |
|
|
|
354,465 |
|
|
|
(8,629 |
) |
|
|
(515,266 |
) |
|
|
380,460 |
|
Interest expense, net of interest income |
|
|
|
|
|
|
|
|
|
|
84,833 |
|
|
|
17,466 |
|
|
|
|
|
|
|
102,299 |
|
Loss from early extinguishment of debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes |
|
|
274,945 |
|
|
|
274,945 |
|
|
|
269,632 |
|
|
|
(26,095 |
) |
|
|
(515,266 |
) |
|
|
278,161 |
|
Provision for income taxes |
|
|
106,682 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
106,682 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
168,263 |
|
|
|
274,945 |
|
|
|
269,632 |
|
|
|
(26,095 |
) |
|
|
(515,266 |
) |
|
|
171,479 |
|
Discontinued operations, net of taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from
operations of hospitals sold or held for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(657 |
) |
|
|
|
|
|
|
(657 |
) |
Net loss on sale of hospitals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,559 |
) |
|
|
|
|
|
|
(2,559 |
) |
Impairment of long-lived assets of
hospital held for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,216 |
) |
|
|
|
|
|
|
(3,216 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
168,263 |
|
|
$ |
274,945 |
|
|
$ |
269,632 |
|
|
$ |
(29,311 |
) |
|
$ |
(515,266 |
) |
|
$ |
168,263 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
39
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
15. Supplemental
Condensed Consolidating Financial Information (Continued)
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(Amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
Year
ended December 31, 2004: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
151,433 |
|
|
$ |
255,504 |
|
|
$ |
255,583 |
|
|
$ |
(10,923 |
) |
|
$ |
(500,164 |
) |
|
$ |
151,433 |
|
Adjustments to reconcile net income to net
cash provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
129,225 |
|
|
|
29,155 |
|
|
|
|
|
|
|
158,380 |
|
Deferred income taxes |
|
|
32,552 |
|
|
|
|
|
|
|
|
|
|
|
9,350 |
|
|
|
|
|
|
|
41,902 |
|
Equity based compensation expense |
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
Loss on early extinguishment of debt |
|
|
788 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
788 |
|
Minority interest in earnings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,578 |
|
|
|
|
|
|
|
1,578 |
|
Impairment on hospital held for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,539 |
|
|
|
|
|
|
|
2,539 |
|
Loss on sale of hospitals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,186 |
|
|
|
|
|
|
|
2,186 |
|
Other non-cash expenses, net |
|
|
|
|
|
|
|
|
|
|
765 |
|
|
|
(96 |
) |
|
|
|
|
|
|
669 |
|
Changes in operating assets and liabilities,
net of effects of acquisitions and divestitures: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient accounts receivable |
|
|
|
|
|
|
|
|
|
|
(28,425 |
) |
|
|
(3,389 |
) |
|
|
|
|
|
|
(31,814 |
) |
Supplies, prepaid expenses and other
current assets |
|
|
|
|
|
|
|
|
|
|
(11,712 |
) |
|
|
(1,837 |
) |
|
|
|
|
|
|
(13,549 |
) |
Accounts payable, accrued liabilities and
income taxes |
|
|
13,250 |
|
|
|
100 |
|
|
|
(37,532 |
) |
|
|
(189 |
) |
|
|
|
|
|
|
(24,371 |
) |
Advances to
subsidiaries, net of return on investment |
|
|
(222,766 |
) |
|
|
(316,460 |
) |
|
|
33,218 |
|
|
|
5,844 |
|
|
|
500,164 |
|
|
|
|
|
Other |
|
|
5,361 |
|
|
|
(3,459 |
) |
|
|
33,694 |
|
|
|
411 |
|
|
|
|
|
|
|
36,007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
(19,380 |
) |
|
|
(64,315 |
) |
|
|
374,816 |
|
|
|
34,629 |
|
|
|
|
|
|
|
325,750 |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisitions of facilities and other
related equipment |
|
|
|
|
|
|
|
|
|
|
(128,850 |
) |
|
|
(4,183 |
) |
|
|
|
|
|
|
(133,033 |
) |
Purchases of property and equipment |
|
|
|
|
|
|
|
|
|
|
(146,835 |
) |
|
|
(17,451 |
) |
|
|
|
|
|
|
(164,286 |
) |
Disposition of hospitals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,850 |
|
|
|
|
|
|
|
7,850 |
|
Proceeds from sale of equipment |
|
|
|
|
|
|
|
|
|
|
770 |
|
|
|
20 |
|
|
|
|
|
|
|
790 |
|
Increase in other assets |
|
|
|
|
|
|
|
|
|
|
(22,066 |
) |
|
|
(7,734 |
) |
|
|
|
|
|
|
(29,800 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities |
|
|
|
|
|
|
|
|
|
|
(296,981 |
) |
|
|
(21,498 |
) |
|
|
|
|
|
|
(318,479 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of stock options |
|
|
9,900 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,900 |
|
Proceeds from senior Subordinated Notes |
|
|
300,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
300,000 |
|
Stock Buy-Back |
|
|
(290,520 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(290,520 |
) |
Deferred financing costs |
|
|
|
|
|
|
|
|
|
|
(12,785 |
) |
|
|
2 |
|
|
|
|
|
|
|
(12,783 |
) |
Excess tax benefits relating to stock-based
compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redemption of convertible notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from minority investors in joint
ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redemption of minority investments in
joint ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,522 |
) |
|
|
|
|
|
|
(3,522 |
) |
Distribution to minority investors in
joint ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,238 |
) |
|
|
|
|
|
|
(1,238 |
) |
Borrowings under Credit Agreement |
|
|
|
|
|
|
1,724,640 |
|
|
|
1,129 |
|
|
|
(1 |
) |
|
|
|
|
|
|
1,725,768 |
|
Repayments of long-term indebtedness |
|
|
|
|
|
|
(1,660,325 |
) |
|
|
(7,388 |
) |
|
|
(996 |
) |
|
|
|
|
|
|
(1,668,709 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by financing activities |
|
|
19,380 |
|
|
|
64,315 |
|
|
|
(19,044 |
) |
|
|
(5,755 |
) |
|
|
|
|
|
|
58,896 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents |
|
|
|
|
|
|
|
|
|
|
58,791 |
|
|
|
7,376 |
|
|
|
|
|
|
|
66,167 |
|
Cash and cash equivalents at beginning of
period |
|
|
|
|
|
|
|
|
|
|
10,516 |
|
|
|
5,815 |
|
|
|
|
|
|
|
16,331 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
|
|
|
$ |
|
|
|
$ |
69,307 |
|
|
$ |
13,191 |
|
|
$ |
|
|
|
$ |
82,498 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
15. Supplemental
Condensed Consolidating Financial Information (Continued)
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(Amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
Year
ended December 31, 2005: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
167,544 |
|
|
$ |
288,326 |
|
|
$ |
288,734 |
|
|
$ |
(12,429 |
) |
|
$ |
(564,631 |
) |
|
$ |
167,544 |
|
Adjustments to reconcile net income to net
cash provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
135,306 |
|
|
|
30,856 |
|
|
|
|
|
|
|
166,162 |
|
Deferred income taxes |
|
|
9,889 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,889 |
|
Stock compensation expense |
|
|
4,956 |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
4,957 |
|
Excess tax benefits relating to
stock-based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interest in earnings |
|
|
|
|
|
|
|
|
|
|
129 |
|
|
|
2,975 |
|
|
|
|
|
|
|
3,104 |
|
Impairment on hospital held for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,718 |
|
|
|
|
|
|
|
6,718 |
|
Loss on sale of hospitals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,295 |
|
|
|
|
|
|
|
6,295 |
|
Other non-cash expenses, net |
|
|
|
|
|
|
|
|
|
|
1,616 |
|
|
|
(876 |
) |
|
|
|
|
|
|
740 |
|
Changes in operating assets and liabilities,
net of effects of acquisitions and divestitures: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient accounts receivable |
|
|
|
|
|
|
|
|
|
|
(39,035 |
) |
|
|
(8,420 |
) |
|
|
|
|
|
|
(47,455 |
) |
Supplies, prepaid expenses and
other current assets |
|
|
|
|
|
|
|
|
|
|
(18,616 |
) |
|
|
1,778 |
|
|
|
|
|
|
|
(16,838 |
) |
Accounts payable, accrued liabilities
and income taxes |
|
|
24,183 |
|
|
|
803 |
|
|
|
40,955 |
|
|
|
19,015 |
|
|
|
|
|
|
|
84,956 |
|
Advances to
subsidiaries, net of return on investment |
|
|
(183,328 |
) |
|
|
(272,332 |
) |
|
|
(92,822 |
) |
|
|
(16,149 |
) |
|
|
564,631 |
|
|
|
|
|
Other |
|
|
7,327 |
|
|
|
(4,797 |
) |
|
|
27,979 |
|
|
|
(5,532 |
) |
|
|
|
|
|
|
24,977 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
30,571 |
|
|
|
12,000 |
|
|
|
344,246 |
|
|
|
24,232 |
|
|
|
|
|
|
|
411,049 |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisitions of facilities and other
related equipment |
|
|
|
|
|
|
|
|
|
|
(125,493 |
) |
|
|
(32,886 |
) |
|
|
|
|
|
|
(158,379 |
) |
Purchases of property and equipment |
|
|
|
|
|
|
|
|
|
|
(162,401 |
) |
|
|
(25,964 |
) |
|
|
|
|
|
|
(188,365 |
) |
Disposition of hospitals |
|
|
|
|
|
|
|
|
|
|
(6,500 |
) |
|
|
58,498 |
|
|
|
|
|
|
|
51,998 |
|
Proceeds from sale of equipment |
|
|
|
|
|
|
|
|
|
|
112 |
|
|
|
2,213 |
|
|
|
|
|
|
|
2,325 |
|
Increase in other assets |
|
|
|
|
|
|
|
|
|
|
(22,444 |
) |
|
|
(12,407 |
) |
|
|
|
|
|
|
(34,851 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities |
|
|
|
|
|
|
|
|
|
|
(316,726 |
) |
|
|
(10,546 |
) |
|
|
|
|
|
|
(327,272 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of stock options |
|
|
49,580 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
49,580 |
|
Stock buy-back |
|
|
(79,853 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(79,853 |
) |
Deferred financing costs |
|
|
|
|
|
|
|
|
|
|
(1,259 |
) |
|
|
|
|
|
|
|
|
|
|
(1,259 |
) |
Excess tax benefits relating to
stock-based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redemption of convertible notes |
|
|
(298 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(298 |
) |
Proceeds from minority investors in joint
ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,383 |
|
|
|
|
|
|
|
1,383 |
|
Redemption of minority investments in
joint ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,242 |
) |
|
|
|
|
|
|
(3,242 |
) |
Distribution to minority investors in
joint ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,939 |
) |
|
|
|
|
|
|
(1,939 |
) |
Borrowings under Credit Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repayments of long-term indebtedness |
|
|
|
|
|
|
(12,000 |
) |
|
|
(11,989 |
) |
|
|
(2,550 |
) |
|
|
|
|
|
|
(26,539 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by financing
activities |
|
|
(30,571 |
) |
|
|
(12,000 |
) |
|
|
(13,248 |
) |
|
|
(6,348 |
) |
|
|
|
|
|
|
(62,167 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents |
|
|
|
|
|
|
|
|
|
|
14,272 |
|
|
|
7,338 |
|
|
|
|
|
|
|
21,610 |
|
Cash and cash equivalents at beginning of
period |
|
|
|
|
|
|
|
|
|
|
69,307 |
|
|
|
13,191 |
|
|
|
|
|
|
|
82,498 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
|
|
|
$ |
|
|
|
$ |
83,579 |
|
|
$ |
20,529 |
|
|
$ |
|
|
|
$ |
104,108 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
15. Supplemental
Condensed Consolidating Financial Information (Continued)
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(Amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
Year
ended December 31, 2006: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
168,263 |
|
|
$ |
274,945 |
|
|
$ |
269,632 |
|
|
$ |
(29,311 |
) |
|
$ |
(515,266 |
) |
|
$ |
168,263 |
|
Adjustments to reconcile net income to net
cash provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
157,307 |
|
|
|
31,464 |
|
|
|
|
|
|
|
188,771 |
|
Deferred income taxes |
|
|
(25,228 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(25,228 |
) |
Stock compensation expense |
|
|
20,073 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,073 |
|
Excess tax benefits relating to
stock-based compensation |
|
|
(6,819 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6,819 |
) |
Minority interest in earnings |
|
|
|
|
|
|
|
|
|
|
59 |
|
|
|
2,736 |
|
|
|
|
|
|
|
2,795 |
|
Impairment on hospital held for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on sale of hospitals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,937 |
|
|
|
|
|
|
|
3,937 |
|
Other non-cash expenses, net |
|
|
|
|
|
|
|
|
|
|
517 |
|
|
|
(17 |
) |
|
|
|
|
|
|
500 |
|
Changes in operating assets and liabilities,
net of effects of acquisitions and divestitures: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient accounts receivable |
|
|
|
|
|
|
|
|
|
|
(67,215 |
) |
|
|
(3,926 |
) |
|
|
|
|
|
|
(71,141 |
) |
Supplies, prepaid expenses and
other current assets |
|
|
|
|
|
|
|
|
|
|
(11,010 |
) |
|
|
6,466 |
|
|
|
|
|
|
|
(4,544 |
) |
Accounts payable, accrued liabilities
and income taxes |
|
|
4,935 |
|
|
|
1,358 |
|
|
|
81,880 |
|
|
|
(36,022 |
) |
|
|
|
|
|
|
52,151 |
|
Advances to
subsidiaries, net of return on investment |
|
|
4,976 |
|
|
|
(655,565 |
) |
|
|
62,468 |
|
|
|
72,855 |
|
|
|
515,266 |
|
|
|
|
|
Other |
|
|
(11,148 |
) |
|
|
(7,738 |
) |
|
|
23,643 |
|
|
|
16,740 |
|
|
|
|
|
|
|
21,497 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
155,052 |
|
|
|
(387,000 |
) |
|
|
517,281 |
|
|
|
64,922 |
|
|
|
|
|
|
|
350,255 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisitions of facilities and other
related equipment |
|
|
|
|
|
|
|
|
|
|
(362,290 |
) |
|
|
(22,328 |
) |
|
|
|
|
|
|
(384,618 |
) |
Purchases of property and equipment |
|
|
|
|
|
|
|
|
|
|
(182,907 |
) |
|
|
(41,612 |
) |
|
|
|
|
|
|
(224,519 |
) |
Disposition of hospitals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
750 |
|
|
|
|
|
|
|
750 |
|
Proceeds from sale of equipment |
|
|
|
|
|
|
|
|
|
|
104 |
|
|
|
4,376 |
|
|
|
|
|
|
|
4,480 |
|
Increase in other assets |
|
|
|
|
|
|
|
|
|
|
(21,559 |
) |
|
|
(14,791 |
) |
|
|
|
|
|
|
(36,350 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities |
|
|
|
|
|
|
|
|
|
|
(566,652 |
) |
|
|
(73,605 |
) |
|
|
|
|
|
|
(640,257 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of stock options |
|
|
14,573 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,573 |
|
Stock buy-back |
|
|
(176,316 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(176,316 |
) |
Deferred financing costs |
|
|
|
|
|
|
|
|
|
|
(2,153 |
) |
|
|
|
|
|
|
|
|
|
|
(2,153 |
) |
Excess tax benefits relating to
stock-based compensation |
|
|
6,819 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,819 |
|
Redemption of convertible notes |
|
|
(128 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(128 |
) |
Proceeds from minority investors in
joint ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,890 |
|
|
|
|
|
|
|
6,890 |
|
Redemption of minority investments in
joint ventures |
|
|
|
|
|
|
|
|
|
|
(56 |
) |
|
|
(859 |
) |
|
|
|
|
|
|
(915 |
) |
Distribution to minority investors in
joint ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,220 |
) |
|
|
|
|
|
|
(3,220 |
) |
Borrowings under Credit Agreement |
|
|
|
|
|
|
1,031,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,031,000 |
|
Repayments of long-term indebtedness |
|
|
|
|
|
|
(644,000 |
) |
|
|
(3,286 |
) |
|
|
(2,804 |
) |
|
|
|
|
|
|
(650,090 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by financing
activities |
|
|
(155,052 |
) |
|
|
387,000 |
|
|
|
(5,495 |
) |
|
|
7 |
|
|
|
|
|
|
|
226,460 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents |
|
|
|
|
|
|
|
|
|
|
(54,866 |
) |
|
|
(8,676 |
) |
|
|
|
|
|
|
(63,542 |
) |
Cash and cash equivalents at beginning
of period |
|
|
|
|
|
|
|
|
|
|
83,579 |
|
|
|
20,529 |
|
|
|
|
|
|
|
104,108 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of
period |
|
$ |
|
|
|
$ |
|
|
|
$ |
28,713 |
|
|
$ |
11,853 |
|
|
$ |
|
|
|
$ |
40,566 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
42
EX-99.2 CONSOLIDATED FINANCIAL STATEMENTS
Exhibit 99.2
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
|
December 31, |
|
|
|
2007 |
|
|
2006 |
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
21,357 |
|
|
$ |
40,566 |
|
Patient accounts receivable, net of allowance for doubtful accounts of
$498,473 and $478,565 at June 30, 2007, and December 31, 2006,
respectively |
|
|
876,523 |
|
|
|
773,984 |
|
Supplies |
|
|
121,964 |
|
|
|
113,320 |
|
Deferred income taxes |
|
|
13,249 |
|
|
|
13,249 |
|
Prepaid expenses and taxes |
|
|
36,287 |
|
|
|
32,385 |
|
Other current assets |
|
|
62,933 |
|
|
|
47,880 |
|
|
|
|
|
|
|
|
Total current assets |
|
|
1,132,313 |
|
|
|
1,021,384 |
|
|
|
|
|
|
|
|
Property and equipment |
|
|
2,809,988 |
|
|
|
2,630,366 |
|
Less accumulated depreciation and amortization |
|
|
(720,846 |
) |
|
|
(643,789 |
) |
|
|
|
|
|
|
|
Property and equipment, net |
|
|
2,089,142 |
|
|
|
1,986,577 |
|
|
|
|
|
|
|
|
Goodwill |
|
|
1,344,956 |
|
|
|
1,336,525 |
|
|
|
|
|
|
|
|
Other assets, net |
|
|
226,700 |
|
|
|
162,093 |
|
Total assets |
|
$ |
4,793,111 |
|
|
$ |
4,506,579 |
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY |
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
Current maturities of long-term debt |
|
$ |
25,757 |
|
|
$ |
35,396 |
|
Accounts payable |
|
|
257,730 |
|
|
|
247,747 |
|
Current income taxes payable |
|
|
49,010 |
|
|
|
7,626 |
|
Accrued interest |
|
|
8,375 |
|
|
|
7,122 |
|
Accrued liabilities |
|
|
270,152 |
|
|
|
277,392 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
611,024 |
|
|
|
575,283 |
|
|
|
|
|
|
|
|
Long-term debt |
|
|
1,974,240 |
|
|
|
1,905,781 |
|
|
|
|
|
|
|
|
Deferred income taxes |
|
|
141,472 |
|
|
|
141,472 |
|
|
|
|
|
|
|
|
Other long-term liabilities |
|
|
205,408 |
|
|
|
160,370 |
|
|
|
|
|
|
|
|
Stockholders equity |
|
|
|
|
|
|
|
|
Preferred stock, $.01 par value per share, 100,000,000 shares authorized,
none issued |
|
|
|
|
|
|
|
|
Common stock, $.01 par value per share, 300,000,000 shares authorized;
95,881,020 shares issued and 94,905,471 shares outstanding at June 30,
2007, and 95,026,494 shares issued and 94,050,945 shares outstanding
at December 31, 2006 |
|
|
959 |
|
|
|
950 |
|
Additional paid-in capital |
|
|
1,215,321 |
|
|
|
1,195,947 |
|
Treasury stock, at cost, 975,549 shares at June 30, 2007 and
December 31, 2006 |
|
|
(6,678 |
) |
|
|
(6,678 |
) |
Accumulated other comprehensive income |
|
|
15,622 |
|
|
|
5,798 |
|
Retained earnings |
|
|
635,743 |
|
|
|
527,656 |
|
|
|
|
|
|
|
|
Total stockholders equity |
|
|
1,860,967 |
|
|
|
1,723,673 |
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity |
|
$ |
4,793,111 |
|
|
$ |
4,506,579 |
|
|
|
|
|
|
|
|
See accompanying notes to the condensed consolidated financial statements.
1
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except share and per share data)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Net operating revenues |
|
$ |
1,249,128 |
|
|
$ |
1,061,054 |
|
|
$ |
2,453,125 |
|
|
$ |
2,087,616 |
|
Operating costs and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits |
|
|
495,085 |
|
|
|
420,147 |
|
|
|
981,421 |
|
|
|
827,815 |
|
Provision for bad debts |
|
|
148,661 |
|
|
|
115,704 |
|
|
|
284,360 |
|
|
|
223,295 |
|
Supplies |
|
|
146,033 |
|
|
|
125,700 |
|
|
|
286,541 |
|
|
|
248,520 |
|
Other operating expenses |
|
|
258,556 |
|
|
|
219,113 |
|
|
|
503,815 |
|
|
|
426,156 |
|
Rent |
|
|
28,244 |
|
|
|
23,646 |
|
|
|
54,240 |
|
|
|
46,628 |
|
Depreciation and amortization |
|
|
53,349 |
|
|
|
47,183 |
|
|
|
104,619 |
|
|
|
89,689 |
|
Minority interest in earnings |
|
|
625 |
|
|
|
455 |
|
|
|
818 |
|
|
|
1,068 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating costs and expenses |
|
|
1,130,553 |
|
|
|
951,948 |
|
|
|
2,215,814 |
|
|
|
1,863,171 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
118,575 |
|
|
|
109,106 |
|
|
|
237,311 |
|
|
|
224,445 |
|
Interest expense, net |
|
|
31,155 |
|
|
|
23,870 |
|
|
|
61,559 |
|
|
|
45,657 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income
taxes |
|
|
87,420 |
|
|
|
85,236 |
|
|
|
175,752 |
|
|
|
178,788 |
|
Provision for income taxes |
|
|
33,657 |
|
|
|
32,867 |
|
|
|
67,665 |
|
|
|
69,165 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
53,763 |
|
|
|
52,369 |
|
|
|
108,087 |
|
|
|
109,623 |
|
Discontinued operations, net of taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations of hospital sold and held
for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(657 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on sale of hospital |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,559 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,216 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
53,763 |
|
|
$ |
52,369 |
|
|
$ |
108,087 |
|
|
$ |
106,407 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.57 |
|
|
$ |
0.55 |
|
|
$ |
1.16 |
|
|
$ |
1.14 |
|
Diluted |
|
$ |
0.57 |
|
|
$ |
0.54 |
|
|
$ |
1.14 |
|
|
$ |
1.13 |
|
Net income per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.57 |
|
|
$ |
0.55 |
|
|
$ |
1.16 |
|
|
$ |
1.11 |
|
Diluted |
|
$ |
0.57 |
|
|
$ |
0.54 |
|
|
$ |
1.14 |
|
|
$ |
1.09 |
|
Weighted-average number of shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
93,518,991 |
|
|
|
95,769,030 |
|
|
|
93,373,357 |
|
|
|
96,158,575 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
94,647,870 |
|
|
|
96,870,315 |
|
|
|
94,422,000 |
|
|
|
97,536,815 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to the condensed consolidated financial statements.
2
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
|
2007 |
|
|
2006 |
|
Cash flows from operating activities |
|
|
|
|
|
|
|
|
Net income |
|
$ |
108,087 |
|
|
$ |
106,407 |
|
Adjustments to reconcile net income to net cash provided by operating
activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
104,619 |
|
|
|
89,689 |
|
Minority interest in earnings |
|
|
818 |
|
|
|
1,068 |
|
Stock-based compensation expense |
|
|
14,295 |
|
|
|
8,946 |
|
Excess tax benefits relating to stock-based compensation |
|
|
(2,295 |
) |
|
|
(4,588 |
) |
Other non-cash expenses, net |
|
|
(1,542 |
) |
|
|
3,306 |
|
Changes in operating assets and liabilities, net of effects of acquisitions
and divestitures: |
|
|
|
|
|
|
|
|
Patient accounts receivable |
|
|
(47,415 |
) |
|
|
(57,961 |
) |
Supplies, prepaid expenses and other current assets |
|
|
(13,458 |
) |
|
|
(93 |
) |
Accounts payable, accrued liabilities and income taxes |
|
|
46,353 |
|
|
|
69,988 |
|
Other |
|
|
6,526 |
|
|
|
(9,716 |
) |
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
215,988 |
|
|
|
207,046 |
|
|
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
Acquisitions of facilities and other related equipment |
|
|
(187,955 |
) |
|
|
(178,015 |
) |
Purchases of property and equipment |
|
|
(108,849 |
) |
|
|
(94,194 |
) |
Disposition of hospital and other ancillary operations |
|
|
12,662 |
|
|
|
750 |
|
Proceeds from sale of equipment |
|
|
234 |
|
|
|
74 |
|
Increase in other assets |
|
|
(25,362 |
) |
|
|
(24,382 |
) |
|
|
|
|
|
|
|
Net cash used in investing activities |
|
|
(309,270 |
) |
|
|
(295,767 |
) |
|
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
|
|
|
|
Proceeds from exercise of stock options |
|
|
6,693 |
|
|
|
8,699 |
|
Excess tax benefits relating to stock-based compensation |
|
|
2,295 |
|
|
|
4,588 |
|
Stock buy-back |
|
|
|
|
|
|
(137,666 |
) |
Deferred financing costs |
|
|
(367 |
) |
|
|
(16 |
) |
Redemption of convertible notes |
|
|
|
|
|
|
(128 |
) |
Proceeds from minority investors in joint ventures |
|
|
1,105 |
|
|
|
3,060 |
|
Redemption of minority investments in joint ventures |
|
|
(1,369 |
) |
|
|
(530 |
) |
Distributions to minority investors in joint ventures |
|
|
(1,705 |
) |
|
|
(1,977 |
) |
Borrowings under credit agreement |
|
|
132,000 |
|
|
|
176,000 |
|
Repayments of long-term indebtedness |
|
|
(64,579 |
) |
|
|
(43,260 |
) |
|
|
|
|
|
|
|
Net cash provided by financing activities |
|
|
74,073 |
|
|
|
8,770 |
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents |
|
|
(19,209 |
) |
|
|
(79,951 |
) |
|
|
|
|
|
|
|
Cash and cash equivalents at beginning of period |
|
|
40,566 |
|
|
|
104,108 |
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
21,357 |
|
|
$ |
24,157 |
|
|
|
|
|
|
|
|
See accompanying notes to the condensed consolidated financial statements.
3
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
1. BASIS OF PRESENTATION
The unaudited condensed consolidated financial statements of Community Health Systems, Inc. and its
Subsidiaries (the Company) as of June 30, 2007 and for the three and six month periods ended June
30, 2007 and June 30, 2006, have been prepared in accordance with accounting principles generally
accepted in the United States of America. In the opinion of management, such information contains
all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation
of the results for such periods. All intercompany transactions and balances have been eliminated.
The results of operations for the three and six months ended June 30, 2007, are not necessarily
indicative of the results to be expected for the full fiscal year ending December 31, 2007. Certain
information and disclosures normally included in the notes to the consolidated financial statements
have been condensed or omitted as permitted by the rules and regulations of the Securities and
Exchange Commission (SEC), although the Company believes the included disclosures are adequate to
make the information presented not misleading. The accompanying unaudited condensed consolidated
financial statements should be read in conjunction with the consolidated financial statements and
notes thereto for the year ended December 31, 2006, contained in the Companys Annual Report on
Form 10-K.
Effective September 30, 2006, the Company began estimating the allowance for doubtful accounts by
reserving a percentage of all self-pay accounts receivable without regard to aging category, based
on collection history, adjusted for expected recoveries and, if present, anticipated changes in
trends. Since the Company has historically collected substantially all third-party insured accounts
receivable, which includes receivables from governmental agencies, within one year of date of
discharge, the Company began reserving 100% of only those third-party insured accounts aging over
365 days from the date of discharge. The percentage used to reserve for all self-pay accounts is
based now on the Companys specific collection history for self-pay accounts. Previously, the
Company estimated the allowance for doubtful accounts by reserving all accounts aging over 150 days
from the date of discharge, without regard to payor class.
2. ACCOUNTING FOR STOCK-BASED COMPENSATION
Stock-based compensation awards are granted under the Community Health Systems, Inc. Amended and
Restated 2000 Stock Option and Award Plan (the 2000 Plan). The 2000 Plan allows for the grant of
incentive stock options intended to qualify under Section 422 of the Internal Revenue Code as well
as stock options which do not so qualify, stock appreciation rights, restricted stock, performance
units and performance shares, phantom stock awards and share awards. Persons eligible to receive
grants under the 2000 Plan include the Companys directors, officers, employees and consultants. To
date, the options granted under the 2000 Plan are nonqualified stock options for tax purposes.
Vesting of these granted options occurs in one third increments on each of the first three
anniversaries of the award date. Options granted prior to 2005 have a 10 year contractual term and
options granted in 2005 and 2006 have an 8 year contractual term. The exercise price of options
granted to employees under the 2000 Plan were equal to the fair value of the Companys common stock
on the option grant date. As of June 30, 2007, 9,863,232 shares of unissued common stock remain
reserved for future grants under the 2000 Plan. The Company also has options outstanding under its
Employee Stock Option Plan (the 1996 Plan). These options are fully vested and exercisable and no
additional grants of options will be made under the 1996 Plan.
The following table reflects the impact of total compensation expense related to stock-based equity
plans under the Statement of Financial Accounting Standards (SFAS) No. 123(R), on the reported
operating results for the respective periods (in thousands, except per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Six months ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Effect on income from continuing
operations before income taxes |
|
$ |
(7,965 |
) |
|
$ |
(5,279 |
) |
|
$ |
(14,295 |
) |
|
$ |
(8,946 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect on net income |
|
$ |
(4,839 |
) |
|
$ |
(3,367 |
) |
|
$ |
(8,684 |
) |
|
$ |
(5,750 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect on net income per share-diluted |
|
$ |
(0.05 |
) |
|
$ |
(0.04 |
) |
|
$ |
(0.09 |
) |
|
$ |
(0.06 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
SFAS No. 123(R) also requires the benefits of tax deductions in excess of the recognized tax
benefit on compensation expense to be reported as a financing cash flow, rather than as an
operating cash flow, as required under APB 25 and related interpretations. This requirement reduced
our net operating cash flows and increased our financing cash flows by $1.5 million and $0.2
million for the three months ended June 30, 2007 and 2006, respectively, and $2.3 million and $4.6
million for the six months ended June 30, 2007 and 2006, respectively.
4
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
2. ACCOUNTING FOR STOCK-BASED COMPENSATION (Continued)
At June 30, 2007, $55.2 million of unrecognized stock-based compensation expense from all
outstanding unvested stock options and restricted stock is expected to be recognized over a
weighted-average period of 20.4 months.
The fair value of stock-based awards was estimated using the Black Scholes option pricing model
with the assumptions and weighted-average fair values during the three and six months ended June
30, 2007 and June 30, 2006, as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Six months ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Expected volatility |
|
|
24.6 |
% |
|
|
23.2 |
% |
|
|
25.5 |
% |
|
|
24.1 |
% |
Expected dividends |
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
Expected term |
|
4 years |
|
4 years |
|
4 years |
|
4 years |
Risk-free interest rate |
|
|
4.77 |
% |
|
|
4.98 |
% |
|
|
4.50 |
% |
|
|
4.67 |
% |
In determining expected return, the Company examined concentrations of option holdings, historical
patterns of option exercises and forfeitures, as well as forward looking factors, to determine if
there were discernable employee populations. From this analysis, the Company identified two
employee populations, one consisting primarily of certain senior executives and the other
consisting of all other recipients.
The expected volatility rate was estimated based on historical volatility. In determining expected
volatility, the Company also reviewed the market based implied volatility of actively traded
options of its common stock and determined that historical volatility did not differ significantly
from the implied volatility.
The expected life computation is based on historical exercise and cancellation patterns and forward
looking factors, where present, for each population identified. The risk-free interest rate is
based on the U.S. Treasury yield curve in effect at the time of the grant. The pre-vesting
forfeiture rate is based on historical rates and forward looking factors for each population
identified. As required under SFAS No. 123(R), the Company will adjust the estimated forfeiture
rate to its actual experience.
Options outstanding and exercisable under the 1996 Plan and the 2000 Plan as of June 30, 2007, and
changes during the three and six months then ended were as follows (in thousands, except share and
per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
average |
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
remaining |
|
|
Aggregate |
|
|
|
|
|
|
|
average |
|
|
contractual |
|
|
intrinsic |
|
|
|
|
|
|
|
exercise |
|
|
term |
|
|
value as of |
|
|
|
Shares |
|
|
price |
|
|
(in years) |
|
|
June 30, 2007 |
|
Outstanding at December 31, 2006 |
|
|
5,482,528 |
|
|
$ |
26.48 |
|
|
|
|
|
|
|
|
|
Granted |
|
|
852,500 |
|
|
|
37.21 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(121,861 |
) |
|
|
26.13 |
|
|
|
|
|
|
|
|
|
Forfeited and cancelled |
|
|
(24,002 |
) |
|
|
35.77 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at March 31, 2007 |
|
|
6,189,165 |
|
|
|
27.93 |
|
|
|
|
|
|
|
|
|
Granted |
|
|
54,000 |
|
|
|
37.20 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(123,321 |
) |
|
|
26.82 |
|
|
|
|
|
|
|
|
|
Forfeited and cancelled |
|
|
(70,841 |
) |
|
|
36.16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at June 30, 2007 |
|
|
6,049,003 |
|
|
$ |
27.94 |
|
|
6.45 years |
|
$ |
75,680 |
|
|
|
|
|
|
|
|
|
|
|
Exercisable at June 30, 2007 |
|
|
4,017,912 |
|
|
$ |
23.53 |
|
|
5.98 years |
|
$ |
67,984 |
|
|
|
|
|
|
|
|
|
|
|
The weighted-average grant date fair value of stock options granted during the six months ended
June 30, 2007 and June 30, 2006, was $10.36 and $10.39, respectively. The aggregate intrinsic value
in the table above represents the total pretax intrinsic value (the difference between the
Companys closing stock price on the last trading day of the reporting period ($40.45) and the
exercise price, multiplied by the number of
5
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
2. ACCOUNTING FOR STOCK-BASED COMPENSATION (Continued)
the in-the-money options) that would have been received by the option holders had all option
holders exercised their options on June 30, 2007. This amount changes based on the market value of
the Companys common stock. The aggregate intrinsic value of options exercised during the three
months ended June 30, 2007 and 2006 was $1.5 million and $0.6 million, respectively, and the
aggregate intrinsic value of options exercised during the six months ended June 30, 2007 and 2006
was $2.9 million and $11.7 million, respectively.
The Company has also awarded restricted stock under the 2000 Plan to various employees and its
directors. The restrictions on these shares generally lapse in one-third increments on each of the
first three anniversaries of the award date. Certain of the restricted stock awards granted to the
Companys senior executives also contain a performance objective that must be met in addition to
the vesting requirements. If the performance objective is not attained the awards will be forfeited
in their entirety. Once the performance objective has been attained, restrictions will lapse in
one-third increments on each of the first three anniversaries of the award date. Notwithstanding
the above mentioned performance objectives and vesting requirements, the restrictions will lapse
earlier in the event of death, disability, termination of employment by employer for reason other
than for cause of the holder of the restricted stock or in the event of change in control of the
Company. Restricted stock awards subject to performance standards are not considered outstanding
for purposes of determining earnings per share until the performance objectives have been
satisfied.
Restricted stock outstanding under the 2000 Plan as of June 30, 2007, and changes during the three
and six months then ended are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
|
average |
|
|
|
|
|
|
|
fair |
|
|
|
Shares |
|
|
value |
|
Unvested at December 31, 2006 |
|
|
969,691 |
|
|
$ |
36.05 |
|
Granted |
|
|
681,000 |
|
|
|
37.19 |
|
Vested |
|
|
(376,679 |
) |
|
|
35.42 |
|
Forfeited |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unvested at March 31, 2007 |
|
|
1,274,012 |
|
|
|
36.84 |
|
Granted |
|
|
8,500 |
|
|
|
37.20 |
|
Vested |
|
|
|
|
|
|
|
|
Forfeited |
|
|
(16,002 |
) |
|
|
36.66 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unvested at June 30, 2007 |
|
|
1,266,510 |
|
|
|
36.84 |
|
|
|
|
|
|
|
|
|
|
|
As of June 30, 2007, there was $38.9 million of unrecognized stock-based compensation expense
related to unvested restricted stock expected to be recognized over a weighted-average period of
21.4 months. Under the Directors Fee Deferral Plan, the Companys outside directors may elect to receive share
equivalent units in lieu of cash for their directors fee. These units are held in the plan until
the director electing to receive the share equivalent units retires or otherwise terminates his/her
directorship with the Company. Share equivalent units are converted to shares of common stock of
the Company at the time of distribution. The following table represents the amount of directors
fees which were deferred and the equivalent units into which they converted for each of the
respective periods:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Six months ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Directors fees earned and deferred into plan |
|
$ |
29,375 |
|
|
$ |
41,875 |
|
|
$ |
65,250 |
|
|
$ |
93,750 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equivalent units |
|
|
726.205 |
|
|
|
1,139.456 |
|
|
|
1,743.936 |
|
|
|
2,574.449 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At June 30, 2007, there are a total of 11,529.937 units deferred in the plan with an aggregate fair
value of $466,386 based on the closing market price of the Companys common stock on the last
trading day of the reporting period of $40.45.
6
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
3. COST OF REVENUE
The majority of the Companys operating costs and expenses are cost of revenue items. Operating
costs that could be classified as general and administrative by the Company would include the
Companys corporate office costs, which were $23.9 million and $23.3 million for the three months
ended June 30, 2007 and 2006, respectively, and $47.0 million and $44.3 million for the six months
ended June 30, 2007 and 2006, respectively. These corporate office costs include stock-based
compensation expense recognized under SFAS No. 123(R).
4. USE OF ESTIMATES
The preparation of financial statements in conformity with accounting principles generally accepted
in the United States of America requires management of the Company to make estimates and
assumptions that affect the amounts reported in the consolidated financial statements. Actual
results could differ from the estimates.
5. ACQUISITIONS AND DIVESTITURES
On July 25, 2007, the Company completed its acquisition of Triad Hospitals, Inc. (Triad) pursuant
to which the Company acquired Triad for $54 per share in cash, or approximately $6.968 billion in
the aggregate, including the assumption of approximately $1.702 billion of existing indebtedness of
Triad. The combined company owns or operates approximately 130 hospitals in 28 states, with a total
bed count of approximately 19,200. The merger was approved by Triads stockholders at a meeting
held on June 13, 2007. In connection with the consummation of the merger, the Company obtained
$7.215 billion of senior secured financing under a new credit facility (the New Credit Facility)
and its wholly-owned subsidiary, CHS/Community Health Systems, Inc. (the Issuer), issued $3.021
billion aggregate principal amount ($3.000 billion, net of discount) of 8.875% senior notes due
2015 (the Notes) at the closing of the merger. The Notes are senior obligations of the Issuer and
are guaranteed on a senior basis by the Company and by certain of the Companys domestic
subsidiaries (including certain of the acquired Triad subsidiaries). The Company used the net
proceeds from the Notes offering and the net proceeds of the $6.065 billion of term loans under the
New Credit Facility to pay the consideration under the merger agreement, to refinance certain of
its indebtedness and indebtedness of Triad, to complete certain related transactions, to pay
certain costs and expenses of the transactions and for general corporate uses. A $750 million
revolving credit facility and a $400 million delayed draw term loan facility is available to the
Company for working capital and general corporate purposes under the New Credit Facility. This
revolving credit facility also will include a subfacility for letters of credit and a swingline
subfacility. Also, in connection with the consummation of the merger, the Company completed an
early repayment of its outstanding $300 million aggregate principal amount of 6-1/2% Senior
Subordinated Notes due 2012 through a cash tender offer and consent solicitation.
Prior to entering the merger agreement, Triad terminated an Agreement and Plan of Merger that it
entered into on February 4, 2007 (the Prior Merger Agreement) with Panthera Partners, LLC,
Panthera Holdco Corp. and Panthera Acquisition Corporation (collectively, Panthera). Concurrent
with the termination of the Prior Merger Agreement and pursuant to the terms thereof, Triad paid a
termination fee of $20 million to Panthera and advanced $20 million to Panthera to cover its
out-of-pocket expenses. The Company has reimbursed Triad for the termination fee and the advance
for expense reimbursement paid to Panthera. These amounts have been included in other assets on the
accompanying June 30, 2007 balance sheet and will subsequently be included in the total allocated
purchase price relative to the Triad acquisition.
Effective April 1, 2007, the Company completed its acquisition of Lincoln General Hospital (157
licensed beds), located in Ruston, Louisiana. The total consideration for this hospital was
approximately $47.8 million, of which $43.6 million was paid in cash and $4.2 million was assumed
in liabilities. On May 1, 2007, the Company completed its acquisition of Porter Health, a 301 bed
acute care hospital located in Valparaiso, Indiana, with a satellite campus in Portage, Indiana,
and outpatient medical campuses in Chesterton, Demotte, and Hebron, Indiana. As part of this
acquisition, the Company has agreed to construct a 225-bed replacement facility for the Valparaiso
hospital no later than April 2011. The total consideration for Porter Health was approximately
$110.1 million, of which $83.2 million was paid in cash and $26.9 million was assumed in
liabilities. During the quarter ended June 30, 2007, the Company made its initial purchase price
allocation relating to these acquisitions resulting in
approximately $6.6 million of goodwill being recorded. This allocation is preliminary pending,
among other things, finalization of appraisals of tangible and intangible assets.
7
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
5. ACQUISITIONS AND DIVESTITURES (Continued)
During 2006, the Company acquired through seven separate purchase transactions and three capital
lease transactions, substantially all of the assets and working capital of eight hospitals and
three home health agencies. On March 1, 2006, the Company acquired, through a combination of
purchasing certain assets and entering into a capital lease for other related assets, Forrest City
Hospital, a 118 bed hospital located in Forrest City, Arkansas. On April 1, 2006, the Company
completed the acquisition of two hospitals from Baptist Health System, Birmingham, Alabama: Baptist
Medical Center DeKalb (134 beds) and Baptist Medical Center Cherokee (60 beds). On May 1,
2006, the Company acquired Via Christi Oklahoma Regional Medical Center, a 140 bed hospital located
in Ponca City, Oklahoma. On June 1, 2006, the Company acquired Mineral Area Regional Medical
Center, a 135 bed hospital located in Farmington, Missouri. On June 30, 2006, the Company acquired
Cottage Home Options, a home health agency and related business, located in Galesburg, Illinois. On
July 1, 2006, the Company acquired the healthcare assets of Vista Health, which included Victory
Memorial Hospital (336 beds) and St. Therese Medical Center (71 non-acute care beds), both located
in Waukegan, Illinois. On September 1, 2006, the Company acquired Humble Texas Home Care, a home
health agency located in Humble, Texas. On October 1, 2006, the Company acquired Helpsource Home
Health, a home health agency located in Wichita Falls, Texas. On November 1, 2006, the Company
acquired through two separate capital lease transactions, Campbell Memorial Hospital, a 99 bed
hospital located in Weatherford, Texas and Union County Hospital, a 25 bed hospital located in
Anna, Illinois. The aggregate consideration for these eight hospitals and three home health
agencies totaled approximately $385.7 million, of which $353.8 million was paid in cash and $31.9
million was assumed in liabilities. Goodwill recognized in these transactions totaled $65.6
million, which is expected to be fully deductible for tax purposes.
Effective March 18, 2006, the Company sold Highland Medical Center, a 123 bed facility located in
Lubbock, Texas, to Shiloh Health Services, Inc. of Louisville, Kentucky. The proceeds from this
sale were $0.5 million. This hospital had previously been classified as held for sale. In
connection with the above sale transaction and in accordance with SFAS No. 144, Accounting for the
Impairment or Disposal of Long-Lived Assets, the Company has classified the results of operations
of Highland Medical Center as discontinued operations in the accompanying condensed consolidated
statements of income.
Net operating revenues and loss from discontinued operations, related to the above mentioned sale,
for the six months ended June 30, 2006 (as applicable) are as follows (in thousands):
|
|
|
|
|
|
|
Six months ended |
|
|
|
June 30, 2006 |
|
Net operating revenues |
|
$ |
4,294 |
|
|
|
|
|
Loss from operations before income taxes |
|
$ |
(1,008 |
) |
Loss on sale of hospital |
|
|
(3,938 |
) |
|
|
|
|
Loss from discontinued operations, before taxes |
|
|
(4,946 |
) |
|
|
|
|
Income tax benefit |
|
|
1,730 |
|
|
|
|
|
Loss from discontinued operations, net of tax |
|
$ |
(3,216 |
) |
|
|
|
|
Since the sale of Highland Medical Center occurred in the first quarter of 2006, there are no net
operating revenues and no loss from discontinued operations for the three months ended June 30,
2006. The computation of the loss from discontinued operations, before taxes, for the six months
ended June 30, 2006 includes the net write-off of $4.4 million of tangible assets at the one
hospital sold during the six months ended June 30, 2006.
There are no material assets or liabilities related to the hospitals classified as discontinued
operations in the accompanying condensed consolidated balance sheets as of June 30, 2007 and
December 31, 2006.
6. INCOME TAXES
The Company adopted the provisions of the Financial Accounting Standards Board (FASB)
Interpretation No. 48, Accounting for Uncertainty in Income Taxes, on January 1, 2007. The total
amount of unrecognized benefit that would affect the effective tax rate, if recognized, is $9.0
million. It is the Companys policy to recognize interest accrued related to unrecognized benefits
in its statement of operations as income tax expense. Approximately $1.2 million of interest is
included in the amount of unrecognized benefit at June 30, 2007. During the year ending December
31, 2007, it is possible the Company could release up to $5.2 million plus accrued interest of $0.8
million of its FASB Interpretation No. 48 liability, as a result of the potential expiration of the
statute of limitations pertaining to tax positions taken in prior years relative to legal
settlements.
The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction
and various state jurisdictions. With few exceptions, the Company is no longer subject to U.S.
federal or state income tax examinations for years prior to 2003. During 2006, the Company agreed
to a settlement at the Internal Revenue Service Appeals Office with respect to the 2003
consolidated income tax year. The Company has since received a closing letter with respect to the
examination for the tax year 2003. The settlement was not material to the Companys consolidated
statement of income or financial position.
Cash paid for income taxes, net of refunds received, was $16.2 million and $15.5 million during the
three months ended June 30, 2007 and 2006, respectively, and $29.4 million and $36.6 million during
the six months ended June 30, 2007 and 2006, respectively.
8
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
7. GOODWILL AND OTHER INTANGIBLE ASSETS
The changes in the carrying amount of goodwill for the six months ended June 30, 2007, are as
follows (in thousands):
|
|
|
|
|
Balance as of December 31, 2006 |
|
$ |
1,336,525 |
|
|
|
|
|
Goodwill acquired as part of acquisitions during 2007 |
|
|
6,577 |
|
Consideration adjustments and finalization of purchase price
allocations for acquisitions completed prior to 2007 |
|
|
3,476 |
|
Goodwill written-off as part of disposal transaction |
|
|
(1,622 |
) |
|
|
|
|
Balance as of June 30, 2007 |
|
$ |
1,344,956 |
|
|
|
|
|
In May 2007, the Company sold certain operations ancillary to one of its hospitals. This
transaction and related operations were not material.
The Company completed its most recent annual goodwill impairment test as required by SFAS No. 142,
Goodwill and Other Intangible Assets, during 2006, using a measurement date of September 30,
2006. Based on the results of the impairment test, the Company was not required to recognize an
impairment of goodwill in 2006.
As previously disclosed and further discussed in the footnote on Subsequent Events, on July 25,
2007, the Company completed its acquisition of Triad. In connection with this transaction, the
Company has engaged a third-party valuation firm to assist it in determining the fair market value
of the tangible and intangible assets acquired from Triad. The Company will make a preliminary
allocation of purchase price in the third quarter of 2007 and anticipates that this transaction
will create a significant amount of goodwill.
The gross carrying amount of the Companys other intangible assets was $15.6 million at June 30,
2007 and $13.7 million at December 31, 2006, and the net carrying amount was $9.7 million at June
30, 2007 and $7.4 million at December 31, 2006. Other intangible assets are included in other
assets, net on the Companys condensed consolidated balance sheets.
The weighted-average amortization period for the intangible assets subject to amortization is
approximately seven years. There are no expected residual values related to these intangible
assets. Amortization expense on these intangible assets during the three months ended June 30, 2007
and 2006 was $0.5 million and $0.4 million, respectively. Amortization expense on these intangible
assets during the six months ended June 30, 2007 and 2006 was $1.0 million and $0.9 million,
respectively. Amortization expense on intangible assets is estimated to be $1.9 million for the
remainder of 2007, $2.1 million in 2008, $1.8 million in 2009, $1.2 million in 2010, $0.6 million
in 2011, and $0.5 million in 2012.
9
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
8. EARNINGS PER SHARE
The following table sets forth the components of the numerator and denominator for the computation
of basic and diluted income from continuing operations per share (in thousands, except share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Six months ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator for basic earnings per share - |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations available to
common stockholders basic |
|
$ |
53,763 |
|
|
$ |
52,369 |
|
|
$ |
108,087 |
|
|
$ |
109,623 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator for diluted earnings per share -
Income from continuing operations |
|
$ |
53,763 |
|
|
$ |
52,369 |
|
|
$ |
108,087 |
|
|
$ |
109,623 |
|
Interest, net of tax, on 4.25% convertible notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
135 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations available to
common stockholders diluted |
|
$ |
53,763 |
|
|
$ |
52,369 |
|
|
$ |
108,087 |
|
|
$ |
109,758 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number of shares
outstanding basic |
|
|
93,518,991 |
|
|
|
95,769,030 |
|
|
|
93,373,357 |
|
|
|
96,158,575 |
|
Effect of dilutive securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-employee director options |
|
|
|
|
|
|
11,850 |
|
|
|
5,913 |
|
|
|
11,882 |
|
Restricted stock awards |
|
|
181,183 |
|
|
|
108,432 |
|
|
|
111,539 |
|
|
|
76,849 |
|
Employee options |
|
|
947,696 |
|
|
|
981,003 |
|
|
|
931,191 |
|
|
|
996,865 |
|
4.25% convertible notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
292,644 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number of shares
outstanding diluted |
|
|
94,647,870 |
|
|
|
96,870,315 |
|
|
|
94,422,000 |
|
|
|
97,536,815 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dilutive securities outstanding not included in
the computation of earnings per share because
their effect is antidilutive: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee options |
|
|
1,032,071 |
|
|
|
1,028,400 |
|
|
|
1,479,319 |
|
|
|
1,045,400 |
|
9. STOCKHOLDERS EQUITY
On January 17, 2006, the Company completed the redemption of all its remaining outstanding 4.25%
Convertible Subordinated Notes due 2008 (the 4.25% Notes). Prior to the call for redemption made
on December 16, 2005, there was $136.6 million in aggregate principal amount of the 4.25% Notes
outstanding. At the conclusion of the call for redemption, $0.1 million in principal amount of the
4.25% Notes were redeemed for cash and $136.5 million of the 4.25% Notes were converted by the
holders into 4,074,510 shares of the Companys common stock, $0.01 par value per share.
On January 14, 2006, the Company commenced an open market repurchase program for up to 5,000,000
shares of the Companys common stock, not to exceed $200 million in repurchases. Under this
program, the Company repurchased the entire 5,000,000 shares at a weighted average price of $35.23.
This program concluded on November 8, 2006 when the maximum number of shares had been repurchased.
On December 13, 2006, the Company commenced another open market repurchase program for up to
5,000,000 shares of the Companys common stock not to exceed $200 million in repurchases. This
program will conclude at the earlier of three years or when the maximum number of shares have been
repurchased. As of June 30, 2007, the Company has not repurchased any shares under this program.
10
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
10. COMPREHENSIVE INCOME
The following table presents the components of comprehensive income, net of related taxes. The net
change in fair value of interest rate swap agreements is a function of the spread between the fixed
interest rate of each swap and the underlying variable interest rate under the Companys credit
facility and the change in fair value of available for sale securities is the unrealized gains
(losses) on the related investments (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Six months ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Net income |
|
$ |
53,763 |
|
|
$ |
52,369 |
|
|
$ |
108,087 |
|
|
$ |
106,407 |
|
Net change in fair value of interest rate swaps |
|
|
13,670 |
|
|
|
2,370 |
|
|
|
9,800 |
|
|
|
7,504 |
|
Net change in fair value of available for sale securities |
|
|
237 |
|
|
|
(138 |
) |
|
|
24 |
|
|
|
28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income |
|
$ |
67,670 |
|
|
$ |
54,601 |
|
|
$ |
117,911 |
|
|
$ |
113,939 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The net change in fair value of the interest rate swap agreements and the net change in fair value
of available for sale securities are included in stockholders equity on the accompanying condensed
consolidated balance sheets.
11. LONG-TERM DEBT
On August 19, 2004, the Company entered into a $1.625 billion senior secured credit facility with a
consortium of lenders which was subsequently amended on December 16, 2004, July 8, 2005 and
December 13, 2006. The purpose of the facility was to refinance the Companys previous credit
agreement, repay specified other indebtedness, and fund general corporate purposes including
amending the credit facility to permit declaration and payment of cash dividends, to repurchase
shares or make other distributions, subject to certain restrictions. This facility replaced the
Companys previous credit facility and consists of a $1.2 billion term loan that matures in 2011
and a $425 million revolving credit facility that matures in 2009. The First Incremental Facility
Amendment, dated as of December 13, 2006, increased our term loans by $400 million (the
Incremental Term Loan Facility) and also gave the Company the ability to add up to $400 million
of additional term loans. The full amount of the Incremental Term Loan Facility was funded on
December 13, 2006, and the proceeds were used to repay the full outstanding amount (approximately
$326 million) of the revolving credit facility under the credit agreement and the balance was
available to be used for general corporate purposes. The Company may elect from time to time an
interest rate per annum for the borrowings under the term loan, including the incremental term
loan, and revolving credit facility equal to (a) an alternate base rate, which will be equal to the
greatest of (i) the Prime Rate (as defined) in effect and (ii) the Federal Funds Effective Rate (as
defined), plus 50 basis points, plus (1) 75 basis points for the term loan and (2) the Applicable
Margin (as defined) for revolving credit loans or (b) the Eurodollar Rate (as defined) plus (1) 175
basis points for the term loan and (2) the Applicable Margin for Eurodollar revolving credit loans.
The Company also pays a commitment fee for the daily average unused commitments under the revolving
credit facility. The commitment fee is based on a pricing grid depending on the Applicable Margin
for Eurodollar revolving credit loans and ranges from 0.250% to 0.500%. The commitment fee is
payable quarterly in arrears and on the revolving credit termination date with respect to the
available revolving credit commitments. In addition, the Company will pay fees for each letter of
credit issued under the credit facility. In connection with this refinancing, the Company recorded
a pre-tax write-off of approximately $0.8 million in deferred loan costs relative to the early
extinguishment of a portion of the previous credit facility.
As of June 30, 2007, the Companys availability for additional borrowings under its revolving
credit facility was $425 million, of which $22.4 million was set aside for outstanding letters of
credit. The Company also had the ability to add up to $200 million of borrowing capacity from
receivable transactions (including securitizations) under its senior secured credit facility which
had not yet been accessed. As stated above, the Company also had the ability to amend the senior
secured credit facility to provide for one or more tranches of term loans in an aggregate principal
amount of $400 million, which the Company had not yet accessed. As of June 30, 2007, the Companys
weighted-average interest rate under its credit facility was 7.5%.
11
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
11. LONG
TERM DEBT (Continued)
Cash paid for interest, net of interest income, was $34.6 million and $28.1 million during the
three months ended June 30, 2007 and 2006, respectively, and $60.3 million and $47.4 million during
the six months ended June 30, 2007 and 2006, respectively.
As previously disclosed and further discussed in the footnote on Subsequent Events, in connection
with the consummation of the acquisition of Triad on July 25, 2007, the Company used a portion of
the net proceeds from its New Credit Facility and Notes offering to repay its outstanding debt
under the above mentioned credit facility. Upon repayment, the above mentioned credit facility was
terminated.
The Company has entered into this New Credit Facility with a syndicate of financial institutions
led by Credit Suisse, as administrative agent and collateral agent. The New Credit Facility
consists of a $6.065 billion funded term loan facility with a maturity of seven years, a $400
million delayed draw term loan facility with a maturity of seven years and a $750 million revolving
credit facility with a maturity of six years. The revolving credit facility also will include a
subfacility for letters of credit and a swingline subfacility. The New Credit Facility requires the
Company to make quarterly amortization payments of each term loan facility in quarterly amounts
equal to 0.25% of the outstanding amount of the term loans, if any, with the outstanding principal
balance payable on the anniversary of the New Credit Facility in 2014.
The term loan facility must be prepaid in an amount equal to (1) 100% of the net cash proceeds of
certain asset sales and dispositions by the Company and its subsidiaries, subject to certain
exceptions and reinvestment rights, (2) 100% of the net cash proceeds of issuances of certain debt
obligations by the Company and its subsidiaries, subject to certain exceptions, and (3) 50%,
subject to reduction to a lower percentage based on the Companys leverage ratio, of excess cash
flow for any year, commencing in 2008, subject to certain exceptions.
Voluntary prepayments and commitment reductions are permitted in whole or in part, without any
premium or penalty, subject to minimum prepayment or reduction requirements.
All of the Companys obligations under the New Credit Facility are unconditionally guaranteed by
the Company and certain existing and subsequently acquired or organized domestic subsidiaries. All
obligations under the New Credit Facility and the related guarantees will be secured by a perfected
first priority lien or security interest in substantially all of the Companys assets and each
subsidiary guarantors assets, including equity interests held by the Company or any subsidiary
guarantor, excluding, among others, the equity interests of non-significant subsidiaries,
syndication subsidiaries, securitization subsidiaries and joint venture subsidiaries. The loans
under the New Credit Facility will bear interest on the outstanding unpaid principal amount at a
rate equal to an applicable percentage plus, at the Companys option, either (a) an alternative
base rate determined by reference to the greater of (1) the prime rate announced by Credit Suisse
and (2) the federal funds rate plus one-half of 1.0%, or (b) a reserve adjusted Eurodollar rate.
The applicable percentage for term loans is 1.25% for alternative base rate loans and 2.25% for
Eurodollar rate loans, and the applicable percentage for revolving loans will be up to 1.25% for
alternative base rate revolving loans and up to 2.25% for Eurodollar revolving loans, in each case
based on the Companys leverage ratio. Loans under the swingline subfacility bear interest at the
rate applicable to alternative base rate loans under the revolving credit facility.
The Company has agreed to pay letter of credit fees equal to the applicable percentage then in
effect with respect to Eurodollar rate loans under the revolving credit facility times the maximum
aggregate amount available to be drawn under all letters of credit issued under the subfacility for
letters of credit. The issuer of any letter of credit issued under the subfacility for letters of
credit will also receive a customary fronting fee and other customary processing charges. The
Company is also obligated to pay commitment fees, depending on our total leverage ratio, of up to
0.50% per annum, on the unused portion of the revolving credit facility. For purposes of this
calculation, swingline loans are not treated as usage of the revolving credit facility. The Company
will also pay arrangement fees on the closing of the New Credit Facility and an annual
administrative agent fee.
12
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
11. LONG
TERM DEBT (Continued)
The New Credit Facility contains customary representations and warranties, subject to limitations
and exceptions, and customary covenants restricting the Company and its subsidiaries ability to,
among other things and subject to various exceptions, (1) declare dividends, make distributions or
redeem or repurchase capital stock, (2) prepay, redeem or repurchase other debt, (3) incur liens or
grant negative pledges, (4) make loans and investments and enter into acquisitions and joint
ventures, (5) incur additional indebtedness, (6) make capital expenditures, (7) engage in mergers,
acquisitions and asset sales, (8) conduct transactions with affiliates, (9) alter the nature of the
Companys businesses, or (10) change the Companys fiscal year. The Company and its subsidiaries
are also required to comply with specified financial covenants (consisting of a leverage ratio and
an interest coverage ratio) and various affirmative covenants.
Events of default under the New Credit Facility include, but are not limited to, (1) the Companys
failure to pay principal, interest, fees or other amounts under the credit agreement when due
(taking into account any applicable grace period), (2) any representation or warranty proving to
have been materially incorrect when made, (3) covenant defaults subject, with respect to certain
covenants, to a grace period, (4) bankruptcy events, (5) a cross default to certain other debt, (6)
certain undischarged judgments (not paid within an applicable grace period), (7) a change of
control, (8) certain ERISA-related defaults, and (9) the invalidity or impairment of specified
security interests.
The Notes issued in connection with the Triad acquisition were issued in the principal amount of
$3.021 billion. These Notes will mature on July 15, 2015. Interest on the Notes will accrue at the
rate of 8.875% per annum and will be payable semiannually in arrears on January 15 and July 15,
commencing January 15, 2008. Interest on the Notes will accrue from the date of original issuance.
Interest will be calculated on the basis of 360-day year comprised of twelve 30-day months.
Except as set forth below, the Issuer is not entitled to redeem the Notes at its option prior to
July 15, 2011.
On and after July 15, 2011, the Issuer is entitled at its option to redeem all or a portion of the
2015 Notes upon not less than 30 nor more than 60 days notice, at the redemption prices (expressed
as a percentage of principal amount on the redemption date), plus accrued interest to the
redemption date (subject to the right of Holders of record on the relevant record date to receive
interest due on the relevant interest payment date), if redeemed during the 12 month period
commencing on July 15 of the years set forth below:
|
|
|
|
|
|
|
Redemption |
|
Period |
|
Price |
|
2011 |
|
|
104.438 |
% |
2012 |
|
|
102.219 |
% |
2013 and thereafter |
|
|
100.000 |
% |
In addition, any time prior to July 15, 2010, the Issuer is entitled at its option on one or more
occasions to redeem the Notes (which include additional Notes, if any) in an aggregate principal
amount not to exceed 35% of the aggregate principal amount of the Notes (which includes additional
Notes, if any) originally issued at a redemption price (expressed as a percentage of principal
amount) of 108.875%, plus accrued and unpaid interest to the redemption date, with the Net Cash
Proceeds (as defined) from one or more Public Equity Offerings (provided that if the Public Equity
Offering (as defined) is an offering by Parent, a portion of the Net Cash Proceeds (as defined)
thereof equal to the amount required to redeem any such Notes is contributed to the equity capital
of the Issuer); provided, however, that
|
(1) |
|
at least 65% of such aggregate principal amount of Notes originally issued remains outstanding
immediately after the occurrence of each such redemption (other than the Notes held, directly
or indirectly, by the Company or its Subsidiaries); and |
|
|
(2) |
|
each such redemption occurs within 90 days after the date of the related Public Equity Offering. |
The Issuer is entitled at its option to redeem the Notes, in whole or in part, at any time prior to
July 15, 2011, upon not less than 30 or more than 60 days notice, at a redemption price equal to
100% of the principal amount of Notes redeemed plus the Application Premium (as defined) and
accrued and unpaid interest, if any, as of the applicable redemption date.
The Notes are unsecured obligations of the Company. Secured debt and other secured obligation of
the Company (including obligations with respect to the New Credit Facility) will be effectively
senior to the Notes to the extent of the value of the assets securing such debt or other
obligations.
The Issuer has agreed, pursuant to the Registration Rights Agreement, that it will be subject to
certain exceptions, file a registration statement (the Exchange Offer Registration Statement)
with the SEC within 90 days of the date the Notes were issued (the Issue Date) to make an offer
to exchange the Notes for new notes (the Exchange Notes) having terms substantially identical in
all material respects to the Notes. If the Exchange Offer Registration Statement is not filed with
the SEC within that 90 day period ,the Exchange Offer Registration Statement is not declared
effective by the SEC on or prior to the 210th day after the Issue Date, the exchange
offer is not consummated on or before the 40th day after the Exchange Offer Registration
Statement is declared effective or certain other circumstances (each, a Registration Default),
additional interest will be paid on the Notes at a rate of 0.25% per annum for the first 90 day
period following the Registration Default, and such rate will increase by an additional 0.25% per
annum with respect to each subsequent 90 day period until all Registration Defaults have been
cured, up to a maximum additional interest rate of 1.0% per annum.
13
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
12. RECENT ACCOUNTING PRONOUNCEMENTS
In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements, which defines fair
value, provides framework for measuring fair value, and expands the disclosures required for fair
value measurements. SFAS No. 157 applies to other accounting pronouncements that require fair value
measurements; it does not require any new fair value measurements. SFAS No. 157 is effective for
fiscal years beginning after November 15, 2007 and is required to be adopted by the Company
beginning in the first quarter of 2008. Although the Company will continue to evaluate the
application of SFAS No. 157, management does not currently believe adoption will have a material
impact on the Companys results of operations or financial position.
13. CONTINGENCIES
The Company is a party to various legal proceedings incidental to its business. In the opinion of
management, any ultimate liability with respect to these actions will not have a material adverse
effect on the Companys consolidated financial position, cash flows or results of operations. In
addition, in connection with the closing of the Triad acquisition on July 25, 2007, the Company has
assumed both recorded and unrecorded contingencies of Triad. The Companys management is not aware
of any unrecorded contingencies, assumed in connection with the Triad acquisition, whose ultimate
outcome will have an adverse effect on the Companys consolidated financial position, cash flows or
results of operations.
14. SUBSEQUENT EVENTS
On July 25, 2007, the Company completed its acquisition of Triad (former NYSE: TRI). Pursuant to
the merger agreement under which the acquisition was completed, shareholders of Triad received $54
in cash per share of common stock, or approximately $6.968 billion in the aggregate, including the
assumption of approximately $1.702 billion of existing indebtedness of Triad. Triad stock ceased to
trade on the New York Stock Exchange effective at the close of business on July 25, 2007.
In connection with the consummation of the Triad merger, the Company obtained $7.215 billion of
senior secured financing under the New Credit Facility and the Issuer, issued $3.021 billion
aggregate principal amount ($3.000 billion, net of discount) of its 8.875% senior notes due 2015 at
the closing of the merger. The Notes are senior obligations of the Issuer and are guaranteed on a
senior basis by the Company and by certain of the Companys domestic subsidiaries. The Company used
the net proceeds from the Notes offering and the net proceeds of the $6.065 billion of term loans
under the New Credit Facility to pay the consideration under the merger agreement, to repay certain
of its indebtedness, including the repayment of term loans under its existing credit agreement and
indebtedness of Triad, to complete certain related transactions, to pay certain costs and expenses
of the transactions and for general corporate uses. A $750 million revolving credit facility and a
$400 million delayed draw term loan facility is available to the Company for working capital and
general corporate purposes under the new credit facility. The revolving credit facility also will
include a subfacility for letters of credit and a swingline subfacility. Also, in connection with
the consummation of the merger, the Company completed an early repayment of its outstanding $300
million aggregate principal amount of 6-1/2% Senior Subordinated Notes due 2012 through a cash
tender offer and consent solicitation.
14
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
15. SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION
The 8.875% Senior Notes maturing July 15, 2015, issued in connection with the Companys July 25,
2007 acquisition of Triad Hospitals Inc., are fully and unconditionally guaranteed by the Company
and certain of its current and future, direct and indirect, 100% owned domestic subsidiaries.
Such guarantees are joint and several. The following condensed consolidating financial statements
present the parent guarantor, the issuer, the subsidiary guarantors, the subsidiary non-guarantors
and eliminations. This condensed consolidating financial information has been prepared and
presented in accordance with SEC Regulation S-X Rule 3-10 Financial Statements of Guarantors and
Affiliates whose Securities Collateralize an issue Registered or Being Registered.
15
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
15.
Supplemental Condensed Consolidating Financial Information
(Continued)
CONSOLIDATED
BALANCE SHEETS
(Amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
December 31, 2006: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
|
|
|
$ |
|
|
|
$ |
28,713 |
|
|
$ |
11,853 |
|
|
$ |
|
|
|
$ |
40,566 |
|
Patient
accounts receivable, net of allowance for
doubtful accounts |
|
|
|
|
|
|
|
|
|
|
634,227 |
|
|
|
139,757 |
|
|
|
|
|
|
|
773,984 |
|
Supplies |
|
|
|
|
|
|
|
|
|
|
94,070 |
|
|
|
19,250 |
|
|
|
|
|
|
|
113,320 |
|
Deferred income taxes |
|
|
13,249 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,249 |
|
Prepaid expenses and taxes |
|
|
|
|
|
|
|
|
|
|
32,447 |
|
|
|
(62 |
) |
|
|
|
|
|
|
32,385 |
|
Other current assets |
|
|
|
|
|
|
|
|
|
|
27,727 |
|
|
|
20,153 |
|
|
|
|
|
|
|
47,880 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
13,249 |
|
|
|
|
|
|
|
817,184 |
|
|
|
190,951 |
|
|
|
|
|
|
|
1,021,384 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net |
|
|
|
|
|
|
|
|
|
|
1,657,517 |
|
|
|
329,060 |
|
|
|
|
|
|
|
1,986,577 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill |
|
|
|
|
|
|
|
|
|
|
1,178,014 |
|
|
|
158,511 |
|
|
|
|
|
|
|
1,336,525 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
assets, net of accumulated amortization |
|
|
|
|
|
|
20,804 |
|
|
|
127,367 |
|
|
|
13,922 |
|
|
|
|
|
|
|
162,093 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment in subsidiaries |
|
|
1,081,747 |
|
|
|
1,068,432 |
|
|
|
367,456 |
|
|
|
|
|
|
|
(2,517,635 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
1,094,996 |
|
|
$ |
1,089,236 |
|
|
$ |
4,147,538 |
|
|
$ |
692,444 |
|
|
$ |
(2,517,635 |
) |
|
$ |
4,506,579 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS
EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
maturities of long-term debt |
|
$ |
|
|
|
$ |
16,000 |
|
|
$ |
20,375 |
|
|
$ |
(979 |
) |
|
$ |
|
|
|
$ |
35,396 |
|
Accounts payable |
|
|
|
|
|
|
|
|
|
|
209,354 |
|
|
|
38,393 |
|
|
|
|
|
|
|
247,747 |
|
Current income taxes payable |
|
|
|
|
|
|
|
|
|
|
7,626 |
|
|
|
|
|
|
|
|
|
|
|
7,626 |
|
Deferred income taxes -
current |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
investment in subsidiary liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee compensation |
|
|
|
|
|
|
|
|
|
|
132,883 |
|
|
|
29,305 |
|
|
|
|
|
|
|
162,188 |
|
Interest |
|
|
867 |
|
|
|
5,866 |
|
|
|
316 |
|
|
|
73 |
|
|
|
|
|
|
|
7,122 |
|
Other |
|
|
|
|
|
|
|
|
|
|
91,096 |
|
|
|
24,108 |
|
|
|
|
|
|
|
115,204 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
867 |
|
|
|
21,866 |
|
|
|
461,650 |
|
|
|
90,900 |
|
|
|
|
|
|
|
575,283 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
|
300,000 |
|
|
|
1,556,000 |
|
|
|
48,962 |
|
|
|
819 |
|
|
|
|
|
|
|
1,905,781 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred income taxes |
|
|
141,472 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
141,472 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other long-term liabilities |
|
|
|
|
|
|
|
|
|
|
125,427 |
|
|
|
34,943 |
|
|
|
|
|
|
|
160,370 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intercompany payable |
|
|
(1,071,016 |
) |
|
|
(1,570,373 |
) |
|
|
2,447,810 |
|
|
|
625,088 |
|
|
|
(431,509 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred
Stock Common Stock |
|
|
950 |
|
|
|
|
|
|
|
1 |
|
|
|
2 |
|
|
|
(3 |
) |
|
|
950 |
|
Additional
paid-in Capital |
|
|
1,195,947 |
|
|
|
|
|
|
|
|
|
|
|
(1 |
) |
|
|
1 |
|
|
|
1,195,947 |
|
Treasury stock, at cost |
|
|
(6,678 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6,678 |
) |
Accumulated
other comprehensive income |
|
|
5,798 |
|
|
|
5,798 |
|
|
|
(7,516 |
) |
|
|
|
|
|
|
1,718 |
|
|
|
5,798 |
|
Retained earnings |
|
|
527,656 |
|
|
|
1,075,945 |
|
|
|
1,071,204 |
|
|
|
(59,307 |
) |
|
|
(2,087,842 |
) |
|
|
527,656 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity |
|
|
1,723,673 |
|
|
|
1,081,743 |
|
|
|
1,063,689 |
|
|
|
(59,306 |
) |
|
|
(2,086,126 |
) |
|
|
1,723,673 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
stockholders equity |
|
$ |
1,094,996 |
|
|
$ |
1,089,236 |
|
|
$ |
4,147,538 |
|
|
$ |
692,444 |
|
|
$ |
(2,517,635 |
) |
|
$ |
4,506,579 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
15. Supplemental
Condensed Consolidating Financial Information (Continued)
CONSOLIDATED
BALANCE SHEETS
(Amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
June 30,
2007: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
|
|
|
$ |
|
|
|
$ |
3,695 |
|
|
$ |
17,662 |
|
|
|
|
|
|
$ |
21,357 |
|
Patient accounts
receivable, net of
allowance for doubtful
accounts |
|
|
|
|
|
|
|
|
|
|
693,496 |
|
|
|
183,027 |
|
|
|
|
|
|
|
876,523 |
|
Supplies |
|
|
|
|
|
|
|
|
|
|
96,579 |
|
|
|
25,385 |
|
|
|
|
|
|
|
121,964 |
|
Prepaid income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred income taxes |
|
|
13,249 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,249 |
|
Prepaid expenses |
|
|
|
|
|
|
|
|
|
|
44,099 |
|
|
|
(7,812 |
) |
|
|
|
|
|
|
36,287 |
|
Other current assets |
|
|
|
|
|
|
1,000 |
|
|
|
37,631 |
|
|
|
24,302 |
|
|
|
|
|
|
|
62,933 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
13,249 |
|
|
|
1,000 |
|
|
|
875,500 |
|
|
|
242,564 |
|
|
|
|
|
|
|
1,132,313 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net |
|
|
|
|
|
|
|
|
|
|
1,707,440 |
|
|
|
381,702 |
|
|
|
|
|
|
|
2,089,142 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill |
|
|
|
|
|
|
|
|
|
|
1,184,171 |
|
|
|
160,785 |
|
|
|
|
|
|
|
1,344,956 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment in
subsidiaries |
|
|
1,265,254 |
|
|
|
1,242,139 |
|
|
|
415,423 |
|
|
|
|
|
|
|
(2,922,816 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets, net of
accumulated
amortization of $95,695
at June 30, 2007 |
|
|
|
|
|
|
36,117 |
|
|
|
174,348 |
|
|
|
16,235 |
|
|
|
|
|
|
|
226,700 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
1,278,503 |
|
|
$ |
1,279,256 |
|
|
$ |
4,356,882 |
|
|
$ |
801,286 |
|
|
$ |
(2,922,816 |
) |
|
$ |
4,793,111 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
STOCKHOLDERS EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current maturities of
long-term debt |
|
$ |
|
|
|
$ |
16,000 |
|
|
$ |
9,325 |
|
|
$ |
432 |
|
|
$ |
|
|
|
$ |
25,757 |
|
Accounts payable |
|
|
|
|
|
|
|
|
|
|
216,500 |
|
|
|
41,230 |
|
|
|
|
|
|
|
257,730 |
|
Current income taxes
payable |
|
|
|
|
|
|
|
|
|
|
49,010 |
|
|
|
|
|
|
|
|
|
|
|
49,010 |
|
Deferred income taxes -
current |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment in
subsidiary liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee compensation |
|
|
|
|
|
|
|
|
|
|
126,384 |
|
|
|
38,749 |
|
|
|
|
|
|
|
165,133 |
|
Interest |
|
|
867 |
|
|
|
6,971 |
|
|
|
469 |
|
|
|
68 |
|
|
|
|
|
|
|
8,375 |
|
Other |
|
|
|
|
|
|
|
|
|
|
85,267 |
|
|
|
19,752 |
|
|
|
|
|
|
|
105,019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
867 |
|
|
|
22,971 |
|
|
|
486,955 |
|
|
|
100,231 |
|
|
|
|
|
|
|
611,024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
|
300,000 |
|
|
|
1,626,000 |
|
|
|
47,886 |
|
|
|
354 |
|
|
|
|
|
|
|
1,974,240 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred income taxes |
|
|
141,472 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
141,472 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other long-term liabilities |
|
|
|
|
|
|
|
|
|
|
165,133 |
|
|
|
40,275 |
|
|
|
|
|
|
|
205,408 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intercompany |
|
|
(1,024,803 |
) |
|
|
(1,634,966 |
) |
|
|
2,420,325 |
|
|
|
722,874 |
|
|
|
(483,430 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock |
|
|
959 |
|
|
|
|
|
|
|
1 |
|
|
|
2 |
|
|
|
(3 |
) |
|
|
959 |
|
Additional paid-in capital |
|
|
1,215,321 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,215,321 |
|
Treasury stock, at cost,
975,549 shares |
|
|
(6,678 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6,678 |
) |
Accumulated other
comprehensive income |
|
|
15,622 |
|
|
|
15,622 |
|
|
|
(7,493 |
) |
|
|
|
|
|
|
(8,129 |
) |
|
|
15,622 |
|
Retained earnings |
|
|
635,743 |
|
|
|
1,249,629 |
|
|
|
1,244,075 |
|
|
|
(62,450 |
) |
|
|
(2,431,254 |
) |
|
|
635,743 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity |
|
|
1,860,967 |
|
|
|
1,265,251 |
|
|
|
1,236,583 |
|
|
|
(62,448 |
) |
|
|
(2,439,386 |
) |
|
|
1,860,967 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
stockholders equity |
|
$ |
1,278,503 |
|
|
$ |
1,279,256 |
|
|
$ |
4,356,882 |
|
|
$ |
801,286 |
|
|
$ |
(2,922,816 |
) |
|
$ |
4,793,111 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
15. Supplemental
Condensed Consolidating Financial Information (Continued)
CONSOLIDATED
STATEMENTS OF INCOME
Six Months Ended June 30, 2007
(Amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
Net Revenue |
|
$ |
|
|
|
$ |
|
|
|
$ |
1,947,912 |
|
|
$ |
505,213 |
|
|
|
|
|
|
$ |
2,453,125 |
|
Expenses and Costs: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits |
|
|
|
|
|
|
|
|
|
|
741,823 |
|
|
|
239,598 |
|
|
|
|
|
|
|
981,421 |
|
Provision for bad debts |
|
|
|
|
|
|
|
|
|
|
233,289 |
|
|
|
51,071 |
|
|
|
|
|
|
|
284,360 |
|
Supplies |
|
|
|
|
|
|
|
|
|
|
225,065 |
|
|
|
61,476 |
|
|
|
|
|
|
|
286,541 |
|
Other operating expenses |
|
|
|
|
|
|
|
|
|
|
392,311 |
|
|
|
111,504 |
|
|
|
|
|
|
|
503,815 |
|
Rent |
|
|
|
|
|
|
|
|
|
|
38,074 |
|
|
|
16,166 |
|
|
|
|
|
|
|
54,240 |
|
Minority Interests in Earnings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
818 |
|
|
|
|
|
|
|
818 |
|
Depreciation & Amortization |
|
|
|
|
|
|
|
|
|
|
86,461 |
|
|
|
18,158 |
|
|
|
|
|
|
|
104,619 |
|
Equity in earnings of subsidiary |
|
|
(175,752 |
) |
|
|
(175,752 |
) |
|
|
3,955 |
|
|
|
|
|
|
|
347,549 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
operating costs and expenses |
|
|
(175,752 |
) |
|
|
(175,752 |
) |
|
|
1,720,978 |
|
|
|
498,791 |
|
|
|
347,549 |
|
|
|
2,215,814 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
175,752 |
|
|
|
175,752 |
|
|
|
226,934 |
|
|
|
6,422 |
|
|
|
(347,549 |
) |
|
|
237,311 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense, net |
|
|
|
|
|
|
|
|
|
|
51,995 |
|
|
|
9,564 |
|
|
|
|
|
|
|
61,559 |
|
Loss from early extinguishment of
debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes |
|
|
175,752 |
|
|
|
175,752 |
|
|
|
174,939 |
|
|
|
(3,142 |
) |
|
|
(347,549 |
) |
|
|
175,752 |
|
Provision for income taxes |
|
|
67,665 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
67,665 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
108,087 |
|
|
|
175,752 |
|
|
|
174,939 |
|
|
|
(3,142 |
) |
|
|
(347,549 |
) |
|
|
108,087 |
|
Discontinued operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income
(loss) from operations of
disc hospitals sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on sale of hospitals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations of
hospital
held for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment of assets held for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income |
|
$ |
108,087 |
|
|
$ |
175,752 |
|
|
$ |
174,939 |
|
|
$ |
(3,142 |
) |
|
$ |
(347,549 |
) |
|
$ |
108,087 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
15.
Supplemental Condensed Consolidating Financial Information
(Continued)
CONSOLIDATED STATEMENTS OF INCOME
Six Months Ended June 30, 2006
(Amounts in Thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
Net Revenue |
|
$ |
|
|
|
$ |
|
|
|
$ |
1,669,845 |
|
|
$ |
417,771 |
|
|
$ |
|
|
|
$ |
2,087,616 |
|
Expenses and Costs: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and
benefits |
|
|
|
|
|
|
|
|
|
|
643,365 |
|
|
|
184,450 |
|
|
|
|
|
|
|
827,815 |
|
Provision for bad
debts |
|
|
|
|
|
|
|
|
|
|
171,448 |
|
|
|
51,847 |
|
|
|
|
|
|
|
223,295 |
|
Supplies |
|
|
|
|
|
|
|
|
|
|
199,683 |
|
|
|
48,837 |
|
|
|
|
|
|
|
248,520 |
|
Other operating
expenses |
|
|
|
|
|
|
|
|
|
|
329,061 |
|
|
|
97,095 |
|
|
|
|
|
|
|
426,156 |
|
Rent |
|
|
|
|
|
|
|
|
|
|
33,376 |
|
|
|
13,252 |
|
|
|
|
|
|
|
46,628 |
|
Minority Interests
in Earnings |
|
|
|
|
|
|
|
|
|
|
13 |
|
|
|
1,055 |
|
|
|
|
|
|
|
1,068 |
|
Depreciation &
Amorization |
|
|
|
|
|
|
|
|
|
|
74,588 |
|
|
|
15,101 |
|
|
|
|
|
|
|
89,689 |
|
Equity in earnings
of subsididary |
|
|
(175,572 |
) |
|
|
(175,572 |
) |
|
|
5,904 |
|
|
|
|
|
|
|
345,240 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
operating costs and expenses |
|
|
(175,572 |
) |
|
|
(175,572 |
) |
|
|
1,457,438 |
|
|
|
411,637 |
|
|
|
345,240 |
|
|
|
1,863,171 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from
operations |
|
|
175,572 |
|
|
|
175,572 |
|
|
|
212,407 |
|
|
|
6,134 |
|
|
|
(345,240 |
) |
|
|
224,445 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense, net |
|
|
|
|
|
|
|
|
|
|
37,153 |
|
|
|
8,504 |
|
|
|
|
|
|
|
45,657 |
|
Loss from early
extinguishment of
debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing
operations
before income taxes |
|
|
175,572 |
|
|
|
175,572 |
|
|
|
175,254 |
|
|
|
(2,370 |
) |
|
|
(345,240 |
) |
|
|
178,788 |
|
Provision for
income taxes |
|
|
69,165 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69,165 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from
continuing
operations |
|
|
106,407 |
|
|
|
175,572 |
|
|
|
175,254 |
|
|
|
(2,370 |
) |
|
|
(345,240 |
) |
|
|
109,623 |
|
Discontinued
operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from
operations of
disc hospitals sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(657 |
) |
|
|
|
|
|
|
(657 |
) |
Loss on sale of
hospitals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,559 |
) |
|
|
|
|
|
|
(2,559 |
) |
Income (loss) from
operations of
hospital held for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment of
assets held for
sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on
discontinued
operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,216 |
) |
|
|
|
|
|
|
(3,216 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income |
|
$ |
106,407 |
|
|
$ |
175,572 |
|
|
$ |
175,254 |
|
|
$ |
(5,586 |
) |
|
$ |
(345,240 |
) |
|
$ |
106,407 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
15.
Supplemental Condensed Consolidating Financial Information
(Continued)
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(Amount in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
Other |
|
|
Non |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
Six
Months Ended June 30, 2007: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating
activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
108,087 |
|
|
$ |
175,752 |
|
|
$ |
174,939 |
|
|
$ |
(3,142 |
) |
|
$ |
(347,549 |
) |
|
$ |
108,087 |
|
Adjustments to reconcile net
income to net cash
provided by operating
activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
86,461 |
|
|
|
18,158 |
|
|
|
|
|
|
|
104,619 |
|
Deferred income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity-based compensation
expense |
|
|
14,295 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,295 |
|
Excess tax benefits relating
to stock-based compensation |
|
|
(2,295 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,295 |
) |
Minority interest in earnings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
818 |
|
|
|
|
|
|
|
818 |
|
Impairment on hospital held
for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Gain) Loss on Sale of
Hospitals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,032 |
) |
|
|
|
|
|
|
(2,032 |
) |
Other non-cash expenses, net |
|
|
|
|
|
|
|
|
|
|
229 |
|
|
|
261 |
|
|
|
|
|
|
|
490 |
|
Changes in operating assets
and liabilities, net of effects of acquisitions
and divestitures: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient accounts receivable |
|
|
|
|
|
|
|
|
|
|
(38,145 |
) |
|
|
(9,270 |
) |
|
|
|
|
|
|
(47,415 |
) |
Supplies, prepaid expenses
and other current assets |
|
|
|
|
|
|
(2,000 |
) |
|
|
(19,062 |
) |
|
|
7,604 |
|
|
|
|
|
|
|
(13,458 |
) |
Accounts payable, accrued
liabilities and income taxes |
|
|
(1,656 |
) |
|
|
(4,408 |
) |
|
|
58,691 |
|
|
|
(6,274 |
) |
|
|
|
|
|
|
46,353 |
|
Advances to subsidiaries,
net of return on investment |
|
|
(137,294 |
) |
|
|
(240,368 |
) |
|
|
(77,539 |
) |
|
|
107,652 |
|
|
|
347,549 |
|
|
|
|
|
Other |
|
|
9,824 |
|
|
|
24 |
|
|
|
3,198 |
|
|
|
(6,520 |
) |
|
|
|
|
|
|
6,526 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by(used
in) operating activities |
|
|
(9,039 |
) |
|
|
(71,000 |
) |
|
|
188,772 |
|
|
|
107,255 |
|
|
|
|
|
|
|
215,988 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing
activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisitions of facilities
and other related equipment |
|
|
|
|
|
|
|
|
|
|
(101,923 |
) |
|
|
(86,032 |
) |
|
|
|
|
|
|
(187,955 |
) |
Purchases of property and
equipment |
|
|
|
|
|
|
|
|
|
|
(93,726 |
) |
|
|
(15,123 |
) |
|
|
|
|
|
|
(108,849 |
) |
Sale of facilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,662 |
|
|
|
|
|
|
|
12,662 |
|
Proceeds from sale of
equipment |
|
|
|
|
|
|
|
|
|
|
203 |
|
|
|
31 |
|
|
|
|
|
|
|
234 |
|
Investment in other assets |
|
|
|
|
|
|
|
|
|
|
(15,716 |
) |
|
|
(9,646 |
) |
|
|
|
|
|
|
(25,362 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used
in) investing activities |
|
|
|
|
|
|
|
|
|
|
(211,162 |
) |
|
|
(98,108 |
) |
|
|
|
|
|
|
(309,270 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing
activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of
stock options |
|
|
6,693 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,693 |
|
Stock buy-back |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred financing costs |
|
|
|
|
|
|
|
|
|
|
(367 |
) |
|
|
|
|
|
|
|
|
|
|
(367 |
) |
Excess tax benefits relating
to stock-based compensation |
|
|
2,295 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,295 |
|
Redemption of convertible
notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from minority
investors in joint ventures |
|
|
51 |
|
|
|
|
|
|
|
|
|
|
|
1,054 |
|
|
|
|
|
|
|
1,105 |
|
Redemption of minority
investments in joint
ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,369 |
) |
|
|
|
|
|
|
(1,369 |
) |
Distribution to minority
investors in joint ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,705 |
) |
|
|
|
|
|
|
(1,705 |
) |
Borrowings under credit
agreement |
|
|
|
|
|
|
132,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
132,000 |
|
Repayments of long-term
indebtedness |
|
|
|
|
|
|
(61,000 |
) |
|
|
(2,261 |
) |
|
|
(1,318 |
) |
|
|
|
|
|
|
(64,579 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used
in) financing activities |
|
|
9,039 |
|
|
|
71,000 |
|
|
|
(2,628 |
) |
|
|
(3,338 |
) |
|
|
|
|
|
|
74,073 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash
equivalents |
|
|
|
|
|
|
|
|
|
|
(25,018 |
) |
|
|
5,809 |
|
|
|
|
|
|
|
(19,209 |
) |
Cash and cash equivalents at
beginning of period |
|
|
|
|
|
|
|
|
|
|
28,713 |
|
|
|
11,853 |
|
|
|
|
|
|
|
40,566 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at
end of period |
|
$ |
|
|
|
$ |
|
|
|
$ |
3,695 |
|
|
$ |
17,662 |
|
|
$ |
|
|
|
$ |
21,357 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
15.
Supplemental Condensed Consolidating Financial Information
(Continued)
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(Amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
Other |
|
|
Non |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
Six
Months ended June 30, 2006: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating
activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
106,407 |
|
|
$ |
175,572 |
|
|
$ |
175,254 |
|
|
$ |
(5,586 |
) |
|
$ |
(345,240 |
) |
|
$ |
106,407 |
|
Adjustments to reconcile net
income to net cash
provided by operating
activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
74,588 |
|
|
|
15,101 |
|
|
|
|
|
|
|
89,689 |
|
Deferred income taxes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity-based compensation
expense |
|
|
8,946 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,946 |
|
Excess tax benefits relating to
stock-based compensation |
|
|
(4,588 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,588 |
) |
Loss on early extinguishment
of debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interest in earnings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,068 |
|
|
|
|
|
|
|
1,068 |
|
Impairment on hospital held
for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Gain) Loss
on Sale of Hospitals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,937 |
|
|
|
|
|
|
|
3,937 |
|
Other non-cash expenses, net |
|
|
4 |
|
|
|
|
|
|
|
193 |
|
|
|
(828 |
) |
|
|
|
|
|
|
(631 |
) |
Changes in operating assets
and liabilities, net of effects of acquisitions and
divestitures: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient accounts receivable |
|
|
|
|
|
|
|
|
|
|
(54,405 |
) |
|
|
(3,556 |
) |
|
|
|
|
|
|
(57,961 |
) |
Supplies, prepaid expenses and
other
current assets |
|
|
|
|
|
|
|
|
|
|
(13,441 |
) |
|
|
13,348 |
|
|
|
|
|
|
|
(93 |
) |
Accounts payable, accrued
liabilities and
income taxes |
|
|
2,704 |
|
|
|
452 |
|
|
|
88,572 |
|
|
|
(21,740 |
) |
|
|
|
|
|
|
69,988 |
|
Advances to
subsidiaries, net of return on investment |
|
|
5,121 |
|
|
|
(307,832 |
) |
|
|
(52,162 |
) |
|
|
9,633 |
|
|
|
345,240 |
|
|
|
|
|
Other |
|
|
5,913 |
|
|
|
(4,192 |
) |
|
|
(8,939 |
) |
|
|
(2,498 |
) |
|
|
|
|
|
|
(9,716 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by(used in)
operating activities |
|
$ |
124,507 |
|
|
$ |
(136,000 |
) |
|
$ |
209,660 |
|
|
$ |
8,879 |
|
|
$ |
|
|
|
$ |
207,046 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing
activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisitions
of facilities and other related equipment |
|
|
|
|
|
|
|
|
|
|
(180,686 |
) |
|
|
2,671 |
|
|
|
|
|
|
|
(178,015 |
) |
Purchases of property and
equipment |
|
|
|
|
|
|
|
|
|
|
(89,755 |
) |
|
|
(4,439 |
) |
|
|
|
|
|
|
(94,194 |
) |
Sale of facilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
750 |
|
|
|
|
|
|
|
750 |
|
Proceeds from sale of equipment |
|
|
|
|
|
|
|
|
|
|
73 |
|
|
|
1 |
|
|
|
|
|
|
|
74 |
|
Investment in other assets |
|
|
|
|
|
|
|
|
|
|
(11,782 |
) |
|
|
(12,601 |
) |
|
|
|
|
|
|
(24,382 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(282,150 |
) |
|
|
(13,617 |
) |
|
|
|
|
|
|
(295,767 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing
activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of
stock options |
|
|
8,698 |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
8,699 |
|
Stock buy-back |
|
|
(137,665 |
) |
|
|
|
|
|
|
|
|
|
|
(1 |
) |
|
|
|
|
|
|
(137,666 |
) |
Deferred financing costs |
|
|
|
|
|
|
|
|
|
|
(16 |
) |
|
|
|
|
|
|
|
|
|
|
(16 |
) |
Excess tax benefits relating
to stock based
compensation |
|
|
4,588 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,588 |
|
Redemption of convertible notes |
|
|
(128 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(128 |
) |
Proceeds
from minority investors in joint ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,060 |
|
|
|
|
|
|
|
3,060 |
|
Redemption
of minority investments in joint ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(530 |
) |
|
|
|
|
|
|
(530 |
) |
Distribution
to minority investors in joint ventures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,977 |
) |
|
|
|
|
|
|
(1,977 |
) |
Borrowings under credit
agreement |
|
|
|
|
|
|
176,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
176,000 |
|
Repayments of long-term
indebtedness |
|
|
|
|
|
|
(40,000 |
) |
|
|
(2,643 |
) |
|
|
(617 |
) |
|
|
|
|
|
|
(43,260 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in)
financing activities |
|
|
(124,507 |
) |
|
|
136,000 |
|
|
|
(2,659 |
) |
|
|
(64 |
) |
|
|
|
|
|
|
8,770 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change
in cash and cash equivalents |
|
|
|
|
|
|
|
|
|
|
(75,149 |
) |
|
|
(4,802 |
) |
|
|
|
|
|
|
(79,951 |
) |
Cash and cash equivalents at
beginning of period |
|
|
|
|
|
|
|
|
|
|
83,579 |
|
|
|
20,529 |
|
|
|
|
|
|
|
104,108 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at
end of period |
|
$ |
|
|
|
$ |
|
|
|
$ |
8,430 |
|
|
$ |
15,727 |
|
|
$ |
|
|
|
$ |
24,157 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22
EX-99.3 CONSOLIDATED FINANCIAL STATEMENTS
Exhibit 99.3
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
Triad Hospitals, Inc.
We have audited the accompanying consolidated balance sheets of Triad Hospitals, Inc. as of
December 31, 2006 and 2005, and the related consolidated statements of operations, equity and cash
flows for each of the three years in the period ended December 31, 2006. These consolidated
financial statements are the responsibility of the management of Triad Hospitals, Inc. (the
Company). Our responsibility is to express an opinion on these financial statements based on our
audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement. An
audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the
financial statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material
respects, the consolidated financial position of Triad Hospitals, Inc. at December 31, 2006 and
2005, and the consolidated results of its operations and its cash flows for each of the three years
in the period ended December 31, 2006, in conformity with U.S. generally accepted accounting
principles.
As discussed in Notes 2 and 13 to the consolidated financial statements, in 2006 the Company
changed its method of accounting for share-based compensation, physician income guarantees and
retirement plans.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight
Board (United States), the effectiveness of Triad Hospitals, Inc.s internal control over financial
reporting as of December 31, 2006, based on criteria established in Internal Control-Integrated
Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our
report dated February 27, 2007 expressed an unqualified opinion thereon.
/s/ ERNST & YOUNG, LLP
Dallas, Texas
February 27, 2007,
except for Note 22, as to which the date is September 21, 2007
1
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
CONSOLIDATED
STATEMENTS OF OPERATIONS
For The Years Ended
December 31, 2006, 2005 And 2004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
(Dollars in millions, except per share amounts)
|
|
|
Revenues
|
|
$
|
5,537.9
|
|
|
$
|
4,747.3
|
|
|
$
|
4,218.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits, including
share-based compensation expense of $27.7, $2.0 and $1.1 for the
years ended December 31, 2006, 2005, and 2004, respectively
|
|
|
2,233.1
|
|
|
|
1,940.2
|
|
|
|
1,695.4
|
|
Reimbursable expenses
|
|
|
49.7
|
|
|
|
51.1
|
|
|
|
51.1
|
|
Supplies
|
|
|
957.9
|
|
|
|
801.3
|
|
|
|
692.4
|
|
Other operating expenses
|
|
|
1,069.8
|
|
|
|
874.0
|
|
|
|
781.2
|
|
Provision for doubtful accounts
|
|
|
576.9
|
|
|
|
403.3
|
|
|
|
427.2
|
|
Depreciation
|
|
|
223.2
|
|
|
|
199.6
|
|
|
|
172.3
|
|
Amortization
|
|
|
6.6
|
|
|
|
6.3
|
|
|
|
6.3
|
|
Interest expense, net of
capitalized interest of $5.2, $5.5 and $5.6 for the years ended
December 31, 2006, 2005, and 2004, respectively
|
|
|
115.3
|
|
|
|
110.6
|
|
|
|
113.7
|
|
Interest income
|
|
|
(20.0
|
)
|
|
|
(9.0
|
)
|
|
|
(2.6
|
)
|
Refinancing transaction costs
|
|
|
|
|
|
|
8.4
|
|
|
|
76.0
|
|
ESOP expense
|
|
|
12.5
|
|
|
|
14.1
|
|
|
|
10.3
|
|
Gain on sales of assets
|
|
|
(6.0
|
)
|
|
|
(0.4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,219.0
|
|
|
|
4,399.5
|
|
|
|
4,023.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before minority interests, equity in earnings and income tax
provision
|
|
|
318.9
|
|
|
|
347.8
|
|
|
|
194.7
|
|
Minority interests in earnings of
consolidated entities
|
|
|
(22.0
|
)
|
|
|
(11.5
|
)
|
|
|
(1.4
|
)
|
Equity in earnings of
unconsolidated affiliates
|
|
|
43.5
|
|
|
|
35.0
|
|
|
|
20.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income tax provision
|
|
|
340.4
|
|
|
|
371.3
|
|
|
|
213.8
|
|
Income tax provision
|
|
|
(132.5
|
)
|
|
|
(141.9
|
)
|
|
|
(81.8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
207.9
|
|
|
|
229.4
|
|
|
|
132.0
|
|
Income (loss) from discontinued
operations, net of tax
|
|
|
14.4
|
|
|
|
(3.4
|
)
|
|
|
59.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
222.3
|
|
|
$
|
226.0
|
|
|
$
|
191.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic:
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
$
|
2.41
|
|
|
$
|
2.80
|
|
|
$
|
1.76
|
|
Discontinued operations
|
|
$
|
0.17
|
|
|
$
|
(0.04
|
)
|
|
$
|
0.78
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
2.58
|
|
|
$
|
2.76
|
|
|
$
|
2.54
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
$
|
2.38
|
|
|
$
|
2.74
|
|
|
$
|
1.72
|
|
Discontinued operations
|
|
$
|
0.17
|
|
|
$
|
(0.04
|
)
|
|
$
|
0.77
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
2.55
|
|
|
$
|
2.70
|
|
|
$
|
2.49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the consolidated
financial statements.
2
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
CONSOLIDATED
BALANCE SHEETS
December 31, 2006
And 2005
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
|
(Dollars in millions)
|
|
|
ASSETS
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
208.6
|
|
|
$
|
310.2
|
|
Accounts receivable, less
allowances for doubtful accounts of $416.3 and $292.8 at
December 31, 2006 and 2005, respectively
|
|
|
917.9
|
|
|
|
800.2
|
|
Inventories
|
|
|
149.4
|
|
|
|
130.0
|
|
Deferred income taxes
|
|
|
38.4
|
|
|
|
31.8
|
|
Prepaid expenses
|
|
|
52.1
|
|
|
|
41.1
|
|
Discontinued operations assets
|
|
|
|
|
|
|
67.6
|
|
Other
|
|
|
128.0
|
|
|
|
93.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,494.4
|
|
|
|
1,473.9
|
|
Property and equipment, at cost:
|
|
|
|
|
|
|
|
|
Land
|
|
|
212.0
|
|
|
|
182.3
|
|
Buildings and improvements
|
|
|
2,011.7
|
|
|
|
1,739.3
|
|
Equipment
|
|
|
1,705.4
|
|
|
|
1,449.1
|
|
Construction in progress (estimated
cost to complete and equip after December 31, 2006 $745.1)
|
|
|
238.8
|
|
|
|
226.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,167.9
|
|
|
|
3,597.0
|
|
Accumulated depreciation
|
|
|
(1,227.7
|
)
|
|
|
(1,012.8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
2,940.2
|
|
|
|
2,584.2
|
|
Goodwill
|
|
|
1,359.7
|
|
|
|
1,301.6
|
|
Intangible assets, net of
accumulated amortization
|
|
|
81.1
|
|
|
|
71.7
|
|
Investment in and advances to
unconsolidated affiliates
|
|
|
242.9
|
|
|
|
204.8
|
|
Other
|
|
|
115.5
|
|
|
|
100.7
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
6,233.8
|
|
|
$
|
5,736.9
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND EQUITY
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
249.8
|
|
|
$
|
197.5
|
|
Accrued salaries
|
|
|
127.0
|
|
|
|
126.8
|
|
Current portion of long-term debt
|
|
|
21.3
|
|
|
|
7.7
|
|
Current income taxes payable
|
|
|
|
|
|
|
17.1
|
|
Discontinued operations liabilities
|
|
|
|
|
|
|
3.1
|
|
Other current liabilities
|
|
|
203.4
|
|
|
|
163.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
601.5
|
|
|
|
515.3
|
|
Long-term debt
|
|
|
1,684.1
|
|
|
|
1,695.8
|
|
Other liabilities
|
|
|
187.5
|
|
|
|
167.8
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
Deferred income taxes
|
|
|
193.5
|
|
|
|
201.9
|
|
Minority interests in equity of
consolidated entities
|
|
|
340.8
|
|
|
|
228.4
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
Common stock $0.01 par value:
120,000,000 shares authorized, 88,339,049 and
86,373,170 shares issued and outstanding at
December 31, 2006 and 2005, respectively
|
|
|
0.9
|
|
|
|
0.9
|
|
Additional paid-in capital
|
|
|
2,410.5
|
|
|
|
2,331.6
|
|
Unearned ESOP compensation
|
|
|
(6.9
|
)
|
|
|
(10.4
|
)
|
Accumulated other comprehensive loss
|
|
|
(7.6
|
)
|
|
|
(1.6
|
)
|
Accumulated earnings
|
|
|
829.5
|
|
|
|
607.2
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
3,226.4
|
|
|
|
2,927.7
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
stockholders equity
|
|
$
|
6,233.8
|
|
|
$
|
5,736.9
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the consolidated
financial statements.
3
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
CONSOLIDATED
STATEMENTS OF EQUITY
For The Years Ended
December 31, 2006, 2005 And 2004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
Unearned
|
|
|
Other
|
|
|
|
|
|
Total
|
|
|
|
Common Stock
|
|
|
Paid-in
|
|
|
ESOP
|
|
|
Comprehensive
|
|
|
Accumulated
|
|
|
Stockholders
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Compensation
|
|
|
Loss
|
|
|
Earnings
|
|
|
Equity
|
|
|
|
(Dollars in millions)
|
|
|
Balance at January 1, 2004
|
|
|
75,633,354
|
|
|
$
|
0.8
|
|
|
$
|
1,904.6
|
|
|
$
|
(17.2
|
)
|
|
$
|
(2.1
|
)
|
|
$
|
190.2
|
|
|
$
|
2,076.3
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
191.0
|
|
|
|
191.0
|
|
Net change in minimum pension
liability, net of income tax benefit of $0.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1.4
|
)
|
|
|
|
|
|
|
(1.4
|
)
|
Unrealized gain on marketable
equity securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.1
|
|
|
|
|
|
|
|
0.1
|
|
Reclassification of gain on
marketable equity securities included in net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
(0.1
|
)
|
Net change in fair value of
interest rate swaps, net of income tax provision of $1.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.8
|
|
|
|
|
|
|
|
1.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
191.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock under
employee plans
|
|
|
361,643
|
|
|
|
|
|
|
|
10.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.4
|
|
Stock options exercised
|
|
|
2,211,027
|
|
|
|
|
|
|
|
39.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
39.7
|
|
Income tax benefit from stock
options exercised
|
|
|
|
|
|
|
|
|
|
|
14.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.1
|
|
ESOP compensation earned
|
|
|
|
|
|
|
|
|
|
|
6.9
|
|
|
|
3.4
|
|
|
|
|
|
|
|
|
|
|
|
10.3
|
|
Share-based compensation expense
|
|
|
|
|
|
|
|
|
|
|
1.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2004
|
|
|
78,206,024
|
|
|
|
0.8
|
|
|
|
1,976.8
|
|
|
|
(13.8
|
)
|
|
|
(1.7
|
)
|
|
|
381.2
|
|
|
|
2,343.3
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
226.0
|
|
|
|
226.0
|
|
Net change in minimum pension
liability, net of income tax benefit of $0.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(0.2
|
)
|
|
|
|
|
|
|
(0.2
|
)
|
Net change in fair value of
interest rate swaps, net of income tax provision of $0.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.3
|
|
|
|
|
|
|
|
0.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
226.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock, net of
expenses
|
|
|
4,289,443
|
|
|
|
0.1
|
|
|
|
218.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
218.2
|
|
Issuance of common stock under
employee plans
|
|
|
490,493
|
|
|
|
|
|
|
|
12.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12.3
|
|
Stock options exercised
|
|
|
3,387,210
|
|
|
|
|
|
|
|
87.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
87.8
|
|
Income tax benefit from stock
options exercised
|
|
|
|
|
|
|
|
|
|
|
23.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.9
|
|
ESOP compensation earned
|
|
|
|
|
|
|
|
|
|
|
10.7
|
|
|
|
3.4
|
|
|
|
|
|
|
|
|
|
|
|
14.1
|
|
Share-based compensation expense
|
|
|
|
|
|
|
|
|
|
|
2.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2005
|
|
|
86,373,170
|
|
|
|
0.9
|
|
|
|
2,331.6
|
|
|
|
(10.4
|
)
|
|
|
(1.6
|
)
|
|
|
607.2
|
|
|
|
2,927.7
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
222.3
|
|
|
|
222.3
|
|
Net change in foreign currency
translation adjustment, net of income tax benefit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
222.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments to initially apply FASB
Statement No. 158, net of income tax benefit of $3.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5.9
|
)
|
|
|
|
|
|
|
(5.9
|
)
|
Issuance of common stock under
employee plans
|
|
|
1,076,171
|
|
|
|
|
|
|
|
14.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.0
|
|
Stock options exercised
|
|
|
889,708
|
|
|
|
|
|
|
|
23.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.6
|
|
Income tax benefit from stock
options exercised
|
|
|
|
|
|
|
|
|
|
|
4.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.6
|
|
ESOP compensation earned
|
|
|
|
|
|
|
|
|
|
|
9.0
|
|
|
|
3.5
|
|
|
|
|
|
|
|
|
|
|
|
12.5
|
|
Share-based compensation expense
|
|
|
|
|
|
|
|
|
|
|
27.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2006
|
|
|
88,339,049
|
|
|
$
|
0.9
|
|
|
$
|
2,410.5
|
|
|
$
|
(6.9
|
)
|
|
$
|
(7.6
|
)
|
|
$
|
829.5
|
|
|
$
|
3,226.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the consolidated
financial statements.
4
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
CONSOLIDATED
STATEMENTS OF CASH FLOWS
For The Years Ended
December 31, 2006, 2005 And 2004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
(Dollars in millions)
|
|
|
Cash flows from operating
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
222.3
|
|
|
$
|
226.0
|
|
|
$
|
191.0
|
|
Adjustments to reconcile net income
to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
(Income) loss from discontinued
operations, net of tax
|
|
|
(14.4
|
)
|
|
|
3.4
|
|
|
|
(59.0
|
)
|
Provision for doubtful accounts
|
|
|
576.9
|
|
|
|
403.3
|
|
|
|
427.2
|
|
Depreciation and amortization
|
|
|
229.8
|
|
|
|
205.9
|
|
|
|
178.6
|
|
ESOP expense
|
|
|
12.5
|
|
|
|
14.1
|
|
|
|
10.3
|
|
Minority interests
|
|
|
22.0
|
|
|
|
11.5
|
|
|
|
1.4
|
|
Equity in earnings of
unconsolidated affiliates
|
|
|
(43.5
|
)
|
|
|
(35.0
|
)
|
|
|
(20.5
|
)
|
Gain on sales of assets
|
|
|
(6.0
|
)
|
|
|
(0.4
|
)
|
|
|
|
|
Deferred income tax provision
(benefit)
|
|
|
(5.7
|
)
|
|
|
12.2
|
|
|
|
3.3
|
|
Non-cash interest expense
|
|
|
3.4
|
|
|
|
4.0
|
|
|
|
5.8
|
|
Refinancing transaction costs
|
|
|
|
|
|
|
8.4
|
|
|
|
76.0
|
|
Non-cash share-based compensation
expense
|
|
|
27.7
|
|
|
|
2.0
|
|
|
|
1.1
|
|
Excess tax benefits on share-based
compensation
|
|
|
(1.7
|
)
|
|
|
|
|
|
|
|
|
Increase (decrease) in cash from
operating assets and liabilities (net of acquisitions):
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(664.4
|
)
|
|
|
(549.9
|
)
|
|
|
(470.6
|
)
|
Inventories and other assets
|
|
|
(91.8
|
)
|
|
|
(16.9
|
)
|
|
|
(14.0
|
)
|
Accounts payable and other current
liabilities
|
|
|
5.0
|
|
|
|
107.0
|
|
|
|
(7.5
|
)
|
Other
|
|
|
31.3
|
|
|
|
24.0
|
|
|
|
35.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating
activities
|
|
|
303.4
|
|
|
|
419.6
|
|
|
|
358.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of property and equipment
|
|
|
(461.8
|
)
|
|
|
(393.7
|
)
|
|
|
(436.0
|
)
|
Distributions and advances from
unconsolidated affiliates, net
|
|
|
1.8
|
|
|
|
20.3
|
|
|
|
12.7
|
|
Proceeds received on disposals of
assets
|
|
|
117.1
|
|
|
|
50.5
|
|
|
|
230.5
|
|
Acquisitions, net of cash acquired
of $5.1 and $0.6 for the years ended December 31, 2006 and
2005, respectively
|
|
|
(124.7
|
)
|
|
|
(277.5
|
)
|
|
|
(16.9
|
)
|
Collections on notes receivable
|
|
|
|
|
|
|
15.9
|
|
|
|
|
|
Other
|
|
|
(0.3
|
)
|
|
|
|
|
|
|
(0.2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing
activities
|
|
|
(467.9
|
)
|
|
|
(584.5
|
)
|
|
|
(209.9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing
activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments of issuance of long-term
debt
|
|
|
(7.6
|
)
|
|
|
(484.6
|
)
|
|
|
(769.8
|
)
|
Proceeds from issuance of long-term
debt
|
|
|
|
|
|
|
520.0
|
|
|
|
675.0
|
|
Payment of debt issue costs
|
|
|
|
|
|
|
(6.4
|
)
|
|
|
(8.7
|
)
|
Payment of refinancing transaction
costs
|
|
|
|
|
|
|
|
|
|
|
(65.8
|
)
|
Proceeds from issuance of common
stock
|
|
|
37.6
|
|
|
|
318.3
|
|
|
|
50.1
|
|
Excess tax benefits on share-based
compensation
|
|
|
1.7
|
|
|
|
|
|
|
|
|
|
Contributions from minority
partners, net of distributions
|
|
|
31.2
|
|
|
|
71.2
|
|
|
|
13.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in)
financing activities
|
|
|
62.9
|
|
|
|
418.5
|
|
|
|
(105.8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents
|
|
|
(101.6
|
)
|
|
|
253.6
|
|
|
|
42.4
|
|
Cash and cash equivalents at
beginning of period
|
|
|
310.2
|
|
|
|
56.6
|
|
|
|
14.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of
period
|
|
$
|
208.6
|
|
|
$
|
310.2
|
|
|
$
|
56.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid for:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
$
|
117.0
|
|
|
$
|
111.9
|
|
|
$
|
117.7
|
|
Income taxes, net of refunds
|
|
$
|
187.4
|
|
|
$
|
77.2
|
|
|
$
|
96.3
|
|
The accompanying notes are an integral part of the consolidated
financial statements.
5
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
NOTE 1
|
MERGER
AGREEMENT
|
On February 4, 2007, we entered into an Agreement and Plan
of Merger (the Merger Agreement) with Panthera
Partners, LLC, a Delaware limited liability company
(Panthera Partners), Panthera Holdco Corp., a
Delaware corporation and a wholly-owned subsidiary of Panthera
Partners (Panthera Holdco, and together with
Panthera Partners, Parent), and Panthera Acquisition
Corporation, a Delaware corporation and a wholly-owned
subsidiary of Panthera Holdco (Merger Sub). Under
the terms of the Merger Agreement, Merger Sub will be merged
with and into the Company, with the Company continuing as the
surviving corporation and a wholly-owned subsidiary of Parent
(the Merger). Parent is owned by private investment
funds affiliated with CCMP Capital Advisors, LLC and Goldman
Sachs & Co. Our Board of Directors approved the Merger
Agreement on the unanimous recommendation of a Special Committee
comprised entirely of disinterested directors (the Special
Committee).
At the effective time of the Merger, each outstanding share of
our common stock, other than shares owned by us, Parent, any
stockholders who are entitled to and who properly exercise
appraisal rights under Delaware law or any stockholders who
enter into agreements with Parent to have their shares convert
into equity of the surviving corporation, will be cancelled and
converted into the right to receive $50.25 in cash, without
interest.
We have made customary representations, warranties and covenants
in the Merger Agreement. The Merger Agreement contains a
go shop provision pursuant to which we have the
right to solicit and engage in discussions and negotiations with
respect to competing acquisition proposals through
March 16, 2007. In accordance with the Merger Agreement,
our Board of Directors, through the Special Committee and with
the assistance of its independent advisors, intends to solicit
superior proposals during this period. There can be no assurance
that the solicitation of superior proposals will result in an
alternative transaction. During the go shop period, Parent does
not have a contractual right to be advised of or match the terms
of any superior proposal. After March 16, 2007, we may
continue discussions with any Excluded Party,
defined as a party that submits a bona fide acquisition proposal
during the go shop period or with whom we are having ongoing
discussions or negotiations as of the end of the go shop period
regarding a bona fide acquisition proposal. No later than
March 19, 2007, we are required to provide the identity of
the Excluded Parties to Parents outside counsel that have
entered into a customary non-disclosure agreement with the
Company not to disclose such identity to Parent or its
affiliates.
Except with respect to Excluded Parties, after March 16,
2007, we are subject to a no shop restriction on our
ability to solicit third party proposals, provide information
and engage in discussions and negotiations with third parties.
The no shop provision is subject to a fiduciary out
provision that allows us to provide information and participate
in discussions and negotiations with respect to third party
acquisition proposals submitted after March 16, 2007 that
the Board of Directors (following the recommendation of the
Special Committee) believes in good faith to be bona fide and
determines in good faith, after consultation with its financial
advisors and outside counsel, constitute or could reasonably be
expected to result in a superior proposal, as
defined in the Merger Agreement.
We may terminate the Merger Agreement under certain
circumstances, including if our Board of Directors (following
the recommendation of the Special Committee) determines in good
faith that it has received a superior proposal and that failure
to terminate the Merger Agreement could violate its fiduciary
duties, and otherwise complies with certain terms of the Merger
Agreement. In connection with such termination, we must pay a
fee of $120 million to Parent, unless such termination is
in connection with a superior proposal submitted by an Excluded
Party, in which case we must pay a fee of $20 million to
Parent and reimburse Parent for up to $20 million in
out-of-pocket expenses. In certain other circumstances, the
6
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Merger Agreement provides for Parent or us to pay to the other
party a fee of $120 million upon termination of the Merger
Agreement.
Parent has obtained equity and debt financing commitments for
the transactions contemplated by the Merger Agreement, the
aggregate proceeds of which will be sufficient for Parent to pay
the aggregate Merger consideration, including any contemplated
refinancing of debt and all related fees and expenses.
Consummation of the Merger is not subject to a financing
condition, but is subject to various other conditions, including
approval of the Merger by our stockholders, expiration or
termination of applicable waiting periods under the
Hart-Scott-Rodino
Antitrust Improvements Act of 1976, the receipt of other
required regulatory approvals and other customary closing
conditions. The parties currently expect to close the
transaction during the second quarter of 2007. Where this Annual
Report on
Form 10-K
discusses our future plans, strategies or activities, such
discussion does not give effect to the proposed Merger.
|
|
NOTE 2
|
ACCOUNTING
POLICIES
|
Reporting
Entity
Triad Hospitals, Inc. is one of the largest publicly owned
hospital companies in the United States and provides healthcare
services through hospitals and ambulatory surgery centers that
we own and operate in small cities and selected urban markets
primarily in the southern, midwestern and western United States.
Our domestic hospital facilities include 53 general acute care
hospitals and 13 ambulatory surgery centers located in the
states of Alabama, Alaska, Arizona, Arkansas, Georgia, Indiana,
Louisiana, Mississippi, Nevada, New Mexico, Ohio, Oklahoma,
Oregon, South Carolina, Tennessee, Texas and West Virginia. We
have one general acute care hospital located in Dublin, Ireland.
Included among our domestic hospital facilities is one hospital
operated through a 50/50 joint venture that is not consolidated
for financial reporting purposes and one hospital that is under
construction. We are also a minority investor in three joint
ventures that own seven general acute care hospitals in Georgia
and Nevada. Through our wholly-owned subsidiary, Quorum Health
Resources, LLC, or QHR, we also provide management and
consulting services to independent general acute care hospitals
located throughout the United States.
Principles
of Consolidation
The consolidated financial statements include our accounts and
all affiliated subsidiaries and entities that we control through
our direct or indirect ownership of a majority voting interest.
All material intercompany transactions have been eliminated.
Investments in entities which we do not control, but in which we
have a substantial ownership interest and can exercise
significant influence, are accounted for using the equity method.
Use of
Estimates
The preparation of the consolidated financial statements in
conformity with accounting principles generally accepted in the
United States requires management to make estimates and
assumptions that affect the amounts reported in the financial
statements and accompanying notes. Actual results could differ
from those estimates.
Revenues
Our healthcare facilities have entered into agreements with
third-party payers, including government programs and managed
care health plans, under which the facilities are paid based
upon several methodologies
7
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
including established charges, the cost of providing services,
predetermined rates per diagnosis, fixed per diem rates or
discounts from established charges. Revenues are recorded at
estimated net amounts due from patients, third-party payers and
others for healthcare services provided. We have multiple
patient accounting systems and, therefore, estimates for
contractual allowances are calculated both systematically and
manually, depending on the type of payer involved and the
patient accounting system used by each hospital. In certain
systems, the contractual payment terms are preloaded into the
system and the system calculates the expected reimbursement
amounts. In other systems, the contractual adjustments are
determined manually using historical collections on each type of
payer. Even for systems that record the expected reimbursement
amount, there are still manual estimates based upon historical
collections recorded for payers that are not significant or do
not have specific contractual terms. All contractual
adjustments, regardless of type of payer or method of
calculation, are reviewed and compared to actual payment
experience. Changes in estimates of contractual allowances for
non-government payers have not historically been significant.
Laws and regulations governing the Medicare and Medicaid
programs are extremely complex, subject to interpretation and
are routinely modified for provider reimbursement. All hospitals
participating in the Medicare and Medicaid programs are required
to meet certain financial reporting requirements. Federal
regulations require submission of annual cost reports covering
medical costs and expenses associated with the services provided
by each hospital to program beneficiaries. Our facilities have
cost reporting year ends throughout our fiscal year. Settlements
under reimbursement agreements with governmental payers are
estimated and recorded in the period the related services are
rendered and are adjusted in future periods as adjustments
become known or as the service years are no longer subject to
audit, review or investigation. Annual cost reports required
under the Medicare and Medicaid programs are subject to routine
audits, which may result in adjustments to the amounts
ultimately determined to be due to us under these reimbursement
programs. These audits often require several years to reach the
final determination of amounts earned under the programs. As a
result, there is at least a reasonable possibility that recorded
estimates will change by a material amount in the near term. We
had $4.0 million, $10.9 million and $2.9 million
of net favorable governmental cost report settlements for the
years ended December 31, 2006, 2005 and 2004, respectively.
The estimated net cost report settlements as of
December 31, 2006 and 2005 were receivables of
approximately $34.2 million and $15.0 million,
respectively, which are included in accounts receivable in the
accompanying consolidated balance sheets.
Beginning in the fourth quarter of 2004, we implemented a
self-pay discount program that offers discounts to uninsured
patients based on personal financial criteria and means testing.
The amount of the discount varies based on each patients
financial condition. This self-pay discount program reduced
revenue by approximately $92.7 million, $85.7 million
and $9.7 million in 2006, 2005 and 2004, respectively,
which we believe resulted in a similar reduction to the
provision for doubtful accounts.
We implemented an additional component to our self-pay discount
program during the second quarter of 2005. This additional
component offers a discount for all uninsured patients based on
the lowest managed care discount in each hospital location. This
component of the self-pay discount program reduced revenues by
approximately $97.6 million and $61.9 million in 2006
and 2005, respectively, which we believe resulted in a similar
reduction to the provision for doubtful accounts.
Various state regulations require us to provide certain levels
of charity care, which is not recorded as revenue. Our charity
care policies related to these requirements vary by facility.
The discounts related to these charity care requirements are not
included in our self-pay discount programs.
8
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Cash
and Cash Equivalents
Cash equivalents consist of all investments with an original
maturity of three months or less.
Accounts
Receivable
Accounts receivable are recorded at the estimated net realizable
amounts from Federal and state agencies (under the Medicare,
Medicaid and TRICARE programs), managed care health plans,
commercial insurance companies, employers and patients. The
largest concentration of our patient accounts receivable is in
uninsured accounts. These include both amounts due from fully
uninsured patients and co-payments and deductibles for which
insured patients are responsible. Each patients insurance
coverage is verified as early as possible before a scheduled
admission or procedure, including eligibility, benefits and
authorization/pre-certification requirements, for all scheduled
accounts so that patients can be notified of their estimated
amounts due. Insurance coverage is verified within 24 hours
for all urgent and direct admissions. Our policy is to write off
accounts after all collection efforts have failed, typically no
longer than one year after date of discharge. Approximately
42.3% and 39.5% of our accounts receivable at December 31,
2006 and 2005, respectively, were uninsured accounts. We are
subject to significant credit risk if these payers ability
to pay deteriorates.
We maintain allowances for doubtful accounts for estimated
losses resulting from payers inability to make payments on
accounts. We estimate our allowance for doubtful accounts by
applying historical uninsured collection rates to current
uninsured receivables. We have multiple patient accounting
systems, which could increase the time needed to analyze
historical uninsured collection rates. We augment our estimate
with other analytical methods such as changes in the level of
uninsured receivables, accounts receivable days, cash
collections and accounts receivable agings. We recorded an
allowance for doubtful accounts of approximately 72.2% and 62.1%
of discounted billed uninsured receivables at December 31,
2006 and 2005, respectively.
Prior to the fourth quarter of 2005, we estimated our allowance
for doubtful accounts using historical net write-offs of
uncollectible accounts. We analyzed the ultimate collectibility
of our accounts receivable after one year, using a regression
analysis of the historical net write-offs to determine the
amount of those accounts receivable that were ultimately not
collected. The results of this analysis were then applied to the
current accounts receivable to determine the allowance necessary
for that period. The impact of our self-pay discounts was
incorporated into the historical net write-offs and accounts
receivable. This process, or AR lookback, is
performed each quarter. The AR lookback was augmented by the
analytical methods discussed above. Our self-pay discount
programs, which reduced the amount of receivables recorded,
distorted the results of the AR lookback leading management to
rely on the procedures discussed above. Although the AR lookback
is not currently used as the primary estimation tool, we
continue to use it as a part of the estimation process. We will
continue to perform the AR lookback process quarterly, but
management anticipates it will be another 6 to 12 months
before the impact of the self-pay discounts will be fully
reflected in the historical write-offs. Once this happens, we
anticipate using the AR lookback as the primary estimation tool
for the allowance for doubtful accounts.
In 2006, after determining that uninsured collection rates had
decreased substantially and reviewing the analytical methods
discussed above, management revised its estimate of
uncollectible accounts which increased the allowance to
approximately 72.2% of discounted uninsured receivables from
62.1%. This resulted in an increase to the provision for
doubtful accounts of approximately $44.4 million and a
reduction to income from continuing operations of approximately
$28.0 million, or $0.32 per diluted share, for 2006.
9
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Over half of our facilities are located in the states of
Alabama, Arkansas, Indiana, and Texas. We do not believe that
there are any other significant concentrations of revenues from
any particular geographic area that would subject us to any
significant credit risks in the collection of our accounts
receivable.
Inventories
Inventories of supplies are stated at the lower of cost
(first-in,
first-out) or market.
Physician
Income Guarantees
We have entered into physician recruiting agreements under which
we supplement physician income to a minimum amount over a period
of time, typically one year, while the physicians establish
themselves in the community. As part of the agreements, the
physicians are required to stay in the community for a period of
time after the payments have ended, typically three years, or
the payments are required to be returned to us. The payments
under these agreements are forgiven ratably if the physicians
stay in the community through the end of the agreement. We
adopted Financial Accounting Standards Board Staff Position
No. FIN 45-3,
Application of FASB Interpretation No. 45 to Minimum
Revenue Guarantees Granted to a Business or Its Owners, or
FIN 45-3,
on January 1, 2006.
FIN 45-3
requires that a liability for the estimated fair value of
minimum revenue guarantees be recorded on new agreements entered
into on or after January 1, 2006 and requires disclosure of
the maximum amount that could be paid on all minimum revenue
guarantees. For agreements entered into prior to the adoption of
FIN 45-3,
we recorded the payments to the physicians as an other asset and
amortize the asset over the forgiveness period. As of
December 31, 2006 and 2005, the unamortized portion of
these physician income guarantees was $67.2 million and
$63.1 million, respectively. For agreements entered into
after the adoption of
FIN 45-3,
we record an asset and liability for the estimated fair value of
the minimum revenue guarantees and amortize the asset from the
beginning of the guarantee payment period through the end of the
agreement. At December 31, 2006, the unamortized part of
these physician income guarantees was $21.5 million.
Property,
Equipment, and Other Amortizable Intangible Assets
Property and equipment are stated at the lower of cost or
market. Routine maintenance and repairs are charged to expense
as incurred. Expenditures that increase capacities or extend
useful lives are capitalized.
We capitalize costs associated with developing computer software
for internal use under the provisions of Statement of Position
98-1
Accounting for the Costs of Computer Software Developed
for Internal Use, or
SOP 98-1.
Under
SOP 98-1,
both direct internal and external costs incurred during the
application development stage, excluding training costs, are
capitalized.
Depreciation expense, computed using the straight-line method,
was $223.2 million, $199.6 million and
$172.3 million for the years ended December 31, 2006,
2005, and 2004, respectively. Buildings and improvements are
depreciated over estimated useful lives ranging from 10 to
40 years. Equipment is depreciated over estimated useful
lives ranging from 3 to 10 years.
Other amortizable intangible assets are comprised of acquired
management contracts which are amortized using the straight-line
method over a period of 15 years, acquired employment
contracts which are amortized using the straight-line method
over a period of two years and non-compete agreements which are
amortized based on the terms of the respective contracts.
We have asset retirement obligations for the removal of asbestos
at several of our facilities. These obligations are conditional,
based on a portion of the facility undergoing major renovations.
We have
10
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
recognized liabilities for this obligation when the fair value
can be reasonably estimated, which typically is when a
settlement date of the obligation can be determined. The amounts
of these liabilities are not significant. For the remainder of
these obligations, the fair value cannot be reasonably estimated
because there is an indeterminate settlement date of the
liability.
We evaluate the carrying value of our property, equipment and
amortizable intangible assets under the provisions of Statement
of Financial Accounting Standards No. 144 Accounting
for the Impairment or Disposal of Long-Lived Assets or
SFAS 144. Under SFAS 144, when events, circumstances
and operating results indicate that the carrying value of
certain property, equipment, and other amortizable intangible
assets to be held and used might be impaired, we prepare
projections of the probability-weighted undiscounted future cash
flows expected to result from the use of the assets and their
eventual disposition. If the projections indicate that the
recorded amounts are not expected to be recoverable, such
amounts are reduced to estimated fair value. The fair value of
assets held for sale is determined using estimated selling
values. Indicators of potential impairment are typically beyond
the control of management. If the probability-weighted cash
flows become less favorable than those projected by management,
impairments may be required. We recorded an impairment related
to assets held for sale in 2005 (see NOTE 5).
Goodwill
and Other
Non-Amortizable
Intangible Assets
Goodwill is the excess of the purchase price in an acquisition
over the fair value of identifiable net assets acquired. We
account for goodwill and other
non-amortizable
intangible assets under the provisions of Statement of Financial
Accounting Standards No. 142 Goodwill and Other
Intangible Assets, or SFAS 142. Under SFAS 142,
goodwill and intangible assets with indefinite lives are not
amortized but reviewed for impairment annually during the fourth
quarter, or more frequently if certain indicators arise.
Goodwill is reviewed at the reporting unit level, which is
defined in SFAS 142 as an operating segment or one level
below an operating segment. We have determined that the
reporting unit for our owned operations segment is at the
division level, which is one level below the segment. We
determine the fair value of the reporting units using discounted
future cash flows. If the fair value of the reporting unit is
less than the carrying value, an indication of impairment
exists. The amount of the impairment would be determined by
estimating the fair values of the tangible and intangible assets
and liabilities, with the remaining fair value assigned to
goodwill. The amount of impairment would be the difference
between the carrying amount of the goodwill and the fair value
of goodwill. No impairment charges were recorded during the
years ended December 31, 2006, 2005 and 2004 under the
provisions of SFAS 142.
Income
Taxes
We account for income taxes under the provisions of Statement of
Financial Accounting Standards No. 109 Accounting for
Income Taxes, or SFAS 109. Under SFAS 109,
deferred tax liabilities and assets are determined based on the
difference between the financial statement and tax bases of
assets and liabilities, using enacted tax rates in effect for
the year in which the differences are expected to reverse.
Valuation allowances are established when necessary to reduce
deferred tax assets to the amounts expected to be realized.
Income tax provision consists of our current provision for
Federal and state income taxes and the change in our deferred
income tax assets and liabilities. While we have considered
several items including ongoing prudent and feasible tax
planning strategies in assessing the need for valuation
allowances, in the event we were to determine that the
realization of our deferred tax asset in the future is different
than our net recorded amount, an adjustment to the income tax
provision would be necessary.
11
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Despite our belief that our tax return positions are accurate
and supportable, we recognize that certain tax benefits claimed
may be subject to challenge and may not be upheld under tax
audit. To reflect the possibility that certain tax benefits may
not be sustained, we establish tax reserves based on
managements judgment and adjust the tax reserves as
required in light of new or changing facts and circumstances,
such as the progress of a tax audit. Generally, the
establishment of tax reserves increases the income tax provision
in the reporting period in which such tax reserves are
established. Any unfavorable adjustments to the tax reserves
increase the income tax provision in that reporting period and
any favorable adjustments to the tax reserves decrease the
income tax provision in that reporting period. We established a
tax reserve through goodwill from the purchase accounting
entries for the Quorum acquisition. Any adjustment to this tax
reserve as a result of a final settlement of the tax position
would increase or decrease the value of the acquired goodwill
instead of the income tax provision.
Self-Insured
Liability Risks
We maintain professional malpractice liability insurance and
general liability insurance in amounts which we believe to be
sufficient for our operations, although it is possible that some
claims may exceed the scope of the coverage in effect.
Substantially all losses in periods prior to the spin-off are
insured through a wholly-owned insurance subsidiary of HCA,
Inc., or HCA, and excess loss policies maintained by HCA. HCA
has agreed to indemnify us in respect of claims covered by such
insurance policies arising prior to the spin-off. After the
spin-off, we obtained insurance coverage on a claims incurred
basis from HCAs wholly-owned insurance subsidiary with
excess coverage obtained from other carriers which is subject to
certain deductibles which we consider to be reasonable. The cost
of general and professional liability coverage is based on
insurance premiums paid and actuarially determined estimates for
deductibles. The cost for the years ended December 31,
2006, 2005, and 2004 was approximately $72.3 million,
$76.2 million and $90.1 million, respectively.
Estimated liabilities for general and professional liability
risks are actuarially determined and discounted using an
interest rate of 5.5%. The estimated liability was
$160.5 million and $144.8 million at December 31,
2006 and 2005, respectively. At December 31, 2006 and 2005,
$37.0 million and $21.2 million, respectively, was
recorded in other current liabilities and $123.5 million
and $123.6 million, respectively, was recorded in other
liabilities in the consolidated balance sheets.
In the fourth quarter of 2006, our semi-annual general and
professional liability actuarial report showed approximately a
$25 million reduction to the estimated liabilities. The
reduction was from reduced claim payments and claim severity. We
also had an increase in our estimated liabilities for general
and professional liability insurance of $10.3 million in
the second quarter of 2006 due to a reduction of the discount
rate to 5.5% from 6.0% and changes in actuarial assumptions to
accelerate claim payment patterns. These events resulted in a
net reduction to our estimated liabilities of $14.7 million
and increased income from continuing operations and net income
by approximately $9.3 million, or $0.11 per diluted share.
For periods after the spin-off, we instituted our own
self-insured programs for workers compensation and health
insurance. Prior to the spin-off, we participated in
self-insured programs for workers compensation and health
insurance administered by HCA. HCA retained sole responsibility
for all workers compensation and health claims incurred
prior to the spin-off. The cost for these programs is based upon
claims paid, plus an actuarially determined amount for claims
incurred but not reported. Estimated liabilities for
workers compensation were $24.2 million and
$27.6 million at December 31, 2006 and 2005,
respectively. Estimated liabilities for health claim liability
risk were $18.7 million and $20.4 million at
December 31, 2006 and 2005, respectively.
12
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
There are many factors that are used in determining the
estimates, including amount and timing of historical payments,
severity of individual cases, anticipated volume of services
provided and discount rates for future cash flows. Ultimate
actual payments for workers compensation and general and
professional liability risks may not become known for several
years after incurrence. Any factors changing the underlying data
used in determining these estimates could result in adjustments
to the liability.
Share-Based
Compensation Expense
We account for our share-based compensation expense under the
provisions of Statement of Financial Accounting Standards
No. 123 (revised 2004) Share-Based
Payment, or SFAS 123R (see NOTE 12). Under this
method, share-based compensation expense is recognized beginning
January 1, 2006 for all share-based payments granted based
on the grant date fair value, using estimated forfeitures. We
adopted SFAS 123R effective January 1, 2006.
Reimbursable
Expenses
Our wholly-owned subsidiary, QHR, recognizes revenue based on a
contractually determined rate as services are performed, plus
direct costs associated with the contract. The direct costs
relate primarily to salaries and benefits of QHR employees who
serve as executives at hospitals managed by QHR. The salaries
and benefits of these employees are legal obligations of and are
paid by QHR, and are reimbursed by the managed hospitals. The
direct costs are recorded as revenues and reimbursable expenses
in the consolidated statements of operations.
Fair
Value of Financial Instruments
Statement of Financial Accounting Standards No. 107
Disclosure About Fair Value of Financial Instruments
requires certain disclosures regarding the fair value of
financial instruments. Cash and cash equivalents, accounts
receivable, accounts payable and accrued liabilities are
reflected in the consolidated financial statements at fair value
because of the short-term maturity of these instruments. The
fair value of long-term debt was determined by using quoted
market prices, when available, or discounted cash flows to
calculate these fair values.
Derivative
Financial Instruments
We account for our derivatives under Statement of Financial
Accounting Standards No. 133 Accounting for
Derivative Instruments and Hedging Activities or
SFAS 133. SFAS 133 requires that all derivative
financial instruments that qualify for hedge accounting be
recognized in the financial statements and measured at fair
value regardless of the purpose or intent for holding them.
Changes in fair value of derivative financial instruments are
either recognized periodically in income or shareholders
equity (as a component of comprehensive income), depending on
whether the derivative is being used to hedge changes in fair
value or cash flows. Our policy is to not hold or issue
derivatives for trading purposes and to avoid derivatives with
leverage features.
Business
Combinations
We account for acquisitions under Statement of Financial
Accounting Standards No. 141 Business
Combinations, or SFAS 141. SFAS 141 requires
that all business combinations be accounted for under the
purchase method of accounting, whereby all assets acquired,
including identifiable intangibles and goodwill,
13
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
and liabilities assumed are recorded at fair value. Results of
operations for entities acquired are included in the
consolidated results of operations beginning on the date of
acquisition.
Discontinued
Operations
We account for discontinued operations under SFAS 144.
SFAS 144 requires that a component of an entity that has
been disposed of or is classified as held for sale after
January 1, 2002 and has operations and cash flows that can
be clearly distinguished from the rest of the entity be reported
as discontinued operations. In the period that a component of an
entity has been disposed of or classified as held for sale, the
results of operations for current and prior periods are
reclassified in a single caption titled discontinued operations.
Recent
Accounting Pronouncements
In June 2006, the Financial Accounting Standards Board issued
FASB Interpretation No. 48 Accounting for Uncertainty
in Income Taxes, or FIN 48, which clarifies the
accounting for uncertainty in income taxes recognized in
accordance with SFAS 109. FIN 48 is effective for
fiscal years beginning after December 15, 2006. The
cumulative effect of applying the provisions of FIN 48
would be reported as an adjustment to the opening balance of
retained earnings in the year of adoption. FIN 48
prescribes a recognition threshold and measurement attribute for
the financial statement recognition and measurement of a tax
position taken or expected to be taken in a tax return.
FIN 48 also provides guidance on derecognition,
classification, interest and penalties, accounting in interim
periods, disclosures, and transition. We adopted FIN 48 on
January 1, 2007, and anticipate that we will reclassify
amounts recorded in our deferred tax liabilities for uncertain
tax positions to other liabilities upon adoption. We currently
do not anticipate any material adjustments to the opening
balance of retained earnings. FIN 48 also requires
additional disclosures with respect to reserves related to tax
uncertainties.
In September 2006, the Financial Accounting Standards Board
issued Statement of Financial Accounting Standards No. 157
Fair Value Measurements, or SFAS 157, which is
effective for fiscal years beginning after November 15,
2007, with early adoption encouraged. This statement provides a
single definition of fair value, establishes a framework for
measuring fair value, and expanded disclosures concerning fair
value measurements. We do not anticipate a material impact on
our results of operations or financial position from the
adoption of SFAS 157.
In September 2006, the SEC issued Staff Accounting
Bulletin No. 108, Considering the Effects of
Prior Year Misstatements when Quantifying Misstatements in
Current Year Financial Statements, or SAB 108, which
is effective for fiscal years ending after November 15,
2006. SAB 108 provides guidance on the consideration of the
effects of prior year immaterial misstatements in quantifying
current year misstatements for the purpose of a materiality
assessment on both the balance sheet and income statement.
SAB 108 requires restatement of prior year financial
statements for current year misstatements even if the revisions
are immaterial to those prior years, if the correction would be
material to the current year. SAB 108 allows for the
cumulative effect of the initial application to be made to
beginning retained earnings. We did not have a material impact
on our results of operations or financial position from the
adoption of SAB 108.
In February 2007, the Financial Accounting Standards Board
issued Statement of Financial Accounting Standards No. 159
The Fair Value Option for Financial Assets and Financial
Liabilities, or SFAS 159, which is effective for
financial statements beginning after November 15, 2007,
with early adoption permitted. The statement permits entities to
choose to measure many financial instruments and certain other
items at fair value. The unrealized gains and losses on items
for which the fair value option has been elected would be
reported in earnings. The objective of SFAS 159 is to
improve financial reporting by providing entities with
14
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
the opportunity to mitigate volatility in reported earnings
caused by measuring related assets and liabilities differently
without having to apply complex hedge accounting provisions. We
have not evaluated all of the provisions of SFAS 159, but
we do not anticipate a material impact on our results of
operations or financial position from the adoption of
SFAS 159.
Effective November 1, 2006, an affiliate of ours acquired a
hospital in Augusta, Georgia and immediately sold ownership
interests in the acquiring entity to members of the medical
staff of the hospital. The purchase price of the hospital was
approximately $33.2 million including working capital. Our
affiliate owns approximately a 65% interest in the venture and
the physician owners own approximately a 35% interest in the
venture. We received approximately $10 million from the
physician owners in the venture.
Effective February 1, 2006, we closed under a definitive
agreement to form a venture with a non-profit entity in
Clarksville, Tennessee. We contributed approximately
$25.6 million in cash for an 80% interest in the venture
and the non-profit contributed the hospitals current
operations, including real estate and equipment, and received a
20% interest in the venture. The venture has begun building a
replacement facility for which we would contribute an additional
$125 million.
Effective February 1, 2006, we closed under a definitive
agreement to form a venture with a non-profit entity in
Massillon, Ohio. We contributed our current hospital in
Massillon and approximately $11.4 million in cash for
approximately a 59% interest in the venture and the non-profit
entity contributed its hospital for approximately a 41% interest
in the venture. In the second quarter of 2006, the non-profit
entity exercised its option to sell a portion of its interest in
the venture to us. We paid approximately $12.2 million and
obtained an additional interest in the venture of approximately
21%, increasing our total interest to approximately 80%.
During 2006, we acquired certain non-hospital healthcare
entities for approximately $42.3 million.
The operations of the acquired entities are included in our
operations from the effective dates of the transactions.
We have obtained appraisals and valuations on the assets and
liabilities acquired and, based on these valuations, intangible
assets of $13.6 million were recorded, of which
$7.2 million was assigned to trade names that are not
subject to amortization and $6.4 million was assigned to
non-compete agreements that are being amortized over a five-year
period. The acquired goodwill, based on the appraisals, totaled
$67.0 million and has been assigned to the owned operations
segment. Approximately $30.2 million of the acquired
goodwill is anticipated to be deductible for tax purposes.
In 2006, we obtained an appraisal for a joint venture formed in
the fourth quarter of 2005 in Birmingham, Alabama. Acquired
intangible assets of $2.4 million were recorded in 2006,
which were assigned to non-compete agreements that are being
amortized over a five-year period. The acquired goodwill, which
was assigned to the owned operations segment, was reduced in
2006 by $10.0 million.
15
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 4
|
GOODWILL
AND INTANGIBLE ASSETS
|
The goodwill allocated to our reportable segments is as follows
(in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Owned
|
|
|
Management
|
|
|
Corporate
|
|
|
|
|
|
|
Operations
|
|
|
Services
|
|
|
and Other
|
|
|
Total
|
|
|
Balance as of January 1, 2005
|
|
$
|
1,140.6
|
|
|
$
|
58.8
|
|
|
$
|
|
|
|
$
|
1,199.4
|
|
Goodwill acquired
|
|
|
106.6
|
|
|
|
|
|
|
|
|
|
|
|
106.6
|
|
Reduction to goodwill from
minority interests acquired
|
|
|
(3.8
|
)
|
|
|
|
|
|
|
|
|
|
|
(3.8
|
)
|
Goodwill written off related to
sales
|
|
|
(0.6
|
)
|
|
|
|
|
|
|
|
|
|
|
(0.6
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31,
2005
|
|
|
1,242.8
|
|
|
|
58.8
|
|
|
|
|
|
|
|
1,301.6
|
|
Goodwill acquired
|
|
|
67.0
|
|
|
|
|
|
|
|
|
|
|
|
67.0
|
|
Increase to goodwill from minority
interests acquired
|
|
|
1.6
|
|
|
|
|
|
|
|
|
|
|
|
1.6
|
|
Purchase price adjustments for
prior year acquisitions
|
|
|
(10.0
|
)
|
|
|
|
|
|
|
|
|
|
|
(10.0
|
)
|
Goodwill written off related to
sales
|
|
|
(0.5
|
)
|
|
|
|
|
|
|
|
|
|
|
(0.5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31,
2006
|
|
$
|
1,300.9
|
|
|
$
|
58.8
|
|
|
$
|
|
|
|
$
|
1,359.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible assets subject to amortization relate primarily to
management contracts acquired in the management services
segment. Amortization expense of intangible assets that still
require amortization under SFAS 142 was $6.6 million,
$6.3 million and $6.3 million for the years ended
December 31, 2006, 2005, and 2004, respectively.
Estimated amortization expense relating to these intangible
assets over the next five years is as follows (in millions):
|
|
|
|
|
2007
|
|
$
|
7.4
|
|
2008
|
|
$
|
7.3
|
|
2009
|
|
$
|
7.2
|
|
2010
|
|
$
|
6.9
|
|
2011
|
|
$
|
6.4
|
|
The gross carrying amount and accumulated amortization of
amortizable intangible assets at December 31, 2006 and 2005
are as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
|
Gross Carrying
|
|
|
Accumulated
|
|
|
Gross Carrying
|
|
|
Accumulated
|
|
|
|
Amount
|
|
|
Amortization
|
|
|
Amount
|
|
|
Amortization
|
|
|
Management contracts
|
|
$
|
79.0
|
|
|
$
|
(29.8
|
)
|
|
$
|
79.0
|
|
|
$
|
(24.6
|
)
|
Other
|
|
|
11.7
|
|
|
|
(2.8
|
)
|
|
|
2.9
|
|
|
|
(1.4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
90.7
|
|
|
$
|
(32.6
|
)
|
|
$
|
81.9
|
|
|
$
|
(26.0
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2006 and 2005 the carrying amount of
intangible assets assigned to trade names that are not subject
to amortization was $23.0 million and $15.8 million,
respectively.
16
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 5
|
DISCONTINUED
OPERATIONS
|
Effective January 1, 2006, we closed on a definitive
agreement to sell our hospitals in Wharton, Texas, Pampa, Texas
and Hope, Arkansas for $75 million plus $15.1 million
for working capital. These facilities were reclassified to
discontinued operations in the fourth quarter of 2005. We
recognized a pre-tax gain on the sale in discontinued operations
of $26.9 million. These facilities were a component of the
owned operations segment.
On November 1, 2005, we closed on an agreement to sell our
hospital in Searcy, Arkansas. At the time of disposal, we
recorded a contingent liability relating to the sale of the
facility. Management determined that the contingency was
resolved and reversed the liability in the second quarter of
2006. A pre-tax gain of approximately $0.3 million was
recognized in discontinued operations.
We closed under an agreement in May 2004 to sell certain assets
related to our leased acute care hospital in Terrell, Texas. At
the time of the disposal, we recorded $3.4 million in notes
receivable. During the third quarter of 2006, the borrower
defaulted on the first payment due under the notes. A reserve on
the notes for the amount in excess of the estimated value of the
collateral of approximately $1.4 million was recorded in
discontinued operations.
The assets and liabilities of entities included in discontinued
operations are presented in the consolidated balance sheets
under the captions Discontinued operations assets
and Discontinued operations liabilities. At
December 31, 2006, all assets and liabilities included in
discontinued operations were sold. The carrying amounts of the
major classes of these assets and liabilities are as follows (in
millions):
|
|
|
|
|
|
|
December 31,
|
|
|
|
2005
|
|
|
Assets
|
|
|
|
|
Accounts receivable, net
|
|
$
|
17.6
|
|
Inventories
|
|
|
2.2
|
|
Other current assets
|
|
|
3.9
|
|
Property and equipment, net
|
|
|
40.5
|
|
Goodwill
|
|
|
3.3
|
|
Other assets
|
|
|
0.1
|
|
|
|
|
|
|
Total discontinued operations
assets
|
|
$
|
67.6
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
Accounts payable
|
|
$
|
1.3
|
|
Accrued salaries
|
|
|
1.8
|
|
|
|
|
|
|
Total discontinued operations
liabilities
|
|
$
|
3.1
|
|
|
|
|
|
|
17
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Revenues and income (loss) for the entities are included in the
consolidated statements of operations as Income (loss)
from discontinued operations, net of tax. The amounts for
the years ended December 31 were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Revenues
|
|
$
|
|
|
|
$
|
169.3
|
|
|
$
|
315.5
|
|
Pre-tax income (loss) from
operations
|
|
|
(1.4
|
)
|
|
|
(5.7
|
)
|
|
|
5.8
|
|
Income tax (provision) benefit
|
|
|
0.5
|
|
|
|
1.9
|
|
|
|
(2.1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(0.9
|
)
|
|
|
(3.8
|
)
|
|
|
3.7
|
|
Impairment charge, net of tax
benefit of $2.8 million for the year ended
December 31, 2005
|
|
|
|
|
|
|
(4.7
|
)
|
|
|
|
|
Gain on disposal, net of tax
provision of $10.5 million, $1.3 million, and
$39.9 million for the years ended December 31, 2006,
2005 and 2004, respectively
|
|
|
15.3
|
|
|
|
5.1
|
|
|
|
55.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
14.4
|
|
|
$
|
(3.4
|
)
|
|
$
|
59.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The income tax (provision) benefit from continuing operations
for the years ended December 31 consists of the following
(dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Current:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
(126.8
|
)
|
|
$
|
(118.0
|
)
|
|
$
|
(70.1
|
)
|
State
|
|
|
(11.4
|
)
|
|
|
(11.7
|
)
|
|
|
(8.4
|
)
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
5.2
|
|
|
|
(11.2
|
)
|
|
|
(3.3
|
)
|
State
|
|
|
0.5
|
|
|
|
(1.0
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(132.5
|
)
|
|
$
|
(141.9
|
)
|
|
$
|
(81.8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
We also had tax (provision) benefit from discontinued operations
of $(10.0) million, $3.4 million and
$(42.0) million for the years ended December 31, 2006,
2005 and 2004, respectively.
A reconciliation of the Federal statutory rate to the effective
income tax rate from continuing operations follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Federal statutory rate
|
|
|
35.0
|
%
|
|
|
35.0
|
%
|
|
|
35.0
|
%
|
State income taxes, net of Federal
income tax benefit
|
|
|
2.0
|
|
|
|
2.0
|
|
|
|
2.0
|
|
State tax rate change
|
|
|
|
|
|
|
|
|
|
|
(0.7
|
)
|
Valuation allowance
|
|
|
1.0
|
|
|
|
|
|
|
|
|
|
Non-deductible ESOP expense
|
|
|
1.0
|
|
|
|
1.0
|
|
|
|
1.2
|
|
Other items, net
|
|
|
(0.1
|
)
|
|
|
0.2
|
|
|
|
0.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective income tax rate
|
|
|
38.9
|
%
|
|
|
38.2
|
%
|
|
|
38.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
During the third quarter of 2004, we had a reduction of our
marginal tax rate from 37.5% to 37.0% from state tax rate
changes. We recorded a reduction to our income tax provision of
approximately $1.5 million relating to an adjustment of our
deferred tax assets and liabilities from the change in the
marginal tax rate.
18
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
A summary of the items comprising the deferred tax assets and
liabilities at December 31 follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
|
Assets
|
|
|
Liabilities
|
|
|
Assets
|
|
|
Liabilities
|
|
|
Depreciation and fixed asset basis
differences
|
|
$
|
|
|
|
$
|
172.2
|
|
|
$
|
|
|
|
$
|
169.8
|
|
Accounts and other receivables
|
|
|
26.0
|
|
|
|
|
|
|
|
19.4
|
|
|
|
|
|
Foreign and state net operating
loss carryforwards
|
|
|
16.3
|
|
|
|
|
|
|
|
14.3
|
|
|
|
|
|
Professional liability risks
|
|
|
59.7
|
|
|
|
|
|
|
|
55.3
|
|
|
|
|
|
Compensation reserves
|
|
|
43.2
|
|
|
|
|
|
|
|
26.3
|
|
|
|
|
|
Amortization and intangible asset
basis differences
|
|
|
|
|
|
|
109.5
|
|
|
|
|
|
|
|
103.1
|
|
Investment basis difference
|
|
|
|
|
|
|
11.7
|
|
|
|
|
|
|
|
9.8
|
|
Prepaid expenses
|
|
|
|
|
|
|
6.3
|
|
|
|
|
|
|
|
5.7
|
|
Other
|
|
|
2.7
|
|
|
|
|
|
|
|
4.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
147.9
|
|
|
|
299.7
|
|
|
|
119.3
|
|
|
|
288.4
|
|
Valuation allowances
|
|
|
(3.3
|
)
|
|
|
|
|
|
|
(1.0
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
144.6
|
|
|
$
|
299.7
|
|
|
$
|
118.3
|
|
|
$
|
288.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As part of the spin-off, we and HCA entered into a tax sharing
and indemnification agreement (see NOTE 15). The tax
sharing and indemnification agreement will not have an impact on
the realization of our deferred tax assets or the payment of our
deferred tax liabilities except to the extent that the temporary
differences giving rise to such deferred tax assets and
liabilities as of the spin-off are adjusted as a result of final
tax settlements after the spin-off. In the event of such
adjustments, the tax sharing and indemnification agreement will
provide for certain payments between HCA and us as appropriate.
Deferred income taxes of $38.4 million and
$31.8 million at December 31, 2006 and 2005,
respectively, are included in current assets. Noncurrent
deferred income tax liabilities totaled $193.5 million and
$201.9 million at December 31, 2006 and 2005,
respectively. Current and noncurrent deferred taxes totaled
$155.1 million and $170.1 million net deferred tax
liability at December 31, 2006 and 2005, respectively.
At December 31, 2006, state net operating loss
carryforwards (expiring in years 2007 through
2025) available to offset future taxable state income
approximated $475.7 million, representing approximately
$15.5 million in deferred tax benefits. Utilization of net
operating loss carryforwards in any one year may be limited and,
in certain cases, result in a reduction of deferred tax assets.
Based on available evidence, it is more likely than not that
some portion of the state net operating loss carryforwards will
not be realized, therefore, a valuation allowance of $2.5 and
$1.0 million has been recorded as of December 31, 2006
and 2005, respectively.
At December 31, 2006, foreign net operating loss
carryforwards (with no expiration date) available to offset
future taxable income approximated $6.5 million
representing approximately $0.8 million in deferred tax
benefits. Based on available evidence, it is more likely than
not that the foreign net operating loss carryforwards will not
be realized, therefore, a valuation allowance of
$0.8 million has been recorded as of December 31, 2006.
19
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Components of long-term debt at December 31 (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying Amount
|
|
|
Fair Value
|
|
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|
2005
|
|
|
Revolving Credit Line
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Term Loan A
|
|
|
493.8
|
|
|
|
500.0
|
|
|
|
493.8
|
|
|
|
500.0
|
|
7% Senior Notes
|
|
|
600.0
|
|
|
|
600.0
|
|
|
|
601.5
|
|
|
|
610.5
|
|
7% Senior Subordinated Notes
|
|
|
600.0
|
|
|
|
600.0
|
|
|
|
605.3
|
|
|
|
598.5
|
|
Other
|
|
|
11.6
|
|
|
|
3.5
|
|
|
|
11.0
|
|
|
|
3.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,705.4
|
|
|
|
1,703.5
|
|
|
$
|
1,711.6
|
|
|
$
|
1,712.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less current portion
|
|
|
21.3
|
|
|
|
7.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,684.1
|
|
|
$
|
1,695.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Term Loan A presently bears interest at LIBOR plus 1.00%
(6.35% at December 31, 2006) with principal amounts
due through 2011, the 7% senior notes principal amounts are
due in 2012 and the 7% senior subordinated notes principal
amounts are due in 2013. The senior notes are callable, at our
option, in May 2008 and the senior subordinated notes are
callable, at our option, in November 2008 and, in both cases,
are callable earlier at our option by paying a make-whole
premium. At December 31, 2006, Triad had a
$600.0 million line of credit which bears interest at LIBOR
plus 1.00%. No amounts were outstanding under the revolving
credit line at December 31, 2006. The revolving credit line
matures in 2007. We had $16.1 million of letters of credit
outstanding at December 31, 2006, which reduce the amount
available under the revolving credit line. The LIBOR spread on
the revolving credit line, including letters of credit
outstanding under the revolving credit line, and our Term Loan A
may increase or decrease depending upon our total leverage. The
interest rate applicable to the credit facilities ranges from
LIBOR plus 0.875% to LIBOR plus 1.75%, based on our total
leverage ratio.
Our term loans and revolving lines of credit are collateralized
by a pledge of substantially all of our assets other than real
estate associated with the former Quorum facilities. The debt
agreements require that we comply with various financial ratios
and tests and have restrictions on, among other things, new
indebtedness, asset sales and use of proceeds therefrom, stock
repurchases and dividends. The debt agreements require, among
other things, that our total leverage ratio not exceed 4.0x as
of December 31, 2006. Our total leverage ratio at
December 31, 2006 was approximately 2.27x. The indentures
governing our other long-term debt also contain covenants
restricting the incurrence of indebtedness, investments,
dividends, asset sales and the incurrence of liens, among other
things. There are no maintenance covenants under the indentures.
Our debt agreements and indentures contain change of control
provisions. A change in control constitutes an event of default
under our credit facility. Under our indentures, if a change in
control occurs, each holder of our notes can require us to
repurchase their notes at 101% of the principal amount thereof,
plus accrued and unpaid interest to the repurchase date. There
are no events of default under our debt agreements or indentures
in the event of a downgrade of our debt ratings. We currently
are in compliance with all debt agreement covenants and
restrictions. If an event of default occurs with respect to our
debt agreements, then the balances of the term loan and
revolving credit line could become due and payable which could
result in other debt obligations also becoming due and payable.
Additionally, there would be no availability under the revolving
credit line.
20
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
We had net debt issue costs of $19.0 million and
$22.4 million as of December 31, 2006 and 2005,
respectively, recorded in other assets in the consolidated
balance sheets. These costs are being amortized using the
effective interest method over the lives of the related debt.
Accumulated amortization of debt issue costs was
$8.5 million and $5.1 million as of December 31,
2006 and 2005, respectively.
We use varying methods and significant assumptions to estimate
fair values of long-term debt (see NOTE 2).
A debt maturity schedule is as follows (in millions):
|
|
|
|
|
2007
|
|
$
|
21.3
|
|
2008
|
|
|
37.5
|
|
2009
|
|
|
44.9
|
|
2010
|
|
|
213.5
|
|
2011
|
|
|
188.1
|
|
Thereafter
|
|
|
1,200.1
|
|
|
|
|
|
|
|
|
$
|
1,705.4
|
|
|
|
|
|
|
|
|
NOTE 8
|
EQUITY
INVESTMENTS
|
We own equity interests of 27.5% in Valley Health System LLC and
26.1% in Summerlin Hospital Medical Center LLC. Universal Health
Systems has the majority interest in Valley Health System LLC
and Summerlin Hospital Medical Center LLC. We own an equity
interest of 38.0% in Macon Healthcare LLC. HCA has the majority
interest in Macon Healthcare LLC. We also own a 50% interest in
MCSA, LLC with our partner, SHARE Foundation, a not-for-profit
foundation. We use the equity method of accounting for our
investments in these entities. Summarized financial information
of these entities is as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
Balance Sheet
|
|
|
|
|
|
|
|
|
Current assets
|
|
$
|
202.8
|
|
|
$
|
159.9
|
|
Non-current assets
|
|
|
568.9
|
|
|
|
569.0
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
771.7
|
|
|
$
|
728.9
|
|
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
$
|
72.8
|
|
|
$
|
71.5
|
|
Non-current liabilities
|
|
|
3.1
|
|
|
|
3.3
|
|
Members equity
|
|
|
695.8
|
|
|
|
654.1
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
771.7
|
|
|
$
|
728.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Income Statement
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
1,145.8
|
|
|
$
|
1,036.4
|
|
|
$
|
906.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
139.5
|
|
|
$
|
108.3
|
|
|
$
|
59.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
We have entered into physician recruiting agreements under which
we supplement physician income to a minimum amount over a period
of time while the physicians establish themselves in the
community (see NOTE 2). Under the provisions of
FIN 45-3,
we recorded a liability for the fair value of minimum revenue
guarantees on new agreements entered into after January 1,
2006. At December 31, 2006, we had liabilities for the
minimum revenue guarantees entered into on or after
January 1, 2006 of $14.8 million. At December 31,
2006, the maximum amount of all unpaid minimum revenue
guarantees, including the minimum revenue guarantees entered
into prior to January 1, 2006, was $58.9 million.
We have entered into agreements whereby we have guaranteed
certain loans entered into by patients for whom services were
performed at our facilities. All uninsured patients are eligible
to apply for these loans. These loans are provided by various
financial institutions who determine whether the loans are made.
The terms of the loans range from 1 to 5 years. We would be
obligated to repay the financial institutions if a patient fails
to repay his or her loan. We could then pursue collections from
the patient. We record a reserve for the estimated defaults on
these loans at the historical default rate, which was
approximately 30.3% and 29.1% at December 31, 2006 and
2005, respectively. At December 31, 2006 and 2005, the
amounts subject to the guarantees were $23.4 million and
$23.6 million, respectively. We had accrued liabilities of
$7.0 million and $6.8 million at December 31,
2006 and 2005, respectively, for the estimated loan defaults
that would be covered under the guarantees.
FASB Interpretation No. 45, Guarantors
Accounting on Disclosure Requirements for Guarantees, Including
Indirect Guarantees of Indebtedness of Others requires
recognition of a liability for the estimated fair value of
guarantee obligations entered into after January 1, 2003
and disclosure of the maximum amount that could be paid under
all guarantee obligations. Prior to January 1, 2003, we
entered into agreements to guarantee the indebtedness of certain
joint ventures that are accounted for by the equity method. The
maximum amount of the guarantees entered into prior to
January 1, 2003 was $2.0 million at December 31,
2006. Subsequent to January 1, 2003, we entered into
agreements to guarantee the indebtedness of joint ventures
accounted for by the equity method. A minimal amount was
recorded for the fair value of the guarantees. The maximum
amount of the guarantees entered into after January 1, 2003
was $1.7 million at December 31, 2006.
|
|
NOTE 10
|
DERIVATIVE
FINANCIAL INSTRUMENTS
|
We had entered into an interest rate swap agreement, which
effectively converted a notional amount of $100 million of
floating rate borrowings to fixed rate borrowings. The term of
the interest rate swap expired in January 2004. We had also
entered into another interest rate swap agreement, which
effectively converted an additional notional amount of
$100 million of floating rate borrowings to fixed rate
borrowings. The term of the interest rate swap expired in June
2005. The change in fair value of the interest rate swaps, net
of income tax, was recognized through other comprehensive income.
22
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
We lease real estate properties, equipment and vehicles under
cancelable and non-cancelable leases. Rental expense for the
years ended December 31, 2006, 2005 and 2004 was
$116.8 million, $92.0 million and $78.0 million,
respectively. Future minimum operating and capital lease
payments are as follows at December 31, 2006 (in millions):
|
|
|
|
|
|
|
|
|
|
|
Operating
|
|
|
Capital
|
|
|
2007
|
|
$
|
64.3
|
|
|
$
|
1.9
|
|
2008
|
|
|
55.0
|
|
|
|
1.4
|
|
2009
|
|
|
47.7
|
|
|
|
1.0
|
|
2010
|
|
|
36.5
|
|
|
|
0.8
|
|
2011
|
|
|
26.9
|
|
|
|
0.5
|
|
Thereafter
|
|
|
120.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total minimum payments
|
|
$
|
350.9
|
|
|
|
5.6
|
|
|
|
|
|
|
|
|
|
|
Less amounts representing interest
|
|
|
|
|
|
|
(0.6
|
)
|
|
|
|
|
|
|
|
|
|
Present value of minimum lease
payments
|
|
|
|
|
|
$
|
5.0
|
|
|
|
|
|
|
|
|
|
|
The following summarizes amounts related to equipment leased by
us under capital leases at December 31 (in millions):
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
Equipment
|
|
$
|
7.2
|
|
|
$
|
2.0
|
|
Accumulated amortization
|
|
|
(1.0
|
)
|
|
|
(0.9
|
)
|
|
|
|
|
|
|
|
|
|
Net book value
|
|
$
|
6.2
|
|
|
$
|
1.1
|
|
|
|
|
|
|
|
|
|
|
|
|
NOTE 12
|
SHARE-BASED
COMPENSATION PLANS
|
At December 31, 2006, we had share-based compensation plans
that, prior to January 1, 2006, were accounted for under
the recognition and measurement principles of APB Opinion
No. 25, Accounting for Stock Issued to
Employees, or APB 25 and related interpretations, as
permitted by Statement of Financial Accounting Standards
No. 123, or SFAS 123, Accounting for Stock-Based
Compensation. APB 25 used the intrinsic value method to
account for options granted to employees. Share-based
compensation expense of $1.3 million was recognized in the
consolidated statement of operations for restricted stock issued
to non-employee members of the Board of Directors and an
executive officer during the year ended December 31, 2005.
No share-based compensation expense was recognized on options
awarded to employees, as all unvested options were granted at
exercise prices equal to the market value of the underlying
common stock on the date of grant. We recorded $0.7 million
in share-based compensation expense during the year ended
December 31, 2005, relating to stock options granted to
non-employees, deferred stock units, or DSUs, granted to
non-employee members of the Board of Directors and shares issued
under Triads Amended and Restated Management Stock
Purchase Plan, or MSPP.
Effective January 1, 2006, we adopted the fair value
recognition provisions of SFAS 123R using the modified
prospective transition method. Under this method, share-based
compensation expense is recognized beginning January 1,
2006 for all share-based payments granted prior to, but not yet
vested at, January 1, 2006 based on the grant date fair
value estimated in accordance with the original provisions of
SFAS 123, and for
23
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
all share-based payments granted subsequent to January 1,
2006 at the grant date fair value, using estimated forfeitures.
Prior periods have not been restated.
The following table illustrates the impact of adopting
SFAS 123R on the consolidated statements of operations for
the year ended December 31, 2006 (amounts in millions,
except per share information):
|
|
|
|
|
Income from continuing operations
before income tax provision
|
|
$
|
(27.7
|
)
|
Income from continuing operations
|
|
$
|
(18.4
|
)
|
Net income
|
|
$
|
(18.4
|
)
|
Basic income from continuing
operations per share
|
|
$
|
(0.21
|
)
|
Basic net income per share
|
|
$
|
(0.21
|
)
|
Diluted income from continuing
operations per share
|
|
$
|
(0.21
|
)
|
Diluted net income per share
|
|
$
|
(0.21
|
)
|
Prior to adopting SFAS 123R, we presented all benefits of
tax deductions for share-based compensation as operating cash
flows in the consolidated statements of cash flows.
SFAS 123R requires that the tax benefit in excess of
compensation costs be classified as financing cash flows. As a
result of adopting SFAS 123R, we reported a reduction of
cash flows from operating activities and a corresponding
increase to cash flows from financing activities of
$1.7 million in the year ended December 31, 2006.
Our Amended and Restated Long-Term Incentive Plan, or LTIP, has
20,500,000 shares of our common stock reserved for
issuance. The LTIP provides for grants of stock options,
restricted stock and other equity-based awards to our officers,
employees and directors. Awards of stock options granted under
the LTIP are generally at an exercise price equal to the market
value of our common stock at the date of grant, become
exercisable over a four-year period and expire 10 years
from the date of grant. The fair value of stock options granted
under the LTIP is estimated on the date of grant using the
Black-Scholes option pricing model. Expected volatility is based
on the historical volatility of our common stock. The expected
term is based on the historical exercise patterns of our stock
options. Awards of restricted stock granted under the LTIP have
a fair value equal to the market value of our common stock on
the date of grant and generally vest over a four-year period
except for awards of restricted stock granted to non-employee
directors, which generally vest one year from the date of grant.
We recorded $23.2 million in share-based compensation
expense in the year ended December 31, 2006, for awards
granted under the LTIP.
Our Outside Directors Stock and Incentive Compensation Plan, or
Outside Directors Plan, has 750,000 shares of our common
stock reserved for issuance. The Outside Directors Plan provides
for grants of stock options and DSUs to non-employee members of
the Board of Directors. Awards of stock options granted under
the Outside Directors Plan are generally at an exercise price
equal to the market value of our common stock at the date of
grant, become exercisable over a four-year period and expire
10 years from the date of grant. The fair value of stock
options granted under the Outside Directors Plan is estimated on
the grant date using the Black-Scholes option pricing model. The
Outside Directors Plan provides outside directors the option to
elect to receive all or a portion (in 25% increments) of their
annual retainer (excluding the annual stipend for the committee
chairpersons) in DSUs that settle in shares of our common stock
at the earlier of the fifth anniversary of the date of grant or
the end of the directors service on the Board of
Directors, at the directors election. If a director elects
to receive DSUs, the number of DSUs granted in payment of all or
a portion of the annual retainer is calculated based on the
market value of our common stock on the date of grant. We
recorded $0.9 million in share-based compensation expense
in the year ended December 31, 2006 for awards granted
under the Outside Directors Plan.
24
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Our MSPP provides certain members of management an opportunity
to purchase restricted shares of our common stock at a discount
through payroll deductions over six month intervals. The
restricted shares are granted at a 25% discount from the
six-month average market price of the common stock on the date
of grant. The vesting period is three years from the date of
grant, and subject to certain exceptions, an employee forfeits
the value of the discount and any appreciation in the stock if
employment is terminated during the vesting period. The fair
value of shares issued under the MSPP is estimated on the date
of grant using the Black-Scholes option pricing model. We
recorded $0.2 million in share-based compensation expense
in the year ended December 31, 2006, for shares issued
under the MSPP.
We have an Employee Stock Purchase Plan, or ESPP, which provides
an opportunity to purchase shares of our common stock to all
eligible employees at a discount through payroll deductions over
six month intervals. The shares are issued at a 15% discount
from the lower of the market price of our common stock at the
beginning date of the plan period or the market price at the
ending date of the plan period. The fair value of shares issued
under the ESPP is estimated at the beginning of the plan period
using the Black-Scholes option pricing model. We recorded
$3.4 million in share-based compensation expense in the
year ended December 31, 2006, for shares issued under the
ESPP. We issued 392,026 shares under the ESPP during the
year ended December 31, 2006.
The following weighted-average assumptions were used in the
Black-Scholes option pricing model for stock options granted for
all plans during the years ended December 31, 2006, 2005
and 2004.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Risk free interest rate
|
|
|
4.71
|
%
|
|
|
3.54
|
%
|
|
|
2.90
|
%
|
Expected life
|
|
|
5 years
|
|
|
|
5 years
|
|
|
|
5 years
|
|
Expected volatility
|
|
|
20.6
|
%
|
|
|
26.3
|
%
|
|
|
41.5
|
%
|
Expected dividend yield
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table illustrates the effect on income from
continuing operations, net income and earnings per share if we
had applied the fair value recognition provisions of
SFAS 123 to our share-based compensation plans prior to
adoption of SFAS 123R:
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
|
|
2005
|
|
|
2004
|
|
|
Income from continuing operations,
as reported
|
|
$
|
229.4
|
|
|
$
|
132.0
|
|
Add: Share-based compensation
expense recorded
|
|
|
1.3
|
|
|
|
0.7
|
|
Less: Fair value share-based
compensation expense
|
|
|
(21.0
|
)
|
|
|
(21.1
|
)
|
|
|
|
|
|
|
|
|
|
Pro forma
|
|
$
|
209.7
|
|
|
$
|
111.6
|
|
|
|
|
|
|
|
|
|
|
Net income, as reported
|
|
$
|
226.0
|
|
|
$
|
191.0
|
|
Add: Share-based compensation
expense recorded
|
|
|
1.3
|
|
|
|
0.7
|
|
Less: Fair value share-based
compensation expense
|
|
|
(21.0
|
)
|
|
|
(21.1
|
)
|
|
|
|
|
|
|
|
|
|
Pro forma
|
|
$
|
206.3
|
|
|
$
|
170.6
|
|
|
|
|
|
|
|
|
|
|
25
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
|
|
2005
|
|
|
2004
|
|
|
Basic income per
share
|
|
|
|
|
|
|
|
|
Income from continuing operations,
as reported
|
|
$
|
2.80
|
|
|
$
|
1.76
|
|
Add: Share-based compensation
expense recorded
|
|
|
0.02
|
|
|
|
0.01
|
|
Less: Fair value share-based
compensation expense
|
|
|
(0.26
|
)
|
|
|
(0.28
|
)
|
|
|
|
|
|
|
|
|
|
Pro forma
|
|
$
|
2.56
|
|
|
$
|
1.49
|
|
|
|
|
|
|
|
|
|
|
Net income, as reported
|
|
$
|
2.76
|
|
|
$
|
2.54
|
|
Add: Share-based compensation
expense recorded
|
|
|
0.02
|
|
|
|
0.01
|
|
Less: Fair value share-based
compensation expense
|
|
|
(0.26
|
)
|
|
|
(0.28
|
)
|
|
|
|
|
|
|
|
|
|
Pro forma
|
|
$
|
2.52
|
|
|
$
|
2.27
|
|
|
|
|
|
|
|
|
|
|
Diluted income per
share
|
|
|
|
|
|
|
|
|
Income from continuing operations,
as reported
|
|
$
|
2.74
|
|
|
$
|
1.72
|
|
Add: Share-based compensation
expense recorded
|
|
|
0.02
|
|
|
|
0.01
|
|
Less: Fair value share-based
compensation expense
|
|
|
(0.20
|
)
|
|
|
(0.25
|
)
|
|
|
|
|
|
|
|
|
|
Pro forma
|
|
$
|
2.56
|
|
|
$
|
1.48
|
|
|
|
|
|
|
|
|
|
|
Net income, as reported
|
|
$
|
2.70
|
|
|
$
|
2.49
|
|
Add: Share-based compensation
expense recorded
|
|
|
0.02
|
|
|
|
0.01
|
|
Less: Fair value share-based
compensation expense
|
|
|
(0.20
|
)
|
|
|
(0.25
|
)
|
|
|
|
|
|
|
|
|
|
Pro forma
|
|
$
|
2.52
|
|
|
$
|
2.25
|
|
|
|
|
|
|
|
|
|
|
A summary of stock option activity under our share-based
compensation plans at December 31, 2006 is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
Remaining
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Contractual
|
|
|
Aggregate
|
|
|
|
Shares
|
|
|
Exercise Price
|
|
|
Term (In Years)
|
|
|
Intrinsic Value
|
|
|
Outstanding at January 1, 2006
|
|
|
8,001,692
|
|
|
$
|
33.04
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
59,200
|
|
|
$
|
38.35
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(889,708
|
)
|
|
$
|
26.57
|
|
|
|
|
|
|
|
|
|
Cancelled
|
|
|
(265,714
|
)
|
|
$
|
38.23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31,
2006
|
|
|
6,905,470
|
|
|
$
|
33.81
|
|
|
|
7.1
|
|
|
$
|
56,755,240
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at December 31,
2006
|
|
|
4,321,007
|
|
|
$
|
31.28
|
|
|
|
6.3
|
|
|
$
|
45,919,613
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The weighted average grant-date fair value of options granted
during the years ended December 31, 2006, 2005 and 2004 was
$10.95, $13.08 and $14.24 per option, respectively. The total
intrinsic value of options exercised during the years ended
December 31, 2006, 2005 and 2004 was $13.2 million,
$64.9 million and $38.5 million, respectively.
26
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
A summary of our non-vested shares at December 31, 2006 is
presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock
|
|
|
MSPP Shares
|
|
|
DSUs
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Average
|
|
|
|
|
|
Average
|
|
|
|
|
|
Average
|
|
|
|
|
|
|
Grant-Date
|
|
|
|
|
|
Grant-Date
|
|
|
|
|
|
Grant-Date
|
|
|
|
Shares
|
|
|
Fair Value
|
|
|
Shares
|
|
|
Fair Value
|
|
|
Shares
|
|
|
Fair Value
|
|
|
Non-vested at January 1, 2006
|
|
|
120,000
|
|
|
$
|
49.42
|
|
|
|
85,086
|
|
|
$
|
10.68
|
|
|
|
23,488
|
|
|
$
|
33.03
|
|
Granted
|
|
|
686,100
|
|
|
$
|
40.77
|
|
|
|
22,505
|
|
|
$
|
11.67
|
|
|
|
6,199
|
|
|
$
|
41.12
|
|
Vested
|
|
|
(20,000
|
)
|
|
$
|
49.42
|
|
|
|
(28,401
|
)
|
|
$
|
9.01
|
|
|
|
(6,263
|
)
|
|
$
|
28.74
|
|
Cancelled
|
|
|
(24,750
|
)
|
|
$
|
40.85
|
|
|
|
(5,972
|
)
|
|
$
|
10.73
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-vested at December 31,
2006
|
|
|
761,350
|
|
|
$
|
41.90
|
|
|
|
73,218
|
|
|
$
|
11.09
|
|
|
|
23,424
|
|
|
$
|
36.31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The total fair value of shares vested during the years ended
December 31, 2006, 2005 and 2004 was $26.4 million,
$32.3 million and $25.4 million, respectively. On
February 8, 2007, we granted 743,756 shares of
restricted stock to employees with a fair value on the grant
date of $49.61 per share.
At December 31, 2006, there was $43.6 million of total
unrecognized share-based compensation expense related to our
non-vested share-based compensation plans that is expected to be
recognized over a contractual weighted average period of
2.3 years. Any unrecognized share-based compensation
expense will generally be accelerated upon a closing under the
Merger Agreement (see NOTE 1).
Cash received from option exercises under share-based payment
arrangements for the years ended December 31, 2006, 2005
and 2004 was $23.6 million, $87.8 million and
$39.7 million, respectively. The actual tax benefit
realized for the tax deductions of the share-based payment
arrangements for the year ended December 31, 2006, 2005 and
2004 was $5.7 million, $24.2 million and
$14.3 million, respectively.
|
|
NOTE 13
|
RETIREMENT
PLANS
|
We have established an Employee Stock Ownership Plan, or ESOP,
for substantially all of our employees. In 1999, the ESOP
purchased, at fair market value, 3,000,000 shares of our
common stock. The purchase was primarily financed by the ESOP
issuing a promissory note to us, which will be repaid annually
in equal installments over a
10-year
period beginning December 31, 1999. We make contributions
to the ESOP which the ESOP uses to repay the loan. Our stock
acquired by the ESOP is held in a suspense account and will be
allocated to participants at market value from the suspense
account as the loan is repaid.
The loan to the ESOP is recorded in unearned ESOP compensation
in the consolidated balance sheets. Reductions are made to
unearned ESOP compensation as shares are committed to be
released to participants at cost. Recognition of ESOP expense is
based on the average market price of shares committed to be
released to participants. Shares are deemed to be committed to
be released ratably during each period as the employees perform
services. The difference between average market price and cost
of the shares is shown as a change in additional paid-in
capital. As the shares are committed to be released, the shares
become outstanding for earnings per share calculations. We
recognized ESOP expense of $12.5 million,
$14.1 million and $10.3 million for the years ended
December 31, 2006, 2005 and 2004, respectively, and the
unearned ESOP compensation was $6.9 million and
$10.4 million at December 31, 2006 and 2005,
respectively.
27
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The ESOP shares as of December 31, 2006 were as follows:
|
|
|
|
|
Shares released
|
|
|
2,100,000
|
|
Shares committed to be released
|
|
|
300,000
|
|
Unreleased shares
|
|
|
600,000
|
|
|
|
|
|
|
Total ESOP shares
|
|
|
3,000,000
|
|
|
|
|
|
|
Fair value of unreleased shares
|
|
$
|
25.1 million
|
|
We have a defined contribution retirement plan which covers
substantially all employees. Benefits are determined primarily
as a percentage of a participants annual income, less
contributions to the ESOP. These benefits are vested over
specific periods of employee service. We have also instituted a
contributory benefit plan which is available to employees who
meet certain minimum requirements. The plan requires that we
match 50% of a participants contribution up to certain
maximum levels. We recorded expense under these plans of
$47.5 million, $43.7 million and $38.1 million
for the years ended December 31, 2006, 2005 and 2004,
respectively. Contributions to the retirement plan are funded
annually. Our contributions to the contributory benefit plan are
funded periodically during the year.
In September 2006, the Financial Accounting Standards Board
issued Statement of Financial Accounting Standards No. 158
Employers Accounting for Defined Benefit Pension and
Other Postretirement Plans, an amendment of FASB Statements
No. 87, 88, 106, and 132(R), or SFAS 158, which
is effective for fiscal years ending after December 15,
2006. SFAS 158 requires recognition of defined benefit plan
funding status, including gains or losses on plan assets, prior
service costs and transition assets or obligations, and
recognizes changes in the funding status of those plans in the
plan sponsors financial statements. Changes in the funding
status are reported in comprehensive income. Additional footnote
disclosures about certain effects on net periodic benefit costs
for the next fiscal year that arise from delayed recognition of
gains or losses on plan assets, prior service costs and
transition assets or obligations are also required.
SFAS 158 also requires the measurement of plan assets and
obligations as of the date of the plan sponsors fiscal
year end. This provision of SFAS 158 is effective for
fiscal years ending after December 15, 2008. We adopted
SFAS 158 on December 15, 2006, and the adoption did
not have a material impact on our results of operations or
financial position.
We have a defined benefit retirement plan for the unionized
employees at one of our hospitals. A minimum pension liability
is required when the actuarial present value of the projected
benefits exceeds the fair value of plan assets. The change in
the minimum pension liability, net of income tax, is recognized
through other comprehensive income. We have a minimum pension
liability of $2.6 million at December 31, 2006. Net
pension costs for the years ended December 31, 2006, 2005
and 2004 were not significant.
We adopted a Supplemental Executive Retirement Plan, or SERP,
effective September 1, 2005, that provides select senior
management with certain benefits upon retirement, death or
disability. Generally, to be eligible for normal retirement
benefits under the SERP, a participant must complete 12
continuous years of service, attain age 60 and be credited
with at least 3 years of service after plan adoption.
Benefits are determined primarily as a percentage of a
participants average annual compensation during the last
three completed calendar years of employment and are payable in
a lump sum to the participant. Death benefits payable to a
surviving spouse are equal to one-half of the benefit that would
have been paid to the participant. A minimum pension liability
is required when the actuarial present value of the projected
benefits exceeds the fair value of plan assets. Upon a change in
control, benefits fully vest and, if permitted by applicable
regulations, become payable immediately in a lump sum. If not so
permitted, change in control benefits become payable in a lump
sum upon termination of employment and attainment of
age 55. At December 31, 2006 and 2005, we recorded a
28
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
minimum pension liability in other long-term liabilities of
$12.5 million and $7.7 million, respectively. We have
established a rabbi trust, the assets of which are not assets of
the SERP, to fund the payment of benefits under the SERP. At
December 31, 2006, we had funded $3.2 million into the
trust.
At December 31, 2006, as a result of adopting
SFAS 158, we recorded a reduction of other assets of
$6.5 million, an increase of $2.8 million in other
long-term liabilities and a decrease of $5.9 million in
accumulated other comprehensive income, net of income tax
benefit of $3.4 million.
At December 31, 2006, the amounts recorded in other
comprehensive income that have not been recognized as components
of net periodic benefit cost are as follows (in millions):
|
|
|
|
|
Net transition obligation
|
|
$
|
8.3
|
|
Net actuarial loss
|
|
|
1.1
|
|
Prior service cost
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
|
|
9.3
|
|
Less income tax benefit
|
|
|
(3.4
|
)
|
|
|
|
|
|
|
|
$
|
5.9
|
|
|
|
|
|
|
Approximately $0.6 million of the net transition obligation
is expected to be recognized as a component of net periodic
benefit cost in 2007.
|
|
NOTE 14
|
INCOME
PER SHARE
|
Income per common share is based on the weighted average number
of shares outstanding adjusted for the shares issued to our ESOP
and unvested restricted shares issued under our share-based
compensation plans. Diluted weighted average shares outstanding
are calculated by adjusting basic weighted shares outstanding by
all potentially dilutive stock options and unvested restricted
stock. For the years ended December 31, 2006, 2005 and
2004, options outstanding of 35,250, 1,751,250 and 174,250,
respectively, were not included in the computation of diluted
income per share because the exercise prices of the options were
greater than the average market price of the common stock.
Weighted average shares are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Weighted average shares exclusive
of unreleased ESOP shares and unvested restricted shares
|
|
|
86,156,434
|
|
|
|
81,851,961
|
|
|
|
75,046,662
|
|
Average of ESOP shares committed
to be released
|
|
|
150,000
|
|
|
|
150,000
|
|
|
|
150,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic weighted average shares
outstanding
|
|
|
86,306,434
|
|
|
|
82,001,961
|
|
|
|
75,196,662
|
|
Effect of dilutive
securities share-based compensation plans
|
|
|
846,585
|
|
|
|
1,601,398
|
|
|
|
1,401,263
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted average shares
outstanding
|
|
|
87,153,019
|
|
|
|
83,603,359
|
|
|
|
76,597,925
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NOTE 15
|
AGREEMENTS
WITH HCA
|
We have entered into distribution and other related agreements
governing the spin-off from HCA and our subsequent relationship
with HCA. These agreements provide certain indemnifications for
the parties and provide for the allocation of tax and other
assets, liabilities and obligations arising from periods prior
to the spin-off.
29
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
HCA and we have entered into a distribution agreement providing
for certain arrangements among HCA and us subsequent to the date
of the spin-off. The distribution agreement generally provides
that we will be financially responsible for liabilities arising
out of or in connection with our assets and entities. The
distribution agreement provides, however, that HCA will
indemnify us for any losses which it incurs arising from certain
governmental investigations of certain of HCAs business
practices. HCA will not indemnify us for losses relating to any
acts, practices and omissions engaged in by us after the date of
the spin-off, whether or not we are indemnified for similar
acts, practices and omissions occurring prior to the date of the
spin-off.
HCA and we have entered into a tax sharing and indemnification
agreement, which allocates tax liabilities among HCA and us, and
addresses certain other tax matters such as responsibility for
filing tax returns, control of and cooperation in tax litigation
and qualification of the spin-off as a tax-free transaction.
Generally, HCA will be responsible for taxes that are allocable
to periods prior to the spin-off, and HCA and we will each be
responsible for our own tax liabilities (including our allocable
share of taxes shown on any consolidated, combined or other tax
return filed by HCA) for periods after the spin-off. The tax
sharing and indemnification agreement prohibits us from taking
actions that could jeopardize the tax treatment of either the
spin-off or the internal restructuring of HCA that preceded the
spin-off, and requires us to indemnify HCA for any taxes or
other losses that result from any such actions.
False
Claims Act Litigation
As a result of our ongoing discussions with the government prior
to our merger with Quorum on April 27, 2001, Quorum learned
of two qui tam complaints against it alleging violations
of the False Claims Act for claims allegedly submitted to the
government involving two managed hospitals. Quorum accrued the
estimated liability on these items prior to the merger and the
matter remains under seal. The government has requested that
Quorum conduct a self audit with respect to one Medicare cost
report for one managed hospital and three other specific issues.
The government has stated that it intends to investigate certain
other allegations.
On September 9, 2003, we were served with a qui tam
complaint alleging, among other things, the submission of false
claims for reimbursement and improper allocation of costs at a
hospital in Mississippi managed by QHR, which is named as an
additional defendant. The Federal government has apparently
elected not to intervene in the case and the complaint was
unsealed. We are vigorously defending this matter and have filed
a motion to dismiss, which is pending before the court. While we
currently believe that we have no liability for any of the
claims alleged in the complaint, discovery has not been
completed and at this time, we cannot predict the final effect
or outcome of the complaint.
On May 18, 2004, we were served with a qui tam
complaint alleging, among other things, the submission of false
claims for reimbursement at two hospitals in Georgia formerly
managed by QHR. This case was dismissed on October 27,
2005. The plaintiff has appealed the dismissal, and we intend to
vigorously contest the appeal.
On April 26, 2005, we received a copy of a qui tam
complaint alleging, among other things, the submission of false
claims for reimbursement at a hospital in Pennsylvania managed
by QHR. The Federal government elected not to intervene in this
case and the complaint was recently unsealed. While we intend to
vigorously defend this matter, we are not yet able to form a
view as to the probable liability for any of the claims alleged
in the complaint.
Our merger agreement with Quorum will not provide us
indemnification in respect of the qui tam complaints and
investigations described above. If we incur material liabilities
as a result of qui tam litigation
30
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
or governmental investigations, these matters could have a
material adverse effect on our business, financial condition,
results of operations or prospects.
At this time we cannot predict the final effect or outcome of
the ongoing investigations or qui tam actions. If
violations of Federal or state laws relating to Medicare,
Medicaid or other government programs are found, then we may be
required to pay substantial fines and civil and criminal damages
and also may be excluded from participation in the Medicare and
Medicaid programs and other government programs. Similarly, the
amount of damages sought in the qui tam actions or in the
future may be substantial. We could be subject to substantial
costs resulting from defending, or from an adverse outcome in,
any current or future investigations, administrative proceedings
or litigation. In an effort to resolve one or more of these
matters, we may choose to negotiate a settlement. Amounts paid
to settle any of these matters may be material. Agreements
entered into as a part of any settlement could also materially
adversely affect us. Any current or future investigations or
actions could have a material adverse effect on our results of
operations or financial position.
From time to time, we may be the subject of additional
investigations or a party to additional litigation, including
qui tam, actions alleging violations of law. We may not
know about those investigations or about qui tam actions
filed against us unless and to the extent such are unsealed. If
any of those matters were successfully asserted against us,
there could be a material adverse effect on our business,
financial position, results of operations or prospects.
Income
Taxes
The Internal Revenue Service, or IRS, has concluded an
examination of the Federal income tax returns for our short
taxable years ended April 27, 2001, June 30, 2001 and
December 31, 2001, and the taxable years ended
December 31, 2002 and 2003. On May 10, 2006, the IRS
issued an examination report, known as a
30-Day
Letter, with proposed adjustments disallowing deductions for
portions of the payments made to the Federal government in
settlement of three qui tam cases that had been brought
against Quorum. The total proposed adjustments with respect to
the settlement payment deductions, if sustained, would increase
taxable income in the amount of approximately $67.3 million
and result in our payment of additional cash taxes of
approximately $24.9 million. Any cash taxes paid resulting
from the proposed adjustments in excess of the tax reserve
previously established would increase goodwill from the
acquisition of Quorum.
We believe our reporting of the deductions with respect to the
settlement of the three qui tam cases was appropriate.
Accordingly, on June 9, 2006, we filed a protest to the
30-Day
Letter to contest the proposed adjustments and the matter has
since been referred to the IRS Appeals Office. In the opinion of
management, even if the IRS proposed adjustments were sustained,
the adjustments would not have a material effect on our results
of operations or financial position.
In the opinion of management, the settlements did not have a
material impact on our results of operations or financial
position.
General
Liability Claims
QHR, The Intensive Resource Group, or IRG, a subsidiary of QHR,
and we are defendants against claims for breach of an employment
contract filed in a lawsuit involving a former employee of
Cambio Health Solutions, a former subsidiary of IRG. QHR, IRG
and we have been vigorously defending the claim. On May 13,
2004, a jury returned a verdict against QHR, IRG and us, and on
June 8, 2004, the court entered a
31
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
judgment on such verdict in the aggregate amount of
approximately $5.9 million. QHR, IRG and we have appealed
such judgment. We have reserved $5.9 million in respect of
this judgment.
Between February 5, 2007 and February 8, 2007, four
putative class action petitions were filed on behalf of alleged
public stockholders of the Company in the District Court of
Collin County, Texas, naming, among others, the Company and
members of the Companys Board of Directors. The petitions
allege, among other things, that the directors of the Company
breached their fiduciary duties in connection with the proposed
Merger by failing to maximize stockholder value. Among other
things, the petitions seek to enjoin the Company and the
directors from consummating the Merger. The Company believes
that the claims asserted in these actions are without merit and
intends to defend these suits vigorously.
We are subject to claims and suits arising in the ordinary
course of business, including claims for personal injuries or
wrongful restriction of, or interference with, physicians
staff privileges. In certain of these actions the claimants may
seek punitive damages against us, which are usually not covered
by insurance. It is managements opinion that the ultimate
resolution of these pending claims and legal proceedings will
not have a material adverse effect on our results of operations
or financial position.
|
|
NOTE 17
|
SEGMENT
INFORMATION
|
Through our affiliates, we operate hospitals and related
healthcare entities. For the years ended December 31, 2006,
2005 and 2004, approximately 29.5%, 31.2%, and 30.6%,
respectively, of our revenues related to patients participating
in the Medicare program.
We have structured our operations into two segments. The owned
operations segment includes our acute care hospitals and related
healthcare entities. The management services segment provides
executive management services to independent acute care
hospitals.
The distribution of our revenues, Adjusted EBITDA (which is used
by management for operating performance review, see (a)) and
assets is summarized in the following tables (dollars in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
Owned operations
|
|
$
|
5,424.2
|
|
|
$
|
4,632.7
|
|
|
$
|
4,106.7
|
|
Management services
|
|
|
112.8
|
|
|
|
114.0
|
|
|
|
111.3
|
|
Corporate and other
|
|
|
0.9
|
|
|
|
0.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
5,537.9
|
|
|
$
|
4,747.3
|
|
|
$
|
4,218.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Adjusted EBITDA(a)
|
|
|
|
|
|
|
|
|
|
|
|
|
Owned operations
|
|
$
|
781.8
|
|
|
$
|
773.8
|
|
|
$
|
650.0
|
|
Management services
|
|
|
19.0
|
|
|
|
21.6
|
|
|
|
10.9
|
|
Corporate and other
|
|
|
(106.8
|
)
|
|
|
(83.0
|
)
|
|
|
(69.7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
694.0
|
|
|
$
|
712.4
|
|
|
$
|
591.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
Owned operations
|
|
$
|
5,693.4
|
|
|
$
|
5,118.6
|
|
Management services
|
|
|
123.1
|
|
|
|
124.5
|
|
Corporate and other
|
|
|
417.3
|
|
|
|
493.8
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
6,233.8
|
|
|
$
|
5,736.9
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA for owned operations includes equity in earnings
of unconsolidated affiliates of $43.5 million,
$35.0 million and $20.5 million for the years ended
December 31, 2006, 2005 and 2004, respectively.
A reconciliation of Adjusted EBITDA to income from continuing
operations before income taxes follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
Total Adjusted EBITDA for
reportable segments
|
|
$
|
694.0
|
|
|
$
|
712.4
|
|
|
$
|
591.2
|
|
Depreciation
|
|
|
223.2
|
|
|
|
199.6
|
|
|
|
172.3
|
|
Amortization
|
|
|
6.6
|
|
|
|
6.3
|
|
|
|
6.3
|
|
Interest expense
|
|
|
115.3
|
|
|
|
110.6
|
|
|
|
113.7
|
|
Interest income
|
|
|
(20.0
|
)
|
|
|
(9.0
|
)
|
|
|
(2.6
|
)
|
Refinancing transaction costs
|
|
|
|
|
|
|
8.4
|
|
|
|
76.0
|
|
ESOP expense
|
|
|
12.5
|
|
|
|
14.1
|
|
|
|
10.3
|
|
Gain on sales of assets
|
|
|
(6.0
|
)
|
|
|
(0.4
|
)
|
|
|
|
|
Minority interests in earnings of
consolidated entities
|
|
|
22.0
|
|
|
|
11.5
|
|
|
|
1.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes
|
|
$
|
340.4
|
|
|
$
|
371.3
|
|
|
$
|
213.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
|
Adjusted EBITDA is defined as earnings before depreciation,
amortization, interest expense, interest income, refinancing
transaction costs, ESOP expense, gain on sales of assets,
minority interests in earnings of consolidated entities, income
tax provision and discontinued operations. Adjusted EBITDA is
commonly used by lenders and investors to assess leverage
capacity, debt service ability and liquidity. Many of our debt
covenants use Adjusted EBITDA, or a modification of Adjusted
EBITDA, in financial covenant calculations. Adjusted EBITDA is
used by management to evaluate financial performance and
resource allocation for each facility and for us as a whole.
Adjusted EBITDA should not be considered as a measure of
financial performance under generally accepted accounting
principles, and the items excluded from Adjusted EBITDA are
significant components in understanding and assessing financial
performance. Adjusted EBITDA should not be considered in
isolation or as an alternative to net income, cash flows
generated by operating, investing or financing activities or
financial statement data presented in the consolidated financial
statements as an indicator of financial performance or
liquidity. Because Adjusted EBITDA is not a measurement
determined in accordance with generally accepted accounting
principles and is thus susceptible to varying calculations,
Adjusted EBITDA as presented may not be comparable to other
similarly titled measures of other companies. |
33
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 18
|
COMPONENTS
OF ACCUMULATED OTHER COMPREHENSIVE LOSS
|
The components of accumulated other comprehensive loss, net of
tax, as of December 31 are as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
Foreign currency translation
adjustment
|
|
$
|
0.1
|
|
|
$
|
|
|
Unrecognized net periodic benefit
costs on adjustment for the SERP
|
|
|
7.5
|
|
|
|
1.6
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
7.6
|
|
|
$
|
1.6
|
|
|
|
|
|
|
|
|
|
|
|
|
NOTE 19
|
OTHER
CURRENT LIABILITIES AND ALLOWANCES FOR DOUBTFUL
ACCOUNTS
|
A summary of other current liabilities as of December 31 follows
(in millions):
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
Due to HCA
|
|
$
|
1.4
|
|
|
$
|
0.9
|
|
Employee retirement plan
|
|
|
32.0
|
|
|
|
27.8
|
|
Taxes, other than income
|
|
|
34.2
|
|
|
|
29.1
|
|
Accrued interest
|
|
|
10.9
|
|
|
|
10.7
|
|
Self-insured employee benefit
programs
|
|
|
39.5
|
|
|
|
42.1
|
|
Current portion of professional
liability risk
|
|
|
37.0
|
|
|
|
21.2
|
|
Deferred income
|
|
|
4.1
|
|
|
|
3.6
|
|
Litigation settlement
|
|
|
5.9
|
|
|
|
5.9
|
|
Physician income guarantees
|
|
|
14.8
|
|
|
|
|
|
Other
|
|
|
23.6
|
|
|
|
21.8
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
203.4
|
|
|
$
|
163.1
|
|
|
|
|
|
|
|
|
|
|
A summary of activity in our allowances for doubtful accounts
follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additions/
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Recoveries)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charged to
|
|
|
Accounts
|
|
|
|
|
|
|
|
|
|
Balances at
|
|
|
Additions
|
|
|
Expense for
|
|
|
Written off,
|
|
|
|
|
|
Balances at
|
|
|
|
Beginning of
|
|
|
Charged
|
|
|
Discontinued
|
|
|
Net of
|
|
|
|
|
|
End of
|
|
|
|
Period
|
|
|
to Expense
|
|
|
Operations
|
|
|
Recoveries
|
|
|
Acquisitions
|
|
|
Period
|
|
|
Allowances for doubtful accounts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, 2004
|
|
$
|
247.2
|
|
|
$
|
427.2
|
|
|
$
|
43.4
|
|
|
$
|
(408.4
|
)
|
|
$
|
1.9
|
|
|
$
|
311.3
|
|
Year ended December 31, 2005
|
|
$
|
311.3
|
|
|
$
|
403.3
|
|
|
$
|
27.3
|
|
|
$
|
(486.9
|
)
|
|
$
|
37.8
|
|
|
$
|
292.8
|
|
Year ended December 31, 2006
|
|
$
|
292.8
|
|
|
$
|
576.9
|
|
|
$
|
(0.5
|
)
|
|
$
|
(467.2
|
)
|
|
$
|
14.3
|
|
|
$
|
416.3
|
|
We retained certain working capital items, including accounts
receivable, on certain facilities included in discontinued
operations.
34
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following tables show the line items in the consolidated
statements of operations that are considered costs of sales (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31,
|
|
|
|
2006
|
|
|
|
|
|
|
General and
|
|
|
|
|
|
|
|
|
|
Administrative
|
|
|
|
|
|
|
Total Expenses
|
|
|
Expenses
|
|
|
Costs of Sales
|
|
|
Salaries and benefits
|
|
$
|
2,233.1
|
|
|
$
|
66.1
|
|
|
$
|
2,167.0
|
|
Reimbursable expenses
|
|
|
49.7
|
|
|
|
|
|
|
|
49.7
|
|
Supplies
|
|
|
957.9
|
|
|
|
0.4
|
|
|
|
957.5
|
|
Other operating expenses
|
|
|
1,069.8
|
|
|
|
40.3
|
|
|
|
1,029.5
|
|
Provision for doubtful accounts
|
|
|
576.9
|
|
|
|
|
|
|
|
576.9
|
|
Depreciation
|
|
|
223.2
|
|
|
|
3.3
|
|
|
|
219.9
|
|
Amortization
|
|
|
6.6
|
|
|
|
|
|
|
|
6.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
5,117.2
|
|
|
$
|
110.1
|
|
|
$
|
5,007.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2005
|
|
|
|
|
|
|
General and
|
|
|
|
|
|
|
|
|
|
Administrative
|
|
|
|
|
|
|
Total Expenses
|
|
|
Expenses
|
|
|
Costs of Sales
|
|
|
Salaries and benefits
|
|
$
|
1,940.2
|
|
|
$
|
44.4
|
|
|
$
|
1,895.8
|
|
Reimbursable expenses
|
|
|
51.1
|
|
|
|
|
|
|
|
51.1
|
|
Supplies
|
|
|
801.3
|
|
|
|
0.5
|
|
|
|
800.8
|
|
Other operating expenses
|
|
|
874.0
|
|
|
|
38.5
|
|
|
|
835.5
|
|
Provision for doubtful accounts
|
|
|
403.3
|
|
|
|
|
|
|
|
403.3
|
|
Depreciation
|
|
|
199.6
|
|
|
|
2.7
|
|
|
|
196.9
|
|
Amortization
|
|
|
6.3
|
|
|
|
|
|
|
|
6.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
4,275.8
|
|
|
$
|
86.1
|
|
|
$
|
4,189.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2004
|
|
|
|
|
|
|
General and
|
|
|
|
|
|
|
|
|
|
Administrative
|
|
|
|
|
|
|
Total Expenses
|
|
|
Expenses
|
|
|
Costs of Sales
|
|
|
Salaries and benefits
|
|
$
|
1,695.4
|
|
|
$
|
40.3
|
|
|
$
|
1,655.1
|
|
Reimbursable expenses
|
|
|
51.1
|
|
|
|
|
|
|
|
51.1
|
|
Supplies
|
|
|
692.4
|
|
|
|
0.4
|
|
|
|
692.0
|
|
Other operating expenses
|
|
|
781.2
|
|
|
|
29.7
|
|
|
|
751.5
|
|
Provision for doubtful accounts
|
|
|
427.2
|
|
|
|
|
|
|
|
427.2
|
|
Depreciation
|
|
|
172.3
|
|
|
|
2.5
|
|
|
|
169.8
|
|
Amortization
|
|
|
6.3
|
|
|
|
|
|
|
|
6.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
3,825.9
|
|
|
$
|
72.9
|
|
|
$
|
3,753.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35
Unless the context requires otherwise, references in these
consolidated financial statements and accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
NOTE 21
|
UNAUDITED
QUARTERLY FINANCIAL INFORMATION
|
The quarterly interim financial information shown below has been
prepared by our management and is unaudited. It should be read
in conjunction with the audited consolidated financial
statements appearing herein (dollars in millions, except per
share amounts).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
|
First
|
|
|
Second
|
|
|
Third
|
|
|
Fourth
|
|
|
Revenues
|
|
$
|
1,369.2
|
|
|
$
|
1,378.1
|
|
|
$
|
1,373.1
|
|
|
$
|
1,417.5
|
|
Income from continuing operations
|
|
$
|
67.9
|
|
|
$
|
60.0
|
(b)
|
|
$
|
40.7
|
(c)
|
|
$
|
39.3
|
(d)
|
Net income
|
|
$
|
83.1
|
(a)
|
|
$
|
60.1
|
(b)
|
|
$
|
39.8
|
(c)
|
|
$
|
39.3
|
(d)
|
Basic income from continuing
operations per share
|
|
$
|
0.79
|
|
|
$
|
0.70
|
(b)
|
|
$
|
0.47
|
(c)
|
|
$
|
0.45
|
(d)
|
Basic net income per share
|
|
$
|
0.97
|
(a)
|
|
$
|
0.70
|
(b)
|
|
$
|
0.46
|
(c)
|
|
$
|
0.45
|
(d)
|
Diluted income from continuing
operations per share
|
|
$
|
0.79
|
|
|
$
|
0.69
|
(b)
|
|
$
|
0.47
|
(c)
|
|
$
|
0.45
|
(d)
|
Diluted net income per share
|
|
$
|
0.96
|
(a)
|
|
$
|
0.69
|
(b)
|
|
$
|
0.46
|
(c)
|
|
$
|
0.45
|
(d)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005
|
|
|
|
First
|
|
|
Second
|
|
|
Third
|
|
|
Fourth
|
|
|
Revenues
|
|
$
|
1,153.1
|
|
|
$
|
1,167.3
|
|
|
$
|
1,160.9
|
|
|
$
|
1,266.0
|
|
Income from continuing operations
|
|
$
|
63.9
|
|
|
$
|
51.2
|
(e)
|
|
$
|
55.3
|
|
|
$
|
59.0
|
|
Net income
|
|
$
|
66.2
|
|
|
$
|
58.9
|
(e)
|
|
$
|
46.3
|
(f)
|
|
$
|
54.6
|
(g)
|
Basic income from continuing
operations per share
|
|
$
|
0.82
|
|
|
$
|
0.64
|
(e)
|
|
$
|
0.65
|
|
|
$
|
0.69
|
|
Basic net income per share
|
|
$
|
0.85
|
|
|
$
|
0.74
|
(e)
|
|
$
|
0.54
|
(f)
|
|
$
|
0.64
|
(g)
|
Diluted income from continuing
operations per share
|
|
$
|
0.80
|
|
|
$
|
0.62
|
(e)
|
|
$
|
0.64
|
|
|
$
|
0.68
|
|
Diluted net income per share
|
|
$
|
0.83
|
|
|
$
|
0.72
|
(e)
|
|
$
|
0.53
|
(f)
|
|
$
|
0.63
|
(g)
|
|
|
|
(a) |
|
During the first quarter of 2006, we recorded a pre-tax gain on
a sale of assets of $25.8 million. |
|
(b) |
|
During the second quarter of 2006, we recorded a
$10.3 million pre-tax change in estimate to increase our
estimated liabilities for general and professional insurance. |
|
(c) |
|
During the third quarter of 2006, we recorded a pre-tax change
in estimate of $15.0 million to increase our allowance for
doubtful accounts. |
|
(d) |
|
During the fourth quarter of 2006, we recorded a pre-tax change
in estimate of $29.4 million to increase our allowance for
doubtful accounts and a $25.1 million pre-tax change in
estimate to reduce our estimated general and professional
liabilities. |
|
(e) |
|
During the second quarter of 2005, we recorded an
$8.4 million pre-tax charge related to refinancing
transaction costs. |
|
(f) |
|
During the third quarter of 2005, we recorded a
$7.5 million pre-tax charge in discontinued operations
related to impairment of certain long-lived assets. |
|
(g) |
|
During the fourth quarter of 2005, we recorded a
$1.7 million pre-tax loss related to the sale of one
hospital. |
NOTE
22 SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION
On July 25, 2007, the Company was acquired by Community Health Systems, Inc. (CHS). In
connection with this transaction, a wholly owned subsidiary of CHS issued 8.875% Senior Notes
maturing in 2015 the (Notes). Along with other subsidiaries of CHS, Triad and certain of its direct and
indirect 100% owned subsidiaries have fully and unconditionally guaranteed those Notes. These guarantees are
also joint and several. The
following condensed consolidating financial statements present the subsidiary guarantors,
subsidiary non-guarantors, eliminations and consolidated Triad as defined in the terms of the
Notes.
36
22.
Supplemental Condensed Consolidating Financial Information
(Continued)
TRIAD HOSPITALS, INC.
CONDENSED CONSOLIDATING BALANCE SHEET
(Amounts in millions)
December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non- |
|
|
|
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Guarantor |
|
|
|
|
|
|
|
|
|
Subsidiaries |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
4.8 |
|
|
|
203.8 |
|
|
|
|
|
|
$ |
208.6 |
|
Accounts
receivable, less allowance for doubtful accounts |
|
|
521.2 |
|
|
|
396.7 |
|
|
|
|
|
|
|
917.9 |
|
Inventories |
|
|
79.5 |
|
|
|
69.9 |
|
|
|
|
|
|
|
149.4 |
|
Deferred income taxes |
|
|
38.4 |
|
|
|
|
|
|
|
|
|
|
|
38.4 |
|
Prepaid expenses |
|
|
14.7 |
|
|
|
37.4 |
|
|
|
|
|
|
|
52.1 |
|
Other |
|
|
72.7 |
|
|
|
57.4 |
|
|
|
(2.1 |
) |
|
|
128.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
731.3 |
|
|
|
765.2 |
|
|
|
(2.1 |
) |
|
|
1,494.4 |
|
Property and
equipment, at cost |
|
|
2,249.0 |
|
|
|
1,918.9 |
|
|
|
|
|
|
|
4,167.9 |
|
Accumulated depreciation |
|
|
(747.5 |
) |
|
|
(480.2 |
) |
|
|
|
|
|
|
(1,227.7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,501.5 |
|
|
|
1,438.7 |
|
|
|
|
|
|
|
2,940.2 |
|
Investments in subsidiaries |
|
|
2,846.3 |
|
|
|
|
|
|
|
(2,846.3 |
) |
|
|
|
|
Goodwill |
|
|
1,101.1 |
|
|
|
258.6 |
|
|
|
|
|
|
|
1,359.7 |
|
Intangible
assets, net of accumulated amortization |
|
|
58.3 |
|
|
|
22.8 |
|
|
|
|
|
|
|
81.1 |
|
Due from affiliates |
|
|
|
|
|
|
586.9 |
|
|
|
(586.9 |
) |
|
|
|
|
Investment
in and advances to unconsolidated affiliates |
|
|
239.3 |
|
|
|
3.6 |
|
|
|
|
|
|
|
242.9 |
|
Other |
|
|
107.5 |
|
|
|
272.2 |
|
|
|
(264.2 |
) |
|
|
115.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
6,585.3 |
|
|
$ |
3,348.0 |
|
|
$ |
(3,699.5 |
) |
|
$ |
6,233.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable |
|
|
110.9 |
|
|
|
138.9 |
|
|
|
|
|
|
|
249.8 |
|
Accrued salaries |
|
|
62.6 |
|
|
|
64.4 |
|
|
|
|
|
|
|
127.0 |
|
Current portion of long term debt |
|
|
19.8 |
|
|
|
3.6 |
|
|
|
(2.1 |
) |
|
|
21.3 |
|
Current income taxes payable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other current liabilities |
|
|
83.5 |
|
|
|
119.9 |
|
|
|
|
|
|
|
203.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
276.8 |
|
|
|
326.8 |
|
|
|
(2.1 |
) |
|
|
601.5 |
|
Due to affiliates |
|
|
586.9 |
|
|
|
|
|
|
|
(586.9 |
) |
|
|
|
|
Long-term debt |
|
|
1,930.6 |
|
|
|
17.7 |
|
|
|
(264.2 |
) |
|
|
1,684.1 |
|
Other liabilities |
|
|
30.3 |
|
|
|
157.2 |
|
|
|
|
|
|
|
187.5 |
|
Deferred
income taxes |
|
|
193.5 |
|
|
|
|
|
|
|
|
|
|
|
193.5 |
|
Minority interests in equity of consolidated
entities |
|
|
340.8 |
|
|
|
|
|
|
|
|
|
|
|
340.8 |
|
Stockholders equity |
|
|
3,226.4 |
|
|
|
2,846.3 |
|
|
|
(2,846.3 |
) |
|
|
3,226.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
liabilities and stockholders equity |
|
$ |
6,585.3 |
|
|
$ |
3,348.0 |
|
|
$ |
(3,699.5 |
) |
|
$ |
6,233.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
37
22.
Supplemental Condensed Consolidating Financial Information
(Continued)
TRIAD HOSPITALS, INC.
CONDENSED CONSOLIDATING STATEMENT OF INCOME
(Amounts in millions)
For the year ended December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Guarantor |
|
|
|
|
|
|
|
|
|
Subsidiaries |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Revenues |
|
$ |
2,983.5 |
|
|
$ |
2,554.4 |
|
|
$ |
|
|
|
$ |
5,537.9 |
|
Salaries and
benefits, including share-based compensation expense |
|
|
1,060.8 |
|
|
|
1,172.3 |
|
|
|
|
|
|
|
2,233.1 |
|
Reimbursable
expenses |
|
|
49.7 |
|
|
|
|
|
|
|
|
|
|
|
49.7 |
|
Supplies |
|
|
487.6 |
|
|
|
470.3 |
|
|
|
|
|
|
|
957.9 |
|
Other operating expenses |
|
|
492.5 |
|
|
|
577.3 |
|
|
|
|
|
|
|
1,069.8 |
|
Provision for doubtful accounts |
|
|
345.0 |
|
|
|
231.9 |
|
|
|
|
|
|
|
576.9 |
|
Depreciation |
|
|
122.3 |
|
|
|
100.9 |
|
|
|
|
|
|
|
223.2 |
|
Amortization |
|
|
5.8 |
|
|
|
0.8 |
|
|
|
|
|
|
|
6.6 |
|
Interest expense allocated |
|
|
(20.7 |
) |
|
|
20.7 |
|
|
|
|
|
|
|
|
|
Interest
expense, net of capitalized interest |
|
|
118.5 |
|
|
|
(3.2 |
) |
|
|
|
|
|
|
115.3 |
|
Interest income |
|
|
(3.7 |
) |
|
|
(16.3 |
) |
|
|
|
|
|
|
(20.0 |
) |
ESOP expense |
|
|
12.5 |
|
|
|
|
|
|
|
|
|
|
|
12.5 |
|
Management fees |
|
|
88.3 |
|
|
|
(88.3 |
) |
|
|
|
|
|
|
|
|
Gain on sale of assets |
|
|
(0.9 |
) |
|
|
(5.1 |
) |
|
|
|
|
|
|
(6.0 |
) |
Impairment of long lived assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
2,757.7 |
|
|
$ |
2,461.3 |
|
|
$ |
|
|
|
$ |
5,219.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before minority interests, equity in
earnings and income tax provision
|
|
$ |
225.8 |
|
|
$ |
93.1 |
|
|
$ |
|
|
|
$ |
318.9 |
|
Minority
interests in earnings of consolidated entities |
|
|
(22.0 |
) |
|
|
|
|
|
|
|
|
|
|
(22.0 |
) |
Equity in
earnings of unconsolidated affiliates |
|
|
151.0 |
|
|
|
0.6 |
|
|
|
(108.1 |
) |
|
|
43.5 |
|
Income from continuing operations
before income tax provision |
|
|
354.8 |
|
|
|
93.7 |
|
|
|
(108.1 |
) |
|
|
340.4 |
|
Income tax provision |
|
|
(132.5 |
) |
|
|
|
|
|
|
|
|
|
|
(132.5 |
) |
Income from continuing operations |
|
|
222.3 |
|
|
|
93.7 |
|
|
|
(108.1 |
) |
|
|
207.9 |
|
Income from discontinued
operations, net of tax |
|
|
|
|
|
|
14.4 |
|
|
|
|
|
|
|
14.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
222.3 |
|
|
$ |
108.1 |
|
|
$ |
(108.1 |
) |
|
$ |
222.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38
22.
Supplemental Condensed Consolidating Financial Information
(Continued)
TRIAD HOSPITALS, INC.
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOW
(Amounts in millions)
For the year ended December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Guarantor |
|
|
|
|
|
|
|
|
|
Subsidiaries |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Cash flows
from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
222.3 |
|
|
$ |
108.1 |
|
|
$ |
(108.1 |
) |
|
$ |
222.3 |
|
Adjustments to reconcile net income to net cash
provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income for discontinued operations, net
of tax |
|
|
|
|
|
|
(14.4 |
) |
|
|
|
|
|
|
(14.4 |
) |
Provision for doubtful accounts |
|
|
345.0 |
|
|
|
231.9 |
|
|
|
|
|
|
|
576.9 |
|
Depreciation and amortization |
|
|
128.1 |
|
|
|
101.7 |
|
|
|
|
|
|
|
229.8 |
|
ESOP expense |
|
|
12.5 |
|
|
|
|
|
|
|
|
|
|
|
12.5 |
|
Minority interests |
|
|
22.0 |
|
|
|
|
|
|
|
|
|
|
|
22.0 |
|
Equity in
earnings of unconsolidated affiliates |
|
|
(151.0 |
) |
|
|
(0.6 |
) |
|
|
108.1 |
|
|
|
(43.5 |
) |
Gain on sale of assets |
|
|
(0.9 |
) |
|
|
(5.1 |
) |
|
|
|
|
|
|
(6.0 |
) |
Deferred income taxes benefit |
|
|
(5.7 |
) |
|
|
|
|
|
|
|
|
|
|
(5.7 |
) |
Non-cash interest expense |
|
|
3.4 |
|
|
|
|
|
|
|
|
|
|
|
3.4 |
|
Non-cash
share based compensation |
|
|
27.7 |
|
|
|
|
|
|
|
|
|
|
|
27.7 |
|
Excess tax benefits on share-based compensation |
|
|
(1.7 |
) |
|
|
|
|
|
|
|
|
|
|
(1.7 |
) |
Increase (decrease) in cash from operating
assets and liabilities (net of acquisitions) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
(385.4 |
) |
|
|
(279.0 |
) |
|
|
|
|
|
|
(664.4 |
) |
Inventories and other assets |
|
|
(12.9 |
) |
|
|
(78.9 |
) |
|
|
|
|
|
|
(91.8 |
) |
Accounts payable and other current liabilities |
|
|
(0.4 |
) |
|
|
5.4 |
|
|
|
|
|
|
|
5.0 |
|
Other |
|
|
(1.3 |
) |
|
|
32.6 |
|
|
|
|
|
|
|
31.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
201.7 |
|
|
|
101.7 |
|
|
|
|
|
|
|
303.4 |
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of property and equipment |
|
|
(144.2 |
) |
|
|
(317.6 |
) |
|
|
|
|
|
|
(461.8 |
) |
Distributions
and advances from unconsolidated affiliates |
|
|
|
|
|
|
1.8 |
|
|
|
|
|
|
|
1.8 |
|
Investment in and advances to consolidated affiliates |
|
|
(325.2 |
) |
|
|
325.2 |
|
|
|
|
|
|
|
|
|
Proceeds
received on disposal of assets |
|
|
5.9 |
|
|
|
111.2 |
|
|
|
|
|
|
|
117.1 |
|
Acquisitions, net of cash acquired |
|
|
(6.1 |
) |
|
|
(118.6 |
) |
|
|
|
|
|
|
(124.7 |
) |
Other |
|
|
(13.8 |
) |
|
|
13.5 |
|
|
|
|
|
|
|
(0.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) investing
activities |
|
|
(483.4 |
) |
|
|
15.5 |
|
|
|
|
|
|
|
(467.9 |
) |
Cash flows from financing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments of long-term debt |
|
|
82.9 |
|
|
|
(90.5 |
) |
|
|
|
|
|
|
(7.6 |
) |
Proceeds from issuance of common stock |
|
|
37.6 |
|
|
|
|
|
|
|
|
|
|
|
37.6 |
|
Excess tax benefits on share-based compensation |
|
|
1.7 |
|
|
|
|
|
|
|
|
|
|
|
1.7 |
|
Contributions
from minority partners, net of distributions |
|
|
|
|
|
|
31.2 |
|
|
|
|
|
|
|
31.2 |
|
Increase (decrease) in due to (from) affiliate |
|
|
157.9 |
|
|
|
(157.9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing
activities |
|
|
280.1 |
|
|
|
(217.2 |
) |
|
|
|
|
|
|
62.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents |
|
|
(1.6 |
) |
|
|
(100.0 |
) |
|
|
|
|
|
|
(101.6 |
) |
Cash and cash equivalents at beginning of period |
|
|
6.4 |
|
|
|
303.8 |
|
|
|
|
|
|
|
310.2 |
|
Cash and cash equivalents at end of period |
|
$ |
4.8 |
|
|
$ |
203.8 |
|
|
$ |
|
|
|
$ |
208.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
39
EX-99.4 CONSOLIDATED FINANCIAL STATEMENTS
Exhibit 99.4
Unless the context requires otherwise, references in these
consolidated financial statements and
accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
TRIAD HOSPITALS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
For the periods ended June 30, 2007 and 2006
Unaudited
(Dollars in millions, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three |
|
|
For the six |
|
|
|
months ended |
|
|
months ended |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Revenues |
|
$ |
1,485.1 |
|
|
$ |
1,378.1 |
|
|
$ |
2,975.9 |
|
|
$ |
2,747.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits, including share-based compensation
expense of $7.9 and $6.9 for the three months ended and
$16.0 and $13.7 for the six months ended June 30, 2007 and
2006, respectively |
|
|
615.6 |
|
|
|
553.9 |
|
|
|
1,230.6 |
|
|
|
1,111.4 |
|
Reimbursable expenses |
|
|
11.9 |
|
|
|
12.3 |
|
|
|
24.6 |
|
|
|
26.0 |
|
Supplies |
|
|
251.5 |
|
|
|
234.5 |
|
|
|
505.7 |
|
|
|
471.7 |
|
Other operating expenses |
|
|
306.0 |
|
|
|
272.3 |
|
|
|
610.3 |
|
|
|
525.4 |
|
Provision for doubtful accounts |
|
|
155.4 |
|
|
|
128.2 |
|
|
|
303.5 |
|
|
|
248.9 |
|
Depreciation |
|
|
60.2 |
|
|
|
55.5 |
|
|
|
119.4 |
|
|
|
108.8 |
|
Amortization |
|
|
1.9 |
|
|
|
2.1 |
|
|
|
3.9 |
|
|
|
3.6 |
|
Interest expense |
|
|
26.5 |
|
|
|
28.9 |
|
|
|
53.9 |
|
|
|
57.6 |
|
Interest income |
|
|
(2.7 |
) |
|
|
(5.2 |
) |
|
|
(5.7 |
) |
|
|
(10.2 |
) |
ESOP expense |
|
|
4.0 |
|
|
|
3.1 |
|
|
|
7.5 |
|
|
|
6.1 |
|
(Gain) loss on sales of assets |
|
|
(0.1 |
) |
|
|
(0.5 |
) |
|
|
0.4 |
|
|
|
(0.6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses |
|
|
1,430.2 |
|
|
|
1,285.1 |
|
|
|
2,854.1 |
|
|
|
2,548.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before minority interests,
equity in earnings and income tax provision |
|
|
54.9 |
|
|
|
93.0 |
|
|
|
121.8 |
|
|
|
198.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interests in earnings of consolidated entities |
|
|
(6.0 |
) |
|
|
(5.2 |
) |
|
|
(12.8 |
) |
|
|
(10.0 |
) |
Equity in earnings of unconsolidated affiliates |
|
|
9.5 |
|
|
|
9.8 |
|
|
|
23.6 |
|
|
|
19.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income tax
provision |
|
|
58.4 |
|
|
|
97.6 |
|
|
|
132.6 |
|
|
|
208.4 |
|
Income tax provision |
|
|
(28.2 |
) |
|
|
(37.6 |
) |
|
|
(60.7 |
) |
|
|
(80.5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
30.2 |
|
|
|
60.0 |
|
|
|
71.9 |
|
|
|
127.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued operations, net of tax |
|
|
0.2 |
|
|
|
0.1 |
|
|
|
(0.4 |
) |
|
|
15.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
30.4 |
|
|
$ |
60.1 |
|
|
$ |
71.5 |
|
|
$ |
143.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.35 |
|
|
$ |
0.70 |
|
|
$ |
0.82 |
|
|
$ |
1.49 |
|
Discontinued operations |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
0.18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net |
|
$ |
0.35 |
|
|
$ |
0.70 |
|
|
$ |
0.82 |
|
|
$ |
1.67 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.34 |
|
|
$ |
0.69 |
|
|
$ |
0.80 |
|
|
$ |
1.48 |
|
Discontinued operations |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
0.17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net |
|
$ |
0.34 |
|
|
$ |
0.69 |
|
|
$ |
0.80 |
|
|
$ |
1.65 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See notes to the condensed consolidated financial statements
1
Unless the context requires otherwise, references in these
consolidated financial statements and
accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
TRIAD HOSPITALS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
Unaudited
(Dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
|
December 31, |
|
|
|
2007 |
|
|
2006 |
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
63.2 |
|
|
$ |
208.6 |
|
Accounts receivable, less allowances for doubtful accounts of $425.6 at June 30, 2007 and
$416.3 at December 31, 2006 |
|
|
979.4 |
|
|
|
917.9 |
|
Inventories |
|
|
152.7 |
|
|
|
149.4 |
|
Deferred income taxes |
|
|
41.6 |
|
|
|
38.4 |
|
Prepaid expenses |
|
|
48.9 |
|
|
|
52.1 |
|
Other |
|
|
100.9 |
|
|
|
128.0 |
|
|
|
|
|
|
|
|
|
|
|
1,386.7 |
|
|
|
1,494.4 |
|
|
|
|
|
|
|
|
|
|
Property and equipment, at cost: |
|
|
|
|
|
|
|
|
Land |
|
|
214.0 |
|
|
|
212.0 |
|
Buildings and improvements |
|
|
2,050.2 |
|
|
|
2,011.7 |
|
Equipment |
|
|
1,788.5 |
|
|
|
1,705.4 |
|
Construction in progress |
|
|
457.4 |
|
|
|
238.8 |
|
|
|
|
|
|
|
|
|
|
|
4,510.1 |
|
|
|
4,167.9 |
|
Accumulated depreciation |
|
|
(1,341.1 |
) |
|
|
(1,227.7 |
) |
|
|
|
|
|
|
|
|
|
|
3,169.0 |
|
|
|
2,940.2 |
|
Goodwill |
|
|
1,365.8 |
|
|
|
1,359.7 |
|
Intangible assets, net of accumulated amortization |
|
|
77.2 |
|
|
|
81.1 |
|
Investment in and advances to unconsolidated affiliates |
|
|
260.2 |
|
|
|
242.9 |
|
Other |
|
|
120.3 |
|
|
|
115.5 |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
6,379.2 |
|
|
$ |
6,233.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
245.1 |
|
|
$ |
249.8 |
|
Accrued salaries |
|
|
145.7 |
|
|
|
127.0 |
|
Current portion of long-term debt |
|
|
26.9 |
|
|
|
21.3 |
|
Current income taxes payable |
|
|
39.5 |
|
|
|
|
|
Other current liabilities |
|
|
202.0 |
|
|
|
203.4 |
|
|
|
|
|
|
|
|
|
|
|
659.2 |
|
|
|
601.5 |
|
Long-term debt |
|
|
1,670.6 |
|
|
|
1,684.1 |
|
Other liabilities |
|
|
201.8 |
|
|
|
187.5 |
|
Deferred income taxes |
|
|
172.2 |
|
|
|
193.5 |
|
Minority interests in equity of consolidated entities |
|
|
339.1 |
|
|
|
340.8 |
|
Stockholders equity: |
|
|
|
|
|
|
|
|
Common stock $0.01 par value: 120,000,000 shares authorized, 89,553,855 and 88,339,049
shares issued and outstanding at June 30, 2007 and December 31, 2006, respectively |
|
|
0.9 |
|
|
|
0.9 |
|
Additional paid-in capital |
|
|
2,450.8 |
|
|
|
2,410.5 |
|
Unearned ESOP compensation |
|
|
(5.2 |
) |
|
|
(6.9 |
) |
Accumulated other comprehensive loss |
|
|
(7.1 |
) |
|
|
(7.6 |
) |
Accumulated earnings |
|
|
900.1 |
|
|
|
829.5 |
|
Less: Treasury stock, at cost, 63,288 shares at June 30, 2007 |
|
|
(3.2 |
) |
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity |
|
|
3,336.3 |
|
|
|
3,226.4 |
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity |
|
$ |
6,379.2 |
|
|
$ |
6,233.8 |
|
|
|
|
|
|
|
|
See notes to the condensed consolidated financial statements
2
Unless the context requires otherwise, references in these
consolidated financial statements and
accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
TRIAD HOSPITALS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the periods ended June 30, 2007 and 2006
Unaudited
(Dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
For the six |
|
|
|
months ended |
|
|
|
2007 |
|
|
2006 |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net income |
|
$ |
71.5 |
|
|
$ |
143.2 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
(Income) loss from discontinued operations, net of tax |
|
|
0.4 |
|
|
|
(15.3 |
) |
Provision for doubtful accounts |
|
|
303.5 |
|
|
|
248.9 |
|
Depreciation and amortization |
|
|
123.3 |
|
|
|
112.4 |
|
ESOP expense |
|
|
7.5 |
|
|
|
6.1 |
|
Minority interests |
|
|
12.8 |
|
|
|
10.0 |
|
Equity in earnings of unconsolidated affiliates |
|
|
(23.6 |
) |
|
|
(19.8 |
) |
(Gain) loss on sales of assets |
|
|
0.4 |
|
|
|
(0.6 |
) |
Deferred income tax benefit |
|
|
(10.4 |
) |
|
|
(11.7 |
) |
Non-cash interest expense |
|
|
1.7 |
|
|
|
1.6 |
|
Non-cash share-based compensation expense |
|
|
16.0 |
|
|
|
13.7 |
|
Excess tax benefits on share-based compensation |
|
|
(1.5 |
) |
|
|
(1.2 |
) |
Increase (decrease) in cash from operating assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
(365.0 |
) |
|
|
(321.7 |
) |
Inventories and other assets |
|
|
19.5 |
|
|
|
(22.5 |
) |
Accounts payable and other current liabilities |
|
|
51.9 |
|
|
|
(31.9 |
) |
Other |
|
|
7.8 |
|
|
|
21.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
215.8 |
|
|
|
132.9 |
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Purchases of property and equipment |
|
|
(350.1 |
) |
|
|
(233.4 |
) |
Distributions and advances (to) from unconsolidated affiliates, net |
|
|
6.3 |
|
|
|
(9.6 |
) |
Proceeds received on disposals of assets |
|
|
2.2 |
|
|
|
102.6 |
|
Acquisitions, net of cash acquired |
|
|
(33.4 |
) |
|
|
(49.2 |
) |
Other |
|
|
|
|
|
|
(0.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities |
|
|
(375.0 |
) |
|
|
(189.7 |
) |
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Payments of long-term debt |
|
|
(7.8 |
) |
|
|
(1.0 |
) |
Proceeds from issuance of common stock |
|
|
16.5 |
|
|
|
21.9 |
|
Payments for purchase of treasury stock |
|
|
(3.2 |
) |
|
|
|
|
Excess tax benefits on share-based compensation |
|
|
1.5 |
|
|
|
1.2 |
|
Contributions from minority partners, net |
|
|
6.8 |
|
|
|
0.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities |
|
|
13.8 |
|
|
|
22.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents |
|
|
(145.4 |
) |
|
|
(34.2 |
) |
Cash and cash equivalents at beginning of period |
|
|
208.6 |
|
|
|
310.2 |
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
63.2 |
|
|
$ |
276.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid for: |
|
|
|
|
|
|
|
|
Interest |
|
$ |
58.7 |
|
|
$ |
58.0 |
|
Income taxes, net of refunds |
|
$ |
8.9 |
|
|
$ |
117.6 |
|
See notes to the condensed consolidated financial statements
3
Unless the context requires otherwise, references in these
consolidated financial statements and
accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
TRIAD HOSPITALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
NOTE 1PROPOSED MERGER
On March 19, 2007, we entered into an Agreement and Plan of Merger (the Merger Agreement),
with Community Health Systems, Inc. (CHS) and FWCT-1 Acquisition Corporation, a wholly-owned
subsidiary of CHS (Merger Sub). Under the terms of the Merger Agreement, Merger Sub will be merged
with and into Triad Hospitals, Inc. (the Company), with the Company continuing as the surviving
corporation and a wholly-owned subsidiary of CHS (the Merger). On February 4, 2007, we entered
into an Agreement and Plan of Merger (the Prior Merger Agreement) with entities owned by private
investment funds affiliated with CCMP Capital Advisors, LLC and Goldman Sachs & Co. (collectively,
Panthera). Immediately prior to the execution of the Merger Agreement, the Company terminated the
Prior Merger Agreement. Our Board of Directors approved the Merger Agreement and the termination
of the Prior Merger Agreement on the unanimous recommendation of a Special Committee comprised
entirely of disinterested directors (the Special Committee). Concurrent with the termination of
the Prior Merger Agreement and pursuant to the terms thereof, we paid Panthera a termination fee of
$20 million and advanced $20 million to Panthera to cover its out-of-pocket expenses (the Prior
Agreement Amount). CHS reimbursed us for such amounts pursuant to the terms of the Merger
Agreement.
At the effective time of the Merger, each outstanding share of our common stock, other than
shares owned by us, CHS, Merger Sub, or any stockholders who are entitled to and who properly
exercise appraisal rights under Delaware law, will be cancelled and converted into the right to
receive $54.00 in cash, without interest.
We have made customary representations, warranties and covenants in the Merger Agreement. The
Merger Agreement contains a no shop restriction on our ability to solicit third party proposals,
provide information and engage in discussions and negotiations with third parties. The no shop
provision is subject to a fiduciary out provision that allows us to provide information and
participate in discussions and negotiations with respect to third party acquisition proposals
submitted after the date of the Merger Agreement that the Board of Directors (following the
recommendation of the Special Committee) believes in good faith to be bona fide and determines in
good faith, after consultation with its financial advisors and outside counsel, constitute or could
reasonably be expected to result in a superior proposal, as defined in the Merger Agreement.
We may terminate the Merger Agreement under certain circumstances, including if our Board of
Directors (following the recommendation of the Special Committee) determines in good faith that it
has received a superior proposal and that failure to terminate the Merger Agreement could violate
its fiduciary duties, and otherwise complies with certain terms of the Merger Agreement. In
connection with such termination, we must pay a fee of $130 million to CHS and reimburse CHS for
any amounts paid by CHS to us in respect of the Prior Agreement Amount. In certain other
circumstances, we must pay a fee of $130 million upon termination of the Merger Agreement. Under
other circumstances upon termination of the Merger Agreement, we must reimburse CHS for its
expenses of up to $15 million and for the Prior Agreement Amount.
The parties to the Merger Agreement are entitled to specific performance of the terms of the
Merger Agreement, in addition to any other remedy to which they are entitled, including damages for
any breach of the Merger Agreement by the other party. CHS has obtained debt financing commitments
for the transactions contemplated by the Merger Agreement, the aggregate proceeds of which,
together with cash on hand, will be sufficient for CHS to pay all amounts required to consummate
the Merger and other transactions contemplated by the Merger Agreement, including any contemplated
refinancing of debt and all related fees and expenses. Consummation of the Merger is not subject
to a financing condition, but is subject to various other conditions, including approval of the
Merger by our stockholders, the receipt of required regulatory approvals and other customary
closing conditions. The applicable 30-day waiting period under the Hart-Scott-Rodino Antitrust
Improvement Act of 1976 expired on April 23, 2007. The parties currently expect to close the
transaction during the third quarter of 2007.
A special meeting of the stockholders was held on Tuesday, June 12, 2007 for stockholders of
record on May 3, 2007. The special meeting was called (i) to vote upon and approve the Merger
Agreement, (ii) to consider and vote upon a proposal to adjourn the special meeting, if necessary
or appropriate, to solicit additional proxies if there
4
Unless the context requires otherwise, references in these
consolidated financial statements and
accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
TRIAD HOSPITALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
NOTE 1PROPOSED MERGER (continued)
were insufficient votes at the time of the special meeting to adopt the Merger Agreement, and (iii)
to transact such other business that may properly come before the special meeting or any
adjournments thereof. The Merger Agreement was approved by a majority of the stockholders at the
special meeting.
We had approximately $10.5 and $20.9 million in costs included in other operating expenses for
the three and six months ended June 30, 2007, respectively, related to the proposed Merger, which
reduced diluted earnings per share by approximately $0.11 and $0.19 per share for the three and six
months ended June 30, 2007, respectively.
NOTE 2BASIS OF PRESENTATION
The accompanying unaudited condensed consolidated financial statements have been prepared in
accordance with U.S. Generally Accepted Accounting Principles for interim financial information.
Accordingly, they do not include all of the information and notes required by U.S. Generally
Accepted Accounting Principles for complete financial statements of Triad Hospitals, Inc. In the
opinion of management, all adjustments necessary for a fair presentation have been included and are
of a normal recurring nature. Interim results are not necessarily indicative of the results that
may be expected for the year. The condensed consolidated financial statements should be read in
conjunction with the consolidated financial statements and notes thereto for the year ended
December 31, 2006.
The condensed consolidated balance sheet at December 31, 2006 has been derived from the
audited consolidated financial statements at that date but does not include all of the information
and notes required by U.S. Generally Accepted Accounting Principles for complete financial
statements.
NOTE 3SHARE-BASED COMPENSATION PLANS
A summary of stock option activity under our share-based compensation plans at June 30, 2007
is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average |
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
Remaining |
|
|
Aggregate |
|
|
|
|
|
|
|
Average |
|
|
Contractual |
|
|
Intrinsic |
|
|
|
Shares |
|
|
Exercise Price |
|
|
Term (in years) |
|
|
Value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at January 1, 2007 |
|
|
6,905,470 |
|
|
$ |
33.81 |
|
|
|
|
|
|
|
|
|
Granted |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(281,393 |
) |
|
$ |
33.01 |
|
|
|
|
|
|
|
|
|
Cancelled |
|
|
(54,260 |
) |
|
$ |
38.80 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at June 30, 2007 |
|
|
6,569,817 |
|
|
$ |
33.80 |
|
|
|
6.2 |
|
|
$ |
131,122,977 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at June 30, 2007 |
|
|
5,161,579 |
|
|
$ |
32.18 |
|
|
|
5.7 |
|
|
$ |
111,363,682 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The total intrinsic value of options exercised during the six months ended June 30, 2007 was
$5.1 million.
A summary of our non-vested shares at June 30, 2007 is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock |
|
MSPP Shares |
|
DSUs |
|
|
|
|
|
|
Weighted Average |
|
|
|
|
|
Weighted Average |
|
|
|
|
|
Weighted Average |
|
|
|
|
|
|
Grant-date |
|
|
|
|
|
Grant-date Fair |
|
|
|
|
|
Grant-date Fair |
|
|
Shares |
|
Fair Value |
|
Shares |
|
Value |
|
Shares |
|
Value |
|
Non-vested at January 1, 2007 |
|
|
761,350 |
|
|
$ |
41.90 |
|
|
|
73,218 |
|
|
$ |
11.09 |
|
|
|
23,424 |
|
|
$ |
36.31 |
|
Granted |
|
|
803,756 |
|
|
$ |
49.89 |
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
Vested |
|
|
(215,466 |
) |
|
$ |
42.15 |
|
|
|
(14,303 |
) |
|
$ |
9.99 |
|
|
|
(2,499 |
) |
|
$ |
40.84 |
|
Cancelled |
|
|
(16,680 |
) |
|
$ |
43.99 |
|
|
|
(2,186 |
) |
|
$ |
11.33 |
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-vested at June 30, 2007 |
|
|
1,332,960 |
|
|
$ |
46.65 |
|
|
|
56,729 |
|
|
$ |
12.04 |
|
|
|
20,925 |
|
|
$ |
35.77 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5
Unless the context requires otherwise, references in these
consolidated financial statements and
accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
TRIAD HOSPITALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
NOTE 3SHARE-BASED COMPENSATION PLANS (continued)
We repurchased 63,288 shares of stock to be held in the treasury for $3.2 million in 2007 in
order to satisfy the amount of minimum tax withholding liabilities that were incurred upon vesting
of restricted stock.
The total fair value of shares vested during the six months ended June 30, 2007 was $23.9
million.
Cash received from option exercises under share-based payment arrangements for the six months
ended June 30, 2007 was $16.5 million. The actual tax benefit realized for the tax deductions of
the share-based payment arrangements for the six months ended June 30, 2007 was $6.4 million.
NOTE 4INCOME TAXES
On January 1, 2007, we adopted the Financial Accounting Standards Board Interpretation No. 48
Accounting for Uncertainty in Income Taxes, or FIN 48, which clarifies the accounting for
uncertainty in income taxes recognized in accordance with the provisions of Statement of Financial
Accounting Standards No. 109 Accounting for Income Taxes, or SFAS 109. The cumulative effect of
applying the provisions of FIN 48 is reported as an adjustment to the January 1, 2007 balance of
retained earnings. FIN 48 prescribes a recognition threshold and measurement attribute for the
financial statement recognition and measurement of a tax position taken or expected to be taken in
a tax return. FIN 48 also provides guidance on derecognition, classification, interest and
penalties, accounting in interim periods, disclosures and transition. We had approximately $11.8
million of unrecognized tax benefits at December 31, 2006. We reduced the January 1, 2007 balance
of retained earnings by $0.9 million from the adoption of FIN 48. Also, the unrecognized tax
benefits previously established through purchase accounting for the Quorum acquisition were reduced
by $3.2 million from the adoption of FIN 48 through a reduction to goodwill. We also reclassified
the unrecognized tax benefits from deferred tax liabilities to other long-term liabilities upon
adoption of FIN 48.
A reconciliation of the beginning and ending balances of unrecognized tax benefits is as
follows (in millions):
|
|
|
|
|
Balance at January 1, 2007 |
|
$ |
9.5 |
|
Additions based on tax positions related to the current year |
|
|
0.4 |
|
Additions for tax positions of prior years |
|
|
2.8 |
|
Reductions for tax positions of prior years |
|
|
(2.3 |
) |
|
|
|
|
Balance at June 30, 2007 |
|
$ |
10.4 |
|
|
|
|
|
The reduction for tax positions of prior years was related to unrecognized tax benefits
previously established through purchase accounting for the Quorum acquisition and was recorded as a
reduction to goodwill based on a tentative settlement with the taxing authorities.
We had approximately $4.0 million of other current liabilities and $6.4 million of other
long-term liabilities for unrecognized tax benefits and accrued interest and penalties at June 30,
2007.
We recognize interest accrued and penalties related to unrecognized tax benefits in our income
tax provision. During the three and six months ended June 30, 2007, we recognized approximately
$0.1 million and $0.7 million respectively in interest and penalties. We made no payments of
interest and penalties during the three and six months ended June 30, 2007.
NOTE 5DISCONTINUED OPERATIONS
Effective January 1, 2006, we closed on a definitive agreement to sell our hospitals in
Wharton, Texas, Pampa, Texas and Hope, Arkansas for $75 million plus $15.1 million for working
capital. These facilities were reclassified to discontinued operations in the fourth quarter of
2005. We recognized a pre-tax gain on the sale in discontinued operations of $27.2 million in the
first quarter of 2006. These facilities were a component of the owned operations segment.
6
Unless the context requires otherwise, references in these
consolidated financial statements and
accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
TRIAD HOSPITALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
NOTE 5DISCONTINUED OPERATIONS (continued)
We closed under an agreement in May 2004 to sell certain assets related to our leased acute
care hospital in Terrell, Texas. At the time of the disposal, we recorded $3.4 million in notes
receivable. During the third quarter of 2006, the borrower defaulted on the first payment due
under the notes. A reserve on the notes for the amount in excess of the estimated value of the
collateral of approximately $1.4 million was recorded in discontinued operations. During the first
quarter of 2007, an additional reserve of approximately $0.6 million was recorded in discontinued
operations.
Revenues and income for these entities are included in the condensed consolidated statements
of operations as Income (loss) from discontinued operations, net of tax for all periods
presented. The amounts are as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months |
|
|
For the six months |
|
|
|
ended June 30, |
|
|
ended June 30, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Revenues |
|
$ |
0.3 |
|
|
$ |
0.3 |
|
|
|
|
|
|
$ |
1.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre-tax income (loss) from operations |
|
|
0.3 |
|
|
|
0.2 |
|
|
|
|
|
|
|
(0.9 |
) |
Income tax (provision) benefit |
|
|
(0.1 |
) |
|
|
(0.1 |
) |
|
|
|
|
|
|
0.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.2 |
|
|
|
0.1 |
|
|
|
|
|
|
|
(0.6 |
) |
Gain (loss) on disposal, net of tax (provision)
benefit of
$0.2 million and ($11.3) million for the six months
ended June 30, 2007 and 2006, respectively |
|
|
|
|
|
|
|
|
|
|
(0.4 |
) |
|
|
15.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
0.2 |
|
|
$ |
0.1 |
|
|
$ |
(0.4 |
) |
|
$ |
15.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NOTE 6 GUARANTEES
We have entered into physician recruiting agreements under which we supplement physician
income to a minimum amount over a period of time while the physicians establish themselves in the
community. As part of the agreements, the physicians are required to stay in the community for a
period of time after the payments have ended, typically three years, or the payments are required
to be returned to us. The payments under these agreements are forgiven ratably if the physicians
stay in the community through the end of the agreement. We record an asset for the estimated fair
value of the minimum revenue guarantees and amortize the asset from the beginning of the guarantee
payment period through the end of the agreement. At June 30, 2007, we had liabilities for the
minimum revenue guarantees entered into after January 1, 2006 of $23.0 million. At June 30, 2007,
including the minimum revenue guarantees entered into prior to January 1, 2006, the maximum amount
of all unpaid minimum revenue guarantees was $51.9 million.
We have entered into agreements whereby we have guaranteed certain loans entered into by
patients for whom services were performed at our facilities. All uninsured patients are eligible
to apply for these loans. These loans are provided by various financial institutions who determine
whether the loans are made. The terms of the loans range from 1 to 5 years. We would be obligated
to repay the financial institutions if a patient fails to repay his or her loan. We could then
pursue collections from the patient. We record a reserve for the estimated defaults on these loans
at the historical default rate, which was approximately 30.3% at June 30, 2007 and December 31,
2006. At June 30, 2007 and December 31, 2006, the amounts subject to the guarantees were $23.5
million and $23.4 million, respectively. We had accrued liabilities of $7.1 and $7.0 million at June 30, 2007 and December
31, 2006, respectively, for the estimated loan defaults that would be covered under the guarantees.
We have entered into agreements to guarantee the indebtedness of certain joint ventures that
are accounted for by the equity method. The maximum amount of the guarantees entered into was $3.3
million at June 30, 2007. Minimum amounts were recorded for the fair value of the guarantees.
NOTE 7INCOME PER SHARE
Income per common share is based on the weighted average number of shares outstanding adjusted
for the shares issued to our Employee Stock Ownership Plan (ESOP) and unvested restricted shares
issued under our
7
Unless the context requires otherwise, references in these
consolidated financial statements and
accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
TRIAD HOSPITALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
NOTE 7INCOME PER SHARE (continued)
share-based compensation plans. Diluted weighted average shares outstanding are calculated by
adjusting basic weighted average shares outstanding by all potentially dilutive stock options and
unvested restricted stock. Stock options outstanding of 1,816,775 for the three and six months
ended June 30, 2006, were not included in the computation of diluted earnings per share because the
exercise prices of the options were greater than the average market price of the common stock.
Weighted average shares are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months |
|
For the six months |
|
|
ended June 30, |
|
ended June 30, |
|
|
2007 |
|
2006 |
|
2007 |
|
2006 |
Weighted average shares exclusive of unreleased
ESOP shares and unvested restricted shares |
|
|
87,410,286 |
|
|
|
86,034,346 |
|
|
|
87,304,366 |
|
|
|
85,883,229 |
|
Average of ESOP shares committed to be released |
|
|
112,500 |
|
|
|
112,500 |
|
|
|
75,000 |
|
|
|
75,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic weighted average shares outstanding |
|
|
87,522,786 |
|
|
|
86,146,846 |
|
|
|
87,379,366 |
|
|
|
85,958,229 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of dilutive securities share-based compensation plans |
|
|
2,287,161 |
|
|
|
847,880 |
|
|
|
1,961,404 |
|
|
|
706,944 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted average shares outstanding |
|
|
89,809,947 |
|
|
|
86,994,726 |
|
|
|
89,340,770 |
|
|
|
86,665,173 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NOTE 8SEGMENT INFORMATION
The distribution of our revenues and Adjusted EBITDA of continuing operations (which is used
by management for operating performance review, see (a)) is summarized in the following table
(dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months |
|
|
For the six months |
|
|
|
ended June 30, |
|
|
ended June 30, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Owned operations |
|
$ |
1,457.4 |
|
|
$ |
1,349.7 |
|
|
$ |
2,919.8 |
|
|
$ |
2,690.2 |
|
Management services |
|
|
27.5 |
|
|
|
28.2 |
|
|
|
55.8 |
|
|
|
56.7 |
|
Corporate and other |
|
|
0.2 |
|
|
|
0.2 |
|
|
|
0.3 |
|
|
|
0.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,485.1 |
|
|
$ |
1,378.1 |
|
|
$ |
2,975.9 |
|
|
$ |
2,747.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months |
|
|
For the six months |
|
|
|
ended June 30, |
|
|
ended June 30, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Adjusted EBITDA (a): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Owned operations |
|
$ |
193.4 |
|
|
$ |
214.1 |
|
|
$ |
401.7 |
|
|
$ |
435.0 |
|
Management services |
|
|
3.9 |
|
|
|
4.6 |
|
|
|
7.9 |
|
|
|
8.0 |
|
Corporate and other |
|
|
(43.1 |
) |
|
|
(32.0 |
) |
|
|
(84.8 |
) |
|
|
(59.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
154.2 |
|
|
$ |
186.7 |
|
|
$ |
324.8 |
|
|
$ |
383.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA for owned operations includes equity in earnings of unconsolidated affiliates
of $9.5 million and $9.8 million for the three months ended June 30, 2007 and 2006, respectively,
and $23.6 million and $19.8 million for the six months ended June 30, 2007 and 2006, respectively.
8
Unless the context requires otherwise, references in these
consolidated financial statements and
accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
TRIAD HOSPITALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
NOTE 8SEGMENT INFORMATION (continued)
A reconciliation of Adjusted EBITDA to income from continuing operations before income tax
provision follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months |
|
|
For the six months |
|
|
|
ended June 30, |
|
|
ended June 30, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Total Adjusted EBITDA for reportable segments |
|
$ |
154.2 |
|
|
$ |
186.7 |
|
|
$ |
324.8 |
|
|
$ |
383.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
|
60.2 |
|
|
|
55.5 |
|
|
|
119.4 |
|
|
|
108.8 |
|
Amortization |
|
|
1.9 |
|
|
|
2.1 |
|
|
|
3.9 |
|
|
|
3.6 |
|
Interest expense |
|
|
26.5 |
|
|
|
28.9 |
|
|
|
53.9 |
|
|
|
57.6 |
|
Interest income |
|
|
(2.7 |
) |
|
|
(5.2 |
) |
|
|
(5.7 |
) |
|
|
(10.2 |
) |
ESOP expense |
|
|
4.0 |
|
|
|
3.1 |
|
|
|
7.5 |
|
|
|
6.1 |
|
(Gain) loss on sales of assets |
|
|
(0.1 |
) |
|
|
(0.5 |
) |
|
|
0.4 |
|
|
|
(0.6 |
) |
Minority interests in earnings of consolidated entities |
|
|
6.0 |
|
|
|
5.2 |
|
|
|
12.8 |
|
|
|
10.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income tax
provision |
|
$ |
58.4 |
|
|
$ |
97.6 |
|
|
$ |
132.6 |
|
|
$ |
208.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
|
Adjusted EBITDA is defined as earnings before depreciation, amortization, interest expense,
interest income, ESOP expense, (gain) loss on sales of assets, minority interests in earnings
of consolidated entities, income tax provision and discontinued operations. Adjusted EBITDA
is commonly used by lenders and investors to assess leverage capacity, debt service ability
and liquidity. Many of our debt covenants use Adjusted EBITDA, or a modification of Adjusted
EBITDA, in financial covenant calculations. Adjusted EBITDA is used by management to evaluate
financial performance and resource allocation for each facility and for us as a whole.
Adjusted EBITDA should not be considered as a measure of financial performance under U.S.
Generally Accepted Accounting Principles, and the items excluded from Adjusted EBITDA are
significant components in understanding and assessing financial performance. Adjusted EBITDA
should not be considered in isolation or as an alternative to net income, cash flows generated
by operating, investing or financing activities or financial statement data presented in the
condensed consolidated financial statements as an indicator of financial performance or
liquidity. Because Adjusted EBITDA is not a measurement determined in accordance with U.S.
Generally Accepted Accounting Principles and is thus susceptible to varying calculations,
Adjusted EBITDA as presented may not be comparable to other similarly titled measures of other
companies. |
NOTE 9COMPREHENSIVE INCOME
Statement of Financial Accounting Standards No. 130, Reporting Comprehensive Income, or SFAS
130 establishes guidelines for reporting changes in equity during a period from transactions and
other events and circumstances from non-owner sources.
The component of comprehensive income, net of income tax, is as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months |
|
|
For the six months |
|
|
|
ended June 30, |
|
|
ended June 30, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Net income |
|
$ |
30.4 |
|
|
$ |
60.1 |
|
|
$ |
71.5 |
|
|
$ |
143.2 |
|
Other comprehensive income, net of income tax: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recognition of unrecognized net periodic benefit costs |
|
|
0.2 |
|
|
|
|
|
|
|
0.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income |
|
$ |
30.6 |
|
|
$ |
60.1 |
|
|
$ |
72.0 |
|
|
$ |
143.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The components of accumulated other comprehensive loss, net of tax, are as follows (in
millions):
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
|
December 31 |
|
|
|
2007 |
|
|
2006 |
|
Foreign currency translation adjustment |
|
$ |
0.1 |
|
|
$ |
0.1 |
|
Unrecognized net periodic benefit costs |
|
|
7.0 |
|
|
|
7.5 |
|
|
|
|
|
|
|
|
|
|
$ |
7.1 |
|
|
$ |
7.6 |
|
|
|
|
|
|
|
|
9
Unless the context requires otherwise, references in these
consolidated financial statements and
accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
TRIAD HOSPITALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
NOTE 10EQUITY INVESTMENTS
We own equity interests of 27.5% in Valley Health System LLC and 26.1% in Summerlin Hospital
Medical Center LLC. Universal Health Systems has the majority interest in Valley Health System LLC
and Summerlin Hospital Medical Center LLC. We own an equity interest of 38.0% in Macon Healthcare
LLC. HCA has the majority interest in Macon Healthcare LLC. We also own a 50% interest in MCSA,
LLC with our partner, SHARE Foundation, a not-for-profit foundation. We use the equity method of
accounting for our investments in these entities. Summarized financial information of these
entities is as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months |
|
|
For the six months |
|
|
|
ended June 30, |
|
|
ended June 30, |
|
|
|
2007 |
|
|
2006 |
|
|
2007 |
|
|
2006 |
|
Revenues |
|
$ |
307.8 |
|
|
$ |
288.6 |
|
|
$ |
638.5 |
|
|
$ |
567.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
35.7 |
|
|
$ |
32.6 |
|
|
$ |
84.4 |
|
|
$ |
66.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NOTE 11CONTINGENCIES
Litigation Concerning Triads Pending Merger
Between February 5, 2007 and March 2, 2007, five putative class action lawsuits, entitled
Market Street Securities v. Shelton, et al., Cause No. 296-0436-07 (Feb. 5, 2007), Clark v. Triad
Hospitals, Inc., et al., Cause No. 296-0461-07 (Feb. 6, 2007), Rubery v. Triad Hospitals, Inc., et
al., Cause No. 296-0566-07 (Feb. 6, 2007), Sternhell v. Shelton, et al., Cause No. 416-0494-0 (Feb.
8, 2007) and Thomas Purdy, III v. Triad Hospitals Inc., et al., Cause No. 296-809-07 (Mar. 2,
2007), were filed against Triad and its directors. The Rubery and Sternhell petitions also named
as defendants CCMP Capital Investors II, L.P. and GS Capital Partners VI, L.P., and the Sternhell
petition further named Panthera Partners, LLC, Panthera Holdco Corp. and Panthera Acquisition
Corporation as defendants. All of the petitions were filed in the District Court of Collin County,
Texas. The petitions, which purported to be brought on behalf of all Triad stockholders (excluding
the defendants and their affiliates), alleged that the $50.25 per share in cash that was to be paid
to stockholders in connection with Triads previously proposed merger with affiliates of CCMP
Capital Investors II, L.P. and GS Capital Partners VI, L.P. was inadequate, and that Triad and its
directors violated their fiduciary obligations to stockholders in negotiating and approving the
merger.
Following the announcement on March 19, 2007 that Triad had terminated its previous merger
agreement with affiliates of CCMP Capital Investors II, L.P. and GS Capital Partners VI, L.P. and
had, instead, entered into a merger agreement at $54.00 per share with CHS, the above-referenced
actions were consolidated in the 296th District Court of Collin County, Texas. On April
23, 2007, plaintiffs filed a consolidated amended petition challenging the proposed transaction
with CHS. The consolidated amended petition alleges, among other things, that (i) the $54.00 per
share in cash that is to be paid to stockholders in connection with Triads proposed merger with
CHS is still inadequate; (ii) the go shop auction process that led to the higher offer from CHS
was flawed; (iii) the directors violated their fiduciary duties to shareholders by administering a
sale process that failed to maximize shareholder value; (iv) the terms of the merger agreement with
CHS, which include a so-called non-solicitation clause and a $130 million termination fee, will
artificially deter higher bids for the Company; (v) the directors breached their fiduciary duties
by approving, in mid-December 2006, amended change in control severance agreements with several
Triad executives; and (vi) the Company failed to disclose certain purportedly material information
relating to the valuation of the Company and the process leading to the approval of the proposed
merger. The consolidated amended petition seeks a judgment declaring that Triad and its directors
breached their fiduciary duties to plaintiffs, enjoining Triad and its directors from executing the
merger with CHS, indemnifying plaintiffs, and awarding plaintiffs attorneys fees and costs.
Plaintiffs counsel in the consolidated action had advised our counsel of
plaintiffs intention to conduct discovery and to file a motion for a temporary injunction by
May 24, 2007; however, plaintiffs counsel have since informed us and the court that plaintiffs do
not intend to seek an injunction, and the hearing that had previously been scheduled for June 7,
2007 for this purpose was removed from the courts docket.
False Claims Act Litigation
As a result of our ongoing discussions with the government prior to our merger with Quorum
Health Group, Inc., or Quorum, on April 27, 2001, Quorum learned of two qui tam complaints against
it alleging violations of the
10
Unless the context requires otherwise, references in these
consolidated financial statements and
accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
TRIAD HOSPITALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
NOTE 11CONTINGENCIES (continued)
False Claims Act for claims allegedly submitted to the government involving two managed hospitals.
Quorum accrued the estimated liability on these items prior to the merger and the matter remains
under seal. The government has requested that Quorum conduct a self audit with respect to one
Medicare cost report for one managed hospital and three other specific issues. The government has
stated that it intends to investigate certain other allegations.
On September 9, 2003, we were served with a qui tam complaint alleging, among other things,
the submission of false claims for reimbursement and improper allocation of costs at a hospital in
Mississippi managed by Quorum Health Resources, LLC, or QHR, which is named as an additional
defendant. The Federal government has apparently elected not to intervene in the case and the
complaint was unsealed. We are vigorously defending this matter and have filed a motion to
dismiss, which is pending before the court. While we currently believe that we have no liability
for any of the claims alleged in the complaint, discovery has not been completed and at this time
we cannot predict the final effect or outcome of the complaint.
On May 18, 2004, we were served with a qui tam complaint alleging, among other things, the
submission of false claims for reimbursement at two hospitals in Georgia formerly managed by QHR.
This case was dismissed on October 27, 2005. The plaintiff appealed the dismissal, and we are
vigorously contesting the appeal.
On April 26, 2005, we received a copy of a qui tam complaint alleging, among other things, the
submission of false claims for reimbursement at a hospital in Pennsylvania managed by QHR. The
Federal government elected not to intervene in this case and the complaint was recently unsealed.
While we intend to vigorously defend this matter, we are not yet able to form a view as to the
probable liability for any of the claims alleged in the complaint.
Our merger agreement with Quorum will not provide indemnification in respect of the qui tam
complaints and investigations described above. If we incur material liabilities as a result of qui
tam litigation or governmental investigation, these matters could have a material adverse effect on
our business, financial condition, results of operations or prospects.
At this time we cannot predict the final effect or outcome of the ongoing investigations or
qui tam actions. If violations of Federal or state laws relating to Medicare, Medicaid or other
government programs are found, then we may be required to pay substantial fines and civil and
criminal damages and also may be excluded from participation in the Medicare and Medicaid programs
and other government programs. Similarly, the amount of damages sought in the qui tam actions or
in the future may be substantial. We could be subject to substantial costs resulting from
defending, or from an adverse outcome in, any current or future investigations, administrative
proceedings or litigation. In an effort to resolve one or more of these matters, we may choose to
negotiate a settlement. Amounts paid to settle any of these matters may be material. Agreements
entered into as a part of any settlement could also materially adversely affect us. Any current or
future investigations or actions could have a material adverse effect on our results of operations
or financial position.
From time to time we may be the subject of additional investigations or a party to additional
litigation, including qui tam actions, alleging violations of law. We may not know about those
investigations or about qui tam
actions filed against us unless and to the extent such matters are unsealed. If any of those
matters were successfully asserted against us, there could be a material adverse effect on our
business, financial position, results of operations or prospects.
Income Taxes
The Internal Revenue Services, or IRS, has concluded conducting an examination of the Federal
income tax returns for our short taxable years ended April 27, 2001, June 30, 2001 and December 31,
2001, and the taxable years ended December 31, 2002 and 2003. On May 10, 2006, the IRS issued an
examination report, known as a 30-Day Letter, with proposed adjustments disallowing deductions for
portions of the payments made to the Federal government in settlement of certain qui tam complaints
that had been brought against Quorum. The total proposed adjustments with respect to the
settlement payment deductions, if sustained, would increase taxable income in the amount of
approximately $67.3 million and result in our payment of additional cash taxes of approximately
$24.9
11
Unless the context requires otherwise, references in these
consolidated financial statements and
accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
TRIAD HOSPITALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
NOTE 11CONTINGENCIES (continued)
million. Any cash taxes paid resulting from the proposed adjustments in excess of the tax reserve
previously established would increase goodwill from the acquisition of Quorum.
We believe our reporting of the deductions with respect to the settlement of the three qui tam
cases was appropriate. Accordingly, on June 9, 2006, we filed a protest to the 30-Day Letter to
contest the proposed adjustments and the matter has since been referred to the IRS Appeals Office.
In the opinion of management, even if the IRS proposed adjustments were sustained, the adjustments
would not have a material effect on our results of operations or financial position.
General Liability Claims
QHR, The Intensive Resource Group, LLC, or IRG, a subsidiary of QHR, and we are defendants
against claims for breach of an employment contract filed in a lawsuit involving a former employee
of Cambio Health Solutions, a former subsidiary of IRG. QHR, IRG and we have been vigorously
defending the claim. On May 13, 2004, a jury returned a verdict against QHR, IRG, and us and on
June 8, 2004, the court entered a judgment on such verdict in the aggregate amount of approximately
$5.9 million. QHR, IRG and we appealed such judgment. We had reserved $5.9 million in respect of
this judgment. In March 2007, we learned that our appeal was unsuccessful and we paid $6.2 million
on the judgment, which includes approximately $0.3 million in accrued interest.
We are subject to claims and suits arising in the ordinary course of business, including
claims for personal injuries or wrongful restriction of, or interference with, physicians staff
privileges. In certain of these actions the claimants may seek punitive damages against us, which
are usually not covered by insurance. It is managements opinion that the ultimate resolution of
these pending claims and legal proceedings will not have a material adverse effect on our results
of operations or financial position.
NOTE 12COSTS OF SALES
The following tables show the line items in the condensed consolidated statements of
operations that are considered costs of sales (dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended June 30, 2007 |
|
|
|
|
|
|
|
General and |
|
|
|
|
|
|
|
|
|
|
Administrative |
|
|
|
|
|
|
Total Expenses |
|
|
Expenses |
|
|
Costs of Sales |
|
Salaries and benefits |
|
$ |
615.6 |
|
|
$ |
19.1 |
|
|
$ |
596.5 |
|
Reimbursable expenses |
|
|
11.9 |
|
|
|
|
|
|
|
11.9 |
|
Supplies |
|
|
251.5 |
|
|
|
|
|
|
|
251.5 |
|
Other operating expenses |
|
|
306.0 |
|
|
|
24.1 |
|
|
|
281.9 |
|
Provision for doubtful accounts |
|
|
155.4 |
|
|
|
|
|
|
|
155.4 |
|
Depreciation |
|
|
60.2 |
|
|
|
0.9 |
|
|
|
59.3 |
|
Amortization |
|
|
1.9 |
|
|
|
|
|
|
|
1.9 |
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1,402.5 |
|
|
$ |
44.1 |
|
|
$ |
1,358.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended June 30, 2006 |
|
|
|
|
|
|
|
General and |
|
|
|
|
|
|
|
|
|
|
Administrative |
|
|
|
|
|
|
Total Expenses |
|
|
Expenses |
|
|
Costs of Sales |
|
Salaries and benefits |
|
$ |
553.9 |
|
|
$ |
19.0 |
|
|
$ |
534.9 |
|
Reimbursable expenses |
|
|
12.3 |
|
|
|
|
|
|
|
12.3 |
|
Supplies |
|
|
234.5 |
|
|
|
0.1 |
|
|
|
234.4 |
|
Other operating expenses |
|
|
272.3 |
|
|
|
13.4 |
|
|
|
258.9 |
|
Provision for doubtful accounts |
|
|
128.2 |
|
|
|
|
|
|
|
128.2 |
|
Depreciation |
|
|
55.5 |
|
|
|
0.7 |
|
|
|
54.8 |
|
Amortization |
|
|
2.1 |
|
|
|
|
|
|
|
2.1 |
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1,258.8 |
|
|
$ |
33.2 |
|
|
$ |
1,225.6 |
|
|
|
|
|
|
|
|
|
|
|
12
Unless the context requires otherwise, references in these
consolidated financial statements and
accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
TRIAD HOSPITALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
NOTE 12COSTS OF SALES (continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the six months ended June 30, 2007 |
|
|
|
|
|
|
|
General and |
|
|
|
|
|
|
|
|
|
|
Administrative |
|
|
|
|
|
|
Total Expenses |
|
|
Expenses |
|
|
Costs of Sales |
|
Salaries and benefits |
|
$ |
1,230.6 |
|
|
$ |
39.8 |
|
|
$ |
1,190.8 |
|
Reimbursable expenses |
|
|
24.6 |
|
|
|
|
|
|
|
24.6 |
|
Supplies |
|
|
505.7 |
|
|
|
0.1 |
|
|
|
505.6 |
|
Other operating expenses |
|
|
610.3 |
|
|
|
45.0 |
|
|
|
565.3 |
|
Provision for doubtful accounts |
|
|
303.5 |
|
|
|
|
|
|
|
303.5 |
|
Depreciation |
|
|
119.4 |
|
|
|
1.8 |
|
|
|
117.6 |
|
Amortization |
|
|
3.9 |
|
|
|
|
|
|
|
3.9 |
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
2,798.0 |
|
|
$ |
86.7 |
|
|
$ |
2,711.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the six months ended June 30, 2006 |
|
|
|
|
|
|
|
General and |
|
|
|
|
|
|
|
|
|
|
Administrative |
|
|
|
|
|
|
Total Expenses |
|
|
Expenses |
|
|
Costs of Sales |
|
Salaries and benefits |
|
$ |
1,111.4 |
|
|
$ |
38.3 |
|
|
$ |
1,073.1 |
|
Reimbursable expenses |
|
|
26.0 |
|
|
|
|
|
|
|
26.0 |
|
Supplies |
|
|
471.7 |
|
|
|
0.2 |
|
|
|
471.5 |
|
Other operating expenses |
|
|
525.4 |
|
|
|
21.4 |
|
|
|
504.0 |
|
Provision for doubtful accounts |
|
|
248.9 |
|
|
|
|
|
|
|
248.9 |
|
Depreciation |
|
|
108.8 |
|
|
|
1.5 |
|
|
|
107.3 |
|
Amortization |
|
|
3.6 |
|
|
|
|
|
|
|
3.6 |
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
2,495.8 |
|
|
$ |
61.4 |
|
|
$ |
2,434.4 |
|
|
|
|
|
|
|
|
|
|
|
NOTE 13RECENT ACCOUNTING PRONOUNCEMENTS
In September 2006, the Financial Accounting Standards Board issued Statement of Financial
Accounting Standards No. 157 Fair Value Measurements, or SFAS 157, which is effective for fiscal
years beginning after November 15, 2007, with early adoption encouraged. This statement provides a
single definition of fair value, establishes a framework for measuring fair value, and expands
disclosures concerning fair value measurements. We do not anticipate a material impact on our
results of operations or financial position from the adoption of SFAS 157.
In September 2006, the Financial Accounting Standards Board issued Statement of Financial
Accounting Standards No. 158 Employers Accounting for Defined Benefit Pension and Other
Postretirement Plans, an amendment of FASB Statements No. 87, 88, 106, and 132(R), or SFAS 158,
which was effective for fiscal years ending after December 15, 2006. SFAS 158 requires recognition
of defined benefit plan funding status, including gains or losses on plan assets, prior service
costs and transition assets or obligations, and recognizes changes in the funding status of those
plans in the plan sponsors financial statements. Changes in the funding status will be reported in
comprehensive income. Additional footnote disclosures about certain effects on net periodic
benefit costs for the next fiscal year that arise from delayed recognition of gains or losses on
plan assets, prior service costs and transition assets or obligations are also required. We
adopted these provisions of SFAS 158 on December 15, 2006. SFAS 158 also requires the measurement
of plan assets and obligations as of the date of the plan sponsors fiscal year end. This
provision of SFAS 158 is effective for fiscal years ending after December 15, 2008. We do not
anticipate a material impact on our results of operations or financial position from the adoption
of this provision of SFAS 158.
In February 2007, the Financial Accounting Standards Board issued Statement of Financial
Accounting Standards No. 159 The Fair Value Option for Financial Assets and Financial
Liabilities, or SFAS 159, which is effective for financial statements beginning after November 15,
2007, with early adoption permitted. The statement permits entities to choose to measure many
financial instruments and certain other items at fair value. The unrealized gains and losses on
items for which the fair value option has been elected would be reported in earnings.
13
Unless the context requires otherwise, references in these
consolidated financial statements and
accompanying notes of
Triad Hospitals, Inc. to we, our,
us and the Company refer to Triad
Hospitals, Inc. and its consolidated subsidiaries.
TRIAD HOSPITALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
NOTE 13RECENT ACCOUNTING PRONOUNCEMENTS (continued)
The objective of SFAS 159 is to improve financial reporting by providing entities with the
opportunity to mitigate volatility in reported earnings caused by measuring related assets and
liabilities differently without having to apply complex hedge accounting provisions. We have not
evaluated all of the provisions of SFAS 159, but we do not anticipate a material impact on our
results of operations or financial position from the adoption of SFAS 159.
NOTE
14SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION
On July 25, 2007, the Company was acquired by Community Health Systems, Inc. (CHS). In
connection with this transaction, a wholly owned subsidiary of CHS issued 8.875% Senior Notes
maturing in 2015 (the Notes). Along with other subsidiaries of CHS, Triad and certain of its direct and
indirect 100% owned subsidiaries have fully and unconditionally guaranteed those Notes. The guarantees are
also joint and several. The
following condensed consolidating financial statements present the subsidiary guarantors,
subsidiary non-guarantors, eliminations and consolidated Triad as defined in the terms of the
Notes.
14
TRIAD HOSPITALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
14.
SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION
(CONTINUED)
Triad Hospitals, Inc.
Condensed Consolidating Balance Sheet
June 30, 2007
(Amounts in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Guarantor |
|
|
|
|
|
|
|
|
|
Subsidiaries |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
4.4 |
|
|
$ |
58.8 |
|
|
$ |
|
|
|
$ |
63.2 |
|
Accounts
receivable, less allowance for doubtful accounts |
|
|
523.9 |
|
|
|
455.5 |
|
|
|
|
|
|
|
979.4 |
|
Inventories |
|
|
74.1 |
|
|
|
78.6 |
|
|
|
|
|
|
|
152.7 |
|
Deferred income taxes |
|
|
41.6 |
|
|
|
|
|
|
|
|
|
|
|
41.6 |
|
Prepaid expenses |
|
|
14.7 |
|
|
|
34.2 |
|
|
|
|
|
|
|
48.9 |
|
Other |
|
|
42.1 |
|
|
|
59.4 |
|
|
|
(0.6 |
) |
|
|
100.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
700.8 |
|
|
|
686.5 |
|
|
|
(0.6 |
) |
|
|
1,386.7 |
|
Property and
equipment, at cost |
|
|
2,263.7 |
|
|
|
2,246.4 |
|
|
|
|
|
|
|
4,510.1 |
|
Accumulated depreciation |
|
|
(772.8 |
) |
|
|
(568.3 |
) |
|
|
|
|
|
|
(1,341.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,490.9 |
|
|
|
1,678.1 |
|
|
|
|
|
|
|
3,169.0 |
|
Investment in subsidiaries |
|
|
3,144.8 |
|
|
|
|
|
|
|
(3,144.8 |
) |
|
|
|
|
Goodwill |
|
|
1,028.3 |
|
|
|
337.5 |
|
|
|
|
|
|
|
1,365.8 |
|
Intangible
assets, net of accumulated amortization |
|
|
60.9 |
|
|
|
16.3 |
|
|
|
|
|
|
|
77.2 |
|
Due from affiliates |
|
|
|
|
|
|
735.2 |
|
|
|
(735.2 |
) |
|
|
|
|
Investments
in and advances to unconsolidated affiliates |
|
|
256.5 |
|
|
|
3.7 |
|
|
|
|
|
|
|
260.2 |
|
Other assets |
|
|
103.2 |
|
|
|
221.1 |
|
|
|
(204.0 |
) |
|
|
120.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
6,785.4 |
|
|
$ |
3,678.4 |
|
|
$ |
(4,084.6 |
) |
|
$ |
6,379.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
99.1 |
|
|
$ |
146.0 |
|
|
$ |
|
|
|
$ |
245.1 |
|
Accrued salaries |
|
|
66.0 |
|
|
|
79.7 |
|
|
|
|
|
|
|
145.7 |
|
Current portion of long term debt |
|
|
25.8 |
|
|
|
1.7 |
|
|
|
(0.6 |
) |
|
|
26.9 |
|
Current income taxes payable |
|
|
39.5 |
|
|
|
|
|
|
|
|
|
|
|
39.5 |
|
Other current liabilities |
|
|
78.1 |
|
|
|
123.9 |
|
|
|
|
|
|
|
202.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
308.5 |
|
|
|
351.3 |
|
|
|
(0.6 |
) |
|
|
659.2 |
|
Due to affiliates |
|
|
735.2 |
|
|
|
|
|
|
|
(735.2 |
) |
|
|
|
|
Long-term debt |
|
|
1,857.0 |
|
|
|
17.6 |
|
|
|
(204.0 |
) |
|
|
1,670.6 |
|
Deferred
income taxes |
|
|
172.2 |
|
|
|
|
|
|
|
|
|
|
|
172.2 |
|
Other liabilities |
|
|
37.1 |
|
|
|
164.7 |
|
|
|
|
|
|
|
201.8 |
|
Minority interests in equity of consolidated entities |
|
|
339.1 |
|
|
|
|
|
|
|
|
|
|
|
339.1 |
|
Stockholders equity |
|
|
3,336.3 |
|
|
|
3,144.8 |
|
|
|
(3,144.8 |
) |
|
|
3,336.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
liabilities and stockholders equity |
|
$ |
6,785.4 |
|
|
$ |
3,678.4 |
|
|
$ |
(4,084.6 |
) |
|
$ |
6,379.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15
TRIAD HOSPITALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
14.
SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION
(CONTINUED)
Triad Hospitals, Inc.
Condensed Consolidating Balance Sheet
December 31, 2006
(Amounts in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Guarantor |
|
|
|
|
|
|
|
|
|
Subsidiaries |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
4.8 |
|
|
|
203.8 |
|
|
|
|
|
|
$ |
208.6 |
|
Accounts
receivable, less allowance for doubtful accounts |
|
|
521.2 |
|
|
|
396.7 |
|
|
|
|
|
|
|
917.9 |
|
Inventories |
|
|
79.5 |
|
|
|
69.9 |
|
|
|
|
|
|
|
149.4 |
|
Deferred income taxes |
|
|
38.4 |
|
|
|
|
|
|
|
|
|
|
|
38.4 |
|
Prepaid expenses |
|
|
14.7 |
|
|
|
37.4 |
|
|
|
|
|
|
|
52.1 |
|
Other |
|
|
72.7 |
|
|
|
57.4 |
|
|
|
(2.1 |
) |
|
|
128.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
731.3 |
|
|
|
765.2 |
|
|
|
(2.1 |
) |
|
|
1,494.4 |
|
Property and
equipment, at cost |
|
|
2,249.0 |
|
|
|
1,918.9 |
|
|
|
|
|
|
|
4,167.9 |
|
Accumulated depreciation |
|
|
(747.5 |
) |
|
|
(480.2 |
) |
|
|
|
|
|
|
(1,227.7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,501.5 |
|
|
|
1,438.7 |
|
|
|
|
|
|
|
2,940.2 |
|
Investments in subsidiaries |
|
|
2,846.3 |
|
|
|
|
|
|
|
(2,846.3 |
) |
|
|
|
|
Goodwill |
|
|
1,101.1 |
|
|
|
258.6 |
|
|
|
|
|
|
|
1,359.7 |
|
Intangible
assets, net of accumulated amortization |
|
|
58.3 |
|
|
|
22.8 |
|
|
|
|
|
|
|
81.1 |
|
Due from affiliates |
|
|
|
|
|
|
586.9 |
|
|
|
(586.9 |
) |
|
|
|
|
Investments
in and advances to unconsolidated affiliates |
|
|
239.3 |
|
|
|
3.6 |
|
|
|
|
|
|
|
242.9 |
|
Other assets |
|
|
107.5 |
|
|
|
272.2 |
|
|
|
(264.2 |
) |
|
|
115.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
6,585.3 |
|
|
$ |
3,348.0 |
|
|
$ |
(3,699.5 |
) |
|
$ |
6,233.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable |
|
|
110.9 |
|
|
|
138.9 |
|
|
|
|
|
|
|
249.8 |
|
Accrued salaries |
|
|
62.6 |
|
|
|
64.4 |
|
|
|
|
|
|
|
127.0 |
|
Current portion of long term debt |
|
|
19.8 |
|
|
|
3.6 |
|
|
|
(2.1 |
) |
|
|
21.3 |
|
Current income taxes payable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other current liabilities |
|
|
83.5 |
|
|
|
119.9 |
|
|
|
|
|
|
|
203.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
276.8 |
|
|
|
326.8 |
|
|
|
(2.1 |
) |
|
|
601.5 |
|
Due to affiliates |
|
|
586.9 |
|
|
|
|
|
|
|
(586.9 |
) |
|
|
|
|
Long-term debt |
|
|
1,930.6 |
|
|
|
17.7 |
|
|
|
(264.2 |
) |
|
|
1,684.1 |
|
Deferred
income taxes |
|
|
193.5 |
|
|
|
|
|
|
|
|
|
|
|
193.5 |
|
Other liabilities |
|
|
30.3 |
|
|
|
157.2 |
|
|
|
|
|
|
|
187.5 |
|
Minority interests in equity of
consolidated entities |
|
|
340.8 |
|
|
|
|
|
|
|
|
|
|
|
340.8 |
|
Equity |
|
|
3,226.4 |
|
|
|
2,846.3 |
|
|
|
(2,846.3 |
) |
|
|
3,226.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
liabilities and stockholders equity |
|
$ |
6,585.3 |
|
|
$ |
3,348.0 |
|
|
$ |
(3,699.5 |
) |
|
$ |
6,233.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16
TRIAD HOSPITALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
14.
SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION
(CONTINUED)
Triad Hospitals, Inc.
Condensed Consolidating Statement of Income
For the six months ended June 30, 2007
Unaudited
(Amounts in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Guarantor |
|
|
|
|
|
|
|
|
|
Subsidiaries |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Revenues |
|
$ |
1,475.0 |
|
|
$ |
1,500.9 |
|
|
$ |
|
|
|
$ |
2,975.9 |
|
Salaries and benefits, including share-based compensation expense |
|
|
535.8 |
|
|
|
694.8 |
|
|
|
|
|
|
|
1,230.6 |
|
Reimbursable
expenses |
|
|
24.6 |
|
|
|
|
|
|
|
|
|
|
|
24.6 |
|
Supplies |
|
|
240.7 |
|
|
|
265.0 |
|
|
|
|
|
|
|
505.7 |
|
Other operating expenses |
|
|
275.6 |
|
|
|
334.7 |
|
|
|
|
|
|
|
610.3 |
|
Provision for doubtful accounts |
|
|
157.0 |
|
|
|
146.5 |
|
|
|
|
|
|
|
303.5 |
|
Depreciation |
|
|
56.5 |
|
|
|
62.9 |
|
|
|
|
|
|
|
119.4 |
|
Amortization |
|
|
3.0 |
|
|
|
0.9 |
|
|
|
|
|
|
|
3.9 |
|
Interest expense allocated |
|
|
63.6 |
|
|
|
(63.6 |
) |
|
|
|
|
|
|
|
|
Interest
expense, net of capitalized interest |
|
|
53.6 |
|
|
|
0.3 |
|
|
|
|
|
|
|
53.9 |
|
Interest income |
|
|
(1.1 |
) |
|
|
(4.6 |
) |
|
|
|
|
|
|
(5.7 |
) |
ESOP expense |
|
|
7.5 |
|
|
|
|
|
|
|
|
|
|
|
7.5 |
|
Management fees |
|
|
43.6 |
|
|
|
(43.6 |
) |
|
|
|
|
|
|
|
|
Loss on sale of assets |
|
|
0.2 |
|
|
|
0.2 |
|
|
|
|
|
|
|
0.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,460.6 |
|
|
|
1,393.5 |
|
|
|
|
|
|
|
2,854.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing
operations before minority
interests, equity in earnings
and income tax provision
|
|
|
14.4 |
|
|
|
107.4 |
|
|
|
|
|
|
|
121.8 |
|
Minority
interests in earnings of consolidated entities |
|
|
(12.8 |
) |
|
|
|
|
|
|
|
|
|
|
(12.8 |
) |
Equity in
earnings of unconsolidated affiliates |
|
|
130.6 |
|
|
|
0.1 |
|
|
|
(107.1 |
) |
|
|
23.6 |
|
Income from continuing
operations before income tax
provision |
|
|
132.2 |
|
|
|
107.5 |
|
|
|
(107.1 |
) |
|
|
132.6 |
|
Income tax provision |
|
|
(60.7 |
) |
|
|
|
|
|
|
|
|
|
|
(60.7 |
) |
Income from continuing
operations |
|
|
71.5 |
|
|
|
107.5 |
|
|
|
(107.1 |
) |
|
|
71.9 |
|
Loss from discontinued
operations, net of tax |
|
|
|
|
|
|
(0.4 |
) |
|
|
|
|
|
|
(0.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
71.5 |
|
|
$ |
107.1 |
|
|
$ |
(107.1 |
) |
|
$ |
71.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17
TRIAD HOSPITALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
14.
SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION
(CONTINUED)
Triad Hospitals, Inc.
Condensed Consolidating Statement of Income
For the six months ended June 30, 2006
Unaudited
(Amounts in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Guarantor |
|
|
|
|
|
|
|
|
|
Subsidiaries |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Revenues |
|
$ |
1,499.9 |
|
|
$ |
1,247.4 |
|
|
$ |
|
|
|
$ |
2,747.3 |
|
Salaries and
benefits, including share-based compensation expense |
|
|
537.4 |
|
|
|
574.0 |
|
|
|
|
|
|
|
1,111.4 |
|
Reimbursable
expenses |
|
|
26.0 |
|
|
|
|
|
|
|
|
|
|
|
26.0 |
|
Supplies |
|
|
240.6 |
|
|
|
231.1 |
|
|
|
|
|
|
|
471.7 |
|
Other operating expenses |
|
|
248.1 |
|
|
|
277.3 |
|
|
|
|
|
|
|
525.4 |
|
Provision for doubtful accounts |
|
|
142.6 |
|
|
|
106.3 |
|
|
|
|
|
|
|
248.9 |
|
Depreciation |
|
|
59.6 |
|
|
|
49.2 |
|
|
|
|
|
|
|
108.8 |
|
Amortization |
|
|
2.9 |
|
|
|
0.7 |
|
|
|
|
|
|
|
3.6 |
|
Interest expense allocated |
|
|
(10.8 |
) |
|
|
10.8 |
|
|
|
|
|
|
|
|
|
Interest
expense, net of capitalized interest |
|
|
60.1 |
|
|
|
(2.5 |
) |
|
|
|
|
|
|
57.6 |
|
Interest income |
|
|
(1.0 |
) |
|
|
(9.2 |
) |
|
|
|
|
|
|
(10.2 |
) |
ESOP expense |
|
|
6.1 |
|
|
|
|
|
|
|
|
|
|
|
6.1 |
|
Management fees |
|
|
45.2 |
|
|
|
(45.2 |
) |
|
|
|
|
|
|
|
|
Gain sale of assets |
|
|
(0.1 |
) |
|
|
(0.5 |
) |
|
|
|
|
|
|
(0.6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,356.7 |
|
|
|
1,192.0 |
|
|
|
|
|
|
|
2,548.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing
operations before minority
interests, equity in earnings
and income tax provision
|
|
|
143.2 |
|
|
|
55.4 |
|
|
|
|
|
|
|
198.6 |
|
Minority
interests in earnings of consolidated entities |
|
|
(10.0 |
) |
|
|
|
|
|
|
|
|
|
|
(10.0 |
) |
Equity in
earnings of unconsolidated affiliates |
|
|
90.5 |
|
|
|
0.3 |
|
|
|
(71.0 |
) |
|
|
19.8 |
|
Income from continuing
operations before income tax
provision |
|
|
223.7 |
|
|
|
55.7 |
|
|
|
(71.0 |
) |
|
|
208.4 |
|
Income tax provision |
|
|
(80.5 |
) |
|
|
|
|
|
|
|
|
|
|
(80.5 |
) |
Income from continuing
operations |
|
|
143.2 |
|
|
|
55.7 |
|
|
|
(71.0 |
) |
|
|
127.9 |
|
Income from discontinued
operations, net of tax |
|
|
|
|
|
|
15.3 |
|
|
|
|
|
|
|
15.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
143.2 |
|
|
$ |
71.0 |
|
|
$ |
(71.0 |
) |
|
$ |
143.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18
TRIAD HOSPITALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
14.
SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION
(CONTINUED)
Triad Hospitals, Inc.
Condensed Consolidating Statement of Cash Flow
For the six months ended June 30, 2007
(Amounts in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Guarantor |
|
|
|
|
|
|
|
|
|
Subsidiaries |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Cash flows from operating activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
71.5 |
|
|
$ |
107.1 |
|
|
$ |
(107.1 |
) |
|
$ |
71.5 |
|
Adjustments to reconcile net income to net cash
provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss for discontinued operations, net of
tax |
|
|
|
|
|
|
0.4 |
|
|
|
|
|
|
|
0.4 |
|
Provision for doubtful accounts |
|
|
157.0 |
|
|
|
146.5 |
|
|
|
|
|
|
|
303.5 |
|
Depreciation and amortization |
|
|
59.5 |
|
|
|
63.8 |
|
|
|
|
|
|
|
123.3 |
|
ESOP expense |
|
|
7.5 |
|
|
|
|
|
|
|
|
|
|
|
7.5 |
|
Minority interests |
|
|
12.8 |
|
|
|
|
|
|
|
|
|
|
|
12.8 |
|
Equity in
earnings of unconsolidated affiliates |
|
|
(130.6 |
) |
|
|
(0.1 |
) |
|
|
107.1 |
|
|
|
(23.6 |
) |
Loss on sale of assets |
|
|
0.2 |
|
|
|
0.2 |
|
|
|
|
|
|
|
0.4 |
|
Deferred income taxes benefit |
|
|
(10.4 |
) |
|
|
|
|
|
|
|
|
|
|
(10.4 |
) |
Non-cash interest expense |
|
|
1.7 |
|
|
|
|
|
|
|
|
|
|
|
1.7 |
|
Non-cash
share based compensation |
|
|
16.0 |
|
|
|
|
|
|
|
|
|
|
|
16.0 |
|
Excess tax benefits on share-based compensation |
|
|
(1.5 |
) |
|
|
|
|
|
|
|
|
|
|
(1.5 |
) |
Increase (decrease) in cash from operating assets
and liabilities (net of acquisitions) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
(159.7 |
) |
|
|
(205.3 |
) |
|
|
|
|
|
|
(365.0 |
) |
Inventories and other assets |
|
|
21.7 |
|
|
|
(2.2 |
) |
|
|
|
|
|
|
19.5 |
|
Accounts payable and other current liabilities |
|
|
45.2 |
|
|
|
6.7 |
|
|
|
|
|
|
|
51.9 |
|
Other |
|
|
0.4 |
|
|
|
7.4 |
|
|
|
|
|
|
|
7.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) operating activities |
|
|
91.3 |
|
|
|
124.5 |
|
|
|
|
|
|
|
215.8 |
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of property and equipment |
|
|
(50.1 |
) |
|
|
(300.0 |
) |
|
|
|
|
|
|
(350.1 |
) |
Distributions
and advances from unconsolidated affiliates |
|
|
6.3 |
|
|
|
|
|
|
|
|
|
|
|
6.3 |
|
Investment in and advances to consolidated affiliates |
|
|
(212.1 |
) |
|
|
212.1 |
|
|
|
|
|
|
|
|
|
Proceeds
received on disposals of assets |
|
|
0.9 |
|
|
|
1.3 |
|
|
|
|
|
|
|
2.2 |
|
Acquisitions, net of cash acquired |
|
|
(3.4 |
) |
|
|
(30.0 |
) |
|
|
|
|
|
|
(33.4 |
) |
Other |
|
|
63.8 |
|
|
|
(63.8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities |
|
|
(194.6 |
) |
|
|
(180.4 |
) |
|
|
|
|
|
|
(375.0 |
) |
Cash flows from financing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments of long-term debt |
|
|
(67.5 |
) |
|
|
59.7 |
|
|
|
|
|
|
|
(7.8 |
) |
Proceeds from issuance of common stock |
|
|
16.5 |
|
|
|
|
|
|
|
|
|
|
|
16.5 |
|
Excess tax benefits on share-based compensation |
|
|
1.5 |
|
|
|
|
|
|
|
|
|
|
|
1.5 |
|
Contributions
from minority partners, net of distributions |
|
|
|
|
|
|
6.8 |
|
|
|
|
|
|
|
6.8 |
|
Increase (decrease) in due to (from) affiliate |
|
|
155.6 |
|
|
|
(155.6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities |
|
|
102.9 |
|
|
|
(89.1 |
) |
|
|
|
|
|
|
13.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents |
|
|
(0.4 |
) |
|
|
(145.0 |
) |
|
|
|
|
|
|
(145.4 |
) |
Cash and cash equivalents at beginning of period |
|
|
4.8 |
|
|
|
203.8 |
|
|
|
|
|
|
|
208.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
4.4 |
|
|
$ |
58.8 |
|
|
$ |
|
|
|
$ |
63.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19
TRIAD HOSPITALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
14.
SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION
(CONTINUED)
Triad Hospitals
Condensed Consolidating Statement of Cash Flow
For the six-months ended June 30, 2006
(Amounts in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Guarantor |
|
|
|
|
|
|
|
|
|
Subsidiaries |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Cash flows from operating activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
143.2 |
|
|
$ |
71.0 |
|
|
$ |
(71.0 |
) |
|
$ |
143.2 |
|
Adjustments to reconcile net income to net cash
provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income for discontinued operations, net of
tax |
|
|
|
|
|
|
(15.3 |
) |
|
|
|
|
|
|
(15.3 |
) |
Provision for doubtful accounts |
|
|
142.6 |
|
|
|
106.3 |
|
|
|
|
|
|
|
248.9 |
|
Depreciation and amortization |
|
|
62.5 |
|
|
|
49.9 |
|
|
|
|
|
|
|
112.4 |
|
ESOP expense |
|
|
6.1 |
|
|
|
|
|
|
|
|
|
|
|
6.1 |
|
Minority interests |
|
|
10.0 |
|
|
|
|
|
|
|
|
|
|
|
10.0 |
|
Equity in
earnings of unconsolidated affiliates |
|
|
(90.5 |
) |
|
|
(0.3 |
) |
|
|
71.0 |
|
|
|
(19.8 |
) |
Gain on sale of assets |
|
|
(0.1 |
) |
|
|
(0.5 |
) |
|
|
|
|
|
|
(0.6 |
) |
Deferred income taxes benefit |
|
|
(11.7 |
) |
|
|
|
|
|
|
|
|
|
|
(11.7 |
) |
Non-cash interest expense |
|
|
1.6 |
|
|
|
|
|
|
|
|
|
|
|
1.6 |
|
Non-cash
share based compensation |
|
|
13.7 |
|
|
|
|
|
|
|
|
|
|
|
13.7 |
|
Excess tax benefits on share-based compensation |
|
|
(1.2 |
) |
|
|
|
|
|
|
|
|
|
|
(1.2 |
) |
Increase (decrease) in cash from operating assets
and liabilities (net of acquisitions) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
(184.7 |
) |
|
|
(137.0 |
) |
|
|
|
|
|
|
(321.7 |
) |
Inventories and other assets |
|
|
(1.5 |
) |
|
|
(21.0 |
) |
|
|
|
|
|
|
(22.5 |
) |
Accounts payable and other current liabilities |
|
|
(39.1 |
) |
|
|
7.2 |
|
|
|
|
|
|
|
(31.9 |
) |
Other |
|
|
(1.0 |
) |
|
|
22.7 |
|
|
|
|
|
|
|
21.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
49.9 |
|
|
|
83.0 |
|
|
|
|
|
|
|
132.9 |
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of property and equipment |
|
|
(56.4 |
) |
|
|
(177.0 |
) |
|
|
|
|
|
|
(233.4 |
) |
Distributions
and advances from unconsolidated affiliates |
|
|
(9.9 |
) |
|
|
0.3 |
|
|
|
|
|
|
|
(9.6 |
) |
Investment in and advances to consolidated affiliates |
|
|
(243.1 |
) |
|
|
243.1 |
|
|
|
|
|
|
|
|
|
Proceeds
received on disposals of assets |
|
|
1.1 |
|
|
|
101.5 |
|
|
|
|
|
|
|
102.6 |
|
Acquisitions, net of cash acquired |
|
|
|
|
|
|
(49.2 |
) |
|
|
|
|
|
|
(49.2 |
) |
Other |
|
|
0.7 |
|
|
|
(0.8 |
) |
|
|
|
|
|
|
(0.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities |
|
|
(307.6 |
) |
|
|
117.9 |
|
|
|
|
|
|
|
(189.7 |
) |
Cash flows from financing activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments of long-term debt |
|
|
118.3 |
|
|
|
(119.3 |
) |
|
|
|
|
|
|
(1.0 |
) |
Proceeds from long-term debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock |
|
|
21.9 |
|
|
|
|
|
|
|
|
|
|
|
21.9 |
|
Excess tax benefits on share-based compensation |
|
|
1.2 |
|
|
|
|
|
|
|
|
|
|
|
2 |
|
Contributions
from minority partners, net of distributions |
|
|
|
|
|
|
0.5 |
|
|
|
|
|
|
|
0.5 |
|
Net borrowings to (from) affiliate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in due to (from) affiliate |
|
|
111.5 |
|
|
|
(111.5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities |
|
|
252.9 |
|
|
|
(230.3 |
) |
|
|
|
|
|
|
22.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents |
|
|
(4.8 |
) |
|
|
(29.4 |
) |
|
|
|
|
|
|
(34.2 |
) |
Cash and cash equivalents at beginning of period |
|
|
6.4 |
|
|
|
303.8 |
|
|
|
|
|
|
|
310.2 |
|
Cash and cash equivalents at end of period |
|
$ |
1.6 |
|
|
$ |
274.4 |
|
|
$ |
|
|
|
$ |
276.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20